[
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:service-provider-trapi:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:automat-robokop:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:service-provider-trapi:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:molepro:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:rtx-kg2:CHEBI:5102--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:automat-drug-central:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:rtx-kg2:CHEBI:5102--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:molepro:CHEBI:50885--biolink:treats--None--None--None--MONDO:0015129--infores:ctd",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:ctd",
    "publications": "PMID:9816363",
    "publications_count": 1,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:molepro:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:spoke:CHEBI:5102--biolink:treats--None--None--None--MONDO:0015129--infores:spoke",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 1,
    "edge_id": "infores:molepro:CHEBI:50885--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 2,
    "edge_id": "medik:creative_edge#6",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 2,
    "edge_id": "medik:edge#6",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9328191;PMC:9303581;PMC:8999997;PMC:5843003",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#6",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "87e53ca9a5b816dbf73ac67f92061cd3",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "39d128f5c2d8",
    "edge_object": "MONDO:0011826",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "glucocorticoid deficiency 2",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats glucocorticoid deficiency 2",
    "primary_source": "infores:gtrx",
    "publications": "PMID:19500760;PMID:17893271;PMID:16868047",
    "publications_count": 3,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "f802af878dc1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0011826",
    "edge_subjectNode_name": "glucocorticoid deficiency 2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "glucocorticoid deficiency 2 subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0011826-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0011826",
    "edge_subjectNode_name": "glucocorticoid deficiency 2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "glucocorticoid deficiency 2 subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "a27a802cad53566cf0037742b636e88f",
    "edge_object": "MONDO:0011826",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "glucocorticoid deficiency 2",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats glucocorticoid deficiency 2",
    "primary_source": "infores:gtrx",
    "publications": "PMID:19500760;PMID:17893271;PMID:16868047",
    "publications_count": 3,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "7075956bfb12",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "ea7d31263cb8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008725-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "acfe075c7bcff2d83c16b5da55f11ee4",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "ef5185d80cbe",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "f0848c2d573e",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008727-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "82b5f11c842d521977a50051eec10fbc",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "a9caaf193e70",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008728",
    "edge_subjectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "374f40c4a4e1",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32190901;PMID:31217034;PMID:25237318;PMID:16912133;PMID:17042033;PMID:17033937",
    "publications_count": 6,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008728-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008728",
    "edge_subjectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "025088bbcd0749a8d04b1d2da5f9b8f1",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32190901;PMID:31217034;PMID:25237318;PMID:16912133;PMID:17042033;PMID:17033937",
    "publications_count": 6,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "36b0b28051a9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "03fc2d5d2c42",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008729-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "f952be994982e0066620a291055cfa2b",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "879e1b431154",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support6-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "e06dca1ad2ad9f65adae104f2212261c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support6-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "087cf9355d38f0e348e32378b9029530",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "54923e56b4c4b081e5af2ba439c87cd9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "inferred-CHEBI:5781-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "2283b98f3a07b3407a5a465d26faf846",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "cortisol sodium phosphate in clinical trials for Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5781-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "CHEBI:5781-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "cortisol sodium phosphate in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5781-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "91b2edab947b9fe620fc84cbfeee6a3e",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5781-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "CHEBI:5781-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5781-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "d1f8ed66a9002f7af9024ba33ac1d56c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:26184416;PMID:216821;PMID:186258;PMID:741991;PMID:72291;PMID:168433;PMID:233701;PMID:27813051;PMID:2557986;PMID:3015556;PMID:6090183;PMID:6273020;PMID:4819287;PMID:10323386;PMID:13481096;PMID:22893258;PMID:22907517;PMID:25781534;PMID:27535620;PMID:20925018;PMID:17609409;PMID:19273569;PMID:3039766;PMID:8013139;PMID:24466047;PMID:24944332;PMID:25400085;PMID:30108094;PMID:26684152;PMID:16580396;PMID:24517155;PMID:31059146;PMID:31611225;PMID:31744021;PMID:32481456;PMID:33236103;PMID:33346052;PMID:36994228;PMID:37855644",
    "publications_count": 39,
    "support_graph_id": "inferred-CHEBI:5781-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "8eee39fd290af3343ff4bc99be6920f7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4578041",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:5781-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:creative_edge#41",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#41",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9126190;PMC:3005832;PMC:9219603;PMC:3948337;PMC:6166869",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#41",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:creative_edge#58",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#58",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4578041",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#58",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:creative_edge#64",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#64",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2866132",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#64",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:creative_edge#205",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#327",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:ctd",
    "publications": "PMID:16682841",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#205",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#336",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#337",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "medik:edge#346",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:biothings-multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "5380571",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "d50dc8159b8c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "8e9470a173ed",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "831708096b78",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "6efe2e83e46a",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "d77738d1",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "d77738d1",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "06a4388d8fbe",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "9945358d8cad",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_14_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_14_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "059d6c66350f",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "9945358d8cad",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_27_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_27_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "57c641f106dc",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "87e53ca9a5b816dbf73ac67f92061cd3",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "39d128f5c2d8",
    "edge_object": "MONDO:0011826",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "glucocorticoid deficiency 2",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats glucocorticoid deficiency 2",
    "primary_source": "infores:gtrx",
    "publications": "PMID:19500760;PMID:17893271;PMID:16868047",
    "publications_count": 3,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "f802af878dc1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0011826",
    "edge_subjectNode_name": "glucocorticoid deficiency 2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "glucocorticoid deficiency 2 subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0011826-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0011826",
    "edge_subjectNode_name": "glucocorticoid deficiency 2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "glucocorticoid deficiency 2 subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "a27a802cad53566cf0037742b636e88f",
    "edge_object": "MONDO:0011826",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "glucocorticoid deficiency 2",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats glucocorticoid deficiency 2",
    "primary_source": "infores:gtrx",
    "publications": "PMID:19500760;PMID:17893271;PMID:16868047",
    "publications_count": 3,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "7075956bfb12",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "ea7d31263cb8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008725-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "acfe075c7bcff2d83c16b5da55f11ee4",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "ef5185d80cbe",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "f0848c2d573e",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support2-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008727-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "82b5f11c842d521977a50051eec10fbc",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "a9caaf193e70",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008728",
    "edge_subjectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "374f40c4a4e1",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32190901;PMID:31217034;PMID:25237318;PMID:16912133;PMID:17042033;PMID:17033937",
    "publications_count": 6,
    "support_graph_id": "support3-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008728-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008728",
    "edge_subjectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "025088bbcd0749a8d04b1d2da5f9b8f1",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32190901;PMID:31217034;PMID:25237318;PMID:16912133;PMID:17042033;PMID:17033937",
    "publications_count": 6,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "36b0b28051a9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "03fc2d5d2c42",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support4-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "expanded-MONDO:0008729-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "f952be994982e0066620a291055cfa2b",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "879e1b431154",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support5-CHEBI:5781-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "4aa427c3ee56",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 3,
    "edge_id": "9eecdf03a11a",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "64bb35714b97690f2edde0081067a09c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "5dcd2b5ea319e26dede7e4f99bc8a187",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "e499be13e9c2",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "inferred-CHEBI:3897-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "CHEBI:3897-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Cortisone acetate in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3897-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "424094ed6aa66f7f723e340a580b7314",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3897-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "CHEBI:3897-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3897-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "ed40f0ee305376a20dda98e6574fdd28",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:27813051;PMID:3763570;PMID:2360419;PMID:6858574;PMID:7380234;PMID:13411674;PMID:13143072;PMID:13293600;PMID:13305188;PMID:13995368;PMID:13040636;PMID:14779134;PMID:14901041;PMID:14914813;PMID:22439046;PMID:35947694",
    "publications_count": 16,
    "support_graph_id": "inferred-CHEBI:3897-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "801b5425e2c0fda14fe89fb7fab68284",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6360643;PMC:6372518;PMC:7983484;PMC:7671249",
    "publications_count": 4,
    "support_graph_id": "inferred-CHEBI:3897-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:creative_edge#38",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:edge#38",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6360643;PMC:6372518;PMC:7983484;PMC:7671249",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#38",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:creative_edge#42",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:edge#42",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9294871;PMC:4635904;PMC:4815489",
    "publications_count": 3,
    "support_graph_id": "medik:auxiliary_graph#42",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:creative_edge#63",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:edge#63",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6360643",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#63",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:creative_edge#78",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:edge#78",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9294871",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#78",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:edge#340",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "medik:edge#341",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "5381899",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "8c24f0da30bb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "a5796ef2552e",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "a1f1c6d95083",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_26_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_26_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "c3ee02c24caf",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "a1f1c6d95083",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_17_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_17_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "7c97fcad3621",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "68e647120020",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "46b32154",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "46b32154",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "7831f711c1ea",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "11c1bbb5",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "2b7182e2f3bd",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "11c1bbb5",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "e27f5fac203d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "efab1ad8d282",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "5dcd2b5ea319e26dede7e4f99bc8a187",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "e499be13e9c2",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3897-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 4,
    "edge_id": "031b541fe935",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "expanded-MONDO:0008725-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "a106e026ceeda652334dcb14c858137d",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "0cf51e2fb789",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "ea7d31263cb8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "expanded-MONDO:0008727-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "df0d5c40788e3397ecd0e1471bfc72d5",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "ef5185d80cbe",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "f58f26e45c63",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "expanded-MONDO:0008729-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "8d73d5f60f3addb930e9c7cb59fa3f40",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "2688335761e7",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "36b0b28051a9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "0298bebb6d3bfcee8190e663773d1629",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "inferred-CHEBI:5102-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "477ac1dd15e9f07c27beccad8071733e",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5102-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "4cdb1b55d86d8fb8f8d011eb85ef37c2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:17386249;PMID:22907517;PMID:22439046;PMID:19858318;PMID:23543658;PMID:16580396;PMID:31059146;PMID:31611225;PMID:31744021;PMID:31994621;PMID:33155789",
    "publications_count": 11,
    "support_graph_id": "inferred-CHEBI:5102-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "CHEBI:5102-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5102-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "54e83e4ede1bb18b23c0deb642f6fe5f",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3805018;PMC:5425479;PMC:8444815;PMC:5606946;PMC:5721876",
    "publications_count": 5,
    "support_graph_id": "inferred-CHEBI:5102-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "medik:creative_edge#11",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "medik:edge#11",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3805018;PMC:5425479;PMC:8444815;PMC:5606946;PMC:5721876",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#11",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "medik:creative_edge#206",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "medik:edge#328",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat Addison Disease",
    "primary_source": "infores:ctd",
    "publications": "PMID:9816363",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#206",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "medik:edge#338",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "5381551",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "d06cf74e9111",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "510a907279c3",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "defdf8565b38",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "6a7e49410888",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "e4f3ca4467d4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:ctd",
    "publications": "PMID:9816363",
    "publications_count": 1,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "d79b78468051",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "expanded-MONDO:0008725-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "a106e026ceeda652334dcb14c858137d",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "0cf51e2fb789",
    "edge_object": "MONDO:0008725",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital lipoid adrenal hyperplasia due to STAR deficency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:32252217;PMID:16449336;PMID:10700722;PMID:9077535;PMID:8948562",
    "publications_count": 5,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "ea7d31263cb8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008725",
    "edge_subjectNode_name": "congenital lipoid adrenal hyperplasia due to STAR deficency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital lipoid adrenal hyperplasia due to STAR deficency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "expanded-MONDO:0008727-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "df0d5c40788e3397ecd0e1471bfc72d5",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "ef5185d80cbe",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008727",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "f58f26e45c63",
    "edge_object": "MONDO:0008727",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:30719691;PMID:29420188",
    "publications_count": 2,
    "support_graph_id": "support1-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "expanded-MONDO:0008729-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "8d73d5f60f3addb930e9c7cb59fa3f40",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "2688335761e7",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 5,
    "edge_id": "36b0b28051a9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support2-CHEBI:5102-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "a8d214dad35eae91c4d4e7168f24101b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "86e4e286f2510bdcf618d0aa435b775b",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "768f2a232018",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "inferred-CHEBI:8378-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "33af76d10cf1a86c591b350fcad59793",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisolone studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8378-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "CHEBI:8378-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisolone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8378-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "07027207db5aecdebdee322c2e758635",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisolone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6510007;PMC:5270276;PMC:8604755",
    "publications_count": 3,
    "support_graph_id": "inferred-CHEBI:8378-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "medik:creative_edge#49",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "medik:edge#49",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisolone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6510007;PMC:5270276;PMC:8604755",
    "publications_count": 3,
    "support_graph_id": "medik:auxiliary_graph#49",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "medik:edge#332",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "medik:edge#333",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "5381922",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "e106c9433237",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "9b99225de8e0",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "e7eeb79681e1",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_13_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_13_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "d181de8f7c93",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "7e833f8b",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "c02fd36215e3",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "7e833f8b",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "d2f9bd3918c4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "0701bbaa",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "8bfbc5edf72c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "0701bbaa",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "6627328802f8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "64b5ca32990d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "e7eeb79681e1",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_22_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_22_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "ec3ca966d4ca",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "c35ac2d41691",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "86e4e286f2510bdcf618d0aa435b775b",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "768f2a232018",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:8378-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "1182ec9d35c8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "6d619d02c41e",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "4163c78c",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 6,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "4163c78c",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "9feefcfe2816470a13fee9ac0028ee1d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "inferred-CHEBI:8382-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "CHEBI:8382-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Prednisone in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8382-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "834c7cba5a554c82dbad45e916397e93",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisone studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8382-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "CHEBI:8382-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8382-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "11cb7ab405397dd49ae4f7649fdec63a",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6454300;PMC:4369965;PMC:8039310;PMC:7388315;PMC:7703713",
    "publications_count": 5,
    "support_graph_id": "inferred-CHEBI:8382-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "medik:creative_edge#12",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "medik:edge#12",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6454300;PMC:4369965;PMC:8039310;PMC:7388315;PMC:7703713",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#12",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "medik:edge#331",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "medik:edge#344",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:biothings-multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "5378990",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "8215f5146ff2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "af611671620c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "386750e3",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "386750e3",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "3372280c3081",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "3bd69a2e38b1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 7,
    "edge_id": "95ab050b6ac7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "familial glucocorticoid deficiency",
    "result_objectNode_id": "MONDO:0008733",
    "result_counter": 8,
    "edge_id": "medik:creative_edge#37",
    "edge_object": "MONDO:0008733",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "familial glucocorticoid deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats familial glucocorticoid deficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "familial glucocorticoid deficiency",
    "result_objectNode_id": "MONDO:0008733",
    "result_counter": 8,
    "edge_id": "medik:edge#37",
    "edge_object": "MONDO:0008733",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "familial glucocorticoid deficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat familial glucocorticoid deficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8477115;PMC:3369203;PMC:2752790;PMC:3603085;PMC:9131826",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#37",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "inferred-CHEBI:28689-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prasterone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "abe11b02abdce0757cb57b333f22814b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Prasterone in clinical trials for Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:28689-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "a39a2ac41787f658b7ef3bac54a28232",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:applied_to_treat",
    "phrase": "Prasterone applied to treat Addison Disease",
    "primary_source": "infores:idisk",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:28689-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "8dc43608630e28a4b8fd303f787567f5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prasterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3845685;PMC:3706977;PMC:2725024;PMC:2725024;PMC:9207529",
    "publications_count": 5,
    "support_graph_id": "inferred-CHEBI:28689-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "infores:rtx-kg2:CHEBI:28689--biolink:in_clinical_trials_for--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prasterone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "medik:creative_edge#10",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prasterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "medik:edge#10",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prasterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3845685;PMC:3706977;PMC:2725024;PMC:9207529",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#10",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "i_6934793",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prasterone treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 9,
    "edge_id": "6934793",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Prasterone in clinical trials for Addison Disease",
    "primary_source": "infores:chembl",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_6934793",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "76584a03a18fe29eaddca97896f906ee",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "91552058b15a239b194db8aa96e24639",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "2b0c4940894a6c82bc2a2ec6b5889a46",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "bcac96c88901",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "inferred-CHEBI:3077-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "e9efca0ced0b5fad2000505b9f747df7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Betamethasone in clinical trials for Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3077-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "43a1fc38223333ff815840313fce906f",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Betamethasone studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3077-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "CHEBI:3077-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Betamethasone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3077-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "medik:edge#342",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "medik:edge#343",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "medik:edge#345",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:biothings-multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "5383536",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "f1500cf1a42d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "41bab05759fe",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_16_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_16_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "03784fa7b76b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "e97b484293af",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "5a06c138b9d7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "41bab05759fe",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_24_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_24_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "9d1a1a6e5ead",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "2b0c4940894a6c82bc2a2ec6b5889a46",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "bcac96c88901",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:3077-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "be415a646bd5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "0fc07b467b0c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "442989e0c553",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "c48b04f5963f",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "770decff",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 10,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "770decff",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "b67389f958e155e150d793f08b84ad4f",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "a83675e6a3d3ed029483390565a3223c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "e9c0d637a531",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "inferred-CHEBI:9667-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "f0fa716baf950b667a2384629e35bf58",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Triamcinolone studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:9667-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "CHEBI:9667-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Triamcinolone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:9667-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:creative_edge#69",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:edge#69",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Triamcinolone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7278611",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#69",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:creative_edge#119",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:edge#155",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:15755863",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#119",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:edge#156",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#119",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:edge#329",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "medik:edge#330",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "5382333",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "98259b28fa61",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "23d5c86544c3",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "e695eb50ab5c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_15_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_15_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "1a59636878bd",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "42b17d0afbbe",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "e8018fd2",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "e8018fd2",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "da5d6af0c1b1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "7d6dd8a15d6f",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_25_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_25_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "57c34a9152a8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "387a442e288c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "b777d3c633cf",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "0a8b791a",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "0a8b791a",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "9a3c9f7966eb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "ac9db24ac5ff",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "a83675e6a3d3ed029483390565a3223c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "e9c0d637a531",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 11,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:9667-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "CHEBI:4462-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "expanded-MONDO:0008729-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0008729",
    "edge_subjectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:4462-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "e543eb4fac507a695bac7876e4916400",
    "edge_object": "MONDO:0008729",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
    "primary_source": "infores:gtrx",
    "publications": "PMID:27928728;PMID:28721898;PMID:28962970;PMID:23345044;PMID:10487675",
    "publications_count": 5,
    "support_graph_id": "support0-CHEBI:4462-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "0c44520882e21452ca6eee5c54452efb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "inferred-CHEBI:4462-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "CHEBI:4462-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "dexamethasone sodium phosphate in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:4462-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "a623533e35851b0c8b8b9deadf5db8e1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "dexamethasone sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:4462-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "CHEBI:4462-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "dexamethasone sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:4462-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "bfc176e7d701f0af06ccc26fc1219955",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "dexamethasone sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7724117;PMC:5410876;PMC:4588454;PMC:5682420;PMC:4271742",
    "publications_count": 5,
    "support_graph_id": "inferred-CHEBI:4462-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "medik:creative_edge#39",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "medik:edge#39",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "dexamethasone sodium phosphate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7724117;PMC:5410876;PMC:4588454;PMC:5682420;PMC:4271742",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#39",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "medik:edge#339",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 12,
    "edge_id": "6927215",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:molepro:CHEBI:17650--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:rtx-kg2:CHEBI:5781--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:molepro:CHEBI:17650--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:automat-robokop:CHEBI:5783--biolink:treats--None--None--None--MONDO:0015129--infores:drugmechdb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:service-provider-trapi:CHEBI:5781--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:rtx-kg2:CHEBI:5781--biolink:treats--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:automat-robokop:CHEBI:5783--biolink:treats--None--None--None--MONDO:0015129--infores:automat-robokop",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:molepro:CHEBI:31677--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:rtx-kg2:CHEBI:5781--biolink:in_clinical_trials_for--None--None--None--MONDO:0018479--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:automat-drug-central:CHEBI:17650--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:automat-robokop:CHEBI:5783--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:rtx-kg2:CHEBI:5781--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:multiomics-clinicaltrials:CHEBI:17650--biolink:treats--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:rtx-kg2:CHEBI:5781--biolink:in_clinical_trials_for--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:automat-drug-central:CHEBI:31677--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:rtx-kg2:CHEBI:5781--biolink:treats--None--None--None--MONDO:0018479--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:service-provider-trapi:CHEBI:5781--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:automat-drug-central:CHEBI:17650--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:multiomics-clinicaltrials:CHEBI:17650--biolink:treats--None--None--None--MONDO:0018479--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 13,
    "edge_id": "infores:molepro:CHEBI:17650--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 14,
    "edge_id": "medik:creative_edge#28",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 14,
    "edge_id": "medik:edge#28",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8505038;PMC:7233741;PMC:9066592;PMC:6565577;PMC:8684478",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "18ea874a39db517fda3aeccd8b251196",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "796fe77c4da0221a812d40df2ebab1cc",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "03f238c382f8",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "inferred-CHEBI:6888-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "053649b3673c42389c143b0ba90cf1a2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Methylprednisolone studied to treat Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6888-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "CHEBI:6888-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Methylprednisolone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6888-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "medik:edge#334",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "medik:edge#335",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "5381873",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "91e6fb3e120b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "a259203e399f",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_12_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_12_e_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "c389baad4a91",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "a259203e399f",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_19_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "6c48ac278460",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:ubergraph",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_e_19_e_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "f84b8a4074cc",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "0a7478ef7092",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "expanded-MONDO:0018479-subclass_of-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "796fe77c4da0221a812d40df2ebab1cc",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "03f238c382f8",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "49f204c91946",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "support0-CHEBI:6888-treats-MONDO:0015129-via_subclass",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "5e5ab07417e8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "697e4f865d7f",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "8059c03e",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "8059c03e",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "aacca3ead239",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "e0152fd3c02d",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "6dd40d70",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "6dd40d70",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "20d25516adc5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 15,
    "edge_id": "e70e743a6246",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "inferred-CHEBI:3901-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "ea2582c0dac2e29a0f373feaca08dee5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Tetracosactide studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7274491;PMC:7274491;PMC:8416901",
    "publications_count": 3,
    "support_graph_id": "inferred-CHEBI:3901-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "CHEBI:3901-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Tetracosactide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3901-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "infores:molepro:CHEBI:3901--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "infores:multiomics-drugapprovals:CHEBI:3901--biolink:treats--None--None--None--MONDO:0015129--infores:multiomics-drugapprovals",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats Addison Disease",
    "primary_source": "infores:multiomics-drugapprovals",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "medik:creative_edge#40",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "medik:edge#40",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Tetracosactide studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7274491;PMC:8416901",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#40",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "inferred_148",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "psev_edge_148",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Tetracosactide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_148",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 16,
    "edge_id": "95ec2054762d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:automat-drug-central:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:rtx-kg2:CHEBI:3897--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:service-provider-trapi:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:service-provider-trapi:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:molepro:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:automat-drug-central:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:automat-robokop:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:drugmechdb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:automat-robokop:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:molepro:CHEBI:3897--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:molepro:CHEBI:16962--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:spoke:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:spoke",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:rtx-kg2:CHEBI:3897--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 17,
    "edge_id": "infores:automat-robokop:CHEBI:3897--biolink:treats--None--None--None--MONDO:0015129--infores:automat-robokop",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 18,
    "edge_id": "medik:creative_edge#31",
    "edge_object": "MONDO:0060783",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortisol sodium phosphate treats classic congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortisol sodium phosphate",
    "result_subjectNode_id": "CHEBI:5781",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 18,
    "edge_id": "medik:edge#31",
    "edge_object": "MONDO:0060783",
    "edge_subject": "CHEBI:5781",
    "edge_subjectNode_name": "cortisol sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortisol sodium phosphate studied to treat classic congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7209435;PMC:7343998;PMC:7096060;PMC:4568140",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#31",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 19,
    "edge_id": "medik:creative_edge#3",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 19,
    "edge_id": "medik:edge#3",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3161212;PMC:6546346;PMC:6345010;PMC:6776599",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#3",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 19,
    "edge_id": "medik:creative_edge#5",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 19,
    "edge_id": "medik:edge#5",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6546346;PMC:6345010;PMC:6776599;PMC:6552856;PMC:7209180",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#5",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 19,
    "edge_id": "medik:creative_edge#32",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Cortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cortisone acetate",
    "result_subjectNode_id": "CHEBI:3897",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 19,
    "edge_id": "medik:edge#32",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3897",
    "edge_subjectNode_name": "Cortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cortisone acetate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8886296;PMC:8663041;PMC:6558150;PMC:2842898;PMC:3894515",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#32",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:service-provider-trapi:CHEBI:4462--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:rtx-kg2:CHEBI:4462--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:molepro:CHEBI:41879--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:molepro:CHEBI:41879--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:molepro:CHEBI:68637--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:rtx-kg2:CHEBI:4462--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:service-provider-trapi:CHEBI:4462--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:spoke:CHEBI:4462--biolink:treats--None--None--None--MONDO:0015129--infores:spoke",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:automat-drug-central:CHEBI:41879--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:automat-robokop:CHEBI:4463--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:molepro:CHEBI:41879--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 20,
    "edge_id": "infores:spoke:CHEBI:41879--biolink:treats--None--None--None--MONDO:0015129--infores:spoke",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:service-provider-trapi:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:rtx-kg2:CHEBI:8378--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:automat-drug-central:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:service-provider-trapi:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:automat-robokop:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:molepro:CHEBI:8378--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:rtx-kg2:CHEBI:8378--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:automat-robokop:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:automat-robokop",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:automat-drug-central:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:molepro:CHEBI:145705--biolink:treats--None--None--None--MONDO:0018479--infores:drug-repurposing-hub",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:molepro:CHEBI:8378--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:automat-robokop:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:drugmechdb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:molepro:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:spoke:CHEBI:8378--biolink:treats--None--None--None--MONDO:0015129--infores:spoke",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 21,
    "edge_id": "infores:molepro:CHEBI:8380--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "inferred-CHEBI:3892-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticotropin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "e86d9034fa2e1a07e816fef91c5f34d7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:216821;PMID:3024866;PMID:3030713;PMID:3004086;PMID:3034555;PMID:2983909;PMID:3019743;PMID:4322461;PMID:6273020;PMID:6097440;PMID:6266250;PMID:6297209;PMID:12739742;PMID:20925018;PMID:2828406;PMID:3039766;PMID:28780517;PMID:16817818;PMID:22587831;PMID:8013141",
    "publications_count": 20,
    "support_graph_id": "inferred-CHEBI:3892-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "CHEBI:3892-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3892-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "68aa705725aacef28bea863b6a492d93",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8861854;PMC:7250207;PMC:7398608",
    "publications_count": 3,
    "support_graph_id": "inferred-CHEBI:3892-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "medik:creative_edge#45",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticotropin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "medik:edge#45",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8861854;PMC:7250207;PMC:7398608",
    "publications_count": 3,
    "support_graph_id": "medik:auxiliary_graph#45",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "medik:creative_edge#208",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticotropin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "medik:edge#348",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:20925018;PMID:216821;PMID:3034555;PMID:4322461;PMID:6273020",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#208",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "inferred_265",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticotropin treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 22,
    "edge_id": "psev_edge_265",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Corticotropin associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_265",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "inferred-CHEBI:16827-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "d3754f19edfb077f9ecf16213b8d99f1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8861854;PMC:8861854",
    "publications_count": 2,
    "support_graph_id": "inferred-CHEBI:16827-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "CHEBI:16827-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16827-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:creative_edge#50",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#50",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8861854",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#50",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:creative_edge#51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8861854",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#51",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:creative_edge#124",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#165",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Corticosterone affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:18650268",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#124",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#166",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#124",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:creative_edge#125",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#167",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Corticosterone affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:21647420",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#125",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#168",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#125",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:creative_edge#224",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 23,
    "edge_id": "medik:edge#364",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:27535620",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#224",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 24,
    "edge_id": "medik:creative_edge#29",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 24,
    "edge_id": "medik:edge#29",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2819226;PMC:6565577;PMC:9066592;PMC:3584273",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#29",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 25,
    "edge_id": "medik:creative_edge#20",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 25,
    "edge_id": "medik:edge#20",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9302862;PMC:8532553;PMC:7711668;PMC:8987274",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:service-provider-trapi:CHEBI:8382--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:treats--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:spoke:CHEBI:8382--biolink:treats--None--None--None--MONDO:0015129--infores:spoke",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:automat-drug-central:CHEBI:8382--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "creative_DTD_prediction_6",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:5243--infores:dgidb",
    "edge_object": "NCBIGene:5243",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "ABCB1",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects ABCB1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:12175731;PMID:25637052",
    "publications_count": 2,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:1493--infores:dgidb",
    "edge_object": "NCBIGene:1493",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "CTLA4",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects CTLA4",
    "primary_source": "infores:dgidb",
    "publications": "PMID:21228734",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:HP:0002902--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002902",
    "edge_subjectNode_name": "Hyponatremia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Hyponatremia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0010264--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0010264",
    "edge_subjectNode_name": "X-linked adrenal hypoplasia congenita",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "X-linked adrenal hypoplasia congenita subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0009279--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0009279",
    "edge_subjectNode_name": "triple-A syndrome",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "triple-A syndrome subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:796--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:796",
    "edge_subjectNode_name": "CALCA",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CALCA gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18779512",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:5243--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:5243",
    "edge_subjectNode_name": "ABCB1",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCB1 gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "PMID:21840870",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:4158--infores:dgidb",
    "edge_object": "NCBIGene:4158",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "MC2R",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects MC2R",
    "primary_source": "infores:dgidb",
    "publications": "PMID:9112644",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:disgenet",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18182467",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:7450--infores:dgidb",
    "edge_object": "NCBIGene:7450",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "VWF",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects VWF",
    "primary_source": "infores:dgidb",
    "publications": "PMID:3146197",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:7038--infores:dgidb",
    "edge_object": "NCBIGene:7038",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "TG",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects TG",
    "primary_source": "infores:dgidb",
    "publications": "PMID:2745931",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37698889;PMID:31815099;PMID:37509636;PMID:29955163;PMID:23805179;PMID:31934840;PMID:33668469;PMID:30773738;PMID:34985196;PMID:28859997;PMID:37895295;PMID:37999247;PMID:25364279;PMID:33491309;PMID:34759794;PMID:25136320;PMID:18980729;PMID:36924141;PMID:30380518;PMID:32803256",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:30018561;PMID:19039140;PMID:24274739;PMID:30287976;PMID:37374323;PMID:20957001;PMID:20814595;PMID:34796908;PMID:32269758;PMID:34803717;PMID:33261141;PMID:20007934;PMID:21485749;PMID:20828336;PMID:34441313;PMID:32021494;PMID:16626867;PMID:29275000;PMID:31805646;PMID:25364282",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:7450--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7450",
    "edge_subjectNode_name": "VWF",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "VWF gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:32871412;PMID:33335028;PMID:30406137;PMID:24949251;PMID:38082222;PMID:32661257;PMID:33946285;PMID:37476587;PMID:30564780;PMID:35905201;PMID:36626546;PMID:34250336;PMID:36851464;PMID:37238951;PMID:37832359;PMID:25949827;PMID:34221026;PMID:14691144;PMID:34763262;PMID:29794143",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:1493--biolink:physically_interacts_with--None--None--None--NCBIGene:57216--infores:intact",
    "edge_object": "NCBIGene:57216",
    "edge_subject": "NCBIGene:1493",
    "edge_subjectNode_name": "CTLA4",
    "edge_objectNode_name": "VANGL2",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "CTLA4 physically interacts with VANGL2",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:35937837;PMID:33058950;PMID:24623797;PMID:16189167;PMID:28637490;PMID:38796770;PMID:34193132;PMID:19846612;PMID:36060294;PMID:28659864;PMID:31570737;PMID:36105398;PMID:37484942;PMID:25609776;PMID:32714392;PMID:35197862;PMID:37484952;PMID:31781041;PMID:35263051;PMID:25428847",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:2908--infores:drugbank",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects NR3C1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:5788--infores:dgidb",
    "edge_object": "NCBIGene:5788",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "PTPRC",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects PTPRC",
    "primary_source": "infores:dgidb",
    "publications": "PMID:17063711",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:1493--biolink:physically_interacts_with--None--None--None--NCBIGene:5190--infores:intact",
    "edge_object": "NCBIGene:5190",
    "edge_subject": "NCBIGene:1493",
    "edge_subjectNode_name": "CTLA4",
    "edge_objectNode_name": "PEX6",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "CTLA4 physically interacts with PEX6",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:57216--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:57216",
    "edge_subjectNode_name": "VANGL2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "VANGL2 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:5190--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:5190",
    "edge_subjectNode_name": "PEX6",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PEX6 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:HP:0002153--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002153",
    "edge_subjectNode_name": "Hyperkalemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Hyperkalemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0015900--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0015900",
    "edge_subjectNode_name": "hypoaldosteronism disease",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "hypoaldosteronism disease subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:2908--infores:dgidb",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects NR3C1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:5243--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5243",
    "edge_subjectNode_name": "ABCB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33208141;PMID:32021205;PMID:27242437;PMID:14749549;PMID:35257288;PMID:36882782;PMID:36559168;PMID:31455857;PMID:26157666;PMID:38004402;PMID:29559914;PMID:31920517;PMID:31071346;PMID:37793994;PMID:37047767;PMID:32066657;PMID:35800371;PMID:21420937;PMID:24213830;PMID:34875340",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--HP:0002902--infores:disgenet",
    "edge_object": "HP:0002902",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "Hyponatremia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition Hyponatremia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0010264--infores:disgenet",
    "edge_object": "MONDO:0010264",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "X-linked adrenal hypoplasia congenita",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition X-linked adrenal hypoplasia congenita",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:5788--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:5788",
    "edge_subjectNode_name": "PTPRC",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPRC gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:21131425;PMID:26808628;PMID:28821584;PMID:37077815;PMID:38110410;PMID:25716998;PMID:28223148;PMID:15238608;PMID:34022844;PMID:25379319;PMID:32153632;PMID:32433977;PMID:20625513;PMID:29761600;PMID:14997189;PMID:31671203;PMID:29559116;PMID:37151983;PMID:24416034;PMID:28819247",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:1557--infores:dgidb",
    "edge_object": "NCBIGene:1557",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "CYP2C19",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects CYP2C19",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:33363514;PMID:35937837;PMID:30018561;PMID:33435513;PMID:22768660;PMID:29460378;PMID:37484942;PMID:37113825;PMID:33661460;PMID:23028665;PMID:20814595;PMID:28670192;PMID:38203272;PMID:27688786;PMID:22802086;PMID:36538565;PMID:34205537;PMID:37253115;PMID:30123187;PMID:37360895",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:2908--infores:drugcentral",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects NR3C1",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--HP:0002153--infores:disgenet",
    "edge_object": "HP:0002153",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "Hyperkalemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition Hyperkalemia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0010264--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mesh",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0010264",
    "edge_subjectNode_name": "X-linked adrenal hypoplasia congenita",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "X-linked adrenal hypoplasia congenita subclass of Addison Disease",
    "primary_source": "infores:mesh",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0010264--infores:diseases",
    "edge_object": "MONDO:0010264",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "X-linked adrenal hypoplasia congenita",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition X-linked adrenal hypoplasia congenita",
    "primary_source": "infores:diseases",
    "publications": "PMID:32938577;PMID:37450570;PMID:33058950;PMID:30400872;PMID:35418949;PMID:33381483;PMID:27485500;PMID:34193132;PMID:21274326;PMID:26038200;PMID:21274298;PMID:36763264;PMID:25287283;PMID:27940298;PMID:35046659;PMID:29956047;PMID:17223989;PMID:34258490;PMID:34278182;PMID:27660747",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:5243--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5243",
    "edge_subjectNode_name": "ABCB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCB1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:17437408;PMID:17924830",
    "publications_count": 2,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:affects--None--None--None--NCBIGene:796--infores:dgidb",
    "edge_object": "NCBIGene:796",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "CALCA",
    "predicate": "biolink:affects",
    "phrase": "Prednisone affects CALCA",
    "primary_source": "infores:dgidb",
    "publications": "PMID:11475715",
    "publications_count": 1,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:1557--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1557",
    "edge_subjectNode_name": "CYP2C19",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP2C19 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:29615902;PMID:35362240;PMID:32683556;PMID:35680739;PMID:34641457;PMID:22957244;PMID:34006449;PMID:30921490;PMID:36559168;PMID:10319191;PMID:36004008;PMID:26089675;PMID:36704740;PMID:31071346;PMID:36902200;PMID:34876814;PMID:24222315;PMID:20146700;PMID:32066657;PMID:36559227",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:7038--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7038",
    "edge_subjectNode_name": "TG",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TG gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:34660491;PMID:33347693;PMID:34248921;PMID:36851302;PMID:31710714;PMID:33332019;PMID:37933077;PMID:34719408;PMID:36065614;PMID:30482242;PMID:29375853;PMID:16357456;PMID:37498128;PMID:23006675;PMID:28620373;PMID:28199315;PMID:28695035;PMID:31632868;PMID:27638303;PMID:32349464",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:5788--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5788",
    "edge_subjectNode_name": "PTPRC",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPRC gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:29559892;PMID:32979312;PMID:37373230;PMID:30406137;PMID:33813280;PMID:33804413;PMID:30703685;PMID:35957525;PMID:36601313;PMID:22567104;PMID:36520518;PMID:25151388;PMID:24843230;PMID:36466804;PMID:33575479;PMID:37628788;PMID:33362469;PMID:37521424;PMID:32042915;PMID:37886538",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0009279--infores:diseases",
    "edge_object": "MONDO:0009279",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "triple-A syndrome",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition triple-A syndrome",
    "primary_source": "infores:diseases",
    "publications": "PMID:32938577;PMID:33381483;PMID:7758515;PMID:35418949;PMID:23012188;PMID:24623797;PMID:36832430;PMID:11353896;PMID:34193132;PMID:21274326;PMID:36060294;PMID:22634753;PMID:36763264;PMID:35046659;PMID:18493136;PMID:20374727;PMID:9758716;PMID:37331934;PMID:18426811;PMID:35627102",
    "publications_count": 20,
    "support_graph_id": "aux_graph_6_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:rtx-kg2:CHEBI:8382--biolink:in_clinical_trials_for--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:molepro:CHEBI:8382--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:automat-robokop:CHEBI:8382--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:molepro:CHEBI:8382--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 26,
    "edge_id": "infores:molepro:CHEBI:8382--biolink:treats--None--None--None--MONDO:0018479--infores:drug-repurposing-hub",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 27,
    "edge_id": "medik:creative_edge#2",
    "edge_object": "MONDO:0060783",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "fludrocortisone acetate treats classic congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fludrocortisone acetate",
    "result_subjectNode_id": "CHEBI:5102",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 27,
    "edge_id": "medik:edge#2",
    "edge_object": "MONDO:0060783",
    "edge_subject": "CHEBI:5102",
    "edge_subjectNode_name": "fludrocortisone acetate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "fludrocortisone acetate studied to treat classic congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8522895;PMC:7235834;PMC:3638875;PMC:6365666;PMC:3894515",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#2",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:automat-robokop:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:automat-robokop:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:drugmechdb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:service-provider-trapi:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:molepro:CHEBI:6889--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:molepro:CHEBI:6889--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:automat-robokop:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:automat-robokop",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:automat-drug-central:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:service-provider-trapi:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "creative_DTD_prediction_2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:4609--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4609",
    "edge_subjectNode_name": "MYC",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MYC gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:23945775;PMID:37007031;PMID:34704275;PMID:23889986;PMID:32709848;PMID:32580510;PMID:31988313;PMID:27597899;PMID:30875083;PMID:33376192;PMID:24774302;PMID:35517869;PMID:32390804;PMID:37383091;PMID:28620373;PMID:27804142;PMID:33476302;PMID:33163396;PMID:30233376;PMID:36035259",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7157--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7157",
    "edge_subjectNode_name": "TP53",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TP53 gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:17270093",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:7124--infores:semmeddb",
    "edge_object": "NCBIGene:7124",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "TNF",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects TNF",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7157--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7157",
    "edge_subjectNode_name": "TP53",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TP53 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:31124939;PMID:29715318;PMID:29267600;PMID:28223148;PMID:34078370;PMID:25379319;PMID:29675060;PMID:32347766;PMID:33083391;PMID:36575670;PMID:36874112;PMID:32943616;PMID:28609451;PMID:23527542;PMID:34461940;PMID:21799993;PMID:32560451;PMID:33391378;PMID:34123841;PMID:36545669",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:596--biolink:physically_interacts_with--None--None--None--NCBIGene:215--infores:intact",
    "edge_object": "NCBIGene:215",
    "edge_subject": "NCBIGene:596",
    "edge_subjectNode_name": "BCL2",
    "edge_objectNode_name": "ABCD1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "BCL2 physically interacts with ABCD1",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:4609--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:4609",
    "edge_subjectNode_name": "MYC",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MYC gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:26927756;PMID:30774653;PMID:31551770;PMID:36211395;PMID:34659577;PMID:21532931;PMID:28223148;PMID:34078370;PMID:36799159;PMID:28900468;PMID:34930980;PMID:26828329;PMID:30224157;PMID:25789467;PMID:21803768;PMID:29728611;PMID:35505177;PMID:27760155;PMID:29212307;PMID:36500482",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:5243--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:5243",
    "edge_subjectNode_name": "ABCB1",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCB1 gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "PMID:21840870",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:4609--infores:dgidb",
    "edge_object": "NCBIGene:4609",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "MYC",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects MYC",
    "primary_source": "infores:dgidb",
    "publications": "PMID:9169090",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:disgenet",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18182467",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:4524--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4524",
    "edge_subjectNode_name": "MTHFR",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MTHFR gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:4609--biolink:physically_interacts_with--None--None--None--NCBIGene:3295--infores:intact",
    "edge_object": "NCBIGene:3295",
    "edge_subject": "NCBIGene:4609",
    "edge_subjectNode_name": "MYC",
    "edge_objectNode_name": "HSD17B4",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "MYC physically interacts with HSD17B4",
    "primary_source": "infores:intact",
    "publications": "PMID:21150319",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:2908--infores:drugcentral",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects NR3C1",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37698889;PMID:31815099;PMID:37509636;PMID:29955163;PMID:23805179;PMID:31934840;PMID:33668469;PMID:30773738;PMID:34985196;PMID:28859997;PMID:37895295;PMID:37999247;PMID:25364279;PMID:33491309;PMID:34759794;PMID:25136320;PMID:18980729;PMID:36924141;PMID:30380518;PMID:32803256",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:30018561;PMID:19039140;PMID:24274739;PMID:30287976;PMID:37374323;PMID:20957001;PMID:20814595;PMID:34796908;PMID:32269758;PMID:34803717;PMID:33261141;PMID:20007934;PMID:21485749;PMID:20828336;PMID:34441313;PMID:32021494;PMID:16626867;PMID:29275000;PMID:31805646;PMID:25364282",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:215--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:215",
    "edge_subjectNode_name": "ABCD1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCD1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:8504--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:8504",
    "edge_subjectNode_name": "PEX3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PEX3 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:causes--None--None--None--HP:0031273--infores:semmeddb",
    "edge_object": "HP:0031273",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "Shock",
    "predicate": "biolink:causes",
    "phrase": "TNF causes Shock",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:1892644;PMID:10948120;PMID:11749775;PMID:12218121;PMID:12188028;PMID:10382751;PMID:27551444;PMID:33273695;PMID:19502556;PMID:17404289;PMID:12652297;PMID:30136236;PMID:33278357;PMID:8834770;PMID:8790597;PMID:20130231;PMID:28894448;PMID:21646349;PMID:11158047;PMID:8711645",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7157--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7157",
    "edge_subjectNode_name": "TP53",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TP53 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:30526315;PMID:36068571;PMID:28607096;PMID:29163365;PMID:31130732;PMID:23889986;PMID:32916028;PMID:32709848;PMID:35628657;PMID:31710714;PMID:19076459;PMID:31563982;PMID:35167649;PMID:16551372;PMID:34221026;PMID:24624135;PMID:33121065;PMID:23270518;PMID:22272008;PMID:36918923",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:HP:0031273--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0031273",
    "edge_subjectNode_name": "Shock",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Shock manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:affects--None--None--None--MONDO:0018076--infores:semmeddb",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:affects",
    "phrase": "TNF affects tuberculosis",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:20173394;PMID:25400917;PMID:23516984;PMID:12745543;PMID:10885842;PMID:29523325;PMID:23672175;PMID:27247233;PMID:37147816",
    "publications_count": 9,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7157--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7157",
    "edge_subjectNode_name": "TP53",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TP53 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:7157--infores:semmeddb",
    "edge_object": "NCBIGene:7157",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "TP53",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects TP53",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:215--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:diseases",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:215",
    "edge_subjectNode_name": "ABCD1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCD1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:30671550;PMID:27766264;PMID:35479665;PMID:25999754;PMID:21164268;PMID:33072949;PMID:36698902;PMID:36060294;PMID:32089906;PMID:28481932;PMID:31074578;PMID:25276129;PMID:26843114;PMID:36046390;PMID:33520891;PMID:33123639;PMID:37563635;PMID:24316281;PMID:7717396;PMID:36003149",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:MONDO:0015900--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0015900",
    "edge_subjectNode_name": "hypoaldosteronism disease",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "hypoaldosteronism disease subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:5243--infores:dgidb",
    "edge_object": "NCBIGene:5243",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "ABCB1",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects ABCB1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:14583680",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:16133992",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:28303499",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:2908--infores:dgidb",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects NR3C1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:5243--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5243",
    "edge_subjectNode_name": "ABCB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33208141;PMID:32021205;PMID:27242437;PMID:14749549;PMID:35257288;PMID:36882782;PMID:36559168;PMID:31455857;PMID:26157666;PMID:38004402;PMID:29559914;PMID:31920517;PMID:31071346;PMID:37793994;PMID:37047767;PMID:32066657;PMID:35800371;PMID:21420937;PMID:24213830;PMID:34875340",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:3295--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3295",
    "edge_subjectNode_name": "HSD17B4",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSD17B4 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35800441;PMID:20129310;PMID:32295518;PMID:37538259;PMID:33953774;PMID:28588493;PMID:27165310;PMID:37401986;PMID:33609255;PMID:34697287;PMID:23889986;PMID:24011127;PMID:35720723;PMID:31172218;PMID:34836549;PMID:37392651;PMID:32308807;PMID:37232744;PMID:33973365;PMID:36339816",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:7157--infores:dgidb",
    "edge_object": "NCBIGene:7157",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "TP53",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects TP53",
    "primary_source": "infores:dgidb",
    "publications": "PMID:16684279",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:33363514;PMID:35937837;PMID:30018561;PMID:33435513;PMID:22768660;PMID:29460378;PMID:37484942;PMID:37113825;PMID:33661460;PMID:23028665;PMID:20814595;PMID:28670192;PMID:38203272;PMID:27688786;PMID:22802086;PMID:36538565;PMID:34205537;PMID:37253115;PMID:30123187;PMID:37360895",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:5243--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5243",
    "edge_subjectNode_name": "ABCB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ABCB1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:17437408;PMID:17924830",
    "publications_count": 2,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:596--infores:dgidb",
    "edge_object": "NCBIGene:596",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "BCL2",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects BCL2",
    "primary_source": "infores:dgidb",
    "publications": "PMID:16141680;PMID:16684279",
    "publications_count": 2,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:physically_interacts_with--None--None--None--NCBIGene:2908--infores:ncit",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "Methylprednisolone physically interacts with NR3C1",
    "primary_source": "infores:ncit",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:28676205;PMID:32353074;PMID:35937690;PMID:31000880;PMID:34504873;PMID:21852947;PMID:25102137;PMID:27242800;PMID:32053993;PMID:23569358;PMID:28418288;PMID:35721093;PMID:23264552;PMID:17998917;PMID:35133578;PMID:20848501;PMID:34943793;PMID:36421613;PMID:37936773;PMID:31116231",
    "publications_count": 20,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:affects--None--None--None--NCBIGene:2908--infores:drugbank",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Methylprednisolone affects NR3C1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:596--biolink:physically_interacts_with--None--None--None--NCBIGene:4524--infores:intact",
    "edge_object": "NCBIGene:4524",
    "edge_subject": "NCBIGene:596",
    "edge_subjectNode_name": "BCL2",
    "edge_objectNode_name": "MTHFR",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "BCL2 physically interacts with MTHFR",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:596--biolink:physically_interacts_with--None--None--None--NCBIGene:8504--infores:intact",
    "edge_object": "NCBIGene:8504",
    "edge_subject": "NCBIGene:596",
    "edge_subjectNode_name": "BCL2",
    "edge_objectNode_name": "PEX3",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "BCL2 physically interacts with PEX3",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--HP:0031273--infores:disgenet",
    "edge_object": "HP:0031273",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "Shock",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition Shock",
    "primary_source": "infores:disgenet",
    "publications": "PMID:7537468",
    "publications_count": 1,
    "support_graph_id": "aux_graph_8_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:automat-drug-central:CHEBI:6888--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:rtx-kg2:CHEBI:6888--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:molepro:CHEBI:135762--biolink:treats--None--None--None--MONDO:0018479--infores:drug-repurposing-hub",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drug-repurposing-hub",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Methylprednisolone",
    "result_subjectNode_id": "CHEBI:6888",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 28,
    "edge_id": "infores:automat-drug-central:CHEBI:6889--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6888",
    "edge_subjectNode_name": "Methylprednisolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Methylprednisolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 29,
    "edge_id": "medik:creative_edge#17",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 29,
    "edge_id": "medik:edge#17",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8999997;PMC:6552504",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#17",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 29,
    "edge_id": "medik:creative_edge#26",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Corticosterone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticosterone",
    "result_subjectNode_id": "CHEBI:16827",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 29,
    "edge_id": "medik:edge#26",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:16827",
    "edge_subjectNode_name": "Corticosterone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticosterone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8999997;PMC:6552504",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#26",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 30,
    "edge_id": "infores:molepro:PUBCHEM.COMPOUND:657180--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Leuprolide treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 30,
    "edge_id": "medik:creative_edge#36",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Leuprolide treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 30,
    "edge_id": "medik:edge#36",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Leuprolide studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7035208;PMC:2905899",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#36",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "inferred-CHEBI:26710-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sodium chloride treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "c56bc85064a36b16ebe9f5a46f7ca58b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sodium chloride studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3600533",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:26710-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "CHEBI:26710-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sodium chloride studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:26710-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "medik:creative_edge#57",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sodium chloride treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "medik:edge#57",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sodium chloride studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3600533",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#57",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "medik:creative_edge#70",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sodium chloride treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 31,
    "edge_id": "medik:edge#70",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sodium chloride studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3600533",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#70",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 32,
    "edge_id": "medik:creative_edge#9",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 32,
    "edge_id": "medik:edge#9",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisone studied to treat classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7233741;PMC:8679847",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#9",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 33,
    "edge_id": "medik:creative_edge#23",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisone",
    "result_subjectNode_id": "CHEBI:8382",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 33,
    "edge_id": "medik:edge#23",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8382",
    "edge_subjectNode_name": "Prednisone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2817381;PMC:7233741;PMC:5036261;PMC:5739705",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#23",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 34,
    "edge_id": "infores:molepro:CHEBI:5739--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "histrelin treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 34,
    "edge_id": "medik:creative_edge#7",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "histrelin treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 34,
    "edge_id": "medik:edge#7",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "histrelin studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7035208",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#7",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 35,
    "edge_id": "inferred-PUBCHEM.COMPOUND:36523-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Gonadorelin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 35,
    "edge_id": "fafe3e4ff57ce2116f27c089211594d4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Gonadorelin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5096505",
    "publications_count": 1,
    "support_graph_id": "inferred-PUBCHEM.COMPOUND:36523-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 35,
    "edge_id": "PUBCHEM.COMPOUND:36523-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Gonadorelin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-PUBCHEM.COMPOUND:36523-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 35,
    "edge_id": "medik:creative_edge#74",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Gonadorelin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 35,
    "edge_id": "medik:edge#74",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Gonadorelin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5096505",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#74",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-robokop:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:molepro:CHEBI:9667--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:molepro:CHEBI:9667--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:service-provider-trapi:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "creative_DTD_prediction_14",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:590--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:590",
    "edge_subjectNode_name": "BCHE",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "BCHE gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:8667461",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:4790--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4790",
    "edge_subjectNode_name": "NFKB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NFKB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:30526315;PMID:37893198;PMID:37401986;PMID:27417803;PMID:36270382;PMID:36846103;PMID:34697287;PMID:32456177;PMID:33946285;PMID:29163365;PMID:35628657;PMID:35919568;PMID:35056657;PMID:19076459;PMID:34054510;PMID:25204979;PMID:37628788;PMID:35656007;PMID:36918923;PMID:24774302",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:2247--infores:dgidb",
    "edge_object": "NCBIGene:2247",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "FGF2",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects FGF2",
    "primary_source": "infores:dgidb",
    "publications": "PMID:15923512",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:1544--infores:dgidb",
    "edge_object": "NCBIGene:1544",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "CYP1A2",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects CYP1A2",
    "primary_source": "infores:dgidb",
    "publications": "PMID:22931300",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:367--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:367",
    "edge_subjectNode_name": "AR",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AR gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:12050225",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:6513--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:6513",
    "edge_subjectNode_name": "SLC2A1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "SLC2A1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:9462754",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:590--infores:dgidb",
    "edge_object": "NCBIGene:590",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "BCHE",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects BCHE",
    "primary_source": "infores:dgidb",
    "publications": "PMID:7937594",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:7040--infores:dgidb",
    "edge_object": "NCBIGene:7040",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "TGFB1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects TGFB1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:12174062",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:disgenet",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18182467",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:1576--infores:dgidb",
    "edge_object": "NCBIGene:1576",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "CYP3A4",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects CYP3A4",
    "primary_source": "infores:dgidb",
    "publications": "PMID:22931300",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36613465;PMID:37893198;PMID:37401986;PMID:33609255;PMID:36846103;PMID:35957525;PMID:36421690;PMID:31455857;PMID:36902200;PMID:34194332;PMID:37862207;PMID:32709848;PMID:25733922;PMID:35056657;PMID:25144875;PMID:23861879;PMID:37034144;PMID:36555783;PMID:37047767;PMID:35720723",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37698889;PMID:31815099;PMID:37509636;PMID:29955163;PMID:23805179;PMID:31934840;PMID:33668469;PMID:30773738;PMID:34985196;PMID:28859997;PMID:37895295;PMID:37999247;PMID:25364279;PMID:33491309;PMID:34759794;PMID:25136320;PMID:18980729;PMID:36924141;PMID:30380518;PMID:32803256",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:30018561;PMID:19039140;PMID:24274739;PMID:30287976;PMID:37374323;PMID:20957001;PMID:20814595;PMID:34796908;PMID:32269758;PMID:34803717;PMID:33261141;PMID:20007934;PMID:21485749;PMID:20828336;PMID:34441313;PMID:32021494;PMID:16626867;PMID:29275000;PMID:31805646;PMID:25364282",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:2908--infores:dgidb",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects NR3C1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:8504--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:8504",
    "edge_subjectNode_name": "PEX3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PEX3 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:590--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:590",
    "edge_subjectNode_name": "BCHE",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "BCHE gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:30521980;PMID:35193667;PMID:37765459;PMID:10565136;PMID:36110430;PMID:27381344;PMID:37259321;PMID:38022336;PMID:33396805;PMID:38174062;PMID:27606012;PMID:30854372;PMID:37575113;PMID:36721811;PMID:35568851;PMID:33807874;PMID:26342014;PMID:34205626;PMID:23056802;PMID:33024940",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:4790--infores:dgidb",
    "edge_object": "NCBIGene:4790",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NFKB1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects NFKB1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:1576--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1576",
    "edge_subjectNode_name": "CYP3A4",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP3A4 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35362240;PMID:33208141;PMID:35680739;PMID:22957244;PMID:21121777;PMID:32150661;PMID:33609255;PMID:26639668;PMID:34006449;PMID:30921490;PMID:36559168;PMID:27429654;PMID:37932838;PMID:26089675;PMID:36704740;PMID:31071346;PMID:27713381;PMID:35477351;PMID:34442409;PMID:34876814",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:1565--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1565",
    "edge_subjectNode_name": "CYP2D6",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP2D6 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37239120;PMID:35362240;PMID:22957244;PMID:21121777;PMID:36559168;PMID:10319191;PMID:36004008;PMID:20698542;PMID:36704740;PMID:31071346;PMID:23407051;PMID:26089675;PMID:23471370;PMID:24222315;PMID:24526565;PMID:32066657;PMID:37293497;PMID:37175536;PMID:27312874;PMID:33491309",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:1544--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1544",
    "edge_subjectNode_name": "CYP1A2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP1A2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35362240;PMID:34641457;PMID:22957244;PMID:21121777;PMID:36559168;PMID:37932838;PMID:26089675;PMID:36704740;PMID:31071346;PMID:36902200;PMID:29559914;PMID:24222315;PMID:37293497;PMID:37521424;PMID:27312874;PMID:37223456;PMID:32855964;PMID:33578259;PMID:31559391;PMID:18568110",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:29483653",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:4780--infores:dgidb",
    "edge_object": "NCBIGene:4780",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NFE2L2",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects NFE2L2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:367--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:367",
    "edge_subjectNode_name": "AR",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AR gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:21030877;PMID:35300443;PMID:37936145;PMID:22253624;PMID:35623621;PMID:35263051;PMID:28791288;PMID:35633791;PMID:33518183;PMID:35600955;PMID:17803691;PMID:35701786;PMID:37699373;PMID:35689291;PMID:29280740;PMID:22662009;PMID:35751545;PMID:32224856;PMID:35846302;PMID:34386394",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:367--infores:dgidb",
    "edge_object": "NCBIGene:367",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "AR",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects AR",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:15102771",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:4780--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:4780",
    "edge_subjectNode_name": "NFE2L2",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NFE2L2 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:33563837;PMID:31551770;PMID:36366400;PMID:28263993;PMID:33013406;PMID:30546363;PMID:31382404;PMID:36979695;PMID:35631013;PMID:29212307;PMID:34064822;PMID:38072952;PMID:34292313;PMID:31611869;PMID:25337584;PMID:32036423;PMID:32376238;PMID:32810243;PMID:36765652;PMID:36677853",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2247--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2247",
    "edge_subjectNode_name": "FGF2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "FGF2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37401986;PMID:20618393;PMID:32661257;PMID:31455857;PMID:36601313;PMID:31130732;PMID:27766071;PMID:28079116;PMID:33575479;PMID:37935829;PMID:23180096;PMID:24365570;PMID:34221026;PMID:35656007;PMID:33251167;PMID:33121268;PMID:21099718;PMID:24472183;PMID:28891994;PMID:35617322",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:6513--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:6513",
    "edge_subjectNode_name": "SLC2A1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "SLC2A1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:38073125;PMID:21649651;PMID:34444875;PMID:35257288;PMID:24892788;PMID:32071845;PMID:38222898;PMID:34040298;PMID:35571021;PMID:10584972;PMID:36065614;PMID:30269351;PMID:35856407;PMID:22957051;PMID:30937099;PMID:36374051;PMID:20129935;PMID:34493617;PMID:26132164;PMID:22989765",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:2908--infores:drugcentral",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects NR3C1",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:MONDO:0015900--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0015900",
    "edge_subjectNode_name": "hypoaldosteronism disease",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "hypoaldosteronism disease subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:6513--infores:dgidb",
    "edge_object": "NCBIGene:6513",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "SLC2A1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects SLC2A1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:10199793",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:1576--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:1576",
    "edge_subjectNode_name": "CYP3A4",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP3A4 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:33024080;PMID:38136599;PMID:22162478;PMID:37392852;PMID:33194923;PMID:36974717;PMID:20814595;PMID:28213088;PMID:35140681;PMID:22873692;PMID:37253115;PMID:35117470;PMID:33236103;PMID:33415088;PMID:20846929;PMID:35915250;PMID:22222232;PMID:31445893;PMID:38300925;PMID:27032061",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:33193365;PMID:37772259;PMID:35232004;PMID:25587366;PMID:17362490;PMID:31816847;PMID:34022844;PMID:37903877;PMID:31763432;PMID:34983490;PMID:31116231;PMID:27261452;PMID:31707357;PMID:33962573;PMID:29559116;PMID:31172218;PMID:19575238;PMID:34386704;PMID:24722473;PMID:22346770",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:590--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:590",
    "edge_subjectNode_name": "BCHE",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "BCHE gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36672595;PMID:36370200;PMID:36421690;PMID:31022458;PMID:24947438;PMID:32438758;PMID:21875407;PMID:34194332;PMID:34959693;PMID:30652263;PMID:24222315;PMID:36385833;PMID:32985464;PMID:32013737;PMID:35923862;PMID:35520948;PMID:37902389;PMID:35297551;PMID:24884823;PMID:35314596",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:33363514;PMID:35937837;PMID:30018561;PMID:33435513;PMID:22768660;PMID:29460378;PMID:37484942;PMID:37113825;PMID:33661460;PMID:23028665;PMID:20814595;PMID:28670192;PMID:38203272;PMID:27688786;PMID:22802086;PMID:36538565;PMID:34205537;PMID:37253115;PMID:30123187;PMID:37360895",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:6513--biolink:physically_interacts_with--None--None--None--NCBIGene:8504--infores:intact",
    "edge_object": "NCBIGene:8504",
    "edge_subject": "NCBIGene:6513",
    "edge_subjectNode_name": "SLC2A1",
    "edge_objectNode_name": "PEX3",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "SLC2A1 physically interacts with PEX3",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:1557--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1557",
    "edge_subjectNode_name": "CYP2C19",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP2C19 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:29615902;PMID:35362240;PMID:32683556;PMID:35680739;PMID:34641457;PMID:22957244;PMID:34006449;PMID:30921490;PMID:36559168;PMID:10319191;PMID:36004008;PMID:26089675;PMID:36704740;PMID:31071346;PMID:36902200;PMID:34876814;PMID:24222315;PMID:20146700;PMID:32066657;PMID:36559227",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2247--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2247",
    "edge_subjectNode_name": "FGF2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "FGF2 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:21269288",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:367--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:367",
    "edge_subjectNode_name": "AR",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AR gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37007031;PMID:16336225;PMID:38313530;PMID:34193245;PMID:36369801;PMID:27790248;PMID:22264391;PMID:33849473;PMID:35905201;PMID:28791288;PMID:35633791;PMID:37999247;PMID:37223033;PMID:30792693;PMID:36553533;PMID:33558665;PMID:29280740;PMID:22844513;PMID:35401196;PMID:36581622",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:NCBIGene:4780--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4780",
    "edge_subjectNode_name": "NFE2L2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NFE2L2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:32021205;PMID:34198733;PMID:20594978;PMID:32800705;PMID:38203348;PMID:32655665;PMID:36846103;PMID:36421690;PMID:37932838;PMID:32574549;PMID:37872210;PMID:33649775;PMID:34073797;PMID:35743109;PMID:33170159;PMID:32528628;PMID:35056657;PMID:37673862;PMID:34054510;PMID:33831409",
    "publications_count": 20,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:2908--infores:drugbank",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects NR3C1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:physically_interacts_with--None--None--None--NCBIGene:2908--infores:ncit",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "Triamcinolone physically interacts with NR3C1",
    "primary_source": "infores:ncit",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:1565--infores:dgidb",
    "edge_object": "NCBIGene:1565",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "CYP2D6",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects CYP2D6",
    "primary_source": "infores:dgidb",
    "publications": "PMID:22931300",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:affects--None--None--None--NCBIGene:1557--infores:dgidb",
    "edge_object": "NCBIGene:1557",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "CYP2C19",
    "predicate": "biolink:affects",
    "phrase": "Triamcinolone affects CYP2C19",
    "primary_source": "infores:dgidb",
    "publications": "PMID:22931300",
    "publications_count": 1,
    "support_graph_id": "aux_graph_10_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-robokop:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:automat-robokop",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:molepro:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:service-provider-trapi:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-drug-central:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:molepro:CHEBI:9669--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-robokop:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:drugmechdb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:molepro:CHEBI:71418--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-drug-central:CHEBI:9669--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:rtx-kg2:CHEBI:9667--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-drug-central:CHEBI:9667--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:automat-drug-central:CHEBI:9669--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Triamcinolone",
    "result_subjectNode_id": "CHEBI:9667",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 36,
    "edge_id": "infores:molepro:CHEBI:9669--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9667",
    "edge_subjectNode_name": "Triamcinolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Triamcinolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 37,
    "edge_id": "medik:creative_edge#27",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "result_objectNode_id": "MONDO:0008728",
    "result_counter": 37,
    "edge_id": "medik:edge#27",
    "edge_object": "MONDO:0008728",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisolone studied to treat classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7233741",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#27",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 38,
    "edge_id": "medik:creative_edge#34",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prednisolone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prednisolone",
    "result_subjectNode_id": "CHEBI:8378",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 38,
    "edge_id": "medik:edge#34",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8378",
    "edge_subjectNode_name": "Prednisolone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prednisolone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3650754;PMC:8901972;PMC:5655680;PMC:2850127;PMC:7233741",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#34",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:molepro:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:molepro:CHEBI:3077--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:service-provider-trapi:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:service-provider-trapi",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:service-provider-trapi",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:automat-robokop:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:automat-robokop",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:automat-robokop",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:automat-drug-central:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:automat-drug-central",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:automat-drug-central",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:automat-drug-central:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:automat-robokop:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:drugmechdb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugmechdb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:automat-robokop:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:service-provider-trapi:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:repodb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:repodb",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:applied_to_treat--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:molepro:CHEBI:3077--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "creative_DTD_prediction_10",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:4512--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4512",
    "edge_subjectNode_name": "COX1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:5617--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5617",
    "edge_subjectNode_name": "PRL",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PRL gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:18678157;PMID:36874857;PMID:37834773;PMID:22466226;PMID:33451362;PMID:36054588;PMID:34573272;PMID:29708552;PMID:24222315;PMID:35250871;PMID:23582916;PMID:30394212;PMID:16355811;PMID:37293497;PMID:30792693;PMID:30684245;PMID:33332019;PMID:37152923;PMID:31011999;PMID:22533152",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:367--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:367",
    "edge_subjectNode_name": "AR",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AR gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:12050225",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:interacts_with--None--None--None--CHEBI:5615--infores:drugbank",
    "edge_object": "CHEBI:5615",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Halothane",
    "predicate": "biolink:interacts_with",
    "phrase": "Betamethasone interacts with Halothane",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:disgenet",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18182467",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:2908--infores:drugcentral",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects NR3C1",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37698889;PMID:31815099;PMID:37509636;PMID:29955163;PMID:23805179;PMID:31934840;PMID:33668469;PMID:30773738;PMID:34985196;PMID:28859997;PMID:37895295;PMID:37999247;PMID:25364279;PMID:33491309;PMID:34759794;PMID:25136320;PMID:18980729;PMID:36924141;PMID:30380518;PMID:32803256",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:30018561;PMID:19039140;PMID:24274739;PMID:30287976;PMID:37374323;PMID:20957001;PMID:20814595;PMID:34796908;PMID:32269758;PMID:34803717;PMID:33261141;PMID:20007934;PMID:21485749;PMID:20828336;PMID:34441313;PMID:32021494;PMID:16626867;PMID:29275000;PMID:31805646;PMID:25364282",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:16469--biolink:affects--None--None--None--NCBIGene:4512--infores:dgidb",
    "edge_object": "NCBIGene:4512",
    "edge_subject": "CHEBI:16469",
    "edge_subjectNode_name": "Estradiol",
    "edge_objectNode_name": "COX1",
    "predicate": "biolink:affects",
    "phrase": "Estradiol affects COX1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:17223066",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:5617--infores:dgidb",
    "edge_object": "NCBIGene:5617",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "PRL",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects PRL",
    "primary_source": "infores:dgidb",
    "publications": "PMID:6548163",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:2908--infores:dgidb",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects NR3C1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:3481--infores:dgidb",
    "edge_object": "NCBIGene:3481",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "IGF2",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects IGF2",
    "primary_source": "infores:dgidb",
    "publications": "PMID:10495414",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:interacts_with--None--None--None--CHEBI:6843--infores:drugbank",
    "edge_object": "CHEBI:6843",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Methoxyflurane",
    "predicate": "biolink:interacts_with",
    "phrase": "Betamethasone interacts with Methoxyflurane",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:43--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:43",
    "edge_subjectNode_name": "ACHE",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ACHE gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:19941057;PMID:27083141",
    "publications_count": 2,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:367--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:367",
    "edge_subjectNode_name": "AR",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AR gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:21030877;PMID:35300443;PMID:37936145;PMID:22253624;PMID:35623621;PMID:35263051;PMID:28791288;PMID:35633791;PMID:33518183;PMID:35600955;PMID:17803691;PMID:35701786;PMID:37699373;PMID:35689291;PMID:29280740;PMID:22662009;PMID:35751545;PMID:32224856;PMID:35846302;PMID:34386394",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:6843--biolink:physically_interacts_with--None--None--None--NCBIGene:4535--infores:drugbank",
    "edge_object": "NCBIGene:4535",
    "edge_subject": "CHEBI:6843",
    "edge_subjectNode_name": "Methoxyflurane",
    "edge_objectNode_name": "ND1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "Methoxyflurane physically interacts with ND1",
    "primary_source": "infores:drugbank",
    "publications": "PMID:4338307;PMID:4149274",
    "publications_count": 2,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:interacts_with--None--None--None--CHEBI:16469--infores:drugbank",
    "edge_object": "CHEBI:16469",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Estradiol",
    "predicate": "biolink:interacts_with",
    "phrase": "Betamethasone interacts with Estradiol",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:4780--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:4780",
    "edge_subjectNode_name": "NFE2L2",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NFE2L2 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:33563837;PMID:31551770;PMID:36366400;PMID:28263993;PMID:33013406;PMID:30546363;PMID:31382404;PMID:36979695;PMID:35631013;PMID:29212307;PMID:34064822;PMID:38072952;PMID:34292313;PMID:31611869;PMID:25337584;PMID:32036423;PMID:32376238;PMID:32810243;PMID:36765652;PMID:36677853",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:MONDO:0015900--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0015900",
    "edge_subjectNode_name": "hypoaldosteronism disease",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "hypoaldosteronism disease subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:43--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:43",
    "edge_subjectNode_name": "ACHE",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ACHE gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:35161777;PMID:37765459;PMID:36904028;PMID:34299505;PMID:31269952;PMID:28924204;PMID:37894604;PMID:29401670;PMID:36405282;PMID:32825737;PMID:38125589;PMID:36678970;PMID:33013406;PMID:27618894;PMID:31763432;PMID:35514936;PMID:32647537;PMID:33024940;PMID:34970114;PMID:37298442",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:2908--infores:drugbank",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects NR3C1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:5617--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:5617",
    "edge_subjectNode_name": "PRL",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PRL gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:30018561;PMID:27902723;PMID:32252736;PMID:26401284;PMID:32431137;PMID:25873114;PMID:36681820;PMID:35623621;PMID:36176844;PMID:36129002;PMID:30394212;PMID:35250884;PMID:36552842;PMID:22715193;PMID:37762862;PMID:30498475;PMID:35600955;PMID:22028893;PMID:35794564;PMID:36292002",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:4780--infores:dgidb",
    "edge_object": "NCBIGene:4780",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "NFE2L2",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects NFE2L2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:5615--biolink:affects--None--None--None--NCBIGene:4535--infores:drugbank",
    "edge_object": "NCBIGene:4535",
    "edge_subject": "CHEBI:5615",
    "edge_subjectNode_name": "Halothane",
    "edge_objectNode_name": "ND1",
    "predicate": "biolink:affects",
    "phrase": "Halothane affects ND1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:33363514;PMID:35937837;PMID:30018561;PMID:33435513;PMID:22768660;PMID:29460378;PMID:37484942;PMID:37113825;PMID:33661460;PMID:23028665;PMID:20814595;PMID:28670192;PMID:38203272;PMID:27688786;PMID:22802086;PMID:36538565;PMID:34205537;PMID:37253115;PMID:30123187;PMID:37360895",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:43--infores:dgidb",
    "edge_object": "NCBIGene:43",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "ACHE",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects ACHE",
    "primary_source": "infores:dgidb",
    "publications": "PMID:3896398",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:367--infores:dgidb",
    "edge_object": "NCBIGene:367",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "AR",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects AR",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:9130--biolink:affects--None--None--None--NCBIGene:4535--infores:dgidb",
    "edge_object": "NCBIGene:4535",
    "edge_subject": "CHEBI:9130",
    "edge_subjectNode_name": "Sevoflurane",
    "edge_objectNode_name": "ND1",
    "predicate": "biolink:affects",
    "phrase": "Sevoflurane affects ND1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:43--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:43",
    "edge_subjectNode_name": "ACHE",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ACHE gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36421690;PMID:32891188;PMID:31710714;PMID:34332638;PMID:34602681;PMID:34054510;PMID:34632168;PMID:36291206;PMID:31731328;PMID:19090989;PMID:36918923;PMID:32722223;PMID:28620373;PMID:34819845;PMID:30813390;PMID:24321454;PMID:37820490;PMID:29056913;PMID:23420180;PMID:32433957",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:367--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:367",
    "edge_subjectNode_name": "AR",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AR gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37007031;PMID:16336225;PMID:38313530;PMID:34193245;PMID:36369801;PMID:27790248;PMID:22264391;PMID:33849473;PMID:35905201;PMID:28791288;PMID:35633791;PMID:37999247;PMID:37223033;PMID:30792693;PMID:36553533;PMID:33558665;PMID:29280740;PMID:22844513;PMID:35401196;PMID:36581622",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:9130--biolink:affects--None--None--None--NCBIGene:4535--infores:drugbank",
    "edge_object": "NCBIGene:4535",
    "edge_subject": "CHEBI:9130",
    "edge_subjectNode_name": "Sevoflurane",
    "edge_objectNode_name": "ND1",
    "predicate": "biolink:affects",
    "phrase": "Sevoflurane affects ND1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:5617--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:5617",
    "edge_subjectNode_name": "PRL",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PRL gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:37547093;PMID:23162357;PMID:32961910;PMID:33865234;PMID:28223148;PMID:28702053;PMID:32153632;PMID:31581718;PMID:33117931;PMID:37371858;PMID:33642886;PMID:28865460;PMID:32743456;PMID:24910844;PMID:36648353;PMID:26790380;PMID:34544399;PMID:30158810;PMID:37077304;PMID:23532440",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:2908--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:4780--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4780",
    "edge_subjectNode_name": "NFE2L2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NFE2L2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:32021205;PMID:34198733;PMID:20594978;PMID:32800705;PMID:38203348;PMID:32655665;PMID:36846103;PMID:36421690;PMID:37932838;PMID:32574549;PMID:37872210;PMID:33649775;PMID:34073797;PMID:35743109;PMID:33170159;PMID:32528628;PMID:35056657;PMID:37673862;PMID:34054510;PMID:33831409",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:5734--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5734",
    "edge_subjectNode_name": "PTGER4",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTGER4 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37732033;PMID:34278440;PMID:34327206;PMID:30763657;PMID:26691993;PMID:26928013;PMID:34304991;PMID:24279689;PMID:36109476;PMID:22311599;PMID:32636528;PMID:33564404;PMID:36765904;PMID:31906013;PMID:25016997;PMID:31904232;PMID:25196047;PMID:30332405;PMID:37458373;PMID:34959306",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:4535--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4535",
    "edge_subjectNode_name": "ND1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ND1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:affects--None--None--None--NCBIGene:5734--infores:dgidb",
    "edge_object": "NCBIGene:5734",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "PTGER4",
    "predicate": "biolink:affects",
    "phrase": "Betamethasone affects PTGER4",
    "primary_source": "infores:dgidb",
    "publications": "PMID:17515865",
    "publications_count": 1,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:interacts_with--None--None--None--CHEBI:9130--infores:drugbank",
    "edge_object": "CHEBI:9130",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Sevoflurane",
    "predicate": "biolink:interacts_with",
    "phrase": "Betamethasone interacts with Sevoflurane",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:NCBIGene:3481--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3481",
    "edge_subjectNode_name": "IGF2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IGF2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:24882635;PMID:29387450;PMID:34769301;PMID:32224912;PMID:36362447;PMID:23582916;PMID:17870057;PMID:30394212;PMID:34250336;PMID:23776849;PMID:28954393;PMID:25136320;PMID:25446346;PMID:36581622;PMID:27187441;PMID:34562518;PMID:31949263;PMID:27708356;PMID:27267688;PMID:30319550",
    "publications_count": 20,
    "support_graph_id": "aux_graph_12_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:in_clinical_trials_for--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:rtx-kg2:CHEBI:3077--biolink:applied_to_treat--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Betamethasone",
    "result_subjectNode_id": "CHEBI:3077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 39,
    "edge_id": "infores:multiomics-clinicaltrials:CHEBI:3077--biolink:treats--None--None--None--MONDO:0015129--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3077",
    "edge_subjectNode_name": "Betamethasone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Betamethasone treats Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 40,
    "edge_id": "inferred-UNII:NQX9KB6PCL-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Somatotropin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 40,
    "edge_id": "3a8539ca09d3b79566f5967004ac94f4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Somatotropin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8015952",
    "publications_count": 1,
    "support_graph_id": "inferred-UNII:NQX9KB6PCL-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 40,
    "edge_id": "UNII:NQX9KB6PCL-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Somatotropin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:NQX9KB6PCL-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 40,
    "edge_id": "medik:creative_edge#68",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Somatotropin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 40,
    "edge_id": "medik:edge#68",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Somatotropin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8015952",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#68",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "inferred-CHEBI:16973-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "desoxycortone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "d917c5e81db1404c427d334957022670",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "desoxycortone studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:13017067;PMID:13039867;PMID:14771944;PMID:14925493;PMID:14935797;PMID:18939205;PMID:20321456;PMID:13171030;PMID:13569185;PMID:13883468;PMID:14914813;PMID:18055426",
    "publications_count": 12,
    "support_graph_id": "inferred-CHEBI:16973-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "e5c6aef5eb9b9d75ff6d8c5d98204858",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "desoxycortone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6055912",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:16973-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "CHEBI:16973-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "desoxycortone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16973-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "medik:creative_edge#48",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "desoxycortone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "medik:edge#48",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "desoxycortone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7813624;PMC:7116186",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#48",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "medik:creative_edge#67",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "desoxycortone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "desoxycortone",
    "result_subjectNode_id": "CHEBI:16973",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 41,
    "edge_id": "medik:edge#67",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16973",
    "edge_subjectNode_name": "desoxycortone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "desoxycortone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6055912",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#67",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 42,
    "edge_id": "medik:creative_edge#30",
    "edge_object": "MONDO:0060783",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats classic congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 42,
    "edge_id": "medik:edge#30",
    "edge_object": "MONDO:0060783",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "dexamethasone sodium phosphate studied to treat classic congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7343997;PMC:6320242;PMC:6552819",
    "publications_count": 3,
    "support_graph_id": "medik:auxiliary_graph#30",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 43,
    "edge_id": "medik:creative_edge#33",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "dexamethasone sodium phosphate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "dexamethasone sodium phosphate",
    "result_subjectNode_id": "CHEBI:4462",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 43,
    "edge_id": "medik:edge#33",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:4462",
    "edge_subjectNode_name": "dexamethasone sodium phosphate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "dexamethasone sodium phosphate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7304558;PMC:7343997;PMC:6320242;PMC:9113802;PMC:3329455",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#33",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 44,
    "edge_id": "medik:creative_edge#18",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Corticotropin treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 44,
    "edge_id": "medik:edge#18",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7264133;PMC:9280500;PMC:3207048;PMC:7473418",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#18",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "autoimmune primary adrenal insufficiency",
    "result_objectNode_id": "MONDO:0100480",
    "result_counter": 45,
    "edge_id": "medik:creative_edge#0",
    "edge_object": "MONDO:0100480",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "autoimmune primary adrenal insufficiency",
    "predicate": "biolink:treats",
    "phrase": "Corticotropin treats autoimmune primary adrenal insufficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticotropin",
    "result_subjectNode_id": "CHEBI:3892",
    "result_objectNode_name": "autoimmune primary adrenal insufficiency",
    "result_objectNode_id": "MONDO:0100480",
    "result_counter": 45,
    "edge_id": "medik:edge#0",
    "edge_object": "MONDO:0100480",
    "edge_subject": "CHEBI:3892",
    "edge_subjectNode_name": "Corticotropin",
    "edge_objectNode_name": "autoimmune primary adrenal insufficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticotropin studied to treat autoimmune primary adrenal insufficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7843184;PMC:4573452;PMC:4949547;PMC:4821366",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 46,
    "edge_id": "medik:creative_edge#8",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Sodium chloride treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium chloride",
    "result_subjectNode_id": "CHEBI:26710",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 46,
    "edge_id": "medik:edge#8",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:26710",
    "edge_subjectNode_name": "Sodium chloride",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sodium chloride studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8272273;PMC:6177667;PMC:5883637;PMC:7785353;PMC:3809734",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#8",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 47,
    "edge_id": "medik:creative_edge#16",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Prasterone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone",
    "result_subjectNode_id": "CHEBI:28689",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 47,
    "edge_id": "medik:edge#16",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:28689",
    "edge_subjectNode_name": "Prasterone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prasterone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4874183;PMC:7881526;PMC:5624825;PMC:6707065;PMC:8826489",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#16",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "autoimmune primary adrenal insufficiency",
    "result_objectNode_id": "MONDO:0100480",
    "result_counter": 48,
    "edge_id": "medik:creative_edge#13",
    "edge_object": "MONDO:0100480",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "autoimmune primary adrenal insufficiency",
    "predicate": "biolink:treats",
    "phrase": "Tetracosactide treats autoimmune primary adrenal insufficiency",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tetracosactide",
    "result_subjectNode_id": "CHEBI:3901",
    "result_objectNode_name": "autoimmune primary adrenal insufficiency",
    "result_objectNode_id": "MONDO:0100480",
    "result_counter": 48,
    "edge_id": "medik:edge#13",
    "edge_object": "MONDO:0100480",
    "edge_subject": "CHEBI:3901",
    "edge_subjectNode_name": "Tetracosactide",
    "edge_objectNode_name": "autoimmune primary adrenal insufficiency",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Tetracosactide studied to treat autoimmune primary adrenal insufficiency",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4949547;PMC:4573452;PMC:7843184;PMC:8466229",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#13",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "inferred-CHEBI:4026-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cyclophosphamide hydrate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "3756c93590fc6a37317351ca7602c6be",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cyclophosphamide hydrate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7690033;PMC:7690033",
    "publications_count": 2,
    "support_graph_id": "inferred-CHEBI:4026-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:creative_edge#55",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cyclophosphamide hydrate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:edge#55",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cyclophosphamide hydrate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7690033",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#55",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:creative_edge#62",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cyclophosphamide hydrate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:edge#62",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cyclophosphamide hydrate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7690033",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#62",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:creative_edge#92",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cyclophosphamide hydrate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:edge#101",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:4026",
    "edge_subjectNode_name": "cyclophosphamide hydrate",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "cyclophosphamide hydrate affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:23395935",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#92",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyclophosphamide hydrate",
    "result_subjectNode_id": "CHEBI:4026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 49,
    "edge_id": "medik:edge#102",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#92",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "inferred-CHEBI:3309-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Calcium gluconate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "26ccad391a626df56e0b1132f9c32740",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Calcium gluconate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4369965",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:3309-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "CHEBI:3309-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Calcium gluconate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:3309-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "medik:creative_edge#56",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Calcium gluconate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "medik:edge#56",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Calcium gluconate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4369965",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#56",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "medik:creative_edge#65",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Calcium gluconate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Calcium gluconate",
    "result_subjectNode_id": "CHEBI:3309",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 50,
    "edge_id": "medik:edge#65",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3309",
    "edge_subjectNode_name": "Calcium gluconate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Calcium gluconate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4369965",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#65",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 51,
    "edge_id": "medik:creative_edge#35",
    "edge_object": "MONDO:0018479",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Somatotropin treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Somatotropin",
    "result_subjectNode_id": "UNII:NQX9KB6PCL",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 51,
    "edge_id": "medik:edge#35",
    "edge_object": "MONDO:0018479",
    "edge_subject": "UNII:NQX9KB6PCL",
    "edge_subjectNode_name": "Somatotropin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Somatotropin studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2817857;PMC:3584711",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#35",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 52,
    "edge_id": "medik:creative_edge#22",
    "edge_object": "MONDO:0018479",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Gonadorelin treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Gonadorelin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:36523",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 52,
    "edge_id": "medik:edge#22",
    "edge_object": "MONDO:0018479",
    "edge_subject": "PUBCHEM.COMPOUND:36523",
    "edge_subjectNode_name": "Gonadorelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Gonadorelin studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5624825;PMC:2905899;PMC:2817857;PMC:5468774;PMC:4506691",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#22",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Testolactone",
    "result_subjectNode_id": "CHEBI:9460",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 53,
    "edge_id": "medik:creative_edge#4",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9460",
    "edge_subjectNode_name": "Testolactone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Testolactone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Testolactone",
    "result_subjectNode_id": "CHEBI:9460",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 53,
    "edge_id": "medik:edge#4",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9460",
    "edge_subjectNode_name": "Testolactone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Testolactone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2905899;PMC:4506691;PMC:6769793;PMC:4568140",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#4",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nevanimibe",
    "result_subjectNode_id": "UNII:VK9OS8R205",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 54,
    "edge_id": "medik:creative_edge#1",
    "edge_object": "MONDO:0060783",
    "edge_subject": "UNII:VK9OS8R205",
    "edge_subjectNode_name": "Nevanimibe",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Nevanimibe treats classic congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nevanimibe",
    "result_subjectNode_id": "UNII:VK9OS8R205",
    "result_objectNode_name": "classic congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0060783",
    "result_counter": 54,
    "edge_id": "medik:edge#1",
    "edge_object": "MONDO:0060783",
    "edge_subject": "UNII:VK9OS8R205",
    "edge_subjectNode_name": "Nevanimibe",
    "edge_objectNode_name": "classic congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Nevanimibe studied to treat classic congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6552740",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#1",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aldosterone",
    "result_subjectNode_id": "CHEBI:27584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 55,
    "edge_id": "inferred-CHEBI:27584-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27584",
    "edge_subjectNode_name": "Aldosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aldosterone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aldosterone",
    "result_subjectNode_id": "CHEBI:27584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 55,
    "edge_id": "4d13c334e902d29bc084292a700a30c5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27584",
    "edge_subjectNode_name": "Aldosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aldosterone studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:168433;PMID:2316393;PMID:14051141;PMID:14393549",
    "publications_count": 4,
    "support_graph_id": "inferred-CHEBI:27584-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aldosterone",
    "result_subjectNode_id": "CHEBI:27584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 55,
    "edge_id": "c6cdcf6f4e000d20fb1dd164809d3446",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27584",
    "edge_subjectNode_name": "Aldosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aldosterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3765115;PMC:3381498",
    "publications_count": 2,
    "support_graph_id": "inferred-CHEBI:27584-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aldosterone",
    "result_subjectNode_id": "CHEBI:27584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 55,
    "edge_id": "CHEBI:27584-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27584",
    "edge_subjectNode_name": "Aldosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aldosterone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:27584-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aldosterone",
    "result_subjectNode_id": "CHEBI:27584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 55,
    "edge_id": "medik:creative_edge#52",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27584",
    "edge_subjectNode_name": "Aldosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aldosterone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aldosterone",
    "result_subjectNode_id": "CHEBI:27584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 55,
    "edge_id": "medik:edge#52",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27584",
    "edge_subjectNode_name": "Aldosterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aldosterone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3765115;PMC:3381498",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#52",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Zoledronic acid",
    "result_subjectNode_id": "CHEBI:46557",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 56,
    "edge_id": "inferred-CHEBI:46557-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46557",
    "edge_subjectNode_name": "Zoledronic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Zoledronic acid treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Zoledronic acid",
    "result_subjectNode_id": "CHEBI:46557",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 56,
    "edge_id": "b14790ff0e47a1d777a46dc8f118fd7c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46557",
    "edge_subjectNode_name": "Zoledronic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Zoledronic acid studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9282361",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:46557-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Zoledronic acid",
    "result_subjectNode_id": "CHEBI:46557",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 56,
    "edge_id": "medik:creative_edge#81",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46557",
    "edge_subjectNode_name": "Zoledronic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Zoledronic acid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Zoledronic acid",
    "result_subjectNode_id": "CHEBI:46557",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 56,
    "edge_id": "medik:edge#81",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46557",
    "edge_subjectNode_name": "Zoledronic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Zoledronic acid studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9282361",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#81",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Zoledronic acid",
    "result_subjectNode_id": "CHEBI:46557",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 56,
    "edge_id": "medik:creative_edge#82",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46557",
    "edge_subjectNode_name": "Zoledronic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Zoledronic acid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Zoledronic acid",
    "result_subjectNode_id": "CHEBI:46557",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 56,
    "edge_id": "medik:edge#82",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46557",
    "edge_subjectNode_name": "Zoledronic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Zoledronic acid studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9282361",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#82",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mitotane",
    "result_subjectNode_id": "CHEBI:6954",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 57,
    "edge_id": "medik:creative_edge#21",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6954",
    "edge_subjectNode_name": "Mitotane",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Mitotane treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mitotane",
    "result_subjectNode_id": "CHEBI:6954",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 57,
    "edge_id": "medik:edge#21",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6954",
    "edge_subjectNode_name": "Mitotane",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Mitotane studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8999997;PMC:6446492;PMC:9156475",
    "publications_count": 3,
    "support_graph_id": "medik:auxiliary_graph#21",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Spironolactone",
    "result_subjectNode_id": "CHEBI:9241",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 58,
    "edge_id": "medik:creative_edge#25",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9241",
    "edge_subjectNode_name": "Spironolactone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Spironolactone treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Spironolactone",
    "result_subjectNode_id": "CHEBI:9241",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 58,
    "edge_id": "medik:edge#25",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:9241",
    "edge_subjectNode_name": "Spironolactone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Spironolactone studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5786744;PMC:7775022;PMC:7132850;PMC:4623929",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#25",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Levoxyl",
    "result_subjectNode_id": "CHEBI:6446",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 59,
    "edge_id": "inferred-CHEBI:6446-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6446",
    "edge_subjectNode_name": "Levoxyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Levoxyl treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Levoxyl",
    "result_subjectNode_id": "CHEBI:6446",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 59,
    "edge_id": "3ee5668b16a54f5d08a261e2a76edd5b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6446",
    "edge_subjectNode_name": "Levoxyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Levoxyl studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5586888;PMC:6236909",
    "publications_count": 2,
    "support_graph_id": "inferred-CHEBI:6446-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Levoxyl",
    "result_subjectNode_id": "CHEBI:6446",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 59,
    "edge_id": "CHEBI:6446-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6446",
    "edge_subjectNode_name": "Levoxyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Levoxyl studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6446-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Levoxyl",
    "result_subjectNode_id": "CHEBI:6446",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 59,
    "edge_id": "medik:creative_edge#76",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6446",
    "edge_subjectNode_name": "Levoxyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Levoxyl treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Levoxyl",
    "result_subjectNode_id": "CHEBI:6446",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 59,
    "edge_id": "medik:edge#76",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6446",
    "edge_subjectNode_name": "Levoxyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Levoxyl studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5586888;PMC:6236909",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#76",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortancyl",
    "result_subjectNode_id": "CHEBI:34655",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 60,
    "edge_id": "medik:creative_edge#14",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:34655",
    "edge_subjectNode_name": "cortancyl",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "cortancyl treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortancyl",
    "result_subjectNode_id": "CHEBI:34655",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 60,
    "edge_id": "medik:edge#14",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:34655",
    "edge_subjectNode_name": "cortancyl",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortancyl studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:6553429;PMC:6838047",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#14",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "abiraterone acetate",
    "result_subjectNode_id": "CHEBI:68639",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 61,
    "edge_id": "medik:creative_edge#15",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:68639",
    "edge_subjectNode_name": "abiraterone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "abiraterone acetate treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "abiraterone acetate",
    "result_subjectNode_id": "CHEBI:68639",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 61,
    "edge_id": "medik:edge#15",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:68639",
    "edge_subjectNode_name": "abiraterone acetate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "abiraterone acetate studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9302862;PMC:8720965;PMC:2905899;PMC:8999997",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#15",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Letrozole",
    "result_subjectNode_id": "CHEBI:6413",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 62,
    "edge_id": "medik:creative_edge#19",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6413",
    "edge_subjectNode_name": "Letrozole",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Letrozole treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Letrozole",
    "result_subjectNode_id": "CHEBI:6413",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 62,
    "edge_id": "medik:edge#19",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6413",
    "edge_subjectNode_name": "Letrozole",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Letrozole studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9163158;PMC:2817857;PMC:8716689;PMC:7035208",
    "publications_count": 4,
    "support_graph_id": "medik:auxiliary_graph#19",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Flutamide",
    "result_subjectNode_id": "CHEBI:5132",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 63,
    "edge_id": "medik:creative_edge#24",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5132",
    "edge_subjectNode_name": "Flutamide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Flutamide treats congenital adrenal hyperplasia",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Flutamide",
    "result_subjectNode_id": "CHEBI:5132",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 63,
    "edge_id": "medik:edge#24",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5132",
    "edge_subjectNode_name": "Flutamide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Flutamide studied to treat congenital adrenal hyperplasia",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2817857;PMC:4506691;PMC:4568140;PMC:6769793;PMC:2905899",
    "publications_count": 5,
    "support_graph_id": "medik:auxiliary_graph#24",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CID 10128037",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10128037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 64,
    "edge_id": "medik:creative_edge#170",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10128037",
    "edge_subjectNode_name": "CID 10128037",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CID 10128037 treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CID 10128037",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10128037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 64,
    "edge_id": "medik:edge#257",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10128037",
    "edge_subjectNode_name": "CID 10128037",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "CID 10128037 affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#170",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CID 10128037",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10128037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 64,
    "edge_id": "medik:edge#258",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#170",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CID 10128037",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10128037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 64,
    "edge_id": "medik:creative_edge#171",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10128037",
    "edge_subjectNode_name": "CID 10128037",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CID 10128037 treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CID 10128037",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10128037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 64,
    "edge_id": "medik:edge#259",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10128037",
    "edge_subjectNode_name": "CID 10128037",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "CID 10128037 affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#171",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CID 10128037",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10128037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 64,
    "edge_id": "medik:edge#260",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#171",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Apixaban",
    "result_subjectNode_id": "CHEBI:72296",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 65,
    "edge_id": "inferred-CHEBI:72296-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:72296",
    "edge_subjectNode_name": "Apixaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Apixaban treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Apixaban",
    "result_subjectNode_id": "CHEBI:72296",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 65,
    "edge_id": "fab3265d7971f6b184cf26b8aae07f1f",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:72296",
    "edge_subjectNode_name": "Apixaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Apixaban studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9254566;PMC:9254566;PMC:9254566",
    "publications_count": 3,
    "support_graph_id": "inferred-CHEBI:72296-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Apixaban",
    "result_subjectNode_id": "CHEBI:72296",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 65,
    "edge_id": "medik:creative_edge#43",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:72296",
    "edge_subjectNode_name": "Apixaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Apixaban treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Apixaban",
    "result_subjectNode_id": "CHEBI:72296",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 65,
    "edge_id": "medik:edge#43",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:72296",
    "edge_subjectNode_name": "Apixaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Apixaban studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9254566",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#43",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10024007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 66,
    "edge_id": "medik:creative_edge#143",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10024007",
    "edge_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10024007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 66,
    "edge_id": "medik:edge#203",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10024007",
    "edge_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:15026058",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#143",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10024007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 66,
    "edge_id": "medik:edge#204",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#143",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10024007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 66,
    "edge_id": "medik:creative_edge#144",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10024007",
    "edge_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10024007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 66,
    "edge_id": "medik:edge#205",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10024007",
    "edge_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15026058",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#144",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-10-Methoxy-2,2,4-trimethyl-5-((S)-3-methyl-cyclohex-2-enyl)-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10024007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 66,
    "edge_id": "medik:edge#206",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#144",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Itraconazole",
    "result_subjectNode_id": "CHEBI:6076",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 67,
    "edge_id": "inferred-CHEBI:6076-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6076",
    "edge_subjectNode_name": "Itraconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Itraconazole treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Itraconazole",
    "result_subjectNode_id": "CHEBI:6076",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 67,
    "edge_id": "b42c5a5bbcbccc556fbf4d52ddd6028b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6076",
    "edge_subjectNode_name": "Itraconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Itraconazole studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7103037;PMC:3772918",
    "publications_count": 2,
    "support_graph_id": "inferred-CHEBI:6076-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Itraconazole",
    "result_subjectNode_id": "CHEBI:6076",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 67,
    "edge_id": "medik:creative_edge#46",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6076",
    "edge_subjectNode_name": "Itraconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Itraconazole treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Itraconazole",
    "result_subjectNode_id": "CHEBI:6076",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 67,
    "edge_id": "medik:edge#46",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6076",
    "edge_subjectNode_name": "Itraconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Itraconazole studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7103037;PMC:3772918",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#46",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rivaroxaban",
    "result_subjectNode_id": "CHEBI:68579",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 68,
    "edge_id": "inferred-CHEBI:68579-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68579",
    "edge_subjectNode_name": "Rivaroxaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Rivaroxaban treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rivaroxaban",
    "result_subjectNode_id": "CHEBI:68579",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 68,
    "edge_id": "2431557d27bb5b4b4759238ff79aafb8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68579",
    "edge_subjectNode_name": "Rivaroxaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Rivaroxaban studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9254566;PMC:9254566;PMC:9254566",
    "publications_count": 3,
    "support_graph_id": "inferred-CHEBI:68579-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rivaroxaban",
    "result_subjectNode_id": "CHEBI:68579",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 68,
    "edge_id": "medik:creative_edge#44",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68579",
    "edge_subjectNode_name": "Rivaroxaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Rivaroxaban treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rivaroxaban",
    "result_subjectNode_id": "CHEBI:68579",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 68,
    "edge_id": "medik:edge#44",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68579",
    "edge_subjectNode_name": "Rivaroxaban",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Rivaroxaban studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9254566",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#44",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10111302",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 69,
    "edge_id": "medik:creative_edge#155",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10111302",
    "edge_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10111302",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 69,
    "edge_id": "medik:edge#227",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10111302",
    "edge_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#155",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10111302",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 69,
    "edge_id": "medik:edge#228",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#155",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10111302",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 69,
    "edge_id": "medik:creative_edge#156",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10111302",
    "edge_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10111302",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 69,
    "edge_id": "medik:edge#229",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10111302",
    "edge_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#156",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanesulfonic acid (1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10111302",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 69,
    "edge_id": "medik:edge#230",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#156",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "alendronate sodium trihydrate",
    "result_subjectNode_id": "CHEBI:2566",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 70,
    "edge_id": "inferred-CHEBI:2566-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2566",
    "edge_subjectNode_name": "alendronate sodium trihydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "alendronate sodium trihydrate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "alendronate sodium trihydrate",
    "result_subjectNode_id": "CHEBI:2566",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 70,
    "edge_id": "b9bbc233cb8af2bee0c401a1a64a4436",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2566",
    "edge_subjectNode_name": "alendronate sodium trihydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "alendronate sodium trihydrate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7033637;PMC:3637297",
    "publications_count": 2,
    "support_graph_id": "inferred-CHEBI:2566-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "alendronate sodium trihydrate",
    "result_subjectNode_id": "CHEBI:2566",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 70,
    "edge_id": "medik:creative_edge#47",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2566",
    "edge_subjectNode_name": "alendronate sodium trihydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "alendronate sodium trihydrate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "alendronate sodium trihydrate",
    "result_subjectNode_id": "CHEBI:2566",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 70,
    "edge_id": "medik:edge#47",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2566",
    "edge_subjectNode_name": "alendronate sodium trihydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "alendronate sodium trihydrate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7033637;PMC:3637297",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#47",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10160645",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 71,
    "edge_id": "medik:creative_edge#183",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10160645",
    "edge_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10160645",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 71,
    "edge_id": "medik:edge#283",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10160645",
    "edge_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:11520196",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#183",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10160645",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 71,
    "edge_id": "medik:edge#284",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#183",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10160645",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 71,
    "edge_id": "medik:creative_edge#184",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10160645",
    "edge_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10160645",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 71,
    "edge_id": "medik:edge#285",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10160645",
    "edge_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:11520196",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#184",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-5-(3-methoxymethoxy-phenyl)-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10160645",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 71,
    "edge_id": "medik:edge#286",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#184",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aspirin",
    "result_subjectNode_id": "CHEBI:15365",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 72,
    "edge_id": "inferred-CHEBI:15365-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15365",
    "edge_subjectNode_name": "Aspirin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aspirin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aspirin",
    "result_subjectNode_id": "CHEBI:15365",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 72,
    "edge_id": "348fd8ffec21b0a4b671c2980fc0e80c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15365",
    "edge_subjectNode_name": "Aspirin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aspirin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3050888",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:15365-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aspirin",
    "result_subjectNode_id": "CHEBI:15365",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 72,
    "edge_id": "CHEBI:15365-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15365",
    "edge_subjectNode_name": "Aspirin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aspirin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:15365-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aspirin",
    "result_subjectNode_id": "CHEBI:15365",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 72,
    "edge_id": "medik:creative_edge#59",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15365",
    "edge_subjectNode_name": "Aspirin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aspirin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aspirin",
    "result_subjectNode_id": "CHEBI:15365",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 72,
    "edge_id": "medik:edge#59",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15365",
    "edge_subjectNode_name": "Aspirin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aspirin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:3050888",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#59",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10210815",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 73,
    "edge_id": "medik:creative_edge#199",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10210815",
    "edge_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10210815",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 73,
    "edge_id": "medik:edge#315",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10210815",
    "edge_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:16078847",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#199",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10210815",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 73,
    "edge_id": "medik:edge#316",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#199",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10210815",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 73,
    "edge_id": "medik:creative_edge#200",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10210815",
    "edge_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10210815",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 73,
    "edge_id": "medik:edge#317",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10210815",
    "edge_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16078847",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#200",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-{5-[4-({[(2,4-Difluorophenyl)methyl](3-methanesulfonamido-2-methylphenyl)amino}methyl)phenoxy]-2-fluorophenoxy}acetic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10210815",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 73,
    "edge_id": "medik:edge#318",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#200",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10172897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 74,
    "edge_id": "medik:creative_edge#186",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10172897",
    "edge_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10172897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 74,
    "edge_id": "medik:edge#289",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10172897",
    "edge_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#186",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10172897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 74,
    "edge_id": "medik:edge#290",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#186",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10172897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 74,
    "edge_id": "medik:creative_edge#187",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10172897",
    "edge_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10172897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 74,
    "edge_id": "medik:edge#291",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10172897",
    "edge_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#187",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10172897",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 74,
    "edge_id": "medik:edge#292",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#187",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Carbamazepine",
    "result_subjectNode_id": "CHEBI:3387",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 75,
    "edge_id": "inferred-CHEBI:3387-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3387",
    "edge_subjectNode_name": "Carbamazepine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Carbamazepine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Carbamazepine",
    "result_subjectNode_id": "CHEBI:3387",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 75,
    "edge_id": "c2434f840010368f039de047d5b1e9c2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3387",
    "edge_subjectNode_name": "Carbamazepine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Carbamazepine studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9035148",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:3387-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Carbamazepine",
    "result_subjectNode_id": "CHEBI:3387",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 75,
    "edge_id": "medik:creative_edge#75",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3387",
    "edge_subjectNode_name": "Carbamazepine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Carbamazepine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Carbamazepine",
    "result_subjectNode_id": "CHEBI:3387",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 75,
    "edge_id": "medik:edge#75",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3387",
    "edge_subjectNode_name": "Carbamazepine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Carbamazepine studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9035148",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#75",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127159",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 76,
    "edge_id": "medik:creative_edge#164",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10127159",
    "edge_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127159",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 76,
    "edge_id": "medik:edge#245",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10127159",
    "edge_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#164",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127159",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 76,
    "edge_id": "medik:edge#246",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#164",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127159",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 76,
    "edge_id": "medik:creative_edge#165",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10127159",
    "edge_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127159",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 76,
    "edge_id": "medik:edge#247",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10127159",
    "edge_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#165",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(6-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127159",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 76,
    "edge_id": "medik:edge#248",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#165",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetaminophen",
    "result_subjectNode_id": "CHEBI:46195",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 77,
    "edge_id": "inferred-CHEBI:46195-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46195",
    "edge_subjectNode_name": "Acetaminophen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Acetaminophen treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetaminophen",
    "result_subjectNode_id": "CHEBI:46195",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 77,
    "edge_id": "6a39067c2b718c431cc208fbf82dca1c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46195",
    "edge_subjectNode_name": "Acetaminophen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Acetaminophen studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4621217",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:46195-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetaminophen",
    "result_subjectNode_id": "CHEBI:46195",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 77,
    "edge_id": "medik:creative_edge#61",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46195",
    "edge_subjectNode_name": "Acetaminophen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Acetaminophen treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetaminophen",
    "result_subjectNode_id": "CHEBI:46195",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 77,
    "edge_id": "medik:edge#61",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46195",
    "edge_subjectNode_name": "Acetaminophen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Acetaminophen studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4621217",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#61",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetate",
    "result_subjectNode_id": "CHEBI:30089",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 78,
    "edge_id": "inferred-CHEBI:30089-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30089",
    "edge_subjectNode_name": "Acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Acetate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetate",
    "result_subjectNode_id": "CHEBI:30089",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 78,
    "edge_id": "a5175556db731dc0dd771e96be8ca61a",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30089",
    "edge_subjectNode_name": "Acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2991381",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:30089-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetate",
    "result_subjectNode_id": "CHEBI:30089",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 78,
    "edge_id": "medik:creative_edge#71",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30089",
    "edge_subjectNode_name": "Acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Acetate",
    "result_subjectNode_id": "CHEBI:30089",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 78,
    "edge_id": "medik:edge#71",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30089",
    "edge_subjectNode_name": "Acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Acetate studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:2991381",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#71",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10136854",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 79,
    "edge_id": "medik:creative_edge#174",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10136854",
    "edge_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10136854",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 79,
    "edge_id": "medik:edge#265",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10136854",
    "edge_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:11520196",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#174",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10136854",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 79,
    "edge_id": "medik:edge#266",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#174",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10136854",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 79,
    "edge_id": "medik:creative_edge#175",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10136854",
    "edge_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10136854",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 79,
    "edge_id": "medik:edge#267",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10136854",
    "edge_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:11520196",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#175",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-(3,5-Difluoro-phenyl)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10136854",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 79,
    "edge_id": "medik:edge#268",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#175",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cholecalciferol",
    "result_subjectNode_id": "CHEBI:27300",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 80,
    "edge_id": "inferred-CHEBI:27300-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27300",
    "edge_subjectNode_name": "Cholecalciferol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cholecalciferol treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cholecalciferol",
    "result_subjectNode_id": "CHEBI:27300",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 80,
    "edge_id": "a2b243a1216dc52d4c18fb5bfa2591fd",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27300",
    "edge_subjectNode_name": "Cholecalciferol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cholecalciferol studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8259612",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:27300-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cholecalciferol",
    "result_subjectNode_id": "CHEBI:27300",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 80,
    "edge_id": "medik:creative_edge#77",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27300",
    "edge_subjectNode_name": "Cholecalciferol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cholecalciferol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cholecalciferol",
    "result_subjectNode_id": "CHEBI:27300",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 80,
    "edge_id": "medik:edge#77",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27300",
    "edge_subjectNode_name": "Cholecalciferol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cholecalciferol studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8259612",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#77",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10027430",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 81,
    "edge_id": "medik:creative_edge#146",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10027430",
    "edge_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10027430",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 81,
    "edge_id": "medik:edge#209",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10027430",
    "edge_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16821781",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#146",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10027430",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 81,
    "edge_id": "medik:edge#210",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#146",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10027430",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 81,
    "edge_id": "medik:creative_edge#147",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10027430",
    "edge_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10027430",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 81,
    "edge_id": "medik:edge#211",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10027430",
    "edge_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:16821781",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#147",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-[(5-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10027430",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 81,
    "edge_id": "medik:edge#212",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#147",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Loperamide",
    "result_subjectNode_id": "CHEBI:6532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 82,
    "edge_id": "inferred-CHEBI:6532-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6532",
    "edge_subjectNode_name": "Loperamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Loperamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Loperamide",
    "result_subjectNode_id": "CHEBI:6532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 82,
    "edge_id": "c202ce61fb4873936a363a54e989e951",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6532",
    "edge_subjectNode_name": "Loperamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Loperamide studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5051368",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:6532-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Loperamide",
    "result_subjectNode_id": "CHEBI:6532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 82,
    "edge_id": "medik:creative_edge#80",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6532",
    "edge_subjectNode_name": "Loperamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Loperamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Loperamide",
    "result_subjectNode_id": "CHEBI:6532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 82,
    "edge_id": "medik:edge#80",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6532",
    "edge_subjectNode_name": "Loperamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Loperamide studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5051368",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#80",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127709",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 83,
    "edge_id": "medik:creative_edge#168",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10127709",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127709",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 83,
    "edge_id": "medik:edge#253",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10127709",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#168",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127709",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 83,
    "edge_id": "medik:edge#254",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#168",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127709",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 83,
    "edge_id": "medik:creative_edge#169",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10127709",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127709",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 83,
    "edge_id": "medik:edge#255",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10127709",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#169",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127709",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 83,
    "edge_id": "medik:edge#256",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#169",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Melatonin",
    "result_subjectNode_id": "CHEBI:16796",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 84,
    "edge_id": "inferred-CHEBI:16796-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16796",
    "edge_subjectNode_name": "Melatonin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Melatonin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Melatonin",
    "result_subjectNode_id": "CHEBI:16796",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 84,
    "edge_id": "41d81fa3b98e3598cbf3a0bef8916d28",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16796",
    "edge_subjectNode_name": "Melatonin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Melatonin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8930624",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:16796-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Melatonin",
    "result_subjectNode_id": "CHEBI:16796",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 84,
    "edge_id": "medik:creative_edge#53",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16796",
    "edge_subjectNode_name": "Melatonin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Melatonin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Melatonin",
    "result_subjectNode_id": "CHEBI:16796",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 84,
    "edge_id": "medik:edge#53",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16796",
    "edge_subjectNode_name": "Melatonin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Melatonin studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8930624",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#53",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173525",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 85,
    "edge_id": "medik:creative_edge#189",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10173525",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173525",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 85,
    "edge_id": "medik:edge#295",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10173525",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#189",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173525",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 85,
    "edge_id": "medik:edge#296",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#189",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173525",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 85,
    "edge_id": "medik:creative_edge#190",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10173525",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173525",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 85,
    "edge_id": "medik:edge#297",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10173525",
    "edge_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#190",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Cyclohexylmethyl-2-hydroxy-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173525",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 85,
    "edge_id": "medik:edge#298",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#190",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Furosemide",
    "result_subjectNode_id": "CHEBI:47426",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 86,
    "edge_id": "inferred-CHEBI:47426-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:47426",
    "edge_subjectNode_name": "Furosemide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Furosemide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Furosemide",
    "result_subjectNode_id": "CHEBI:47426",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 86,
    "edge_id": "54016e0569791d93d3c10811cea34bf8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:47426",
    "edge_subjectNode_name": "Furosemide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Furosemide studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4369965",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:47426-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Furosemide",
    "result_subjectNode_id": "CHEBI:47426",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 86,
    "edge_id": "medik:creative_edge#73",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:47426",
    "edge_subjectNode_name": "Furosemide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Furosemide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Furosemide",
    "result_subjectNode_id": "CHEBI:47426",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 86,
    "edge_id": "medik:edge#73",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:47426",
    "edge_subjectNode_name": "Furosemide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Furosemide studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4369965",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#73",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Risedronate sodium",
    "result_subjectNode_id": "CHEBI:8868",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 87,
    "edge_id": "inferred-CHEBI:8868-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8868",
    "edge_subjectNode_name": "Risedronate sodium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Risedronate sodium treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Risedronate sodium",
    "result_subjectNode_id": "CHEBI:8868",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 87,
    "edge_id": "b8632fe6d00ea267708e638665505ffa",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8868",
    "edge_subjectNode_name": "Risedronate sodium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Risedronate sodium studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7033637",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:8868-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Risedronate sodium",
    "result_subjectNode_id": "CHEBI:8868",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 87,
    "edge_id": "medik:creative_edge#79",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8868",
    "edge_subjectNode_name": "Risedronate sodium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Risedronate sodium treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Risedronate sodium",
    "result_subjectNode_id": "CHEBI:8868",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 87,
    "edge_id": "medik:edge#79",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8868",
    "edge_subjectNode_name": "Risedronate sodium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Risedronate sodium studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7033637",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#79",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metyrapone",
    "result_subjectNode_id": "CHEBI:44241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 88,
    "edge_id": "inferred-CHEBI:44241-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:44241",
    "edge_subjectNode_name": "Metyrapone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Metyrapone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metyrapone",
    "result_subjectNode_id": "CHEBI:44241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 88,
    "edge_id": "379f71841c178d7f6a0d6fb13a01f5b0",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:44241",
    "edge_subjectNode_name": "Metyrapone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Metyrapone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5682420",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:44241-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metyrapone",
    "result_subjectNode_id": "CHEBI:44241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 88,
    "edge_id": "medik:creative_edge#72",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:44241",
    "edge_subjectNode_name": "Metyrapone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Metyrapone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metyrapone",
    "result_subjectNode_id": "CHEBI:44241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 88,
    "edge_id": "medik:edge#72",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:44241",
    "edge_subjectNode_name": "Metyrapone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Metyrapone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:5682420",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#72",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sulfasalazine",
    "result_subjectNode_id": "CHEBI:9334",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 89,
    "edge_id": "inferred-CHEBI:9334-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9334",
    "edge_subjectNode_name": "Sulfasalazine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sulfasalazine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sulfasalazine",
    "result_subjectNode_id": "CHEBI:9334",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 89,
    "edge_id": "d7fd5635c8a00821e56668207ce5946d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9334",
    "edge_subjectNode_name": "Sulfasalazine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sulfasalazine studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4616459",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:9334-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sulfasalazine",
    "result_subjectNode_id": "CHEBI:9334",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 89,
    "edge_id": "medik:creative_edge#54",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9334",
    "edge_subjectNode_name": "Sulfasalazine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sulfasalazine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sulfasalazine",
    "result_subjectNode_id": "CHEBI:9334",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 89,
    "edge_id": "medik:edge#54",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9334",
    "edge_subjectNode_name": "Sulfasalazine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sulfasalazine studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4616459",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#54",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "methylprednisolone suleptanate",
    "result_subjectNode_id": "CHEBI:135864",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 90,
    "edge_id": "infores:molepro:CHEBI:135864--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:135864",
    "edge_subjectNode_name": "methylprednisolone suleptanate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "methylprednisolone suleptanate treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "methylprednisolone suleptanate",
    "result_subjectNode_id": "CHEBI:135864",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 90,
    "edge_id": "infores:molepro:CHEBI:135864--biolink:treats--None--None--None--MONDO:0018479--infores:drugcentral",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:135864",
    "edge_subjectNode_name": "methylprednisolone suleptanate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "methylprednisolone suleptanate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "methylprednisolone suleptanate",
    "result_subjectNode_id": "CHEBI:135864",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 90,
    "edge_id": "infores:molepro:CHEBI:135864--biolink:treats--None--None--None--MONDO:0015129--infores:drugcentral",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:135864",
    "edge_subjectNode_name": "methylprednisolone suleptanate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "methylprednisolone suleptanate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Oxycodone",
    "result_subjectNode_id": "CHEBI:7852",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 91,
    "edge_id": "inferred-CHEBI:7852-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7852",
    "edge_subjectNode_name": "Oxycodone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Oxycodone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Oxycodone",
    "result_subjectNode_id": "CHEBI:7852",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 91,
    "edge_id": "dfee59c29420ab22cb075014262d1564",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7852",
    "edge_subjectNode_name": "Oxycodone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Oxycodone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4621217",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:7852-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Oxycodone",
    "result_subjectNode_id": "CHEBI:7852",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 91,
    "edge_id": "medik:creative_edge#60",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7852",
    "edge_subjectNode_name": "Oxycodone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Oxycodone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Oxycodone",
    "result_subjectNode_id": "CHEBI:7852",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 91,
    "edge_id": "medik:edge#60",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7852",
    "edge_subjectNode_name": "Oxycodone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Oxycodone studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:4621217",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#60",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "creative_DTD_prediction_1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "vasopressin treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:3315--infores:dgidb",
    "edge_object": "NCBIGene:3315",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "HSPB1",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects HSPB1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:9925748",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:4512--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4512",
    "edge_subjectNode_name": "COX1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:1576--infores:dgidb",
    "edge_object": "NCBIGene:1576",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "CYP3A4",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects CYP3A4",
    "primary_source": "infores:dgidb",
    "publications": "PMID:18431272",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:554--biolink:gene_associated_with_condition--None--None--None--HP:0002902--infores:disgenet",
    "edge_object": "HP:0002902",
    "edge_subject": "NCBIGene:554",
    "edge_subjectNode_name": "AVPR2",
    "edge_objectNode_name": "Hyponatremia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AVPR2 gene associated with condition Hyponatremia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:552--infores:semmeddb",
    "edge_object": "NCBIGene:552",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "AVPR1A",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects AVPR1A",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:5587--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5587",
    "edge_subjectNode_name": "PRKD1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PRKD1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:34316303;PMID:36553572;PMID:36176941;PMID:38028995;PMID:34176514;PMID:34448047;PMID:31231176;PMID:22777493;PMID:31710714;PMID:29920362;PMID:35292049;PMID:31653548;PMID:20736978;PMID:34409748;PMID:30941118;PMID:29273751;PMID:36833359;PMID:37993913;PMID:30424739;PMID:37842082",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:HP:0002902--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002902",
    "edge_subjectNode_name": "Hyponatremia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Hyponatremia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:3315--infores:semmeddb",
    "edge_object": "NCBIGene:3315",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "HSPB1",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects HSPB1",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:554--infores:drugcentral",
    "edge_object": "NCBIGene:554",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "AVPR2",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects AVPR2",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:5054--infores:dgidb",
    "edge_object": "NCBIGene:5054",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "SERPINE1",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects SERPINE1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:7482412",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:554--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:554",
    "edge_subjectNode_name": "AVPR2",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AVPR2 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:17218722",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:552--infores:dgidb",
    "edge_object": "NCBIGene:552",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "AVPR1A",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects AVPR1A",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:1432--infores:dgidb",
    "edge_object": "NCBIGene:1432",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "MAPK14",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects MAPK14",
    "primary_source": "infores:dgidb",
    "publications": "PMID:10679516;PMID:11029753",
    "publications_count": 2,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:554--infores:dgidb",
    "edge_object": "NCBIGene:554",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "AVPR2",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects AVPR2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:1636--infores:semmeddb",
    "edge_object": "NCBIGene:1636",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "ACE",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects ACE",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:5587--biolink:gene_associated_with_condition--None--None--None--HP:0011968--infores:disgenet",
    "edge_object": "HP:0011968",
    "edge_subject": "NCBIGene:5587",
    "edge_subjectNode_name": "PRKD1",
    "edge_objectNode_name": "Feeding Problem",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PRKD1 gene associated with condition Feeding Problem",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:1432--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1432",
    "edge_subjectNode_name": "MAPK14",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MAPK14 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35222122;PMID:33229747;PMID:36711845;PMID:37556347;PMID:37007031;PMID:31542363;PMID:34834539;PMID:25754968;PMID:34308255;PMID:32961703;PMID:35330088;PMID:33763064;PMID:35655441;PMID:22311599;PMID:29662436;PMID:36275900;PMID:31222732;PMID:21078373;PMID:25733148;PMID:32722328",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:554--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:554",
    "edge_subjectNode_name": "AVPR2",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AVPR2 gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:1576--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1576",
    "edge_subjectNode_name": "CYP3A4",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP3A4 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35362240;PMID:33208141;PMID:35680739;PMID:22957244;PMID:21121777;PMID:32150661;PMID:33609255;PMID:26639668;PMID:34006449;PMID:30921490;PMID:36559168;PMID:27429654;PMID:37932838;PMID:26089675;PMID:36704740;PMID:31071346;PMID:27713381;PMID:35477351;PMID:34442409;PMID:34876814",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:1636--infores:dgidb",
    "edge_object": "NCBIGene:1636",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "ACE",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects ACE",
    "primary_source": "infores:dgidb",
    "publications": "PMID:6289972",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:5587--infores:dgidb",
    "edge_object": "NCBIGene:5587",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "PRKD1",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects PRKD1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:11514571",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:interacts_with--None--None--None--NCBIGene:760--infores:semmeddb",
    "edge_object": "NCBIGene:760",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "CA2",
    "predicate": "biolink:interacts_with",
    "phrase": "vasopressin interacts with CA2",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:1510155;PMID:1662726;PMID:1692103;PMID:1769064;PMID:2327989;PMID:2542314;PMID:6439053;PMID:7818985;PMID:7980392;PMID:8994441;PMID:9306269",
    "publications_count": 11,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:760--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:760",
    "edge_subjectNode_name": "CA2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CA2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33648390;PMID:32810346;PMID:37049983;PMID:35768159;PMID:33585783;PMID:31710714;PMID:37047767;PMID:31627429;PMID:37902389;PMID:31842669;PMID:33895779;PMID:37312840;PMID:37111236;PMID:34605430;PMID:38004276;PMID:23908634;PMID:34068564;PMID:36950364;PMID:34385849;PMID:22658432",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:816--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:816",
    "edge_subjectNode_name": "CAMK2B",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CAMK2B gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36731029;PMID:34017130;PMID:33337489;PMID:33907032;PMID:24086344;PMID:35753512;PMID:35860309;PMID:33362469;PMID:34307364;PMID:32009883;PMID:28191466;PMID:33807010;PMID:25432637;PMID:24462093;PMID:34549305;PMID:38155836;PMID:29604330;PMID:22207321;PMID:20214899;PMID:29973860",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:5021--infores:semmeddb",
    "edge_object": "NCBIGene:5021",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "OXTR",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects OXTR",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:554--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:554",
    "edge_subjectNode_name": "AVPR2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AVPR2 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:5054--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5054",
    "edge_subjectNode_name": "SERPINE1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "SERPINE1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36287908;PMID:32153685;PMID:36851302;PMID:33451362;PMID:35919568;PMID:35888713;PMID:36535285;PMID:37238951;PMID:27597899;PMID:25949827;PMID:28230174;PMID:30875730;PMID:31963327;PMID:22114580;PMID:21857935;PMID:35617322;PMID:36581622;PMID:29901135;PMID:25205048;PMID:34781995",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:1576--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:1576",
    "edge_subjectNode_name": "CYP3A4",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP3A4 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:33024080;PMID:38136599;PMID:22162478;PMID:37392852;PMID:33194923;PMID:36974717;PMID:20814595;PMID:28213088;PMID:35140681;PMID:22873692;PMID:37253115;PMID:35117470;PMID:33236103;PMID:33415088;PMID:20846929;PMID:35915250;PMID:22222232;PMID:31445893;PMID:38300925;PMID:27032061",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:3315--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3315",
    "edge_subjectNode_name": "HSPB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSPB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:27081917;PMID:27246909;PMID:34194332;PMID:34482756;PMID:18781161;PMID:38003363;PMID:33819264;PMID:35047630;PMID:26100331;PMID:20685377;PMID:28250763;PMID:15571513;PMID:37628788;PMID:16749930;PMID:28709429;PMID:33642401;PMID:31492812;PMID:31583588;PMID:33396566;PMID:25949827",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:816--biolink:gene_associated_with_condition--None--None--None--HP:0011968--infores:disgenet",
    "edge_object": "HP:0011968",
    "edge_subject": "NCBIGene:816",
    "edge_subjectNode_name": "CAMK2B",
    "edge_objectNode_name": "Feeding Problem",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CAMK2B gene associated with condition Feeding Problem",
    "primary_source": "infores:disgenet",
    "publications": "PMID:29100089",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:5587--biolink:physically_interacts_with--None--None--None--NCBIGene:4512--infores:intact",
    "edge_object": "NCBIGene:4512",
    "edge_subject": "NCBIGene:5587",
    "edge_subjectNode_name": "PRKD1",
    "edge_objectNode_name": "COX1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "PRKD1 physically interacts with COX1",
    "primary_source": "infores:intact",
    "publications": "PMID:31980649",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:HP:0011968--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0011968",
    "edge_subjectNode_name": "Feeding Problem",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Feeding Problem manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:5021--infores:dgidb",
    "edge_object": "NCBIGene:5021",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "OXTR",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects OXTR",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:816--infores:dgidb",
    "edge_object": "NCBIGene:816",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "CAMK2B",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects CAMK2B",
    "primary_source": "infores:dgidb",
    "publications": "PMID:15845548",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:5021--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5021",
    "edge_subjectNode_name": "OXTR",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "OXTR gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:22206823;PMID:26441542;PMID:37834773;PMID:24198778;PMID:34575625;PMID:26739971;PMID:34050248;PMID:24790981;PMID:34857904;PMID:35865627;PMID:34301983;PMID:27795858;PMID:30026695;PMID:21078373;PMID:35430029;PMID:37626482;PMID:32050523;PMID:36414006;PMID:35448033;PMID:33122985",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:554--infores:semmeddb",
    "edge_object": "NCBIGene:554",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "AVPR2",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects AVPR2",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:554--biolink:gene_associated_with_condition--None--None--None--HP:0011968--infores:disgenet",
    "edge_object": "HP:0011968",
    "edge_subject": "NCBIGene:554",
    "edge_subjectNode_name": "AVPR2",
    "edge_objectNode_name": "Feeding Problem",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AVPR2 gene associated with condition Feeding Problem",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:1636--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1636",
    "edge_subjectNode_name": "ACE",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ACE gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37698889;PMID:33609255;PMID:26594078;PMID:36421690;PMID:32075790;PMID:31710714;PMID:27230616;PMID:38132210;PMID:34054510;PMID:37927663;PMID:29213969;PMID:23349098;PMID:16551372;PMID:25410743;PMID:37232744;PMID:33636661;PMID:33014275;PMID:28443033;PMID:36585697;PMID:34763262",
    "publications_count": 20,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:816--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:816",
    "edge_subjectNode_name": "CAMK2B",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CAMK2B gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:29100089",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:CHEBI:34543--biolink:affects--None--None--None--NCBIGene:552--infores:drugcentral",
    "edge_object": "NCBIGene:552",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "AVPR1A",
    "predicate": "biolink:affects",
    "phrase": "vasopressin affects AVPR1A",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "infores:rtx-kg2:NCBIGene:552--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:disgenet",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:552",
    "edge_subjectNode_name": "AVPR1A",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AVPR1A gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:17218722",
    "publications_count": 1,
    "support_graph_id": "aux_graph_19_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "medik:creative_edge#215",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "vasopressin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "vasopressin",
    "result_subjectNode_id": "CHEBI:34543",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 92,
    "edge_id": "medik:edge#355",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34543",
    "edge_subjectNode_name": "vasopressin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "vasopressin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:3039766",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#215",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "abiraterone acetate",
    "result_subjectNode_id": "CHEBI:68639",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 93,
    "edge_id": "inferred-CHEBI:68639-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68639",
    "edge_subjectNode_name": "abiraterone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "abiraterone acetate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "abiraterone acetate",
    "result_subjectNode_id": "CHEBI:68639",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 93,
    "edge_id": "CHEBI:68639-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68639",
    "edge_subjectNode_name": "abiraterone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "abiraterone acetate in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:68639-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "abiraterone acetate",
    "result_subjectNode_id": "CHEBI:68639",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 93,
    "edge_id": "CHEBI:68639-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68639",
    "edge_subjectNode_name": "abiraterone acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "abiraterone acetate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:68639-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Pioglitazone",
    "result_subjectNode_id": "CHEBI:8228",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 94,
    "edge_id": "infores:rtx-kg2:CHEBI:8228--biolink:in_clinical_trials_for--None--None--None--MONDO:0018479--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:8228",
    "edge_subjectNode_name": "Pioglitazone",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Pioglitazone treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "creative_DTD_prediction_18",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Angiotensin II treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:4512--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4512",
    "edge_subjectNode_name": "COX1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:26191--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:26191",
    "edge_subjectNode_name": "PTPN22",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPN22 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18301444",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:5595--infores:semmeddb",
    "edge_object": "NCBIGene:5595",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "MAPK3",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects MAPK3",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:interacts_with--None--None--None--NCBIGene:1398--infores:semmeddb",
    "edge_object": "NCBIGene:1398",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "CRK",
    "predicate": "biolink:interacts_with",
    "phrase": "Angiotensin II interacts with CRK",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:15123696;PMID:17624368;PMID:18645046;PMID:19915702;PMID:24448199;PMID:25659900;PMID:25997428;PMID:28887229;PMID:29417337;PMID:9776729",
    "publications_count": 10,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:interacts_with--None--None--None--NCBIGene:7040--infores:semmeddb",
    "edge_object": "NCBIGene:7040",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "TGFB1",
    "predicate": "biolink:interacts_with",
    "phrase": "Angiotensin II interacts with TGFB1",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:10494801;PMID:10701820;PMID:11967815;PMID:15487702;PMID:15682830;PMID:15770925;PMID:16182431;PMID:17601799;PMID:17765135;PMID:22964022;PMID:23137784;PMID:24155898;PMID:27520486;PMID:30345862;PMID:9737942",
    "publications_count": 15,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:interacts_with--None--None--None--NCBIGene:7124--infores:semmeddb",
    "edge_object": "NCBIGene:7124",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "TNF",
    "predicate": "biolink:interacts_with",
    "phrase": "Angiotensin II interacts with TNF",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:10525314;PMID:11081773;PMID:11153758;PMID:11928713;PMID:12480812;PMID:14644777;PMID:14965324;PMID:16419651;PMID:17192125;PMID:17406976;PMID:22223068;PMID:23056347;PMID:23846262;PMID:9458834",
    "publications_count": 14,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:387--infores:semmeddb",
    "edge_object": "NCBIGene:387",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "RHOA",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects RHOA",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:4514--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4514",
    "edge_subjectNode_name": "COX3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX3 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:59272--infores:semmeddb",
    "edge_object": "NCBIGene:59272",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "ACE2",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects ACE2",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36613465;PMID:37893198;PMID:37401986;PMID:33609255;PMID:36846103;PMID:35957525;PMID:36421690;PMID:31455857;PMID:36902200;PMID:34194332;PMID:37862207;PMID:32709848;PMID:25733922;PMID:35056657;PMID:25144875;PMID:23861879;PMID:37034144;PMID:36555783;PMID:37047767;PMID:35720723",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:5879--biolink:physically_interacts_with--None--None--None--NCBIGene:4514--infores:intact",
    "edge_object": "NCBIGene:4514",
    "edge_subject": "NCBIGene:5879",
    "edge_subjectNode_name": "RAC1",
    "edge_objectNode_name": "COX3",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "RAC1 physically interacts with COX3",
    "primary_source": "infores:intact",
    "publications": "PMID:21988832",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:1432--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1432",
    "edge_subjectNode_name": "MAPK14",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MAPK14 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35222122;PMID:33229747;PMID:36711845;PMID:37556347;PMID:37007031;PMID:31542363;PMID:34834539;PMID:25754968;PMID:34308255;PMID:32961703;PMID:35330088;PMID:33763064;PMID:35655441;PMID:22311599;PMID:29662436;PMID:36275900;PMID:31222732;PMID:21078373;PMID:25733148;PMID:32722328",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:causes--None--None--None--HP:0031273--infores:semmeddb",
    "edge_object": "HP:0031273",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "Shock",
    "predicate": "biolink:causes",
    "phrase": "TNF causes Shock",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:1892644;PMID:10948120;PMID:11749775;PMID:12218121;PMID:12188028;PMID:10382751;PMID:27551444;PMID:33273695;PMID:19502556;PMID:17404289;PMID:12652297;PMID:30136236;PMID:33278357;PMID:8834770;PMID:8790597;PMID:20130231;PMID:28894448;PMID:21646349;PMID:11158047;PMID:8711645",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:29483653",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:387--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:387",
    "edge_subjectNode_name": "RHOA",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "RHOA gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:31213978;PMID:32425757;PMID:35562853;PMID:36323241;PMID:26542704;PMID:27713499;PMID:36739316;PMID:31516995;PMID:35783090;PMID:32065105;PMID:31861860;PMID:30201915;PMID:31710714;PMID:29250526;PMID:25733148;PMID:29249937;PMID:25221471;PMID:30468666;PMID:28941295;PMID:36013378",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:HP:0031273--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0031273",
    "edge_subjectNode_name": "Shock",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Shock manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:15102771",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:interacts_with--None--None--None--NCBIGene:185--infores:semmeddb",
    "edge_object": "NCBIGene:185",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "AGTR1",
    "predicate": "biolink:interacts_with",
    "phrase": "Angiotensin II interacts with AGTR1",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:22116365;PMID:33952303;PMID:7738168;PMID:28034895;PMID:29178049;PMID:9892146;PMID:23942780;PMID:20353822;PMID:33795351;PMID:35964178;PMID:19724024;PMID:21450123;PMID:36555515;PMID:33745438;PMID:16036315;PMID:36175813;PMID:27588004",
    "publications_count": 17,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:affects--None--None--None--MONDO:0018076--infores:semmeddb",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:affects",
    "phrase": "TNF affects tuberculosis",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:20173394;PMID:25400917;PMID:23516984;PMID:12745543;PMID:10885842;PMID:29523325;PMID:23672175;PMID:27247233;PMID:37147816",
    "publications_count": 9,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:1432--infores:semmeddb",
    "edge_object": "NCBIGene:1432",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "MAPK14",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects MAPK14",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:4538--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4538",
    "edge_subjectNode_name": "ND4",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ND4 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:16133992",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:28303499",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:4513--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4513",
    "edge_subjectNode_name": "COX2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX2 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:6774--infores:semmeddb",
    "edge_object": "NCBIGene:6774",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "STAT3",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects STAT3",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7040--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7040",
    "edge_subjectNode_name": "TGFB1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TGFB1 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:33193365;PMID:37772259;PMID:35232004;PMID:25587366;PMID:17362490;PMID:31816847;PMID:34022844;PMID:37903877;PMID:31763432;PMID:34983490;PMID:31116231;PMID:27261452;PMID:31707357;PMID:33962573;PMID:29559116;PMID:31172218;PMID:19575238;PMID:34386704;PMID:24722473;PMID:22346770",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:5595--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5595",
    "edge_subjectNode_name": "MAPK3",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MAPK3 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:26441542;PMID:32325033;PMID:32709848;PMID:33819264;PMID:35056657;PMID:37047767;PMID:36555783;PMID:34054510;PMID:36437888;PMID:35867745;PMID:20543890;PMID:30733059;PMID:23316347;PMID:33083721;PMID:35211808;PMID:28620373;PMID:38075775;PMID:33747107;PMID:19914906;PMID:35822169",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:59272--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:59272",
    "edge_subjectNode_name": "ACE2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ACE2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:32871412;PMID:32430637;PMID:32427134;PMID:33609255;PMID:36672595;PMID:34248921;PMID:32685076;PMID:32633678;PMID:32655490;PMID:36851302;PMID:32578165;PMID:32912745;PMID:36229517;PMID:36389157;PMID:33992187;PMID:31710714;PMID:35998873;PMID:33060875;PMID:36203574;PMID:33426593",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:387--biolink:physically_interacts_with--None--None--None--NCBIGene:4513--infores:intact",
    "edge_object": "NCBIGene:4513",
    "edge_subject": "NCBIGene:387",
    "edge_subjectNode_name": "RHOA",
    "edge_objectNode_name": "COX2",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "RHOA physically interacts with COX2",
    "primary_source": "infores:intact",
    "publications": "PMID:31980649",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:5879--biolink:physically_interacts_with--None--None--None--NCBIGene:4538--infores:intact",
    "edge_object": "NCBIGene:4538",
    "edge_subject": "NCBIGene:5879",
    "edge_subjectNode_name": "RAC1",
    "edge_objectNode_name": "ND4",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "RAC1 physically interacts with ND4",
    "primary_source": "infores:intact",
    "publications": "PMID:31980649",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:5879--infores:semmeddb",
    "edge_object": "NCBIGene:5879",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "RAC1",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects RAC1",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35800441;PMID:20129310;PMID:32295518;PMID:37538259;PMID:33953774;PMID:28588493;PMID:27165310;PMID:37401986;PMID:33609255;PMID:34697287;PMID:23889986;PMID:24011127;PMID:35720723;PMID:31172218;PMID:34836549;PMID:37392651;PMID:32308807;PMID:37232744;PMID:33973365;PMID:36339816",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:5879--biolink:physically_interacts_with--None--None--None--NCBIGene:4512--infores:intact",
    "edge_object": "NCBIGene:4512",
    "edge_subject": "NCBIGene:5879",
    "edge_subjectNode_name": "RAC1",
    "edge_objectNode_name": "COX1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "RAC1 physically interacts with COX1",
    "primary_source": "infores:intact",
    "publications": "PMID:31980649",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:185--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:185",
    "edge_subjectNode_name": "AGTR1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "AGTR1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:31695023;PMID:37732033;PMID:36624096;PMID:33424536;PMID:36244037;PMID:32671136;PMID:35755063;PMID:25183238;PMID:37443678;PMID:34535637;PMID:35411297;PMID:26415143;PMID:32231577;PMID:36591299;PMID:33447758;PMID:35888713;PMID:30233358;PMID:28769090;PMID:29894319;PMID:33426593",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:26191--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:diseases",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:26191",
    "edge_subjectNode_name": "PTPN22",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPN22 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:24614117;PMID:20959028;PMID:29310926;PMID:29849176;PMID:35456512;PMID:32971447;PMID:29529281;PMID:21205883;PMID:26618927;PMID:26405069;PMID:38957156;PMID:33966174;PMID:20455416;PMID:21617108;PMID:34074094;PMID:36980146;PMID:25579746;PMID:16403820;PMID:36755664;PMID:20969580",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:interacts_with--None--None--None--NCBIGene:472--infores:semmeddb",
    "edge_object": "NCBIGene:472",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "ATM",
    "predicate": "biolink:interacts_with",
    "phrase": "Angiotensin II interacts with ATM",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:21358416;PMID:10693967;PMID:16443562;PMID:9889388;PMID:2041570;PMID:7738168;PMID:23325393;PMID:8984739;PMID:15888919;PMID:18420589;PMID:9316213;PMID:12553854;PMID:24817179;PMID:9756092;PMID:18182223;PMID:8993847;PMID:8839447;PMID:28253719;PMID:23988828;PMID:12608526",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:2185--infores:semmeddb",
    "edge_object": "NCBIGene:2185",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "PTK2B",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects PTK2B",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:interacts_with--None--None--None--NCBIGene:59272--infores:semmeddb",
    "edge_object": "NCBIGene:59272",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "ACE2",
    "predicate": "biolink:interacts_with",
    "phrase": "Angiotensin II interacts with ACE2",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:35563515;PMID:23535237;PMID:20347904;PMID:19923158;PMID:31901211;PMID:25484288;PMID:36378226;PMID:27085714;PMID:19717501;PMID:29196099",
    "publications_count": 10,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:5595--biolink:gene_associated_with_condition--None--None--None--HP:0031273--infores:disgenet",
    "edge_object": "HP:0031273",
    "edge_subject": "NCBIGene:5595",
    "edge_subjectNode_name": "MAPK3",
    "edge_objectNode_name": "Shock",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MAPK3 gene associated with condition Shock",
    "primary_source": "infores:disgenet",
    "publications": "PMID:29110153",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:CHEBI:2719--biolink:affects--None--None--None--NCBIGene:1398--infores:semmeddb",
    "edge_object": "NCBIGene:1398",
    "edge_subject": "CHEBI:2719",
    "edge_subjectNode_name": "Angiotensin II",
    "edge_objectNode_name": "CRK",
    "predicate": "biolink:affects",
    "phrase": "Angiotensin II affects CRK",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:1398--biolink:directly_physically_interacts_with--None--None--None--NCBIGene:26191--infores:intact",
    "edge_object": "NCBIGene:26191",
    "edge_subject": "NCBIGene:1398",
    "edge_subjectNode_name": "CRK",
    "edge_objectNode_name": "PTPN22",
    "predicate": "biolink:directly_physically_interacts_with",
    "phrase": "CRK directly physically interacts with PTPN22",
    "primary_source": "infores:intact",
    "publications": "PMID:35044719",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:472--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:472",
    "edge_subjectNode_name": "ATM",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ATM gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36287908;PMID:23060898;PMID:29313802;PMID:29547541;PMID:25432731;PMID:28607096;PMID:38222898;PMID:36229517;PMID:30981321;PMID:36637312;PMID:32709848;PMID:31710714;PMID:36003051;PMID:35672297;PMID:25002129;PMID:26486089;PMID:33277461;PMID:28230174;PMID:20106545;PMID:35886058",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:28676205;PMID:32353074;PMID:35937690;PMID:31000880;PMID:34504873;PMID:21852947;PMID:25102137;PMID:27242800;PMID:32053993;PMID:23569358;PMID:28418288;PMID:35721093;PMID:23264552;PMID:17998917;PMID:35133578;PMID:20848501;PMID:34943793;PMID:36421613;PMID:37936773;PMID:31116231",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:472--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:472",
    "edge_subjectNode_name": "ATM",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ATM gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:6774--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:6774",
    "edge_subjectNode_name": "STAT3",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "STAT3 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:30526315;PMID:37893198;PMID:32800705;PMID:35957525;PMID:34697287;PMID:36902200;PMID:32709848;PMID:35628657;PMID:22542945;PMID:35056657;PMID:31879799;PMID:31481878;PMID:34632168;PMID:34083789;PMID:23180096;PMID:27597899;PMID:24365570;PMID:34221026;PMID:34941738;PMID:33715827",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:7124--biolink:gene_associated_with_condition--None--None--None--HP:0031273--infores:disgenet",
    "edge_object": "HP:0031273",
    "edge_subject": "NCBIGene:7124",
    "edge_subjectNode_name": "TNF",
    "edge_objectNode_name": "Shock",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TNF gene associated with condition Shock",
    "primary_source": "infores:disgenet",
    "publications": "PMID:7537468",
    "publications_count": 1,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Angiotensin II",
    "result_subjectNode_id": "CHEBI:2719",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 95,
    "edge_id": "infores:rtx-kg2:NCBIGene:2185--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2185",
    "edge_subjectNode_name": "PTK2B",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTK2B gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35562853;PMID:29021340;PMID:22959996;PMID:36865551;PMID:38593702;PMID:34503576;PMID:34135628;PMID:33946378;PMID:31033776;PMID:35656941;PMID:18946537;PMID:28259165;PMID:28779178;PMID:37834213;PMID:34083789;PMID:36359887;PMID:28929972;PMID:31317506;PMID:36836731;PMID:28322340",
    "publications_count": 20,
    "support_graph_id": "aux_graph_21_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nafarelin",
    "result_subjectNode_id": "CHEBI:7445",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 96,
    "edge_id": "infores:molepro:CHEBI:7445--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:7445",
    "edge_subjectNode_name": "Nafarelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Nafarelin treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tildacerfont",
    "result_subjectNode_id": "UNII:09QCEV5481",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 97,
    "edge_id": "inferred-UNII:09QCEV5481-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:09QCEV5481",
    "edge_subjectNode_name": "Tildacerfont",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tildacerfont treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tildacerfont",
    "result_subjectNode_id": "UNII:09QCEV5481",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 97,
    "edge_id": "UNII:09QCEV5481-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:09QCEV5481",
    "edge_subjectNode_name": "Tildacerfont",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Tildacerfont in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:09QCEV5481-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Hydroxyprogesterone caproate",
    "result_subjectNode_id": "CHEBI:5812",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 98,
    "edge_id": "inferred-CHEBI:5812-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5812",
    "edge_subjectNode_name": "Hydroxyprogesterone caproate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Hydroxyprogesterone caproate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Hydroxyprogesterone caproate",
    "result_subjectNode_id": "CHEBI:5812",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 98,
    "edge_id": "CHEBI:5812-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5812",
    "edge_subjectNode_name": "Hydroxyprogesterone caproate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Hydroxyprogesterone caproate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5812-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126196",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 99,
    "edge_id": "medik:creative_edge#159",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10126196",
    "edge_subjectNode_name": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126196",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 99,
    "edge_id": "medik:edge#235",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10126196",
    "edge_subjectNode_name": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#159",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Isobutyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126196",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 99,
    "edge_id": "medik:edge#236",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#159",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10156793",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 100,
    "edge_id": "medik:creative_edge#181",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10156793",
    "edge_subjectNode_name": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10156793",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 100,
    "edge_id": "medik:edge#279",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10156793",
    "edge_subjectNode_name": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:12620078",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#181",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Allyl-10-difluoromethoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10156793",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 100,
    "edge_id": "medik:edge#280",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#181",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173217",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 101,
    "edge_id": "medik:creative_edge#188",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10173217",
    "edge_subjectNode_name": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173217",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 101,
    "edge_id": "medik:edge#293",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10173217",
    "edge_subjectNode_name": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#188",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-4-methyl-2,4-diphenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173217",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 101,
    "edge_id": "medik:edge#294",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#188",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cytisine",
    "result_subjectNode_id": "CHEBI:4055",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 102,
    "edge_id": "medik:creative_edge#106",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4055",
    "edge_subjectNode_name": "Cytisine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cytisine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cytisine",
    "result_subjectNode_id": "CHEBI:4055",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 102,
    "edge_id": "medik:edge#129",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:4055",
    "edge_subjectNode_name": "Cytisine",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Cytisine affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:17630191",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#106",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cytisine",
    "result_subjectNode_id": "CHEBI:4055",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 102,
    "edge_id": "medik:edge#130",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#106",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nifedipine",
    "result_subjectNode_id": "CHEBI:7565",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 103,
    "edge_id": "infores:rtx-kg2:CHEBI:7565--biolink:in_clinical_trials_for--None--None--None--MONDO:0018479--infores:multiomics-clinicaltrials",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:7565",
    "edge_subjectNode_name": "Nifedipine",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Nifedipine treats congenital adrenal hyperplasia",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127269",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 104,
    "edge_id": "medik:creative_edge#166",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10127269",
    "edge_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127269",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 104,
    "edge_id": "medik:edge#249",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10127269",
    "edge_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#166",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-((2-methylnaphthalen-1-yl)methyl)pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127269",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 104,
    "edge_id": "medik:edge#250",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#166",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10177869",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 105,
    "edge_id": "medik:creative_edge#193",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10177869",
    "edge_subjectNode_name": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10177869",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 105,
    "edge_id": "medik:edge#303",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10177869",
    "edge_subjectNode_name": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#193",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Hydroxymethyl-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10177869",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 105,
    "edge_id": "medik:edge#304",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#193",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nevanimibe",
    "result_subjectNode_id": "UNII:VK9OS8R205",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 106,
    "edge_id": "inferred-UNII:VK9OS8R205-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:VK9OS8R205",
    "edge_subjectNode_name": "Nevanimibe",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Nevanimibe treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nevanimibe",
    "result_subjectNode_id": "UNII:VK9OS8R205",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 106,
    "edge_id": "UNII:VK9OS8R205-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:VK9OS8R205",
    "edge_subjectNode_name": "Nevanimibe",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Nevanimibe studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:VK9OS8R205-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126940",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 107,
    "edge_id": "medik:creative_edge#163",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10126940",
    "edge_subjectNode_name": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126940",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 107,
    "edge_id": "medik:edge#243",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10126940",
    "edge_subjectNode_name": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#163",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3-Fluoro-4-(4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)benzonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126940",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 107,
    "edge_id": "medik:edge#244",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#163",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Atrazine",
    "result_subjectNode_id": "CHEBI:15930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 108,
    "edge_id": "medik:creative_edge#98",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15930",
    "edge_subjectNode_name": "Atrazine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Atrazine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Atrazine",
    "result_subjectNode_id": "CHEBI:15930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 108,
    "edge_id": "medik:edge#113",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:15930",
    "edge_subjectNode_name": "Atrazine",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Atrazine affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:25433234",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#98",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Atrazine",
    "result_subjectNode_id": "CHEBI:15930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 108,
    "edge_id": "medik:edge#114",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#98",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CORTISONE",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL111861",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 109,
    "edge_id": "5383527",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL111861",
    "edge_subjectNode_name": "CORTISONE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CORTISONE treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "SODIUM CATION",
    "result_subjectNode_id": "CHEBI:26717",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 110,
    "edge_id": "infores:molepro:CHEBI:26717--biolink:treats--None--None--None--MONDO:0015129--infores:sider",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26717",
    "edge_subjectNode_name": "SODIUM CATION",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "SODIUM CATION treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "SODIUM CATION",
    "result_subjectNode_id": "CHEBI:26717",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 110,
    "edge_id": "407758898b2e",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26717",
    "edge_subjectNode_name": "SODIUM CATION",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "SODIUM CATION treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Chloral hydrate",
    "result_subjectNode_id": "CHEBI:28142",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 111,
    "edge_id": "medik:creative_edge#91",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28142",
    "edge_subjectNode_name": "Chloral hydrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Chloral hydrate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Chloral hydrate",
    "result_subjectNode_id": "CHEBI:28142",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 111,
    "edge_id": "medik:edge#99",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:28142",
    "edge_subjectNode_name": "Chloral hydrate",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Chloral hydrate affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:17077186",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#91",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Chloral hydrate",
    "result_subjectNode_id": "CHEBI:28142",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 111,
    "edge_id": "medik:edge#100",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#91",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "DEXAMETHASONE SODIUM PHOSPHATE",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:23667621",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 112,
    "edge_id": "5381292",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:23667621",
    "edge_subjectNode_name": "DEXAMETHASONE SODIUM PHOSPHATE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "DEXAMETHASONE SODIUM PHOSPHATE treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aurin",
    "result_subjectNode_id": "CHEBI:34544",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 113,
    "edge_id": "medik:creative_edge#130",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34544",
    "edge_subjectNode_name": "Aurin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aurin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aurin",
    "result_subjectNode_id": "CHEBI:34544",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 113,
    "edge_id": "medik:edge#177",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:34544",
    "edge_subjectNode_name": "Aurin",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Aurin affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:19255438",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#130",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aurin",
    "result_subjectNode_id": "CHEBI:34544",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 113,
    "edge_id": "medik:edge#178",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#130",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dactinomycin",
    "result_subjectNode_id": "CHEBI:27666",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 114,
    "edge_id": "medik:creative_edge#113",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27666",
    "edge_subjectNode_name": "Dactinomycin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Dactinomycin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dactinomycin",
    "result_subjectNode_id": "CHEBI:27666",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 114,
    "edge_id": "medik:edge#143",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:27666",
    "edge_subjectNode_name": "Dactinomycin",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Dactinomycin affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:21569845",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#113",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dactinomycin",
    "result_subjectNode_id": "CHEBI:27666",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 114,
    "edge_id": "medik:edge#144",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#113",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethylene Dichloride",
    "result_subjectNode_id": "CHEBI:27789",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 115,
    "edge_id": "medik:creative_edge#102",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27789",
    "edge_subjectNode_name": "Ethylene Dichloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ethylene Dichloride treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethylene Dichloride",
    "result_subjectNode_id": "CHEBI:27789",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 115,
    "edge_id": "medik:edge#121",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:27789",
    "edge_subjectNode_name": "Ethylene Dichloride",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Ethylene Dichloride affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:24228488",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#102",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethylene Dichloride",
    "result_subjectNode_id": "CHEBI:27789",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 115,
    "edge_id": "medik:edge#122",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#102",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dichloroacetic acid",
    "result_subjectNode_id": "CHEBI:36386",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 116,
    "edge_id": "medik:creative_edge#94",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:36386",
    "edge_subjectNode_name": "Dichloroacetic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Dichloroacetic acid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dichloroacetic acid",
    "result_subjectNode_id": "CHEBI:36386",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 116,
    "edge_id": "medik:edge#105",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:36386",
    "edge_subjectNode_name": "Dichloroacetic acid",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Dichloroacetic acid affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:22705712",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#94",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dichloroacetic acid",
    "result_subjectNode_id": "CHEBI:36386",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 116,
    "edge_id": "medik:edge#106",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#94",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Trichostatin A",
    "result_subjectNode_id": "CHEBI:46024",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 117,
    "edge_id": "medik:creative_edge#131",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46024",
    "edge_subjectNode_name": "Trichostatin A",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Trichostatin A treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Trichostatin A",
    "result_subjectNode_id": "CHEBI:46024",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 117,
    "edge_id": "medik:edge#179",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:46024",
    "edge_subjectNode_name": "Trichostatin A",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Trichostatin A affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:31778773",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#131",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Trichostatin A",
    "result_subjectNode_id": "CHEBI:46024",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 117,
    "edge_id": "medik:edge#180",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#131",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Androstenedione",
    "result_subjectNode_id": "CHEBI:16422",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 118,
    "edge_id": "inferred-CHEBI:16422-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16422",
    "edge_subjectNode_name": "Androstenedione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Androstenedione treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Androstenedione",
    "result_subjectNode_id": "CHEBI:16422",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 118,
    "edge_id": "CHEBI:16422-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16422",
    "edge_subjectNode_name": "Androstenedione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Androstenedione studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16422-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10002879",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 119,
    "edge_id": "medik:creative_edge#141",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10002879",
    "edge_subjectNode_name": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10002879",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 119,
    "edge_id": "medik:edge#199",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10002879",
    "edge_subjectNode_name": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17118655",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#141",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)butan-2-yl)-2,4,6-trichlorobenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10002879",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 119,
    "edge_id": "medik:edge#200",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#141",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:6850791",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 120,
    "edge_id": "infores:molepro:PUBCHEM.COMPOUND:6850791--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "PUBCHEM.COMPOUND:6850791",
    "edge_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metreton",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:4896",
    "result_objectNode_name": "congenital adrenal hyperplasia",
    "result_objectNode_id": "MONDO:0018479",
    "result_counter": 121,
    "edge_id": "infores:molepro:PUBCHEM.COMPOUND:4896--biolink:treats--None--None--None--MONDO:0018479--infores:sider",
    "edge_object": "MONDO:0018479",
    "edge_subject": "PUBCHEM.COMPOUND:4896",
    "edge_subjectNode_name": "Metreton",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Metreton treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10177943",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 122,
    "edge_id": "medik:creative_edge#194",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10177943",
    "edge_subjectNode_name": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10177943",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 122,
    "edge_id": "medik:edge#305",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10177943",
    "edge_subjectNode_name": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#194",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Methoxy-6-pyridin-2-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10177943",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 122,
    "edge_id": "medik:edge#306",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#194",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "glucocorticoid",
    "result_subjectNode_id": "CHEBI:24261",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 123,
    "edge_id": "inferred-CHEBI:24261-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:24261",
    "edge_subjectNode_name": "glucocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "glucocorticoid treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "glucocorticoid",
    "result_subjectNode_id": "CHEBI:24261",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 123,
    "edge_id": "4fcaf0b28fc0ece430922842882a2bae",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:24261",
    "edge_subjectNode_name": "glucocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "glucocorticoid studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:2162013;PMID:3019857;PMID:7950508;PMID:14655804;PMID:15256782;PMID:21585418;PMID:26800219;PMID:31532828;PMID:32436184",
    "publications_count": 9,
    "support_graph_id": "inferred-CHEBI:24261-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "glucocorticoid",
    "result_subjectNode_id": "CHEBI:24261",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 123,
    "edge_id": "CHEBI:24261-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:24261",
    "edge_subjectNode_name": "glucocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "glucocorticoid studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:24261-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10193599",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 124,
    "edge_id": "medik:creative_edge#195",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10193599",
    "edge_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10193599",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 124,
    "edge_id": "medik:edge#307",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10193599",
    "edge_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#195",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-propyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10193599",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 124,
    "edge_id": "medik:edge#308",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#195",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Graphite",
    "result_subjectNode_id": "CHEBI:27594",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 125,
    "edge_id": "medik:creative_edge#89",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27594",
    "edge_subjectNode_name": "Graphite",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Graphite treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Graphite",
    "result_subjectNode_id": "CHEBI:27594",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 125,
    "edge_id": "medik:edge#95",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:27594",
    "edge_subjectNode_name": "Graphite",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Graphite affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:27440207",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#89",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Graphite",
    "result_subjectNode_id": "CHEBI:27594",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 125,
    "edge_id": "medik:edge#96",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#89",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Progesterone",
    "result_subjectNode_id": "CHEBI:17026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 126,
    "edge_id": "inferred-CHEBI:17026-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17026",
    "edge_subjectNode_name": "Progesterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Progesterone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Progesterone",
    "result_subjectNode_id": "CHEBI:17026",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 126,
    "edge_id": "CHEBI:17026-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17026",
    "edge_subjectNode_name": "Progesterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Progesterone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:17026-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Testosterone cypionate",
    "result_subjectNode_id": "CHEBI:9463",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 127,
    "edge_id": "inferred-CHEBI:9463-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9463",
    "edge_subjectNode_name": "Testosterone cypionate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Testosterone cypionate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Testosterone cypionate",
    "result_subjectNode_id": "CHEBI:9463",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 127,
    "edge_id": "CHEBI:9463-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9463",
    "edge_subjectNode_name": "Testosterone cypionate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Testosterone cypionate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:9463-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10071810",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 128,
    "edge_id": "medik:creative_edge#151",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10071810",
    "edge_subjectNode_name": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10071810",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 128,
    "edge_id": "medik:edge#219",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10071810",
    "edge_subjectNode_name": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17181172",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#151",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-[4-(5-fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl]-1H-[1,5]naphthyridin-4-one",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10071810",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 128,
    "edge_id": "medik:edge#220",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#151",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rifampicin",
    "result_subjectNode_id": "CHEBI:28077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 129,
    "edge_id": "medik:creative_edge#90",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28077",
    "edge_subjectNode_name": "Rifampicin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Rifampicin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rifampicin",
    "result_subjectNode_id": "CHEBI:28077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 129,
    "edge_id": "medik:edge#97",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:28077",
    "edge_subjectNode_name": "Rifampicin",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Rifampicin affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:27933861",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#90",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rifampicin",
    "result_subjectNode_id": "CHEBI:28077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 129,
    "edge_id": "medik:edge#98",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#90",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151995",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 130,
    "edge_id": "medik:creative_edge#180",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10151995",
    "edge_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151995",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 130,
    "edge_id": "medik:edge#277",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10151995",
    "edge_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#180",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[[7-(trifluoromethyl)-1H-indol-2-yl]methyl]pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151995",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 130,
    "edge_id": "medik:edge#278",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#180",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "carbamate",
    "result_subjectNode_id": "CHEBI:13941",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 131,
    "edge_id": "medik:creative_edge#97",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:13941",
    "edge_subjectNode_name": "carbamate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "carbamate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "carbamate",
    "result_subjectNode_id": "CHEBI:13941",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 131,
    "edge_id": "medik:edge#111",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:13941",
    "edge_subjectNode_name": "carbamate",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "carbamate affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:19455394",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#97",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "carbamate",
    "result_subjectNode_id": "CHEBI:13941",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 131,
    "edge_id": "medik:edge#112",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#97",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10194268",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 132,
    "edge_id": "medik:creative_edge#197",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10194268",
    "edge_subjectNode_name": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10194268",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 132,
    "edge_id": "medik:edge#311",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10194268",
    "edge_subjectNode_name": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#197",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "6-(5-Fluoro-2-methoxyphenyl)-6-methyl-1-phenyl-4-(trifluoromethyl)heptan-4-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10194268",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 132,
    "edge_id": "medik:edge#312",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#197",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "mineralocorticoid",
    "result_subjectNode_id": "CHEBI:25354",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 133,
    "edge_id": "inferred-CHEBI:25354-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:25354",
    "edge_subjectNode_name": "mineralocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "mineralocorticoid treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "mineralocorticoid",
    "result_subjectNode_id": "CHEBI:25354",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 133,
    "edge_id": "022d3f784514107a5072643a537ac932",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:25354",
    "edge_subjectNode_name": "mineralocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "mineralocorticoid studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:403602;PMID:3706393;PMID:2061574;PMID:10210741;PMID:14655804;PMID:30562824;PMID:38034003",
    "publications_count": 7,
    "support_graph_id": "inferred-CHEBI:25354-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "mineralocorticoid",
    "result_subjectNode_id": "CHEBI:25354",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 133,
    "edge_id": "CHEBI:25354-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:25354",
    "edge_subjectNode_name": "mineralocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "mineralocorticoid studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:25354-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "mineralocorticoid",
    "result_subjectNode_id": "CHEBI:25354",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 133,
    "edge_id": "medik:creative_edge#207",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:25354",
    "edge_subjectNode_name": "mineralocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "mineralocorticoid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "mineralocorticoid",
    "result_subjectNode_id": "CHEBI:25354",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 133,
    "edge_id": "medik:edge#347",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:25354",
    "edge_subjectNode_name": "mineralocorticoid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "mineralocorticoid studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:10210741;PMID:14655804;PMID:2061574;PMID:30562824;PMID:3706393;PMID:403602",
    "publications_count": 6,
    "support_graph_id": "medik:auxiliary_graph#207",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45265930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 134,
    "edge_id": "medik:creative_edge#122",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:45265930",
    "edge_subjectNode_name": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45265930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 134,
    "edge_id": "medik:edge#161",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:45265930",
    "edge_subjectNode_name": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17681466",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#122",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "6-(5-fluoro-2-methoxyphenyl)-2,2-dimethyl-4-(1-prop-2-enoxyethyl)-1H-quinoline;hydrobromide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45265930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 134,
    "edge_id": "medik:edge#162",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#122",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Budesonide",
    "result_subjectNode_id": "CHEBI:3207",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 135,
    "edge_id": "medik:creative_edge#116",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:3207",
    "edge_subjectNode_name": "Budesonide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Budesonide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Budesonide",
    "result_subjectNode_id": "CHEBI:3207",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 135,
    "edge_id": "medik:edge#149",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:3207",
    "edge_subjectNode_name": "Budesonide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Budesonide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:28937774",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#116",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Budesonide",
    "result_subjectNode_id": "CHEBI:3207",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 135,
    "edge_id": "medik:edge#150",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#116",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tarceva",
    "result_subjectNode_id": "CHEBI:53509",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 136,
    "edge_id": "medik:creative_edge#88",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:53509",
    "edge_subjectNode_name": "Tarceva",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tarceva treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tarceva",
    "result_subjectNode_id": "CHEBI:53509",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 136,
    "edge_id": "medik:edge#93",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:53509",
    "edge_subjectNode_name": "Tarceva",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Tarceva affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:21195724",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#88",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tarceva",
    "result_subjectNode_id": "CHEBI:53509",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 136,
    "edge_id": "medik:edge#94",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#88",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phenyl benzoate",
    "result_subjectNode_id": "CHEBI:86919",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 137,
    "edge_id": "medik:creative_edge#107",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:86919",
    "edge_subjectNode_name": "phenyl benzoate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "phenyl benzoate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phenyl benzoate",
    "result_subjectNode_id": "CHEBI:86919",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 137,
    "edge_id": "medik:edge#131",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:86919",
    "edge_subjectNode_name": "phenyl benzoate",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "phenyl benzoate affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:22245253",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#107",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phenyl benzoate",
    "result_subjectNode_id": "CHEBI:86919",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 137,
    "edge_id": "medik:edge#132",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#107",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10026120",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 138,
    "edge_id": "medik:creative_edge#145",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10026120",
    "edge_subjectNode_name": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10026120",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 138,
    "edge_id": "medik:edge#207",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10026120",
    "edge_subjectNode_name": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17181172",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#145",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-(trifluoromethyl)pentyl)quinazolin-4(1H)-one",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10026120",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 138,
    "edge_id": "medik:edge#208",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#145",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "androgen",
    "result_subjectNode_id": "CHEBI:50113",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 139,
    "edge_id": "inferred-CHEBI:50113-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50113",
    "edge_subjectNode_name": "androgen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "androgen treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "androgen",
    "result_subjectNode_id": "CHEBI:50113",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 139,
    "edge_id": "CHEBI:50113-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50113",
    "edge_subjectNode_name": "androgen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "androgen studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:50113-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "androgen",
    "result_subjectNode_id": "CHEBI:50113",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 139,
    "edge_id": "medik:creative_edge#212",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50113",
    "edge_subjectNode_name": "androgen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "androgen treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "androgen",
    "result_subjectNode_id": "CHEBI:50113",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 139,
    "edge_id": "medik:edge#352",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50113",
    "edge_subjectNode_name": "androgen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "androgen studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:464794;PMID:8473406",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#212",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Pioglitazone",
    "result_subjectNode_id": "CHEBI:8228",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 140,
    "edge_id": "inferred-CHEBI:8228-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8228",
    "edge_subjectNode_name": "Pioglitazone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Pioglitazone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Pioglitazone",
    "result_subjectNode_id": "CHEBI:8228",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 140,
    "edge_id": "CHEBI:8228-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8228",
    "edge_subjectNode_name": "Pioglitazone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Pioglitazone in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8228-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Pioglitazone",
    "result_subjectNode_id": "CHEBI:8228",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 140,
    "edge_id": "CHEBI:8228-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8228",
    "edge_subjectNode_name": "Pioglitazone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Pioglitazone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:8228-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Spironolactone",
    "result_subjectNode_id": "CHEBI:9241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 141,
    "edge_id": "inferred-CHEBI:9241-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9241",
    "edge_subjectNode_name": "Spironolactone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Spironolactone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Spironolactone",
    "result_subjectNode_id": "CHEBI:9241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 141,
    "edge_id": "CHEBI:9241-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9241",
    "edge_subjectNode_name": "Spironolactone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Spironolactone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:9241-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10046928",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 142,
    "edge_id": "medik:creative_edge#149",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10046928",
    "edge_subjectNode_name": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10046928",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 142,
    "edge_id": "medik:edge#215",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10046928",
    "edge_subjectNode_name": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15115388",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#149",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(R)-[(4aR,5S)-1-(4-fluorophenyl)-4a-methyl-1H,4H,4aH,5H,6H,7H,8H-cyclohexa[f]indazol-5-yl](2-fluorophenyl)methanol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10046928",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 142,
    "edge_id": "medik:edge#216",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#149",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204038",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 143,
    "edge_id": "medik:creative_edge#134",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204038",
    "edge_subjectNode_name": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204038",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 143,
    "edge_id": "medik:edge#185",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204038",
    "edge_subjectNode_name": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:23131342",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#134",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "trans-5-benzyl-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204038",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 143,
    "edge_id": "medik:edge#186",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#134",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "creative_DTD_prediction_13",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Urea treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:1499--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1499",
    "edge_subjectNode_name": "CTNNB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CTNNB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37171308;PMID:37401986;PMID:33437373;PMID:28607096;PMID:32709848;PMID:36004035;PMID:35056657;PMID:37047767;PMID:23861879;PMID:36555783;PMID:37593441;PMID:37628788;PMID:27597899;PMID:30875083;PMID:34221026;PMID:36942388;PMID:34941738;PMID:33251167;PMID:30733059;PMID:21093602",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3172--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:3172",
    "edge_subjectNode_name": "HNF4A",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HNF4A gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:6197--infores:dgidb",
    "edge_object": "NCBIGene:6197",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "RPS6KA3",
    "predicate": "biolink:affects",
    "phrase": "Urea affects RPS6KA3",
    "primary_source": "infores:dgidb",
    "publications": "PMID:9458825",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:1499--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:1499",
    "edge_subjectNode_name": "CTNNB1",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CTNNB1 gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3308--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3308",
    "edge_subjectNode_name": "HSPA4",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSPA4 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:21415884;PMID:21944942;PMID:36287908;PMID:36923110;PMID:8625535;PMID:36274992;PMID:34206722;PMID:28223148;PMID:28470727;PMID:27195120;PMID:26587210;PMID:25789467;PMID:9406344;PMID:37795270;PMID:31554244;PMID:38256033;PMID:37262021;PMID:34445373;PMID:17714584;PMID:37601355",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:51081--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:51081",
    "edge_subjectNode_name": "MRPS7",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MRPS7 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:7066--infores:dgidb",
    "edge_object": "NCBIGene:7066",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "THPO",
    "predicate": "biolink:affects",
    "phrase": "Urea affects THPO",
    "primary_source": "infores:dgidb",
    "publications": "PMID:9726418",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3172--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:3172",
    "edge_subjectNode_name": "HNF4A",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HNF4A gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:23264425;PMID:33292863;PMID:36526632;PMID:25209997;PMID:27187615;PMID:31360071;PMID:20936117;PMID:30038292;PMID:20957001;PMID:35237236;PMID:30250231;PMID:33526762;PMID:25981666;PMID:29290922;PMID:29391777;PMID:20644627;PMID:33217903;PMID:23029263;PMID:23032149;PMID:23776849",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:1508--infores:dgidb",
    "edge_object": "NCBIGene:1508",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "CTSB",
    "predicate": "biolink:affects",
    "phrase": "Urea affects CTSB",
    "primary_source": "infores:dgidb",
    "publications": "PMID:3223934",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:physically_interacts_with--None--None--None--NCBIGene:760--infores:drugbank",
    "edge_object": "NCBIGene:760",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "CA2",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "Urea physically interacts with CA2",
    "primary_source": "infores:drugbank",
    "publications": "PMID:20005709;PMID:27789330;PMID:28705076",
    "publications_count": 3,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:1499--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1499",
    "edge_subjectNode_name": "CTNNB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CTNNB1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:3308--infores:dgidb",
    "edge_object": "NCBIGene:3308",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "HSPA4",
    "predicate": "biolink:affects",
    "phrase": "Urea affects HSPA4",
    "primary_source": "infores:dgidb",
    "publications": "PMID:7548155",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3172--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:disgenet",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:3172",
    "edge_subjectNode_name": "HNF4A",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HNF4A gene associated with condition hypoglycemia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18268044",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:6197--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:6197",
    "edge_subjectNode_name": "RPS6KA3",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "RPS6KA3 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:3172--infores:dgidb",
    "edge_object": "NCBIGene:3172",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "HNF4A",
    "predicate": "biolink:affects",
    "phrase": "Urea affects HNF4A",
    "primary_source": "infores:dgidb",
    "publications": "PMID:8167573",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:760--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:760",
    "edge_subjectNode_name": "CA2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CA2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33648390;PMID:32810346;PMID:37049983;PMID:35768159;PMID:33585783;PMID:31710714;PMID:37047767;PMID:31627429;PMID:37902389;PMID:31842669;PMID:33895779;PMID:37312840;PMID:37111236;PMID:34605430;PMID:38004276;PMID:23908634;PMID:34068564;PMID:36950364;PMID:34385849;PMID:22658432",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3308--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:3308",
    "edge_subjectNode_name": "HSPA4",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSPA4 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:31731801;PMID:36923110;PMID:28250896;PMID:36855205;PMID:26303512;PMID:25066924;PMID:36358564;PMID:22584135;PMID:29456783;PMID:25529848;PMID:31614478;PMID:36743691;PMID:33514437;PMID:37759536;PMID:25009498;PMID:27841866;PMID:24705207;PMID:21329796;PMID:23318458;PMID:35265260",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:6197--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:6197",
    "edge_subjectNode_name": "RPS6KA3",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "RPS6KA3 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:26421060;PMID:37231359;PMID:31341639;PMID:36033434;PMID:29547541;PMID:29654346;PMID:31906484;PMID:24291236;PMID:21559295;PMID:36362447;PMID:28831921;PMID:30696942;PMID:33642401;PMID:19182539;PMID:18940229;PMID:23966835;PMID:27257474;PMID:28871168;PMID:31752929;PMID:24679524",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:383--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:383",
    "edge_subjectNode_name": "ARG1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ARG1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:physically_interacts_with--None--None--None--NCBIGene:383--infores:drugbank",
    "edge_object": "NCBIGene:383",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "ARG1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "Urea physically interacts with ARG1",
    "primary_source": "infores:drugbank",
    "publications": "PMID:17139284;PMID:17016423;PMID:10592235",
    "publications_count": 3,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3146--biolink:physically_interacts_with--None--None--None--NCBIGene:51081--infores:intact",
    "edge_object": "NCBIGene:51081",
    "edge_subject": "NCBIGene:3146",
    "edge_subjectNode_name": "HMGB1",
    "edge_objectNode_name": "MRPS7",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "HMGB1 physically interacts with MRPS7",
    "primary_source": "infores:intact",
    "publications": "PMID:29721183",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:383--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:383",
    "edge_subjectNode_name": "ARG1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ARG1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:22566357;PMID:23407051;PMID:32709848;PMID:34683918;PMID:31710714;PMID:34246313;PMID:33905419;PMID:31722723;PMID:25128239;PMID:30050649;PMID:35803929;PMID:37886538;PMID:27696527;PMID:30923617;PMID:36918923;PMID:31105520;PMID:25847097;PMID:37867233;PMID:33498928;PMID:34962634",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3315--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3315",
    "edge_subjectNode_name": "HSPB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSPB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:27081917;PMID:27246909;PMID:34194332;PMID:34482756;PMID:18781161;PMID:38003363;PMID:33819264;PMID:35047630;PMID:26100331;PMID:20685377;PMID:28250763;PMID:15571513;PMID:37628788;PMID:16749930;PMID:28709429;PMID:33642401;PMID:31492812;PMID:31583588;PMID:33396566;PMID:25949827",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:1499--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:1499",
    "edge_subjectNode_name": "CTNNB1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CTNNB1 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:36916943;PMID:32663221;PMID:34659577;PMID:33732379;PMID:25887795;PMID:21113306;PMID:34671564;PMID:28223148;PMID:32886511;PMID:35176813;PMID:27790045;PMID:31763432;PMID:33116121;PMID:31301084;PMID:27080341;PMID:34445373;PMID:35145403;PMID:37859591;PMID:27337470;PMID:34096454",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:7066--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7066",
    "edge_subjectNode_name": "THPO",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "THPO gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--UMLS:C0014653--infores:semmeddb",
    "edge_object": "UMLS:C0014653",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "Equilibrium",
    "predicate": "biolink:affects",
    "phrase": "Urea affects Equilibrium",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:14439279;PMID:15143136;PMID:24617561;PMID:25049759;PMID:2669972;PMID:27705762;PMID:28678492;PMID:29443520;PMID:30516001;PMID:30626534;PMID:819196",
    "publications_count": 11,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3308--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3308",
    "edge_subjectNode_name": "HSPA4",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSPA4 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:24141017;PMID:37373230;PMID:23945775;PMID:36287908;PMID:18568016;PMID:22821687;PMID:32041096;PMID:34865660;PMID:34680600;PMID:32438758;PMID:34194332;PMID:36358564;PMID:38003363;PMID:32709848;PMID:23560231;PMID:34568018;PMID:28987175;PMID:28250763;PMID:27498238;PMID:37628788",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:physically_interacts_with--None--None--None--NCBIGene:1499--infores:drugbank",
    "edge_object": "NCBIGene:1499",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "CTNNB1",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "Urea physically interacts with CTNNB1",
    "primary_source": "infores:drugbank",
    "publications": "PMID:17139284;PMID:17016423;PMID:10592235",
    "publications_count": 3,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:UMLS:C0014653--biolink:affects--None--None--None--MONDO:0005027--infores:semmeddb",
    "edge_object": "MONDO:0005027",
    "edge_subject": "UMLS:C0014653",
    "edge_subjectNode_name": "Equilibrium",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:affects",
    "phrase": "Equilibrium affects epilepsy",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:32300887;PMID:8921300;PMID:25370443;PMID:30921410;PMID:9737136;PMID:34589049;PMID:31254841;PMID:27146976;PMID:31521949;PMID:9610219;PMID:14751211",
    "publications_count": 11,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:383--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:383",
    "edge_subjectNode_name": "ARG1",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ARG1 gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:3315--infores:dgidb",
    "edge_object": "NCBIGene:3315",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "HSPB1",
    "predicate": "biolink:affects",
    "phrase": "Urea affects HSPB1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:9094264",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3172--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3172",
    "edge_subjectNode_name": "HNF4A",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HNF4A gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35615065;PMID:38151490;PMID:25990246;PMID:32961703;PMID:28385385;PMID:24035588;PMID:34944434;PMID:34260143;PMID:35628657;PMID:32049522;PMID:29900117;PMID:32850846;PMID:33589815;PMID:34568018;PMID:23869298;PMID:25345514;PMID:38178152;PMID:37293497;PMID:33287247;PMID:33042988",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:1508--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:1508",
    "edge_subjectNode_name": "CTSB",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CTSB gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:21415884;PMID:25657086;PMID:27572605;PMID:34286362;PMID:23253353;PMID:32968930;PMID:32943616;PMID:29495555;PMID:34123841;PMID:28601357;PMID:34079897;PMID:36316476;PMID:37334378;PMID:32252352;PMID:33813519;PMID:22792442;PMID:30897858;PMID:33193317;PMID:24312100;PMID:31991703",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:1508--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1508",
    "edge_subjectNode_name": "CTSB",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CTSB gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:32343048;PMID:36613465;PMID:34198733;PMID:32733872;PMID:37066044;PMID:36033434;PMID:36421690;PMID:36834953;PMID:34149605;PMID:32225060;PMID:19478259;PMID:36685206;PMID:37895137;PMID:21325429;PMID:34604555;PMID:36612049;PMID:21858011;PMID:34335879;PMID:36551898;PMID:33973365",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:CHEBI:16199--biolink:affects--None--None--None--NCBIGene:3146--infores:dgidb",
    "edge_object": "NCBIGene:3146",
    "edge_subject": "CHEBI:16199",
    "edge_subjectNode_name": "Urea",
    "edge_objectNode_name": "HMGB1",
    "predicate": "biolink:affects",
    "phrase": "Urea affects HMGB1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:3342876",
    "publications_count": 1,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3172--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3172",
    "edge_subjectNode_name": "HNF4A",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HNF4A gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Urea",
    "result_subjectNode_id": "CHEBI:16199",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 144,
    "edge_id": "infores:rtx-kg2:NCBIGene:3146--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3146",
    "edge_subjectNode_name": "HMGB1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HMGB1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:36713841;PMID:36619717;PMID:36963363;PMID:34198733;PMID:37373230;PMID:22807916;PMID:37932838;PMID:36301030;PMID:23560231;PMID:35572589;PMID:34054510;PMID:35889939;PMID:31945125;PMID:36389834;PMID:29674955;PMID:29343030;PMID:34335879;PMID:35558368;PMID:35360161",
    "publications_count": 20,
    "support_graph_id": "aux_graph_29_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Isoflurophate",
    "result_subjectNode_id": "CHEBI:17941",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 145,
    "edge_id": "medik:creative_edge#111",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17941",
    "edge_subjectNode_name": "Isoflurophate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Isoflurophate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Isoflurophate",
    "result_subjectNode_id": "CHEBI:17941",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 145,
    "edge_id": "medik:edge#139",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:17941",
    "edge_subjectNode_name": "Isoflurophate",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Isoflurophate affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:3545320",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#111",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Isoflurophate",
    "result_subjectNode_id": "CHEBI:17941",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 145,
    "edge_id": "medik:edge#140",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#111",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "endrin",
    "result_subjectNode_id": "CHEBI:81526",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 146,
    "edge_id": "medik:creative_edge#133",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:81526",
    "edge_subjectNode_name": "endrin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "endrin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "endrin",
    "result_subjectNode_id": "CHEBI:81526",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 146,
    "edge_id": "medik:edge#183",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:81526",
    "edge_subjectNode_name": "endrin",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "endrin affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:19927138",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#133",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "endrin",
    "result_subjectNode_id": "CHEBI:81526",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 146,
    "edge_id": "medik:edge#184",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#133",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "glucosamine",
    "result_subjectNode_id": "CHEBI:20993",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 147,
    "edge_id": "medik:creative_edge#100",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:20993",
    "edge_subjectNode_name": "glucosamine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "glucosamine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "glucosamine",
    "result_subjectNode_id": "CHEBI:20993",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 147,
    "edge_id": "medik:edge#117",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:20993",
    "edge_subjectNode_name": "glucosamine",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "glucosamine affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:14507305",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#100",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "glucosamine",
    "result_subjectNode_id": "CHEBI:20993",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 147,
    "edge_id": "medik:edge#118",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#100",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide",
    "result_subjectNode_id": "MESH:C517552",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 148,
    "edge_id": "medik:creative_edge#85",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:C517552",
    "edge_subjectNode_name": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide",
    "result_subjectNode_id": "MESH:C517552",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 148,
    "edge_id": "medik:edge#87",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "MESH:C517552",
    "edge_subjectNode_name": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:16787663",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#85",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide",
    "result_subjectNode_id": "MESH:C517552",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 148,
    "edge_id": "medik:edge#88",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#85",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10094808",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 149,
    "edge_id": "medik:creative_edge#154",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10094808",
    "edge_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10094808",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 149,
    "edge_id": "medik:edge#225",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10094808",
    "edge_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17118655",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#154",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-2,4,6-triisopropylbenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10094808",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 149,
    "edge_id": "medik:edge#226",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#154",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "creative_DTD_prediction_0",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1201564",
    "edge_subjectNode_name": "INTERFERON GAMMA-1B",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "INTERFERON GAMMA-1B treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:NCBIGene:3459--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:ncit",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3459",
    "edge_subjectNode_name": "IFNGR1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNGR1 gene associated with condition tuberculosis",
    "primary_source": "infores:ncit",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:NCBIGene:3460--biolink:physically_interacts_with--None--None--None--NCBIGene:5194--infores:intact",
    "edge_object": "NCBIGene:5194",
    "edge_subject": "NCBIGene:3460",
    "edge_subjectNode_name": "IFNGR2",
    "edge_objectNode_name": "PEX13",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "IFNGR2 physically interacts with PEX13",
    "primary_source": "infores:intact",
    "publications": "PMID:33961781",
    "publications_count": 1,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:NCBIGene:3459--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3459",
    "edge_subjectNode_name": "IFNGR1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNGR1 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:37999184;PMID:21852947;PMID:32067110;PMID:34693385;PMID:31298204;PMID:33117339;PMID:16233916;PMID:33193291;PMID:19575238;PMID:37727920;PMID:32125282;PMID:23785507;PMID:36630059;PMID:37781922;PMID:19026454;PMID:34301764;PMID:34315005;PMID:19356949;PMID:30167433;PMID:32546788",
    "publications_count": 20,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:NCBIGene:3459--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3459",
    "edge_subjectNode_name": "IFNGR1",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNGR1 gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:12753505",
    "publications_count": 1,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201564--biolink:affects--None--None--None--NCBIGene:3459--infores:dgidb",
    "edge_object": "NCBIGene:3459",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1201564",
    "edge_subjectNode_name": "INTERFERON GAMMA-1B",
    "edge_objectNode_name": "IFNGR1",
    "predicate": "biolink:affects",
    "phrase": "INTERFERON GAMMA-1B affects IFNGR1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:NCBIGene:5194--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:5194",
    "edge_subjectNode_name": "PEX13",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PEX13 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "INTERFERON GAMMA-1B",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1201564",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 150,
    "edge_id": "infores:rtx-kg2:CHEMBL.COMPOUND:CHEMBL1201564--biolink:affects--None--None--None--NCBIGene:3460--infores:dgidb",
    "edge_object": "NCBIGene:3460",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1201564",
    "edge_subjectNode_name": "INTERFERON GAMMA-1B",
    "edge_objectNode_name": "IFNGR2",
    "predicate": "biolink:affects",
    "phrase": "INTERFERON GAMMA-1B affects IFNGR2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_31_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Adrenal Cortex Hormones",
    "result_subjectNode_id": "MESH:D000305",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 151,
    "edge_id": "inferred-MESH:D000305-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D000305",
    "edge_subjectNode_name": "Adrenal Cortex Hormones",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Adrenal Cortex Hormones treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Adrenal Cortex Hormones",
    "result_subjectNode_id": "MESH:D000305",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 151,
    "edge_id": "e0c07b371b8ba0748af69ec79c80a663",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D000305",
    "edge_subjectNode_name": "Adrenal Cortex Hormones",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Adrenal Cortex Hormones studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:8842762;PMID:5607728;PMID:4639560;PMID:8092569;PMID:20321456;PMID:19273936;PMID:25834753;PMID:36010128;PMID:37200146",
    "publications_count": 9,
    "support_graph_id": "inferred-MESH:D000305-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Adrenal Cortex Hormones",
    "result_subjectNode_id": "MESH:D000305",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 151,
    "edge_id": "MESH:D000305-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D000305",
    "edge_subjectNode_name": "Adrenal Cortex Hormones",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Adrenal Cortex Hormones studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-MESH:D000305-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cadmium",
    "result_subjectNode_id": "CHEBI:22977",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 152,
    "edge_id": "medik:creative_edge#101",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:22977",
    "edge_subjectNode_name": "Cadmium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cadmium treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cadmium",
    "result_subjectNode_id": "CHEBI:22977",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 152,
    "edge_id": "medik:edge#119",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:22977",
    "edge_subjectNode_name": "Cadmium",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Cadmium affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:30572105",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#101",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cadmium",
    "result_subjectNode_id": "CHEBI:22977",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 152,
    "edge_id": "medik:edge#120",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#101",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216117",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 153,
    "edge_id": "medik:creative_edge#202",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10216117",
    "edge_subjectNode_name": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216117",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 153,
    "edge_id": "medik:edge#321",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10216117",
    "edge_subjectNode_name": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#202",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Benzyl-10-methoxy-2,2,4-trimethyl-1,5-dihydrochromeno[3,4-f]quinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216117",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 153,
    "edge_id": "medik:edge#322",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#202",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10131608",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 154,
    "edge_id": "medik:creative_edge#172",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10131608",
    "edge_subjectNode_name": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10131608",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 154,
    "edge_id": "medik:edge#261",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10131608",
    "edge_subjectNode_name": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#172",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethyl-(1-methoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10131608",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 154,
    "edge_id": "medik:edge#262",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#172",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Phenytoin",
    "result_subjectNode_id": "CHEBI:8107",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 155,
    "edge_id": "inferred-CHEBI:8107-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8107",
    "edge_subjectNode_name": "Phenytoin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Phenytoin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Phenytoin",
    "result_subjectNode_id": "CHEBI:8107",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 155,
    "edge_id": "fe4277a93fef30b8c6e155d4f9755a61",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:8107",
    "edge_subjectNode_name": "Phenytoin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Phenytoin studied to treat Addison Disease",
    "primary_source": "infores:suppkg",
    "publications": "PMID:3706393",
    "publications_count": 1,
    "support_graph_id": "inferred-CHEBI:8107-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126475",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 156,
    "edge_id": "medik:creative_edge#160",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10126475",
    "edge_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126475",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 156,
    "edge_id": "medik:edge#237",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10126475",
    "edge_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#160",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(2-methyl-benzyl)-pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126475",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 156,
    "edge_id": "medik:edge#238",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#160",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126476",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 157,
    "edge_id": "medik:creative_edge#161",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10126476",
    "edge_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126476",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 157,
    "edge_id": "medik:edge#239",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10126476",
    "edge_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#161",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-Trifluoro-4-(5-fluoro-2-methoxy-phenyl)-4-methyl-2-(4-methyl-benzyl)-pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126476",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 157,
    "edge_id": "medik:edge#240",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#161",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "creative_DTD_prediction_3",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:136034",
    "edge_subjectNode_name": "Afamelanotide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Afamelanotide treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:CHEBI:136034--biolink:affects--None--None--None--NCBIGene:4160--infores:dgidb",
    "edge_object": "NCBIGene:4160",
    "edge_subject": "CHEBI:136034",
    "edge_subjectNode_name": "Afamelanotide",
    "edge_objectNode_name": "MC4R",
    "predicate": "biolink:affects",
    "phrase": "Afamelanotide affects MC4R",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:CHEBI:136034--biolink:affects--None--None--None--NCBIGene:4157--infores:dgidb",
    "edge_object": "NCBIGene:4157",
    "edge_subject": "CHEBI:136034",
    "edge_subjectNode_name": "Afamelanotide",
    "edge_objectNode_name": "MC1R",
    "predicate": "biolink:affects",
    "phrase": "Afamelanotide affects MC1R",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:NCBIGene:4157--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4157",
    "edge_subjectNode_name": "MC1R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC1R gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:NCBIGene:4160--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4160",
    "edge_subjectNode_name": "MC4R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC4R gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:31440210;PMID:34072450;PMID:22206823;PMID:36984824;PMID:30014268;PMID:18568016;PMID:31324766;PMID:24410812;PMID:34414418;PMID:33922961;PMID:38028995;PMID:30509933;PMID:28421338;PMID:35236781;PMID:32317913;PMID:34857904;PMID:24035588;PMID:22582733;PMID:26956990;PMID:36048516",
    "publications_count": 20,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:CHEBI:136034--biolink:affects--None--None--None--NCBIGene:4157--infores:drugbank",
    "edge_object": "NCBIGene:4157",
    "edge_subject": "CHEBI:136034",
    "edge_subjectNode_name": "Afamelanotide",
    "edge_objectNode_name": "MC1R",
    "predicate": "biolink:affects",
    "phrase": "Afamelanotide affects MC1R",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:CHEBI:136034--biolink:affects--None--None--None--NCBIGene:4160--infores:drugcentral",
    "edge_object": "NCBIGene:4160",
    "edge_subject": "CHEBI:136034",
    "edge_subjectNode_name": "Afamelanotide",
    "edge_objectNode_name": "MC4R",
    "predicate": "biolink:affects",
    "phrase": "Afamelanotide affects MC4R",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Afamelanotide",
    "result_subjectNode_id": "CHEBI:136034",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 158,
    "edge_id": "infores:rtx-kg2:CHEBI:136034--biolink:affects--None--None--None--NCBIGene:4157--infores:drugcentral",
    "edge_object": "NCBIGene:4157",
    "edge_subject": "CHEBI:136034",
    "edge_subjectNode_name": "Afamelanotide",
    "edge_objectNode_name": "MC1R",
    "predicate": "biolink:affects",
    "phrase": "Afamelanotide affects MC1R",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_33_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metformin",
    "result_subjectNode_id": "CHEBI:6801",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 159,
    "edge_id": "inferred-CHEBI:6801-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6801",
    "edge_subjectNode_name": "Metformin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Metformin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metformin",
    "result_subjectNode_id": "CHEBI:6801",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 159,
    "edge_id": "CHEBI:6801-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6801",
    "edge_subjectNode_name": "Metformin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Metformin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6801-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126871",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 160,
    "edge_id": "medik:creative_edge#162",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10126871",
    "edge_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126871",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 160,
    "edge_id": "medik:edge#241",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10126871",
    "edge_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#162",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-2-(1H-indol-2-ylmethyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10126871",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 160,
    "edge_id": "medik:edge#242",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#162",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Particulate Matter",
    "result_subjectNode_id": "MESH:D052638",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 161,
    "edge_id": "medik:creative_edge#87",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D052638",
    "edge_subjectNode_name": "Particulate Matter",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Particulate Matter treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Particulate Matter",
    "result_subjectNode_id": "MESH:D052638",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 161,
    "edge_id": "medik:edge#91",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "MESH:D052638",
    "edge_subjectNode_name": "Particulate Matter",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Particulate Matter affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:12676610",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#87",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Particulate Matter",
    "result_subjectNode_id": "MESH:D052638",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 161,
    "edge_id": "medik:edge#92",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#87",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10193967",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 162,
    "edge_id": "medik:creative_edge#196",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10193967",
    "edge_subjectNode_name": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10193967",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 162,
    "edge_id": "medik:edge#309",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10193967",
    "edge_subjectNode_name": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#196",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[2-(10-Methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysen-5-yl)-ethyl]-dimethyl-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10193967",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 162,
    "edge_id": "medik:edge#310",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#196",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mercuric chloride",
    "result_subjectNode_id": "CHEBI:31823",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 163,
    "edge_id": "medik:creative_edge#128",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:31823",
    "edge_subjectNode_name": "Mercuric chloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Mercuric chloride treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mercuric chloride",
    "result_subjectNode_id": "CHEBI:31823",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 163,
    "edge_id": "medik:edge#173",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:31823",
    "edge_subjectNode_name": "Mercuric chloride",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Mercuric chloride affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:15250541",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#128",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mercuric chloride",
    "result_subjectNode_id": "CHEBI:31823",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 163,
    "edge_id": "medik:edge#174",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#128",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10157532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 164,
    "edge_id": "medik:creative_edge#182",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10157532",
    "edge_subjectNode_name": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10157532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 164,
    "edge_id": "medik:edge#281",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10157532",
    "edge_subjectNode_name": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#182",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Ethoxy-6-phenyl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10157532",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 164,
    "edge_id": "medik:edge#282",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#182",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "creative_DTD_prediction_4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:142437",
    "edge_subjectNode_name": "lepirudin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "lepirudin treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:NCBIGene:2147--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2147",
    "edge_subjectNode_name": "F2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "F2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:29856166;PMID:33335028;PMID:30949745;PMID:26749026;PMID:34539133;PMID:37601774;PMID:30921490;PMID:34697287;PMID:35778702;PMID:31208005;PMID:21976928;PMID:34690677;PMID:37927663;PMID:29881812;PMID:26346729;PMID:36626546;PMID:33520894;PMID:33889819;PMID:32367165;PMID:38283678",
    "publications_count": 20,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:CHEBI:142437--biolink:affects--None--None--None--NCBIGene:2149--infores:dgidb",
    "edge_object": "NCBIGene:2149",
    "edge_subject": "CHEBI:142437",
    "edge_subjectNode_name": "lepirudin",
    "edge_objectNode_name": "F2R",
    "predicate": "biolink:affects",
    "phrase": "lepirudin affects F2R",
    "primary_source": "infores:dgidb",
    "publications": "PMID:16038707",
    "publications_count": 1,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:NCBIGene:2149--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2149",
    "edge_subjectNode_name": "F2R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "F2R gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33467143;PMID:25954157;PMID:19057019;PMID:34421575;PMID:36338344;PMID:25295869;PMID:30982627;PMID:28533260;PMID:35281298;PMID:24973918;PMID:31396149;PMID:31007884;PMID:28256580;PMID:30564010;PMID:36721118;PMID:34584183;PMID:32178287;PMID:34993481;PMID:37915722;PMID:33414387",
    "publications_count": 20,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:CHEBI:142437--biolink:affects--None--None--None--NCBIGene:2147--infores:drugcentral",
    "edge_object": "NCBIGene:2147",
    "edge_subject": "CHEBI:142437",
    "edge_subjectNode_name": "lepirudin",
    "edge_objectNode_name": "F2",
    "predicate": "biolink:affects",
    "phrase": "lepirudin affects F2",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:CHEBI:142437--biolink:affects--None--None--None--NCBIGene:5340--infores:dgidb",
    "edge_object": "NCBIGene:5340",
    "edge_subject": "CHEBI:142437",
    "edge_subjectNode_name": "lepirudin",
    "edge_objectNode_name": "PLG",
    "predicate": "biolink:affects",
    "phrase": "lepirudin affects PLG",
    "primary_source": "infores:dgidb",
    "publications": "PMID:15894352",
    "publications_count": 1,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:NCBIGene:5340--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5340",
    "edge_subjectNode_name": "PLG",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PLG gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33208141;PMID:36439263;PMID:33362701;PMID:34326601;PMID:34865660;PMID:37601774;PMID:32287168;PMID:34809712;PMID:28432428;PMID:33682719;PMID:37238951;PMID:25949827;PMID:36176317;PMID:34190197;PMID:34763262;PMID:20835362;PMID:22114580;PMID:38072952;PMID:36793087;PMID:22693670",
    "publications_count": 20,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lepirudin",
    "result_subjectNode_id": "CHEBI:142437",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 165,
    "edge_id": "infores:rtx-kg2:CHEBI:142437--biolink:affects--None--None--None--NCBIGene:2147--infores:dgidb",
    "edge_object": "NCBIGene:2147",
    "edge_subject": "CHEBI:142437",
    "edge_subjectNode_name": "lepirudin",
    "edge_objectNode_name": "F2",
    "predicate": "biolink:affects",
    "phrase": "lepirudin affects F2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_35_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10167930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 166,
    "edge_id": "medik:creative_edge#185",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10167930",
    "edge_subjectNode_name": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10167930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 166,
    "edge_id": "medik:edge#287",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10167930",
    "edge_subjectNode_name": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15261265",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#185",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[3-(Benzyl-{4-[4-((1R,3S)-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylmethoxy)-phenoxy]-benzyl}-amino)-2-methyl-phenyl]-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10167930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 166,
    "edge_id": "medik:edge#288",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#185",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10215137",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 167,
    "edge_id": "medik:creative_edge#201",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10215137",
    "edge_subjectNode_name": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10215137",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 167,
    "edge_id": "medik:edge#319",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10215137",
    "edge_subjectNode_name": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#201",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4,5-tetramethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10215137",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 167,
    "edge_id": "medik:edge#320",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#201",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Colchicine",
    "result_subjectNode_id": "CHEBI:27882",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 168,
    "edge_id": "inferred-CHEBI:27882-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27882",
    "edge_subjectNode_name": "Colchicine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Colchicine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Colchicine",
    "result_subjectNode_id": "CHEBI:27882",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 168,
    "edge_id": "CHEBI:27882-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27882",
    "edge_subjectNode_name": "Colchicine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Colchicine studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:27882-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Colchicine",
    "result_subjectNode_id": "CHEBI:27882",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 168,
    "edge_id": "medik:creative_edge#114",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27882",
    "edge_subjectNode_name": "Colchicine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Colchicine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Colchicine",
    "result_subjectNode_id": "CHEBI:27882",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 168,
    "edge_id": "medik:edge#145",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:27882",
    "edge_subjectNode_name": "Colchicine",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Colchicine affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:20448266",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#114",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Colchicine",
    "result_subjectNode_id": "CHEBI:27882",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 168,
    "edge_id": "medik:edge#146",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#114",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "NVP ABE171",
    "result_subjectNode_id": "MESH:C451724",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 169,
    "edge_id": "medik:creative_edge#84",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:C451724",
    "edge_subjectNode_name": "NVP ABE171",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "NVP ABE171 treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "NVP ABE171",
    "result_subjectNode_id": "MESH:C451724",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 169,
    "edge_id": "medik:edge#85",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "MESH:C451724",
    "edge_subjectNode_name": "NVP ABE171",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "NVP ABE171 affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:11907180",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#84",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "NVP ABE171",
    "result_subjectNode_id": "MESH:C451724",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 169,
    "edge_id": "medik:edge#86",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#84",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "15-deoxy-delta(12,14)-prostaglandin J2",
    "result_subjectNode_id": "MESH:C097240",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 170,
    "edge_id": "medik:creative_edge#83",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:C097240",
    "edge_subjectNode_name": "15-deoxy-delta(12,14)-prostaglandin J2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "15-deoxy-delta(12,14)-prostaglandin J2 treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "15-deoxy-delta(12,14)-prostaglandin J2",
    "result_subjectNode_id": "MESH:C097240",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 170,
    "edge_id": "medik:edge#83",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "MESH:C097240",
    "edge_subjectNode_name": "15-deoxy-delta(12,14)-prostaglandin J2",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "15-deoxy-delta(12,14)-prostaglandin J2 affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:16844232",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#83",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "15-deoxy-delta(12,14)-prostaglandin J2",
    "result_subjectNode_id": "MESH:C097240",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 170,
    "edge_id": "medik:edge#84",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#83",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "creative_DTD_prediction_5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bremelanotide treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4158--infores:drugbank",
    "edge_object": "NCBIGene:4158",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC2R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC2R",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:HP:0002902--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002902",
    "edge_subjectNode_name": "Hyponatremia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Hyponatremia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4157--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4157",
    "edge_subjectNode_name": "MC1R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC1R gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0010264--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0010264",
    "edge_subjectNode_name": "X-linked adrenal hypoplasia congenita",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "X-linked adrenal hypoplasia congenita subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0009279--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0009279",
    "edge_subjectNode_name": "triple-A syndrome",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "triple-A syndrome subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4160--infores:drugcentral",
    "edge_object": "NCBIGene:4160",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC4R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC4R",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4160--infores:drugbank",
    "edge_object": "NCBIGene:4160",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC4R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC4R",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4157--infores:dgidb",
    "edge_object": "NCBIGene:4157",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC1R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC1R",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:35937837;PMID:33058950;PMID:24623797;PMID:16189167;PMID:28637490;PMID:38796770;PMID:34193132;PMID:19846612;PMID:36060294;PMID:28659864;PMID:31570737;PMID:36105398;PMID:37484942;PMID:25609776;PMID:32714392;PMID:35197862;PMID:37484952;PMID:31781041;PMID:35263051;PMID:25428847",
    "publications_count": 20,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:30827252;PMID:33363514;PMID:35937837;PMID:35861830;PMID:25859357;PMID:33435513;PMID:21494136;PMID:25896481;PMID:21949634;PMID:33777551;PMID:33194923;PMID:35197862;PMID:37484952;PMID:38203272;PMID:36129002;PMID:32872281;PMID:34165441;PMID:24027733;PMID:8952579;PMID:37868187",
    "publications_count": 20,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4160--infores:dgidb",
    "edge_object": "NCBIGene:4160",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC4R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC4R",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4157--infores:drugbank",
    "edge_object": "NCBIGene:4157",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC1R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC1R",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:37893201;PMID:36923110;PMID:35967126;PMID:36660017;PMID:22500955;PMID:34796908;PMID:35656117;PMID:36809682;PMID:35407628;PMID:38288475;PMID:27188921;PMID:33720773;PMID:35815257;PMID:20549539;PMID:32924331;PMID:35678922;PMID:30267153;PMID:37833776;PMID:34766565;PMID:34947882",
    "publications_count": 20,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--HP:0002902--infores:disgenet",
    "edge_object": "HP:0002902",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "Hyponatremia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition Hyponatremia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:HP:0002153--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002153",
    "edge_subjectNode_name": "Hyperkalemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Hyperkalemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--MONDO:0015900--infores:disgenet",
    "edge_object": "MONDO:0015900",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "hypoaldosteronism disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition hypoaldosteronism disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0015900--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0015900",
    "edge_subjectNode_name": "hypoaldosteronism disease",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "hypoaldosteronism disease subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--HP:0011968--infores:disgenet",
    "edge_object": "HP:0011968",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "Feeding Problem",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition Feeding Problem",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4157--infores:drugcentral",
    "edge_object": "NCBIGene:4157",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC1R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC1R",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--HP:0002902--infores:disgenet",
    "edge_object": "HP:0002902",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "Hyponatremia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition Hyponatremia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0010264--infores:disgenet",
    "edge_object": "MONDO:0010264",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "X-linked adrenal hypoplasia congenita",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition X-linked adrenal hypoplasia congenita",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:HP:0011968--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0011968",
    "edge_subjectNode_name": "Feeding Problem",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Feeding Problem manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4160--infores:semmeddb",
    "edge_object": "NCBIGene:4160",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC4R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC4R",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--HP:0002153--infores:disgenet",
    "edge_object": "HP:0002153",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "Hyperkalemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition Hyperkalemia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4158--infores:drugcentral",
    "edge_object": "NCBIGene:4158",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "MC2R",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects MC2R",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--HP:0002153--infores:disgenet",
    "edge_object": "HP:0002153",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "Hyperkalemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition Hyperkalemia",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:CHEBI:177849--biolink:affects--None--None--None--NCBIGene:4306--infores:dgidb",
    "edge_object": "NCBIGene:4306",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "NR3C2",
    "predicate": "biolink:affects",
    "phrase": "Bremelanotide affects NR3C2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0010264--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mesh",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0010264",
    "edge_subjectNode_name": "X-linked adrenal hypoplasia congenita",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "X-linked adrenal hypoplasia congenita subclass of Addison Disease",
    "primary_source": "infores:mesh",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0010264--infores:diseases",
    "edge_object": "MONDO:0010264",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "X-linked adrenal hypoplasia congenita",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition X-linked adrenal hypoplasia congenita",
    "primary_source": "infores:diseases",
    "publications": "PMID:32938577;PMID:37450570;PMID:33058950;PMID:30400872;PMID:35418949;PMID:33381483;PMID:27485500;PMID:34193132;PMID:21274326;PMID:26038200;PMID:21274298;PMID:36763264;PMID:25287283;PMID:27940298;PMID:35046659;PMID:29956047;PMID:17223989;PMID:34258490;PMID:34278182;PMID:27660747",
    "publications_count": 20,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4306--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:disgenet",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:4306",
    "edge_subjectNode_name": "NR3C2",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C2 gene associated with condition hypoglycemia",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18182467",
    "publications_count": 1,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4160--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4160",
    "edge_subjectNode_name": "MC4R",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC4R gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:31440210;PMID:34072450;PMID:22206823;PMID:36984824;PMID:30014268;PMID:18568016;PMID:31324766;PMID:24410812;PMID:34414418;PMID:33922961;PMID:38028995;PMID:30509933;PMID:28421338;PMID:35236781;PMID:32317913;PMID:34857904;PMID:24035588;PMID:22582733;PMID:26956990;PMID:36048516",
    "publications_count": 20,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "infores:rtx-kg2:NCBIGene:4158--biolink:gene_associated_with_condition--None--None--None--MONDO:0009279--infores:diseases",
    "edge_object": "MONDO:0009279",
    "edge_subject": "NCBIGene:4158",
    "edge_subjectNode_name": "MC2R",
    "edge_objectNode_name": "triple-A syndrome",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MC2R gene associated with condition triple-A syndrome",
    "primary_source": "infores:diseases",
    "publications": "PMID:32938577;PMID:33381483;PMID:7758515;PMID:35418949;PMID:23012188;PMID:24623797;PMID:36832430;PMID:11353896;PMID:34193132;PMID:21274326;PMID:36060294;PMID:22634753;PMID:36763264;PMID:35046659;PMID:18493136;PMID:20374727;PMID:9758716;PMID:37331934;PMID:18426811;PMID:35627102",
    "publications_count": 20,
    "support_graph_id": "aux_graph_37_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "inferred_257",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bremelanotide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bremelanotide",
    "result_subjectNode_id": "CHEBI:177849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 171,
    "edge_id": "psev_edge_257",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:177849",
    "edge_subjectNode_name": "Bremelanotide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bremelanotide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_257",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mifepristone",
    "result_subjectNode_id": "CHEBI:50692",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 172,
    "edge_id": "medik:creative_edge#118",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50692",
    "edge_subjectNode_name": "Mifepristone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Mifepristone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mifepristone",
    "result_subjectNode_id": "CHEBI:50692",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 172,
    "edge_id": "medik:edge#153",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:50692",
    "edge_subjectNode_name": "Mifepristone",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Mifepristone affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:18650268",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#118",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mifepristone",
    "result_subjectNode_id": "CHEBI:50692",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 172,
    "edge_id": "medik:edge#154",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#118",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Hydroxyprogesterones",
    "result_subjectNode_id": "MESH:D006908",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 173,
    "edge_id": "inferred-MESH:D006908-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D006908",
    "edge_subjectNode_name": "Hydroxyprogesterones",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Hydroxyprogesterones treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Hydroxyprogesterones",
    "result_subjectNode_id": "MESH:D006908",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 173,
    "edge_id": "MESH:D006908-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D006908",
    "edge_subjectNode_name": "Hydroxyprogesterones",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Hydroxyprogesterones studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-MESH:D006908-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "21-deoxycortisol",
    "result_subjectNode_id": "CHEBI:28697",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 174,
    "edge_id": "inferred-CHEBI:28697-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28697",
    "edge_subjectNode_name": "21-deoxycortisol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "21-deoxycortisol treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "21-deoxycortisol",
    "result_subjectNode_id": "CHEBI:28697",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 174,
    "edge_id": "CHEBI:28697-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28697",
    "edge_subjectNode_name": "21-deoxycortisol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "21-deoxycortisol studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:28697-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Antigens, Dermatophagoides",
    "result_subjectNode_id": "MESH:D039741",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 175,
    "edge_id": "medik:creative_edge#86",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D039741",
    "edge_subjectNode_name": "Antigens, Dermatophagoides",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Antigens, Dermatophagoides treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Antigens, Dermatophagoides",
    "result_subjectNode_id": "MESH:D039741",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 175,
    "edge_id": "medik:edge#89",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "MESH:D039741",
    "edge_subjectNode_name": "Antigens, Dermatophagoides",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Antigens, Dermatophagoides affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:9344832",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#86",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Antigens, Dermatophagoides",
    "result_subjectNode_id": "MESH:D039741",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 175,
    "edge_id": "medik:edge#90",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#86",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173659",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 176,
    "edge_id": "medik:creative_edge#192",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10173659",
    "edge_subjectNode_name": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173659",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 176,
    "edge_id": "medik:edge#301",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10173659",
    "edge_subjectNode_name": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#192",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-2-(3-hydroxy-benzyl)-4-methyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173659",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 176,
    "edge_id": "medik:edge#302",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#192",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nifedipine",
    "result_subjectNode_id": "CHEBI:7565",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 177,
    "edge_id": "inferred-CHEBI:7565-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7565",
    "edge_subjectNode_name": "Nifedipine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Nifedipine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nifedipine",
    "result_subjectNode_id": "CHEBI:7565",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 177,
    "edge_id": "CHEBI:7565-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7565",
    "edge_subjectNode_name": "Nifedipine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Nifedipine in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:7565-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Isoxaflutole",
    "result_subjectNode_id": "CHEBI:141213",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 178,
    "edge_id": "inferred-CHEBI:141213-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:141213",
    "edge_subjectNode_name": "Isoxaflutole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Isoxaflutole treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Isoxaflutole",
    "result_subjectNode_id": "CHEBI:141213",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 178,
    "edge_id": "CHEBI:141213-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:141213",
    "edge_subjectNode_name": "Isoxaflutole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Isoxaflutole in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:141213-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "UNII:JQ9EK2H6BG",
    "result_subjectNode_id": "UNII:JQ9EK2H6BG",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 179,
    "edge_id": "inferred-UNII:JQ9EK2H6BG-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:JQ9EK2H6BG",
    "edge_subjectNode_name": "UNII:JQ9EK2H6BG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "UNII:JQ9EK2H6BG treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "UNII:JQ9EK2H6BG",
    "result_subjectNode_id": "UNII:JQ9EK2H6BG",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 179,
    "edge_id": "5bcad64d4ff50a444878a7ef85d909ce",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:JQ9EK2H6BG",
    "edge_subjectNode_name": "UNII:JQ9EK2H6BG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "UNII:JQ9EK2H6BG in clinical trials for Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:JQ9EK2H6BG-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "SODIUM ACETATE",
    "result_subjectNode_id": "CHEBI:32138",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 180,
    "edge_id": "inferred-CHEBI:32138-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:32138",
    "edge_subjectNode_name": "SODIUM ACETATE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "SODIUM ACETATE treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "SODIUM ACETATE",
    "result_subjectNode_id": "CHEBI:32138",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 180,
    "edge_id": "CHEBI:32138-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:32138",
    "edge_subjectNode_name": "SODIUM ACETATE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "SODIUM ACETATE in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:32138-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "LICORICE",
    "result_subjectNode_id": "UNII:61ZBX54883",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 181,
    "edge_id": "inferred-UNII:61ZBX54883-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:61ZBX54883",
    "edge_subjectNode_name": "LICORICE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "LICORICE treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "LICORICE",
    "result_subjectNode_id": "UNII:61ZBX54883",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 181,
    "edge_id": "037901d099c9a25a887651f8e74b0373",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:61ZBX54883",
    "edge_subjectNode_name": "LICORICE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "LICORICE in clinical trials for Addison Disease",
    "primary_source": "infores:multiomics-clinicaltrials",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:61ZBX54883-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Crinecerfont",
    "result_subjectNode_id": "CHEBI:34969",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 182,
    "edge_id": "inferred-CHEBI:34969-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34969",
    "edge_subjectNode_name": "Crinecerfont",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Crinecerfont treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Crinecerfont",
    "result_subjectNode_id": "CHEBI:34969",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 182,
    "edge_id": "CHEBI:34969-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34969",
    "edge_subjectNode_name": "Crinecerfont",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "Crinecerfont in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:34969-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride",
    "result_subjectNode_id": "UNII:TK694ZFS57",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 183,
    "edge_id": "inferred-UNII:TK694ZFS57-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:TK694ZFS57",
    "edge_subjectNode_name": "N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride",
    "result_subjectNode_id": "UNII:TK694ZFS57",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 183,
    "edge_id": "UNII:TK694ZFS57-in_clinical_trials_for-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:TK694ZFS57",
    "edge_subjectNode_name": "N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:in_clinical_trials_for",
    "phrase": "N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride in clinical trials for Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:TK694ZFS57-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Glycyrrhiza",
    "result_subjectNode_id": "NCBITaxon:46347",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 184,
    "edge_id": "inferred-NCBITaxon:46347-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBITaxon:46347",
    "edge_subjectNode_name": "Glycyrrhiza",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Glycyrrhiza treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Glycyrrhiza",
    "result_subjectNode_id": "NCBITaxon:46347",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 184,
    "edge_id": "a631c245a2b18a1c9a8b3a029d77d14c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBITaxon:46347",
    "edge_subjectNode_name": "Glycyrrhiza",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:applied_to_treat",
    "phrase": "Glycyrrhiza applied to treat Addison Disease",
    "primary_source": "infores:idisk",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-NCBITaxon:46347-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mitotane",
    "result_subjectNode_id": "CHEBI:6954",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 185,
    "edge_id": "inferred-CHEBI:6954-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6954",
    "edge_subjectNode_name": "Mitotane",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Mitotane treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mitotane",
    "result_subjectNode_id": "CHEBI:6954",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 185,
    "edge_id": "CHEBI:6954-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6954",
    "edge_subjectNode_name": "Mitotane",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Mitotane studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6954-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanol",
    "result_subjectNode_id": "CHEBI:16236",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 186,
    "edge_id": "inferred-CHEBI:16236-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16236",
    "edge_subjectNode_name": "Ethanol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ethanol treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ethanol",
    "result_subjectNode_id": "CHEBI:16236",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 186,
    "edge_id": "CHEBI:16236-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16236",
    "edge_subjectNode_name": "Ethanol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Ethanol studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16236-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10125859",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 187,
    "edge_id": "medik:creative_edge#157",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10125859",
    "edge_subjectNode_name": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10125859",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 187,
    "edge_id": "medik:edge#231",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10125859",
    "edge_subjectNode_name": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#157",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "5-Ethyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10125859",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 187,
    "edge_id": "medik:edge#232",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#157",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216535",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 188,
    "edge_id": "medik:creative_edge#204",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10216535",
    "edge_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216535",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 188,
    "edge_id": "medik:edge#325",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10216535",
    "edge_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#204",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-[(4-methyl-1H-indol-2-yl)methyl]pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216535",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 188,
    "edge_id": "medik:edge#326",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#204",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173634",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 189,
    "edge_id": "medik:creative_edge#191",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10173634",
    "edge_subjectNode_name": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173634",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 189,
    "edge_id": "medik:edge#299",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10173634",
    "edge_subjectNode_name": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#191",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Hydroxy-4-methyl-2-phenethyl-4-phenyl-pentanoic acid (1-oxo-1,3-dihydro-isobenzofuran-5-yl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10173634",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 189,
    "edge_id": "medik:edge#300",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#191",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "creative_DTD_prediction_7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:92293",
    "edge_subjectNode_name": "piperacetazine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "piperacetazine treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:CHEBI:92293--biolink:affects--None--None--None--NCBIGene:1565--infores:dgidb",
    "edge_object": "NCBIGene:1565",
    "edge_subject": "CHEBI:92293",
    "edge_subjectNode_name": "piperacetazine",
    "edge_objectNode_name": "CYP2D6",
    "predicate": "biolink:affects",
    "phrase": "piperacetazine affects CYP2D6",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:NCBIGene:1565--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1565",
    "edge_subjectNode_name": "CYP2D6",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP2D6 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37239120;PMID:35362240;PMID:22957244;PMID:21121777;PMID:36559168;PMID:10319191;PMID:36004008;PMID:20698542;PMID:36704740;PMID:31071346;PMID:23407051;PMID:26089675;PMID:23471370;PMID:24222315;PMID:24526565;PMID:32066657;PMID:37293497;PMID:37175536;PMID:27312874;PMID:33491309",
    "publications_count": 20,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:NCBIGene:1544--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1544",
    "edge_subjectNode_name": "CYP1A2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CYP1A2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35362240;PMID:34641457;PMID:22957244;PMID:21121777;PMID:36559168;PMID:37932838;PMID:26089675;PMID:36704740;PMID:31071346;PMID:36902200;PMID:29559914;PMID:24222315;PMID:37293497;PMID:37521424;PMID:27312874;PMID:37223456;PMID:32855964;PMID:33578259;PMID:31559391;PMID:18568110",
    "publications_count": 20,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:CHEBI:92293--biolink:affects--None--None--None--NCBIGene:1544--infores:dgidb",
    "edge_object": "NCBIGene:1544",
    "edge_subject": "CHEBI:92293",
    "edge_subjectNode_name": "piperacetazine",
    "edge_objectNode_name": "CYP1A2",
    "predicate": "biolink:affects",
    "phrase": "piperacetazine affects CYP1A2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:NCBIGene:1813--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1813",
    "edge_subjectNode_name": "DRD2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "DRD2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35681545;PMID:30967763;PMID:26790724;PMID:23326379;PMID:29674970;PMID:28255461;PMID:35919568;PMID:31481665;PMID:31367015;PMID:27021288;PMID:31358974;PMID:37993913;PMID:38163879;PMID:33491309;PMID:20581683;PMID:35800019;PMID:32368062;PMID:30766477;PMID:31162983;PMID:20190961",
    "publications_count": 20,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:CHEBI:92293--biolink:affects--None--None--None--NCBIGene:1813--infores:dgidb",
    "edge_object": "NCBIGene:1813",
    "edge_subject": "CHEBI:92293",
    "edge_subjectNode_name": "piperacetazine",
    "edge_objectNode_name": "DRD2",
    "predicate": "biolink:affects",
    "phrase": "piperacetazine affects DRD2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "piperacetazine",
    "result_subjectNode_id": "CHEBI:92293",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 190,
    "edge_id": "infores:rtx-kg2:NCBIGene:1813--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1813",
    "edge_subjectNode_name": "DRD2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "DRD2 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:1829682;PMID:7936204",
    "publications_count": 2,
    "support_graph_id": "aux_graph_39_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "licorice",
    "result_subjectNode_id": "UMLS:C0086555",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 191,
    "edge_id": "inferred-UMLS:C0086555-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0086555",
    "edge_subjectNode_name": "licorice",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "licorice treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "licorice",
    "result_subjectNode_id": "UMLS:C0086555",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 191,
    "edge_id": "0332f6cc8448a6cbf7246e6db2096a45",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0086555",
    "edge_subjectNode_name": "licorice",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "licorice studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:14806786;PMID:13153117;PMID:13339268;PMID:17594790;PMID:21896619",
    "publications_count": 5,
    "support_graph_id": "inferred-UMLS:C0086555-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204062",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 192,
    "edge_id": "medik:creative_edge#138",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204062",
    "edge_subjectNode_name": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204062",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 192,
    "edge_id": "medik:edge#193",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204062",
    "edge_subjectNode_name": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:23131342",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#138",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-3-(2-(dimethylamino)ethyl)-5-(3-methylbenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204062",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 192,
    "edge_id": "medik:edge#194",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#138",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Testolactone",
    "result_subjectNode_id": "CHEBI:9460",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 193,
    "edge_id": "inferred-CHEBI:9460-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9460",
    "edge_subjectNode_name": "Testolactone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Testolactone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Testolactone",
    "result_subjectNode_id": "CHEBI:9460",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 193,
    "edge_id": "CHEBI:9460-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9460",
    "edge_subjectNode_name": "Testolactone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Testolactone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:9460-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "arsenic atom",
    "result_subjectNode_id": "CHEBI:27563",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 194,
    "edge_id": "medik:creative_edge#126",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27563",
    "edge_subjectNode_name": "arsenic atom",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "arsenic atom treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "arsenic atom",
    "result_subjectNode_id": "CHEBI:27563",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 194,
    "edge_id": "medik:edge#169",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:27563",
    "edge_subjectNode_name": "arsenic atom",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "arsenic atom affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:21784148",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#126",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "arsenic atom",
    "result_subjectNode_id": "CHEBI:27563",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 194,
    "edge_id": "medik:edge#170",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#126",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)]",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL362988",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 195,
    "edge_id": "medik:creative_edge#139",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL362988",
    "edge_subjectNode_name": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)]",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)] treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)]",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL362988",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 195,
    "edge_id": "medik:edge#195",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL362988",
    "edge_subjectNode_name": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)]",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)] affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:15911283",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#139",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(4-fluorophenyl)-4',4a,6'-trimethyl-(4'R,4aS,6'S)-spiro[1,4,4a,5,6,7-hexahydrocyclopenta[f]indazole-5,2'-(dihydro-4'H-[1,3]dioxane)]",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL362988",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 195,
    "edge_id": "medik:edge#196",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#139",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Enoxolone",
    "result_subjectNode_id": "CHEBI:30853",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 196,
    "edge_id": "inferred-CHEBI:30853-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30853",
    "edge_subjectNode_name": "Enoxolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Enoxolone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Enoxolone",
    "result_subjectNode_id": "CHEBI:30853",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 196,
    "edge_id": "34d7d3aed2efd775e5c05eead05fe8d4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30853",
    "edge_subjectNode_name": "Enoxolone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Enoxolone studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:13087468;PMID:13063571;PMID:13339268;PMID:13071674",
    "publications_count": 4,
    "support_graph_id": "inferred-CHEBI:30853-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 197,
    "edge_id": "inferred-CHEBI:5739-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "histrelin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 197,
    "edge_id": "CHEBI:5739-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "histrelin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5739-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 197,
    "edge_id": "8486817e43eb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "histrelin treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 197,
    "edge_id": "ace02344924c",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:5739",
    "edge_subjectNode_name": "histrelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "histrelin treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "e0d93d15",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "histrelin",
    "result_subjectNode_id": "CHEBI:5739",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 197,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "e0d93d15",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 198,
    "edge_id": "inferred-CHEBI:6427-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Leuprolide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 198,
    "edge_id": "CHEBI:6427-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Leuprolide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6427-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 198,
    "edge_id": "9c7ac7ac090d",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Leuprolide treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 198,
    "edge_id": "082e42c770db",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:6427",
    "edge_subjectNode_name": "Leuprolide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Leuprolide treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "38f24bc7",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Leuprolide",
    "result_subjectNode_id": "CHEBI:6427",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 198,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "38f24bc7",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminoglutethimide",
    "result_subjectNode_id": "CHEBI:2654",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 199,
    "edge_id": "inferred-CHEBI:2654-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2654",
    "edge_subjectNode_name": "Aminoglutethimide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aminoglutethimide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminoglutethimide",
    "result_subjectNode_id": "CHEBI:2654",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 199,
    "edge_id": "CHEBI:2654-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2654",
    "edge_subjectNode_name": "Aminoglutethimide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aminoglutethimide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:2654-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "alanosine",
    "result_subjectNode_id": "UMLS:C0051066",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 200,
    "edge_id": "inferred-UMLS:C0051066-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0051066",
    "edge_subjectNode_name": "alanosine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "alanosine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "alanosine",
    "result_subjectNode_id": "UMLS:C0051066",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 200,
    "edge_id": "UMLS:C0051066-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0051066",
    "edge_subjectNode_name": "alanosine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "alanosine studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UMLS:C0051066-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "chlorpyrifos",
    "result_subjectNode_id": "CHEBI:34631",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 201,
    "edge_id": "medik:creative_edge#104",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34631",
    "edge_subjectNode_name": "chlorpyrifos",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "chlorpyrifos treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "chlorpyrifos",
    "result_subjectNode_id": "CHEBI:34631",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 201,
    "edge_id": "medik:edge#125",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:34631",
    "edge_subjectNode_name": "chlorpyrifos",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "chlorpyrifos affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:31152760",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#104",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "chlorpyrifos",
    "result_subjectNode_id": "CHEBI:34631",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 201,
    "edge_id": "medik:edge#126",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#104",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10070842",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 202,
    "edge_id": "medik:creative_edge#150",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10070842",
    "edge_subjectNode_name": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10070842",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 202,
    "edge_id": "medik:edge#217",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10070842",
    "edge_subjectNode_name": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16386422",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#150",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "4-(4-Chlorophenylsulfanylmethyl)-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10070842",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 202,
    "edge_id": "medik:edge#218",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#150",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "creative_DTD_prediction_8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:D016899",
    "edge_subjectNode_name": "Interferon-beta",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Interferon-beta treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:7099--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7099",
    "edge_subjectNode_name": "TLR4",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TLR4 gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:17709420",
    "publications_count": 1,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:7099--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7099",
    "edge_subjectNode_name": "TLR4",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TLR4 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:MONDO:0004946--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0004946",
    "edge_subjectNode_name": "hypoglycemia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "hypoglycemia manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:MESH:D016899--biolink:affects--None--None--None--NCBIGene:7099--infores:semmeddb",
    "edge_object": "NCBIGene:7099",
    "edge_subject": "MESH:D016899",
    "edge_subjectNode_name": "Interferon-beta",
    "edge_objectNode_name": "TLR4",
    "predicate": "biolink:affects",
    "phrase": "Interferon-beta affects TLR4",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:7099--biolink:gene_associated_with_condition--None--None--None--MONDO:0004946--infores:diseases",
    "edge_object": "MONDO:0004946",
    "edge_subject": "NCBIGene:7099",
    "edge_subjectNode_name": "TLR4",
    "edge_objectNode_name": "hypoglycemia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TLR4 gene associated with condition hypoglycemia",
    "primary_source": "infores:diseases",
    "publications": "PMID:35457182;PMID:38001494;PMID:30406137;PMID:33143088;PMID:36937182;PMID:28400771;PMID:27990144;PMID:22385956;PMID:27192151;PMID:33477354;PMID:29850615;PMID:29559914;PMID:33672754;PMID:30042604;PMID:36421613;PMID:34790827;PMID:31467596;PMID:30210342;PMID:33925827;PMID:28400405",
    "publications_count": 20,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:26191--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:diseases",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:26191",
    "edge_subjectNode_name": "PTPN22",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPN22 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:24614117;PMID:20959028;PMID:29310926;PMID:29849176;PMID:35456512;PMID:32971447;PMID:29529281;PMID:21205883;PMID:26618927;PMID:26405069;PMID:38957156;PMID:33966174;PMID:20455416;PMID:21617108;PMID:34074094;PMID:36980146;PMID:25579746;PMID:16403820;PMID:36755664;PMID:20969580",
    "publications_count": 20,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:26191--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:26191",
    "edge_subjectNode_name": "PTPN22",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPN22 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18301444",
    "publications_count": 1,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:7099--biolink:gene_associated_with_condition--None--None--None--HP:0031273--infores:disgenet",
    "edge_object": "HP:0031273",
    "edge_subject": "NCBIGene:7099",
    "edge_subjectNode_name": "TLR4",
    "edge_objectNode_name": "Shock",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TLR4 gene associated with condition Shock",
    "primary_source": "infores:disgenet",
    "publications": "PMID:16508260",
    "publications_count": 1,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:7099--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:7099",
    "edge_subjectNode_name": "TLR4",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TLR4 gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:37772259;PMID:23835515;PMID:35683020;PMID:36361735;PMID:21852947;PMID:22906120;PMID:34285595;PMID:29267600;PMID:34222132;PMID:26913035;PMID:28257033;PMID:25102137;PMID:25716998;PMID:32961910;PMID:37077815;PMID:31906014;PMID:34693385;PMID:27713627;PMID:36421613;PMID:33064982",
    "publications_count": 20,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:HP:0031273--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0031273",
    "edge_subjectNode_name": "Shock",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Shock manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:NCBIGene:7099--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:7099",
    "edge_subjectNode_name": "TLR4",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "TLR4 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:34072450;PMID:36713841;PMID:35683020;PMID:37893198;PMID:37007031;PMID:35628657;PMID:35056657;PMID:28987175;PMID:34445350;PMID:34054510;PMID:25204979;PMID:31208369;PMID:35720723;PMID:32580510;PMID:34221026;PMID:34502166;PMID:36339816;PMID:33014275;PMID:23270518;PMID:36052359",
    "publications_count": 20,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon-beta",
    "result_subjectNode_id": "MESH:D016899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 203,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_41_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Streptomycin",
    "result_subjectNode_id": "CHEBI:17076",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 204,
    "edge_id": "inferred-CHEBI:17076-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17076",
    "edge_subjectNode_name": "Streptomycin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Streptomycin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Streptomycin",
    "result_subjectNode_id": "CHEBI:17076",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 204,
    "edge_id": "9cdde2e1a6bc9f1ae58018bac9c18f6c",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17076",
    "edge_subjectNode_name": "Streptomycin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Streptomycin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:14811095;PMID:13070740;PMID:15440192;PMID:18115284",
    "publications_count": 4,
    "support_graph_id": "inferred-CHEBI:17076-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Phorbol 12-myristate 13-acetate diester",
    "result_subjectNode_id": "CHEBI:37537",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 205,
    "edge_id": "medik:creative_edge#105",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:37537",
    "edge_subjectNode_name": "Phorbol 12-myristate 13-acetate diester",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Phorbol 12-myristate 13-acetate diester treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Phorbol 12-myristate 13-acetate diester",
    "result_subjectNode_id": "CHEBI:37537",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 205,
    "edge_id": "medik:edge#127",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:37537",
    "edge_subjectNode_name": "Phorbol 12-myristate 13-acetate diester",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Phorbol 12-myristate 13-acetate diester affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:21569788",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#105",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Phorbol 12-myristate 13-acetate diester",
    "result_subjectNode_id": "CHEBI:37537",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 205,
    "edge_id": "medik:edge#128",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#105",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "17-oxo steroid",
    "result_subjectNode_id": "CHEBI:19168",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 206,
    "edge_id": "inferred-CHEBI:19168-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:19168",
    "edge_subjectNode_name": "17-oxo steroid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "17-oxo steroid treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "17-oxo steroid",
    "result_subjectNode_id": "CHEBI:19168",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 206,
    "edge_id": "CHEBI:19168-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:19168",
    "edge_subjectNode_name": "17-oxo steroid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "17-oxo steroid studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:19168-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aromatase Inhibitors",
    "result_subjectNode_id": "UMLS:C0593802",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 207,
    "edge_id": "inferred-UMLS:C0593802-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0593802",
    "edge_subjectNode_name": "Aromatase Inhibitors",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aromatase Inhibitors treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aromatase Inhibitors",
    "result_subjectNode_id": "UMLS:C0593802",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 207,
    "edge_id": "UMLS:C0593802-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0593802",
    "edge_subjectNode_name": "Aromatase Inhibitors",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Aromatase Inhibitors studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UMLS:C0593802-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cinerubine B",
    "result_subjectNode_id": "MESH:C000482",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 208,
    "edge_id": "medik:creative_edge#109",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:C000482",
    "edge_subjectNode_name": "cinerubine B",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cinerubine B treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cinerubine B",
    "result_subjectNode_id": "MESH:C000482",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 208,
    "edge_id": "medik:edge#135",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "MESH:C000482",
    "edge_subjectNode_name": "cinerubine B",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "cinerubine B affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:19255438",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#109",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cinerubine B",
    "result_subjectNode_id": "MESH:C000482",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 208,
    "edge_id": "medik:edge#136",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#109",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Flutamide",
    "result_subjectNode_id": "CHEBI:5132",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 209,
    "edge_id": "inferred-CHEBI:5132-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5132",
    "edge_subjectNode_name": "Flutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Flutamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Flutamide",
    "result_subjectNode_id": "CHEBI:5132",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 209,
    "edge_id": "CHEBI:5132-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5132",
    "edge_subjectNode_name": "Flutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Flutamide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5132-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10150851",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 210,
    "edge_id": "medik:creative_edge#176",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10150851",
    "edge_subjectNode_name": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10150851",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 210,
    "edge_id": "medik:edge#269",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10150851",
    "edge_subjectNode_name": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#176",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(3-Chlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10150851",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 210,
    "edge_id": "medik:edge#270",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#176",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "steroid",
    "result_subjectNode_id": "CHEBI:35341",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 211,
    "edge_id": "inferred-CHEBI:35341-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:35341",
    "edge_subjectNode_name": "steroid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "steroid treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "steroid",
    "result_subjectNode_id": "CHEBI:35341",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 211,
    "edge_id": "CHEBI:35341-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:35341",
    "edge_subjectNode_name": "steroid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "steroid studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:35341-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bisphenol Z",
    "result_subjectNode_id": "CHEBI:165198",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 212,
    "edge_id": "medik:creative_edge#123",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:165198",
    "edge_subjectNode_name": "Bisphenol Z",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bisphenol Z treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bisphenol Z",
    "result_subjectNode_id": "CHEBI:165198",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 212,
    "edge_id": "medik:edge#163",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:165198",
    "edge_subjectNode_name": "Bisphenol Z",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Bisphenol Z affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:31195007",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#123",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bisphenol Z",
    "result_subjectNode_id": "CHEBI:165198",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 212,
    "edge_id": "medik:edge#164",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#123",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone sulfate",
    "result_subjectNode_id": "CHEBI:16814",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 213,
    "edge_id": "inferred-CHEBI:16814-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16814",
    "edge_subjectNode_name": "Prasterone sulfate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prasterone sulfate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prasterone sulfate",
    "result_subjectNode_id": "CHEBI:16814",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 213,
    "edge_id": "CHEBI:16814-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16814",
    "edge_subjectNode_name": "Prasterone sulfate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prasterone sulfate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16814-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Topiramate",
    "result_subjectNode_id": "CHEBI:63631",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 214,
    "edge_id": "inferred-CHEBI:63631-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:63631",
    "edge_subjectNode_name": "Topiramate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Topiramate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Topiramate",
    "result_subjectNode_id": "CHEBI:63631",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 214,
    "edge_id": "CHEBI:63631-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:63631",
    "edge_subjectNode_name": "Topiramate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Topiramate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:63631-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Propylparaben",
    "result_subjectNode_id": "CHEBI:32063",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 215,
    "edge_id": "medik:creative_edge#121",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:32063",
    "edge_subjectNode_name": "Propylparaben",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Propylparaben treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Propylparaben",
    "result_subjectNode_id": "CHEBI:32063",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 215,
    "edge_id": "medik:edge#159",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:32063",
    "edge_subjectNode_name": "Propylparaben",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Propylparaben affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:25448277",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#121",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Propylparaben",
    "result_subjectNode_id": "CHEBI:32063",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 215,
    "edge_id": "medik:edge#160",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#121",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Growth Hormone",
    "result_subjectNode_id": "UMLS:C0037663",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 216,
    "edge_id": "inferred-UMLS:C0037663-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0037663",
    "edge_subjectNode_name": "Growth Hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Growth Hormone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Growth Hormone",
    "result_subjectNode_id": "UMLS:C0037663",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 216,
    "edge_id": "UMLS:C0037663-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0037663",
    "edge_subjectNode_name": "Growth Hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Growth Hormone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UMLS:C0037663-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "creative_DTD_prediction_9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:25E79B5CTM",
    "edge_subjectNode_name": "Denileukin diftitox",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Denileukin diftitox treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:NCBIGene:1938--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1938",
    "edge_subjectNode_name": "EEF2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "EEF2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35625895;PMID:37035671;PMID:34675774;PMID:34718744;PMID:25647575;PMID:34944455;PMID:32054133;PMID:35364140;PMID:35478659;PMID:32099466;PMID:33353946;PMID:37492719;PMID:25032491;PMID:29867948;PMID:35250559;PMID:32582210;PMID:26412068;PMID:26509083;PMID:34526091;PMID:35513392",
    "publications_count": 20,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:UNII:25E79B5CTM--biolink:affects--None--None--None--NCBIGene:1938--infores:dgidb",
    "edge_object": "NCBIGene:1938",
    "edge_subject": "UNII:25E79B5CTM",
    "edge_subjectNode_name": "Denileukin diftitox",
    "edge_objectNode_name": "EEF2",
    "predicate": "biolink:affects",
    "phrase": "Denileukin diftitox affects EEF2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:UNII:25E79B5CTM--biolink:affects--None--None--None--NCBIGene:3560--infores:dgidb",
    "edge_object": "NCBIGene:3560",
    "edge_subject": "UNII:25E79B5CTM",
    "edge_subjectNode_name": "Denileukin diftitox",
    "edge_objectNode_name": "IL2RB",
    "predicate": "biolink:affects",
    "phrase": "Denileukin diftitox affects IL2RB",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:UNII:25E79B5CTM--biolink:affects--None--None--None--NCBIGene:3560--infores:drugbank",
    "edge_object": "NCBIGene:3560",
    "edge_subject": "UNII:25E79B5CTM",
    "edge_subjectNode_name": "Denileukin diftitox",
    "edge_objectNode_name": "IL2RB",
    "predicate": "biolink:affects",
    "phrase": "Denileukin diftitox affects IL2RB",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:UNII:25E79B5CTM--biolink:directly_physically_interacts_with--None--None--None--NCBIGene:3560--infores:drugcentral",
    "edge_object": "NCBIGene:3560",
    "edge_subject": "UNII:25E79B5CTM",
    "edge_subjectNode_name": "Denileukin diftitox",
    "edge_objectNode_name": "IL2RB",
    "predicate": "biolink:directly_physically_interacts_with",
    "phrase": "Denileukin diftitox directly physically interacts with IL2RB",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:NCBIGene:3560--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:disgenet",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3560",
    "edge_subjectNode_name": "IL2RB",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IL2RB gene associated with condition tuberculosis",
    "primary_source": "infores:disgenet",
    "publications": "PMID:24057671",
    "publications_count": 1,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denileukin diftitox",
    "result_subjectNode_id": "UNII:25E79B5CTM",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 217,
    "edge_id": "infores:rtx-kg2:NCBIGene:3560--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3560",
    "edge_subjectNode_name": "IL2RB",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IL2RB gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:37942326;PMID:35968218;PMID:32085976;PMID:36799159;PMID:20106866;PMID:37986378;PMID:37091679;PMID:25132095;PMID:22084544;PMID:28491060;PMID:23226242;PMID:31708740;PMID:34058283;PMID:36224474;PMID:34123875;PMID:30589870;PMID:33340461;PMID:26652001;PMID:17554300;PMID:36316476",
    "publications_count": 20,
    "support_graph_id": "aux_graph_43_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bisphenol A",
    "result_subjectNode_id": "CHEBI:33216",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 218,
    "edge_id": "medik:creative_edge#129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:33216",
    "edge_subjectNode_name": "Bisphenol A",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bisphenol A treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bisphenol A",
    "result_subjectNode_id": "CHEBI:33216",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 218,
    "edge_id": "medik:edge#175",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:33216",
    "edge_subjectNode_name": "Bisphenol A",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Bisphenol A affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:26996129",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#129",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bisphenol A",
    "result_subjectNode_id": "CHEBI:33216",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 218,
    "edge_id": "medik:edge#176",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#129",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Estradiol",
    "result_subjectNode_id": "CHEBI:16469",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 219,
    "edge_id": "inferred-CHEBI:16469-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16469",
    "edge_subjectNode_name": "Estradiol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Estradiol treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Estradiol",
    "result_subjectNode_id": "CHEBI:16469",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 219,
    "edge_id": "CHEBI:16469-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16469",
    "edge_subjectNode_name": "Estradiol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Estradiol studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16469-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "C60 fullerene",
    "result_subjectNode_id": "CHEBI:33128",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 220,
    "edge_id": "medik:creative_edge#103",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:33128",
    "edge_subjectNode_name": "C60 fullerene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "C60 fullerene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "C60 fullerene",
    "result_subjectNode_id": "CHEBI:33128",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 220,
    "edge_id": "medik:edge#123",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:33128",
    "edge_subjectNode_name": "C60 fullerene",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "C60 fullerene affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:20064541",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#103",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "C60 fullerene",
    "result_subjectNode_id": "CHEBI:33128",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 220,
    "edge_id": "medik:edge#124",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#103",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151165",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 221,
    "edge_id": "medik:creative_edge#177",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10151165",
    "edge_subjectNode_name": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151165",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 221,
    "edge_id": "medik:edge#271",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10151165",
    "edge_subjectNode_name": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#177",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1,1,1-trifluoro-2-[(5-fluoro-1H-indol-2-yl)methyl]-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151165",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 221,
    "edge_id": "medik:edge#272",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#177",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216465",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 222,
    "edge_id": "medik:creative_edge#203",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10216465",
    "edge_subjectNode_name": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216465",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 222,
    "edge_id": "medik:edge#323",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10216465",
    "edge_subjectNode_name": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#203",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(3-Chloro-5-methylbenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10216465",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 222,
    "edge_id": "medik:edge#324",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#203",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Podofilox",
    "result_subjectNode_id": "CHEBI:50305",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 223,
    "edge_id": "medik:creative_edge#117",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50305",
    "edge_subjectNode_name": "Podofilox",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Podofilox treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Podofilox",
    "result_subjectNode_id": "CHEBI:50305",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 223,
    "edge_id": "medik:edge#151",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:50305",
    "edge_subjectNode_name": "Podofilox",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Podofilox affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:19364854",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#117",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Podofilox",
    "result_subjectNode_id": "CHEBI:50305",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 223,
    "edge_id": "medik:edge#152",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#117",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "methylprednisolone suleptanate",
    "result_subjectNode_id": "CHEBI:135864",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 224,
    "edge_id": "899771b2e329",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:135864",
    "edge_subjectNode_name": "methylprednisolone suleptanate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "methylprednisolone suleptanate treats Addison Disease",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "methylprednisolone suleptanate",
    "result_subjectNode_id": "CHEBI:135864",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 224,
    "edge_id": "fc5ac89ac91e",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:135864",
    "edge_subjectNode_name": "methylprednisolone suleptanate",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "methylprednisolone suleptanate treats congenital adrenal hyperplasia",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "6a479b52",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "methylprednisolone suleptanate",
    "result_subjectNode_id": "CHEBI:135864",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 224,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "6a479b52",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "creative_DTD_prediction_11",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aminocaproic acid treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5340--infores:semmeddb",
    "edge_object": "NCBIGene:5340",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLG",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLG",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5327--infores:dgidb",
    "edge_object": "NCBIGene:5327",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLAT",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLAT",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5327--infores:drugbank",
    "edge_object": "NCBIGene:5327",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLAT",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLAT",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:NCBIGene:5327--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5327",
    "edge_subjectNode_name": "PLAT",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PLAT gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33208141;PMID:37492169;PMID:35309326;PMID:29399057;PMID:33362701;PMID:34865660;PMID:21206535;PMID:31205830;PMID:31278571;PMID:11738978;PMID:31117907;PMID:37644776;PMID:25821957;PMID:32859784;PMID:34522589;PMID:25733922;PMID:34809712;PMID:21627891;PMID:25844636;PMID:31686629",
    "publications_count": 20,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5340--infores:dgidb",
    "edge_object": "NCBIGene:5340",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLG",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLG",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5327--infores:drugcentral",
    "edge_object": "NCBIGene:5327",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLAT",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLAT",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5340--infores:drugbank",
    "edge_object": "NCBIGene:5340",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLG",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLG",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:NCBIGene:5340--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5340",
    "edge_subjectNode_name": "PLG",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PLG gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33208141;PMID:36439263;PMID:33362701;PMID:34326601;PMID:34865660;PMID:37601774;PMID:32287168;PMID:34809712;PMID:28432428;PMID:33682719;PMID:37238951;PMID:25949827;PMID:36176317;PMID:34190197;PMID:34763262;PMID:20835362;PMID:22114580;PMID:38072952;PMID:36793087;PMID:22693670",
    "publications_count": 20,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminocaproic acid",
    "result_subjectNode_id": "CHEBI:16586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 225,
    "edge_id": "infores:rtx-kg2:CHEBI:16586--biolink:affects--None--None--None--NCBIGene:5340--infores:drugcentral",
    "edge_object": "NCBIGene:5340",
    "edge_subject": "CHEBI:16586",
    "edge_subjectNode_name": "Aminocaproic acid",
    "edge_objectNode_name": "PLG",
    "predicate": "biolink:affects",
    "phrase": "Aminocaproic acid affects PLG",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_45_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127593",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 226,
    "edge_id": "medik:creative_edge#167",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10127593",
    "edge_subjectNode_name": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127593",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 226,
    "edge_id": "medik:edge#251",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10127593",
    "edge_subjectNode_name": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:16112571",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#167",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-benzyl-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-4-phenylpentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10127593",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 226,
    "edge_id": "medik:edge#252",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#167",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10044332",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 227,
    "edge_id": "medik:creative_edge#148",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10044332",
    "edge_subjectNode_name": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10044332",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 227,
    "edge_id": "medik:edge#213",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10044332",
    "edge_subjectNode_name": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:25706100",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#148",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,3R,4aR,10aS)-4a-ethyl-3,9-dimethyl-2-phenyl-4,10a-dihydro-1H-phenanthrene-2,3,7-triol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10044332",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 227,
    "edge_id": "medik:edge#214",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#148",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10072320",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 228,
    "edge_id": "medik:creative_edge#152",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10072320",
    "edge_subjectNode_name": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10072320",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 228,
    "edge_id": "medik:edge#221",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10072320",
    "edge_subjectNode_name": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17681466",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#152",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "4-{1-[2-(3-Chlorophenyl)ethoxy]ethyl}-6-(2-methoxyphenyl)-2,2-dimethyl-1,2-dihydroquinoline",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10072320",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 228,
    "edge_id": "medik:edge#222",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#152",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Luteinizing hormone",
    "result_subjectNode_id": "CHEBI:81568",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 229,
    "edge_id": "inferred-CHEBI:81568-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:81568",
    "edge_subjectNode_name": "Luteinizing hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Luteinizing hormone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Luteinizing hormone",
    "result_subjectNode_id": "CHEBI:81568",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 229,
    "edge_id": "CHEBI:81568-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:81568",
    "edge_subjectNode_name": "Luteinizing hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Luteinizing hormone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:81568-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Luteinizing hormone",
    "result_subjectNode_id": "CHEBI:81568",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 229,
    "edge_id": "medik:creative_edge#218",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:81568",
    "edge_subjectNode_name": "Luteinizing hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Luteinizing hormone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Luteinizing hormone",
    "result_subjectNode_id": "CHEBI:81568",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 229,
    "edge_id": "medik:edge#358",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:81568",
    "edge_subjectNode_name": "Luteinizing hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Luteinizing hormone studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:9506718",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#218",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ciclesonide",
    "result_subjectNode_id": "CHEBI:31397",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 230,
    "edge_id": "medik:creative_edge#115",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:31397",
    "edge_subjectNode_name": "Ciclesonide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ciclesonide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ciclesonide",
    "result_subjectNode_id": "CHEBI:31397",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 230,
    "edge_id": "medik:edge#147",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:31397",
    "edge_subjectNode_name": "Ciclesonide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Ciclesonide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:15878996",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#115",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ciclesonide",
    "result_subjectNode_id": "CHEBI:31397",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 230,
    "edge_id": "medik:edge#148",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#115",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "creative_DTD_prediction_12",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:135910",
    "edge_subjectNode_name": "Ganirelix",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ganirelix treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:NCBIGene:2798--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2798",
    "edge_subjectNode_name": "GNRHR",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "GNRHR gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:35359850;PMID:19944289;PMID:16202169;PMID:37493574;PMID:33663580;PMID:33797780;PMID:33294761;PMID:24747343;PMID:31572300;PMID:36110220;PMID:28332880;PMID:21274298;PMID:28295047;PMID:32564094;PMID:35083794;PMID:33798258;PMID:23875799;PMID:37321569;PMID:31781041;PMID:35518925",
    "publications_count": 20,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:CHEBI:135910--biolink:affects--None--None--None--NCBIGene:2798--infores:drugbank",
    "edge_object": "NCBIGene:2798",
    "edge_subject": "CHEBI:135910",
    "edge_subjectNode_name": "Ganirelix",
    "edge_objectNode_name": "GNRHR",
    "predicate": "biolink:affects",
    "phrase": "Ganirelix affects GNRHR",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:CHEBI:135910--biolink:affects--None--None--None--NCBIGene:2798--infores:dgidb",
    "edge_object": "NCBIGene:2798",
    "edge_subject": "CHEBI:135910",
    "edge_subjectNode_name": "Ganirelix",
    "edge_objectNode_name": "GNRHR",
    "predicate": "biolink:affects",
    "phrase": "Ganirelix affects GNRHR",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:CHEBI:135910--biolink:affects--None--None--None--NCBIGene:2798--infores:drugcentral",
    "edge_object": "NCBIGene:2798",
    "edge_subject": "CHEBI:135910",
    "edge_subjectNode_name": "Ganirelix",
    "edge_objectNode_name": "GNRHR",
    "predicate": "biolink:affects",
    "phrase": "Ganirelix affects GNRHR",
    "primary_source": "infores:drugcentral",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ganirelix",
    "result_subjectNode_id": "CHEBI:135910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 231,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_47_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204049",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 232,
    "edge_id": "medik:creative_edge#136",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204049",
    "edge_subjectNode_name": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204049",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 232,
    "edge_id": "medik:edge#189",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204049",
    "edge_subjectNode_name": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:23131342",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#136",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-5-(2,6-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204049",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 232,
    "edge_id": "medik:edge#190",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#136",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204047",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 233,
    "edge_id": "medik:creative_edge#135",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204047",
    "edge_subjectNode_name": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204047",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 233,
    "edge_id": "medik:edge#187",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204047",
    "edge_subjectNode_name": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:23131342",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#135",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-5-(2,3-dichlorobenzyl)-6-(4-phenylcyclohexyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204047",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 233,
    "edge_id": "medik:edge#188",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#135",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151357",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 234,
    "edge_id": "medik:creative_edge#179",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10151357",
    "edge_subjectNode_name": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151357",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 234,
    "edge_id": "medik:edge#275",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10151357",
    "edge_subjectNode_name": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:17692519",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#179",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(2,5-Dichlorobenzyl)-1,1,1-trifluoro-4-(5-fluoro-2-methoxyphenyl)-4-methylpentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151357",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 234,
    "edge_id": "medik:edge#276",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#179",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "sulfonamide",
    "result_subjectNode_id": "CHEBI:35358",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 235,
    "edge_id": "medik:creative_edge#108",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:35358",
    "edge_subjectNode_name": "sulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "sulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "sulfonamide",
    "result_subjectNode_id": "CHEBI:35358",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 235,
    "edge_id": "medik:edge#133",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:35358",
    "edge_subjectNode_name": "sulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "sulfonamide affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:19927138",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#108",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "sulfonamide",
    "result_subjectNode_id": "CHEBI:35358",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 235,
    "edge_id": "medik:edge#134",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#108",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium arsenite",
    "result_subjectNode_id": "CHEBI:29678",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 236,
    "edge_id": "medik:creative_edge#96",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:29678",
    "edge_subjectNode_name": "Sodium arsenite",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sodium arsenite treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium arsenite",
    "result_subjectNode_id": "CHEBI:29678",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 236,
    "edge_id": "medik:edge#109",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:29678",
    "edge_subjectNode_name": "Sodium arsenite",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Sodium arsenite affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:24218229",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#96",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium arsenite",
    "result_subjectNode_id": "CHEBI:29678",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 236,
    "edge_id": "medik:edge#110",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#96",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "creative_DTD_prediction_15",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:5TAA004E22",
    "edge_subjectNode_name": "Sargramostim",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sargramostim treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "infores:rtx-kg2:NCBIGene:1437--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1437",
    "edge_subjectNode_name": "CSF2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CSF2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:25600911;PMID:30526315;PMID:22000099;PMID:32427134;PMID:34641457;PMID:32295518;PMID:26988816;PMID:31781052;PMID:32663221;PMID:33609255;PMID:35772364;PMID:30406137;PMID:27313138;PMID:32800705;PMID:37496672;PMID:30921373;PMID:29312313;PMID:23293627;PMID:35056657;PMID:32225060",
    "publications_count": 20,
    "support_graph_id": "aux_graph_49_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_49_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "infores:rtx-kg2:NCBIGene:6383--biolink:physically_interacts_with--None--None--None--NCBIGene:57216--infores:intact",
    "edge_object": "NCBIGene:57216",
    "edge_subject": "NCBIGene:6383",
    "edge_subjectNode_name": "SDC2",
    "edge_objectNode_name": "VANGL2",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "SDC2 physically interacts with VANGL2",
    "primary_source": "infores:intact",
    "publications": "PMID:28514442",
    "publications_count": 1,
    "support_graph_id": "aux_graph_49_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "infores:rtx-kg2:UNII:5TAA004E22--biolink:affects--None--None--None--NCBIGene:6383--infores:drugbank",
    "edge_object": "NCBIGene:6383",
    "edge_subject": "UNII:5TAA004E22",
    "edge_subjectNode_name": "Sargramostim",
    "edge_objectNode_name": "SDC2",
    "predicate": "biolink:affects",
    "phrase": "Sargramostim affects SDC2",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_49_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "infores:rtx-kg2:UNII:5TAA004E22--biolink:derives_from--None--None--None--NCBIGene:1437--infores:drugbank",
    "edge_object": "NCBIGene:1437",
    "edge_subject": "UNII:5TAA004E22",
    "edge_subjectNode_name": "Sargramostim",
    "edge_objectNode_name": "CSF2",
    "predicate": "biolink:derives_from",
    "phrase": "Sargramostim derives from CSF2",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_49_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sargramostim",
    "result_subjectNode_id": "UNII:5TAA004E22",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 237,
    "edge_id": "infores:rtx-kg2:NCBIGene:57216--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:57216",
    "edge_subjectNode_name": "VANGL2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "VANGL2 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_49_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL4758563",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 238,
    "edge_id": "medik:creative_edge#140",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL4758563",
    "edge_subjectNode_name": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL4758563",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 238,
    "edge_id": "medik:edge#197",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL4758563",
    "edge_subjectNode_name": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:32738970",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#140",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2,2,2-trifluoro-N-((1R,2S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-p-tolylpropan-2-yl)acetamide",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL4758563",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 238,
    "edge_id": "medik:edge#198",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#140",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butyrate",
    "result_subjectNode_id": "CHEBI:17968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 239,
    "edge_id": "medik:creative_edge#99",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17968",
    "edge_subjectNode_name": "butyrate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butyrate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butyrate",
    "result_subjectNode_id": "CHEBI:17968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 239,
    "edge_id": "medik:edge#115",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:17968",
    "edge_subjectNode_name": "butyrate",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "butyrate affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:11024006",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#99",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butyrate",
    "result_subjectNode_id": "CHEBI:17968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 239,
    "edge_id": "medik:edge#116",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#99",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Benralizumab",
    "result_subjectNode_id": "UNII:71492GE1FX",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 240,
    "edge_id": "inferred-UNII:71492GE1FX-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:71492GE1FX",
    "edge_subjectNode_name": "Benralizumab",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Benralizumab treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Benralizumab",
    "result_subjectNode_id": "UNII:71492GE1FX",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 240,
    "edge_id": "f51cca6270471dcc05fb78432d7e7618",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:71492GE1FX",
    "edge_subjectNode_name": "Benralizumab",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Benralizumab studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:8360169",
    "publications_count": 1,
    "support_graph_id": "inferred-UNII:71492GE1FX-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denosumab",
    "result_subjectNode_id": "UNII:4EQZ6YO2HI",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 241,
    "edge_id": "inferred-UNII:4EQZ6YO2HI-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:4EQZ6YO2HI",
    "edge_subjectNode_name": "Denosumab",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Denosumab treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Denosumab",
    "result_subjectNode_id": "UNII:4EQZ6YO2HI",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 241,
    "edge_id": "df65e5f75075ead9ac92043aaf0dd63f",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:4EQZ6YO2HI",
    "edge_subjectNode_name": "Denosumab",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Denosumab studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:9282361",
    "publications_count": 1,
    "support_graph_id": "inferred-UNII:4EQZ6YO2HI-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rituximab",
    "result_subjectNode_id": "UNII:4F4X42SYQ6",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 242,
    "edge_id": "inferred-UNII:4F4X42SYQ6-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:4F4X42SYQ6",
    "edge_subjectNode_name": "Rituximab",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Rituximab treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Rituximab",
    "result_subjectNode_id": "UNII:4F4X42SYQ6",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 242,
    "edge_id": "e5dbc8553b150dc3b7fb9c16a795bfe2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:4F4X42SYQ6",
    "edge_subjectNode_name": "Rituximab",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Rituximab studied to treat Addison Disease",
    "primary_source": "infores:text-mining-provider-targeted",
    "publications": "PMC:7274491;PMC:7274491",
    "publications_count": 2,
    "support_graph_id": "inferred-UNII:4F4X42SYQ6-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Letrozole",
    "result_subjectNode_id": "CHEBI:6413",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 243,
    "edge_id": "inferred-CHEBI:6413-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6413",
    "edge_subjectNode_name": "Letrozole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Letrozole treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Letrozole",
    "result_subjectNode_id": "CHEBI:6413",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 243,
    "edge_id": "CHEBI:6413-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6413",
    "edge_subjectNode_name": "Letrozole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Letrozole studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:6413-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nilutamide",
    "result_subjectNode_id": "CHEBI:7573",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 244,
    "edge_id": "inferred-CHEBI:7573-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7573",
    "edge_subjectNode_name": "Nilutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Nilutamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nilutamide",
    "result_subjectNode_id": "CHEBI:7573",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 244,
    "edge_id": "CHEBI:7573-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7573",
    "edge_subjectNode_name": "Nilutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Nilutamide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:7573-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "amphetamine sulfate",
    "result_subjectNode_id": "CHEBI:51063",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 245,
    "edge_id": "inferred-CHEBI:51063-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:51063",
    "edge_subjectNode_name": "amphetamine sulfate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "amphetamine sulfate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "amphetamine sulfate",
    "result_subjectNode_id": "CHEBI:51063",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 245,
    "edge_id": "CHEBI:51063-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:51063",
    "edge_subjectNode_name": "amphetamine sulfate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "amphetamine sulfate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:51063-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Fulvestrant",
    "result_subjectNode_id": "CHEBI:31638",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 246,
    "edge_id": "inferred-CHEBI:31638-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:31638",
    "edge_subjectNode_name": "Fulvestrant",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Fulvestrant treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Fulvestrant",
    "result_subjectNode_id": "CHEBI:31638",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 246,
    "edge_id": "CHEBI:31638-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:31638",
    "edge_subjectNode_name": "Fulvestrant",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Fulvestrant studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:31638-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bicalutamide",
    "result_subjectNode_id": "CHEBI:144093",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 247,
    "edge_id": "inferred-CHEBI:144093-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:144093",
    "edge_subjectNode_name": "Bicalutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bicalutamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bicalutamide",
    "result_subjectNode_id": "CHEBI:144093",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 247,
    "edge_id": "CHEBI:144093-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:144093",
    "edge_subjectNode_name": "Bicalutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Bicalutamide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:144093-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Enzalutamide",
    "result_subjectNode_id": "CHEBI:68534",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 248,
    "edge_id": "inferred-CHEBI:68534-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68534",
    "edge_subjectNode_name": "Enzalutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Enzalutamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Enzalutamide",
    "result_subjectNode_id": "CHEBI:68534",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 248,
    "edge_id": "CHEBI:68534-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:68534",
    "edge_subjectNode_name": "Enzalutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Enzalutamide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:68534-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Niacin",
    "result_subjectNode_id": "CHEBI:15940",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 249,
    "edge_id": "inferred-CHEBI:15940-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15940",
    "edge_subjectNode_name": "Niacin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Niacin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Niacin",
    "result_subjectNode_id": "CHEBI:15940",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 249,
    "edge_id": "CHEBI:15940-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15940",
    "edge_subjectNode_name": "Niacin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Niacin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:15940-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Darolutamide",
    "result_subjectNode_id": "UNII:X05U0N2RCO",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 250,
    "edge_id": "inferred-UNII:X05U0N2RCO-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:X05U0N2RCO",
    "edge_subjectNode_name": "Darolutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Darolutamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Darolutamide",
    "result_subjectNode_id": "UNII:X05U0N2RCO",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 250,
    "edge_id": "UNII:X05U0N2RCO-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:X05U0N2RCO",
    "edge_subjectNode_name": "Darolutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Darolutamide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:X05U0N2RCO-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ketoconazole",
    "result_subjectNode_id": "CHEBI:47518",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 251,
    "edge_id": "inferred-CHEBI:47518-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:47518",
    "edge_subjectNode_name": "Ketoconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ketoconazole treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ketoconazole",
    "result_subjectNode_id": "CHEBI:47518",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 251,
    "edge_id": "CHEBI:47518-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:47518",
    "edge_subjectNode_name": "Ketoconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Ketoconazole studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:47518-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Fluconazole",
    "result_subjectNode_id": "CHEBI:46081",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 252,
    "edge_id": "inferred-CHEBI:46081-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46081",
    "edge_subjectNode_name": "Fluconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Fluconazole treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Fluconazole",
    "result_subjectNode_id": "CHEBI:46081",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 252,
    "edge_id": "CHEBI:46081-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:46081",
    "edge_subjectNode_name": "Fluconazole",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Fluconazole studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:46081-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nitrous oxide",
    "result_subjectNode_id": "CHEBI:17045",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 253,
    "edge_id": "inferred-CHEBI:17045-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17045",
    "edge_subjectNode_name": "Nitrous oxide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Nitrous oxide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nitrous oxide",
    "result_subjectNode_id": "CHEBI:17045",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 253,
    "edge_id": "CHEBI:17045-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17045",
    "edge_subjectNode_name": "Nitrous oxide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Nitrous oxide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:17045-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Verucerfont",
    "result_subjectNode_id": "UNII:X60608B091",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 254,
    "edge_id": "inferred-UNII:X60608B091-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:X60608B091",
    "edge_subjectNode_name": "Verucerfont",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Verucerfont treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Verucerfont",
    "result_subjectNode_id": "UNII:X60608B091",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 254,
    "edge_id": "UNII:X60608B091-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:X60608B091",
    "edge_subjectNode_name": "Verucerfont",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Verucerfont studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:X60608B091-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium bicarbonate",
    "result_subjectNode_id": "CHEBI:32139",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 255,
    "edge_id": "inferred-CHEBI:32139-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:32139",
    "edge_subjectNode_name": "Sodium bicarbonate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Sodium bicarbonate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Sodium bicarbonate",
    "result_subjectNode_id": "CHEBI:32139",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 255,
    "edge_id": "CHEBI:32139-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:32139",
    "edge_subjectNode_name": "Sodium bicarbonate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Sodium bicarbonate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:32139-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Apalutamide",
    "result_subjectNode_id": "UNII:4T36H88UA7",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 256,
    "edge_id": "inferred-UNII:4T36H88UA7-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:4T36H88UA7",
    "edge_subjectNode_name": "Apalutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Apalutamide treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Apalutamide",
    "result_subjectNode_id": "UNII:4T36H88UA7",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 256,
    "edge_id": "UNII:4T36H88UA7-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:4T36H88UA7",
    "edge_subjectNode_name": "Apalutamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Apalutamide studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:4T36H88UA7-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cocaine",
    "result_subjectNode_id": "CHEBI:27958",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 257,
    "edge_id": "inferred-CHEBI:27958-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27958",
    "edge_subjectNode_name": "Cocaine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Cocaine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Cocaine",
    "result_subjectNode_id": "CHEBI:27958",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 257,
    "edge_id": "CHEBI:27958-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:27958",
    "edge_subjectNode_name": "Cocaine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Cocaine studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:27958-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortancyl",
    "result_subjectNode_id": "CHEBI:34655",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 258,
    "edge_id": "inferred-CHEBI:34655-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34655",
    "edge_subjectNode_name": "cortancyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cortancyl treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cortancyl",
    "result_subjectNode_id": "CHEBI:34655",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 258,
    "edge_id": "CHEBI:34655-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:34655",
    "edge_subjectNode_name": "cortancyl",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cortancyl studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:34655-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Estrogen",
    "result_subjectNode_id": "CHEBI:41922",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 259,
    "edge_id": "inferred-CHEBI:41922-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:41922",
    "edge_subjectNode_name": "Estrogen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Estrogen treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Estrogen",
    "result_subjectNode_id": "CHEBI:41922",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 259,
    "edge_id": "CHEBI:41922-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:41922",
    "edge_subjectNode_name": "Estrogen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Estrogen studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:41922-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Etomidate",
    "result_subjectNode_id": "CHEBI:4910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 260,
    "edge_id": "inferred-CHEBI:4910-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4910",
    "edge_subjectNode_name": "Etomidate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Etomidate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Etomidate",
    "result_subjectNode_id": "CHEBI:4910",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 260,
    "edge_id": "CHEBI:4910-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4910",
    "edge_subjectNode_name": "Etomidate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Etomidate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:4910-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Amlodipine",
    "result_subjectNode_id": "CHEBI:2668",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 261,
    "edge_id": "inferred-CHEBI:2668-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2668",
    "edge_subjectNode_name": "Amlodipine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Amlodipine treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Amlodipine",
    "result_subjectNode_id": "CHEBI:2668",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 261,
    "edge_id": "CHEBI:2668-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:2668",
    "edge_subjectNode_name": "Amlodipine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Amlodipine studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:2668-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Digoxin",
    "result_subjectNode_id": "CHEBI:4551",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 262,
    "edge_id": "inferred-CHEBI:4551-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4551",
    "edge_subjectNode_name": "Digoxin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Digoxin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Digoxin",
    "result_subjectNode_id": "CHEBI:4551",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 262,
    "edge_id": "CHEBI:4551-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4551",
    "edge_subjectNode_name": "Digoxin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Digoxin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:4551-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticorelin ovine triflutate",
    "result_subjectNode_id": "CHEBI:65307",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 263,
    "edge_id": "inferred-CHEBI:65307-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:65307",
    "edge_subjectNode_name": "Corticorelin ovine triflutate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Corticorelin ovine triflutate treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Corticorelin ovine triflutate",
    "result_subjectNode_id": "CHEBI:65307",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 263,
    "edge_id": "CHEBI:65307-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:65307",
    "edge_subjectNode_name": "Corticorelin ovine triflutate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Corticorelin ovine triflutate studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:65307-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon alfa",
    "result_subjectNode_id": "UNII:43K1W2T1M6",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 264,
    "edge_id": "inferred-UNII:43K1W2T1M6-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:43K1W2T1M6",
    "edge_subjectNode_name": "Interferon alfa",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Interferon alfa treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Interferon alfa",
    "result_subjectNode_id": "UNII:43K1W2T1M6",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 264,
    "edge_id": "UNII:43K1W2T1M6-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:43K1W2T1M6",
    "edge_subjectNode_name": "Interferon alfa",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Interferon alfa studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-UNII:43K1W2T1M6-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "chenodiol",
    "result_subjectNode_id": "CHEBI:16755",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 265,
    "edge_id": "inferred-CHEBI:16755-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16755",
    "edge_subjectNode_name": "chenodiol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "chenodiol treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "chenodiol",
    "result_subjectNode_id": "CHEBI:16755",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 265,
    "edge_id": "CHEBI:16755-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:16755",
    "edge_subjectNode_name": "chenodiol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "chenodiol studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:16755-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Biotin",
    "result_subjectNode_id": "CHEBI:15956",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 266,
    "edge_id": "inferred-CHEBI:15956-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15956",
    "edge_subjectNode_name": "Biotin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Biotin treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Biotin",
    "result_subjectNode_id": "CHEBI:15956",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 266,
    "edge_id": "CHEBI:15956-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:15956",
    "edge_subjectNode_name": "Biotin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Biotin studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:15956-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyproterone",
    "result_subjectNode_id": "CHEBI:50742",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 267,
    "edge_id": "inferred-CHEBI:50742-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50742",
    "edge_subjectNode_name": "cyproterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cyproterone treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cyproterone",
    "result_subjectNode_id": "CHEBI:50742",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 267,
    "edge_id": "CHEBI:50742-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:50742",
    "edge_subjectNode_name": "cyproterone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "cyproterone studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:50742-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Finasteride",
    "result_subjectNode_id": "CHEBI:5062",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 268,
    "edge_id": "inferred-CHEBI:5062-treats-MONDO:0015129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5062",
    "edge_subjectNode_name": "Finasteride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Finasteride treats Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Finasteride",
    "result_subjectNode_id": "CHEBI:5062",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 268,
    "edge_id": "CHEBI:5062-treats_or_applied_or_studied_to_treat-MONDO:0015129-via_subclass",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5062",
    "edge_subjectNode_name": "Finasteride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Finasteride studied to treat Addison Disease",
    "primary_source": "infores:biothings-explorer",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "inferred-CHEBI:5062-treats-MONDO:0015129-support0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10134499",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 269,
    "edge_id": "medik:creative_edge#173",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10134499",
    "edge_subjectNode_name": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10134499",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 269,
    "edge_id": "medik:edge#263",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10134499",
    "edge_subjectNode_name": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:15080982",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#173",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-Methoxy-6-pyridin-3-yl-6H-benzo[c]chromen-8-yl)-methanesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10134499",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 269,
    "edge_id": "medik:edge#264",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#173",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10090072",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 270,
    "edge_id": "medik:creative_edge#153",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10090072",
    "edge_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10090072",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 270,
    "edge_id": "medik:edge#223",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10090072",
    "edge_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:17118655",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#153",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(1-(1H-indol-3-yl)propan-2-yl)-3-chloro-2-methylbenzenesulfonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10090072",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 270,
    "edge_id": "medik:edge#224",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#153",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204058",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 271,
    "edge_id": "medik:creative_edge#137",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204058",
    "edge_subjectNode_name": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204058",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 271,
    "edge_id": "medik:edge#191",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL2204058",
    "edge_subjectNode_name": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:23131342",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#137",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cis-6-(4-phenylcyclohexyl)-5-((6-(trifluoromethyl)pyridin-2-yl)methyl)pyrimidine-2,4(1H,3H)-dione",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL2204058",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 271,
    "edge_id": "medik:edge#192",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#137",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "creative_DTD_prediction_16",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Olaparib treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:4540--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4540",
    "edge_subjectNode_name": "ND5",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ND5 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2100--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2100",
    "edge_subjectNode_name": "ESR2",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ESR2 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:32861072;PMID:36130284;PMID:34867827;PMID:34362377;PMID:37360895;PMID:31384717;PMID:34441313;PMID:37171897;PMID:36755919;PMID:23435015;PMID:36034179;PMID:29042182;PMID:32224856;PMID:18962445;PMID:35846302;PMID:34084179;PMID:35722187;PMID:36289764;PMID:28401679;PMID:36768521",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:4609--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:4609",
    "edge_subjectNode_name": "MYC",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MYC gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:23945775;PMID:37007031;PMID:34704275;PMID:23889986;PMID:32709848;PMID:32580510;PMID:31988313;PMID:27597899;PMID:30875083;PMID:33376192;PMID:24774302;PMID:35517869;PMID:32390804;PMID:37383091;PMID:28620373;PMID:27804142;PMID:33476302;PMID:33163396;PMID:30233376;PMID:36035259",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:2064--infores:dgidb",
    "edge_object": "NCBIGene:2064",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "ERBB2",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects ERBB2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:10735--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:10735",
    "edge_subjectNode_name": "STAG2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "STAG2 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:51081--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:51081",
    "edge_subjectNode_name": "MRPS7",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MRPS7 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3845--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3845",
    "edge_subjectNode_name": "KRAS",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "KRAS gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:4609--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:4609",
    "edge_subjectNode_name": "MYC",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MYC gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:26927756;PMID:30774653;PMID:31551770;PMID:36211395;PMID:34659577;PMID:21532931;PMID:28223148;PMID:34078370;PMID:36799159;PMID:28900468;PMID:34930980;PMID:26828329;PMID:30224157;PMID:25789467;PMID:21803768;PMID:29728611;PMID:35505177;PMID:27760155;PMID:29212307;PMID:36500482",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:5728--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5728",
    "edge_subjectNode_name": "PTEN",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTEN gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:20618393;PMID:37574648;PMID:31838155;PMID:28666118;PMID:29879582;PMID:23889986;PMID:11885374;PMID:31710714;PMID:31481878;PMID:35633791;PMID:37628788;PMID:34632168;PMID:32308807;PMID:34221026;PMID:27855659;PMID:25853262;PMID:30482242;PMID:36961622;PMID:28034353;PMID:30214630",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:672--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:672",
    "edge_subjectNode_name": "BRCA1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "BRCA1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37893198;PMID:36748709;PMID:37274607;PMID:35887150;PMID:27829687;PMID:30981321;PMID:23889986;PMID:32224912;PMID:34285640;PMID:35905201;PMID:22869039;PMID:32506634;PMID:26486089;PMID:37592452;PMID:20106545;PMID:31930280;PMID:30875730;PMID:22748121;PMID:32226532;PMID:23459471",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:5728--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:5728",
    "edge_subjectNode_name": "PTEN",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTEN gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:28676205;PMID:37008951;PMID:36012113;PMID:38259491;PMID:28666118;PMID:26828329;PMID:37128213;PMID:29504895;PMID:33116121;PMID:36926119;PMID:27261452;PMID:37224724;PMID:34263024;PMID:22346770;PMID:36010323;PMID:34093557;PMID:21885342;PMID:21306238;PMID:33340461;PMID:34975885",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3845--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:3845",
    "edge_subjectNode_name": "KRAS",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "KRAS gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:35002108;PMID:27688654;PMID:38259856;PMID:34671564;PMID:34609564;PMID:29125580;PMID:28666118;PMID:35659175;PMID:30224157;PMID:29675060;PMID:26706596;PMID:37004004;PMID:32391058;PMID:37529904;PMID:29915207;PMID:29152156;PMID:36263628;PMID:31802895;PMID:30981987;PMID:32943616",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2099--biolink:physically_interacts_with--None--None--None--NCBIGene:4540--infores:intact",
    "edge_object": "NCBIGene:4540",
    "edge_subject": "NCBIGene:2099",
    "edge_subjectNode_name": "ESR1",
    "edge_objectNode_name": "ND5",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "ESR1 physically interacts with ND5",
    "primary_source": "infores:intact",
    "publications": "PMID:31527615",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:5290--infores:dgidb",
    "edge_object": "NCBIGene:5290",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "PIK3CA",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects PIK3CA",
    "primary_source": "infores:dgidb",
    "publications": "PMID:26909613",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:4609--biolink:physically_interacts_with--None--None--None--NCBIGene:3295--infores:intact",
    "edge_object": "NCBIGene:3295",
    "edge_subject": "NCBIGene:4609",
    "edge_subjectNode_name": "MYC",
    "edge_objectNode_name": "HSD17B4",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "MYC physically interacts with HSD17B4",
    "primary_source": "infores:intact",
    "publications": "PMID:21150319",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2099--biolink:physically_interacts_with--None--None--None--NCBIGene:51081--infores:intact",
    "edge_object": "NCBIGene:51081",
    "edge_subject": "NCBIGene:2099",
    "edge_subjectNode_name": "ESR1",
    "edge_objectNode_name": "MRPS7",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "ESR1 physically interacts with MRPS7",
    "primary_source": "infores:intact",
    "publications": "PMID:31527615",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2100--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2100",
    "edge_subjectNode_name": "ESR2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ESR2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:24882635;PMID:32741419;PMID:26441542;PMID:28066250;PMID:32066657;PMID:37275786;PMID:37223033;PMID:30792693;PMID:37240765;PMID:23034522;PMID:38257177;PMID:33658312;PMID:33557333;PMID:30744972;PMID:33360539;PMID:30374289;PMID:27690666;PMID:25205048;PMID:33721181;PMID:35178159",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3418--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3418",
    "edge_subjectNode_name": "IDH2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IDH2 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:27469509",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:5728--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5728",
    "edge_subjectNode_name": "PTEN",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTEN gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:3845--infores:dgidb",
    "edge_object": "NCBIGene:3845",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "KRAS",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects KRAS",
    "primary_source": "infores:dgidb",
    "publications": "PMID:28363999",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2064--biolink:colocalizes_with--None--None--None--NCBIGene:3295--infores:intact",
    "edge_object": "NCBIGene:3295",
    "edge_subject": "NCBIGene:2064",
    "edge_subjectNode_name": "ERBB2",
    "edge_objectNode_name": "HSD17B4",
    "predicate": "biolink:colocalizes_with",
    "phrase": "ERBB2 colocalizes with HSD17B4",
    "primary_source": "infores:intact",
    "publications": "PMID:35384245",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:57216--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:57216",
    "edge_subjectNode_name": "VANGL2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "VANGL2 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:2099--infores:dgidb",
    "edge_object": "NCBIGene:2099",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "ESR1",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects ESR1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:3418--infores:dgidb",
    "edge_object": "NCBIGene:3418",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "IDH2",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects IDH2",
    "primary_source": "infores:dgidb",
    "publications": "PMID:28148839",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:5290--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5290",
    "edge_subjectNode_name": "PIK3CA",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PIK3CA gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:5290--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5290",
    "edge_subjectNode_name": "PIK3CA",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PIK3CA gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37007031;PMID:36846103;PMID:21647871;PMID:35957525;PMID:37574648;PMID:36421690;PMID:28607096;PMID:28666118;PMID:35330088;PMID:21904677;PMID:20618393;PMID:33649775;PMID:31130732;PMID:23889986;PMID:32916028;PMID:32709848;PMID:27475769;PMID:31710714;PMID:35056657;PMID:31879799",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:672--infores:dgidb",
    "edge_object": "NCBIGene:672",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "BRCA1",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects BRCA1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2099--biolink:physically_interacts_with--None--None--None--NCBIGene:4513--infores:intact",
    "edge_object": "NCBIGene:4513",
    "edge_subject": "NCBIGene:2099",
    "edge_subjectNode_name": "ESR1",
    "edge_objectNode_name": "COX2",
    "predicate": "biolink:physically_interacts_with",
    "phrase": "ESR1 physically interacts with COX2",
    "primary_source": "infores:intact",
    "publications": "PMID:31527615",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:4513--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4513",
    "edge_subjectNode_name": "COX2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX2 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:3417--infores:dgidb",
    "edge_object": "NCBIGene:3417",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "IDH1",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects IDH1",
    "primary_source": "infores:dgidb",
    "publications": "PMID:28148839",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3845--biolink:colocalizes_with--None--None--None--NCBIGene:3295--infores:intact",
    "edge_object": "NCBIGene:3295",
    "edge_subject": "NCBIGene:3845",
    "edge_subjectNode_name": "KRAS",
    "edge_objectNode_name": "HSD17B4",
    "predicate": "biolink:colocalizes_with",
    "phrase": "KRAS colocalizes with HSD17B4",
    "primary_source": "infores:intact",
    "publications": "PMID:30194290",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:4609--infores:dgidb",
    "edge_object": "NCBIGene:4609",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "MYC",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects MYC",
    "primary_source": "infores:dgidb",
    "publications": "PMID:28490518",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3295--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3295",
    "edge_subjectNode_name": "HSD17B4",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "HSD17B4 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:efo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:efo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3418--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3418",
    "edge_subjectNode_name": "IDH2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IDH2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:37151152;PMID:34621585;PMID:33917812;PMID:34829656;PMID:37970011;PMID:35743109;PMID:29163365;PMID:27469509;PMID:32916028;PMID:19076459;PMID:31563982;PMID:36702211;PMID:33575479;PMID:27493954;PMID:32046310;PMID:31331834;PMID:33014275;PMID:36961622;PMID:27608730;PMID:30233320",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3845--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3845",
    "edge_subjectNode_name": "KRAS",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "KRAS gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:34649968;PMID:23060898;PMID:37834773;PMID:38136956;PMID:28607096;PMID:28666118;PMID:29387450;PMID:35659175;PMID:37168803;PMID:34285640;PMID:36643573;PMID:22595134;PMID:34143182;PMID:34829274;PMID:36864519;PMID:37886538;PMID:30352490;PMID:36013378;PMID:28710498;PMID:31992957",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:10735--infores:dgidb",
    "edge_object": "NCBIGene:10735",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "STAG2",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects STAG2",
    "primary_source": "infores:dgidb",
    "publications": "PMID:21852505;PMID:24356817",
    "publications_count": 2,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:5728--infores:dgidb",
    "edge_object": "NCBIGene:5728",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "PTEN",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects PTEN",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:5290--biolink:gene_associated_with_condition--None--None--None--MONDO:0018076--infores:diseases",
    "edge_object": "MONDO:0018076",
    "edge_subject": "NCBIGene:5290",
    "edge_subjectNode_name": "PIK3CA",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PIK3CA gene associated with condition tuberculosis",
    "primary_source": "infores:diseases",
    "publications": "PMID:28676205;PMID:33193365;PMID:37772259;PMID:20558725;PMID:32708265;PMID:29267600;PMID:28666118;PMID:28223148;PMID:34930980;PMID:34693385;PMID:32153632;PMID:32433977;PMID:32664977;PMID:20837474;PMID:33083391;PMID:27261452;PMID:28356910;PMID:36263628;PMID:34659565;PMID:36671249",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3417--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:3417",
    "edge_subjectNode_name": "IDH1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IDH1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:35681545;PMID:29615902;PMID:23451252;PMID:37151152;PMID:38154474;PMID:34621585;PMID:26639668;PMID:37151445;PMID:33917812;PMID:34829656;PMID:37970011;PMID:36601313;PMID:32574549;PMID:29163365;PMID:35743109;PMID:35128400;PMID:36712600;PMID:27469509;PMID:32916028;PMID:34389161",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:2100--infores:dgidb",
    "edge_object": "NCBIGene:2100",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "ESR2",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects ESR2",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:CHEBI:83766--biolink:affects--None--None--None--NCBIGene:472--infores:dgidb",
    "edge_object": "NCBIGene:472",
    "edge_subject": "CHEBI:83766",
    "edge_subjectNode_name": "Olaparib",
    "edge_objectNode_name": "ATM",
    "predicate": "biolink:affects",
    "phrase": "Olaparib affects ATM",
    "primary_source": "infores:dgidb",
    "publications": "PMID:20739657;PMID:26510020;PMID:32343890;PMID:28363999;PMID:20124459;PMID:24841718",
    "publications_count": 6,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:MONDO:0018479--biolink:subclass_of--None--None--None--MONDO:0015129--infores:mondo",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:mondo",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:472--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:472",
    "edge_subjectNode_name": "ATM",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ATM gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:36287908;PMID:23060898;PMID:29313802;PMID:29547541;PMID:25432731;PMID:28607096;PMID:38222898;PMID:36229517;PMID:30981321;PMID:36637312;PMID:32709848;PMID:31710714;PMID:36003051;PMID:35672297;PMID:25002129;PMID:26486089;PMID:33277461;PMID:28230174;PMID:20106545;PMID:35886058",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:3845--biolink:colocalizes_with--None--None--None--NCBIGene:57216--infores:intact",
    "edge_object": "NCBIGene:57216",
    "edge_subject": "NCBIGene:3845",
    "edge_subjectNode_name": "KRAS",
    "edge_objectNode_name": "VANGL2",
    "predicate": "biolink:colocalizes_with",
    "phrase": "KRAS colocalizes with VANGL2",
    "primary_source": "infores:intact",
    "publications": "PMID:30194290",
    "publications_count": 1,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:472--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:472",
    "edge_subjectNode_name": "ATM",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ATM gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Olaparib",
    "result_subjectNode_id": "CHEBI:83766",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 272,
    "edge_id": "infores:rtx-kg2:NCBIGene:2099--biolink:gene_associated_with_condition--None--None--None--MONDO:0018479--infores:diseases",
    "edge_object": "MONDO:0018479",
    "edge_subject": "NCBIGene:2099",
    "edge_subjectNode_name": "ESR1",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ESR1 gene associated with condition congenital adrenal hyperplasia",
    "primary_source": "infores:diseases",
    "publications": "PMID:25159688;PMID:33058950;PMID:37635968;PMID:23762093;PMID:31592911;PMID:24747343;PMID:32861072;PMID:36130284;PMID:32913460;PMID:23841484;PMID:34362377;PMID:30394212;PMID:35565107;PMID:38292507;PMID:32629476;PMID:34754857;PMID:22029021;PMID:33854119;PMID:28321205;PMID:37253115",
    "publications_count": 20,
    "support_graph_id": "aux_graph_51_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Selenious acid",
    "result_subjectNode_id": "CHEBI:26642",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 273,
    "edge_id": "medik:creative_edge#112",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:26642",
    "edge_subjectNode_name": "Selenious acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Selenious acid treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Selenious acid",
    "result_subjectNode_id": "CHEBI:26642",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 273,
    "edge_id": "medik:edge#141",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:26642",
    "edge_subjectNode_name": "Selenious acid",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Selenious acid affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:2298732",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#112",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Selenious acid",
    "result_subjectNode_id": "CHEBI:26642",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 273,
    "edge_id": "medik:edge#142",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#112",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10125966",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 274,
    "edge_id": "medik:creative_edge#158",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10125966",
    "edge_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10125966",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 274,
    "edge_id": "medik:edge#233",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10125966",
    "edge_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:11728194",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#158",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "10-Methoxy-2,2,4-trimethyl-5-prop-2-ynyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10125966",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 274,
    "edge_id": "medik:edge#234",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#158",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metreton",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:4896",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 275,
    "edge_id": "6de79333765b",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:4896",
    "edge_subjectNode_name": "Metreton",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Metreton treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metreton",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:4896",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 275,
    "edge_id": "481e1d1671a9",
    "edge_object": "MONDO:0018479",
    "edge_subject": "PUBCHEM.COMPOUND:4896",
    "edge_subjectNode_name": "Metreton",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Metreton treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "83cb4e88",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Metreton",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:4896",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 275,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "83cb4e88",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:6850791",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 276,
    "edge_id": "5101fe731cf9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:6850791",
    "edge_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:6850791",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 276,
    "edge_id": "62fd714c9bb3",
    "edge_object": "MONDO:0018479",
    "edge_subject": "PUBCHEM.COMPOUND:6850791",
    "edge_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "f114bb2b",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:6850791",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 276,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "f114bb2b",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nafarelin",
    "result_subjectNode_id": "CHEBI:7445",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 277,
    "edge_id": "8011a9c60398",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7445",
    "edge_subjectNode_name": "Nafarelin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Nafarelin treats Addison Disease",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nafarelin",
    "result_subjectNode_id": "CHEBI:7445",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 277,
    "edge_id": "a7b322830a06",
    "edge_object": "MONDO:0018479",
    "edge_subject": "CHEBI:7445",
    "edge_subjectNode_name": "Nafarelin",
    "edge_objectNode_name": "congenital adrenal hyperplasia",
    "predicate": "biolink:treats",
    "phrase": "Nafarelin treats congenital adrenal hyperplasia",
    "primary_source": "infores:sider",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "8e9d41b6",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Nafarelin",
    "result_subjectNode_id": "CHEBI:7445",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 277,
    "edge_id": "43a3fb438c51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018479",
    "edge_subjectNode_name": "congenital adrenal hyperplasia",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:subclass_of",
    "phrase": "congenital adrenal hyperplasia subclass of Addison Disease",
    "primary_source": "infores:molepro",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "8e9d41b6",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10194889",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 278,
    "edge_id": "medik:creative_edge#198",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10194889",
    "edge_subjectNode_name": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10194889",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 278,
    "edge_id": "medik:edge#313",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10194889",
    "edge_subjectNode_name": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol affects NR3C1",
    "primary_source": "infores:pharos",
    "publications": "PMID:20727743",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#198",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(Quinolin-5-ylamino)-4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-(trifluoromethyl)pentan-2-ol",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10194889",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 278,
    "edge_id": "medik:edge#314",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#198",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "15-deoxyprostaglandin J2",
    "result_subjectNode_id": "MESH:C477819",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 279,
    "edge_id": "medik:creative_edge#110",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MESH:C477819",
    "edge_subjectNode_name": "15-deoxyprostaglandin J2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "15-deoxyprostaglandin J2 treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "15-deoxyprostaglandin J2",
    "result_subjectNode_id": "MESH:C477819",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 279,
    "edge_id": "medik:edge#137",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "MESH:C477819",
    "edge_subjectNode_name": "15-deoxyprostaglandin J2",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "15-deoxyprostaglandin J2 affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:15531761",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#110",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "15-deoxyprostaglandin J2",
    "result_subjectNode_id": "MESH:C477819",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 279,
    "edge_id": "medik:edge#138",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#110",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Arsenite ion",
    "result_subjectNode_id": "CHEBI:29866",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 280,
    "edge_id": "medik:creative_edge#127",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:29866",
    "edge_subjectNode_name": "Arsenite ion",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Arsenite ion treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Arsenite ion",
    "result_subjectNode_id": "CHEBI:29866",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 280,
    "edge_id": "medik:edge#171",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:29866",
    "edge_subjectNode_name": "Arsenite ion",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Arsenite ion affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:15310238",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#127",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Arsenite ion",
    "result_subjectNode_id": "CHEBI:29866",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 280,
    "edge_id": "medik:edge#172",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#127",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "creative_DTD_prediction_17",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:0R4NLX88O4",
    "edge_subjectNode_name": "Taliglucerase alfa",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Taliglucerase alfa treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "infores:rtx-kg2:NCBIGene:2629--biolink:gene_associated_with_condition--None--None--None--HP:0011968--infores:disgenet",
    "edge_object": "HP:0011968",
    "edge_subject": "NCBIGene:2629",
    "edge_subjectNode_name": "GBA1",
    "edge_objectNode_name": "Feeding Problem",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "GBA1 gene associated with condition Feeding Problem",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_53_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "infores:rtx-kg2:HP:0011968--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0011968",
    "edge_subjectNode_name": "Feeding Problem",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Feeding Problem manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_53_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "infores:rtx-kg2:UNII:0R4NLX88O4--biolink:affects--None--None--None--NCBIGene:2629--infores:dgidb",
    "edge_object": "NCBIGene:2629",
    "edge_subject": "UNII:0R4NLX88O4",
    "edge_subjectNode_name": "Taliglucerase alfa",
    "edge_objectNode_name": "GBA1",
    "predicate": "biolink:affects",
    "phrase": "Taliglucerase alfa affects GBA1",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_53_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_53_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "infores:rtx-kg2:NCBIGene:2629--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2629",
    "edge_subjectNode_name": "GBA1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "GBA1 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:27284392;PMID:34198733;PMID:31781052;PMID:33281718;PMID:34304991;PMID:23532493;PMID:33958783;PMID:38222898;PMID:38033869;PMID:34149605;PMID:32066657;PMID:32010038;PMID:35658878;PMID:30332838;PMID:33711910;PMID:27001828;PMID:31649052;PMID:37759536;PMID:16984815;PMID:36836867",
    "publications_count": 20,
    "support_graph_id": "aux_graph_53_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Taliglucerase alfa",
    "result_subjectNode_id": "UNII:0R4NLX88O4",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 281,
    "edge_id": "infores:rtx-kg2:NCBIGene:2629--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:2629",
    "edge_subjectNode_name": "GBA1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "GBA1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:9040001",
    "publications_count": 1,
    "support_graph_id": "aux_graph_53_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "ursodiol",
    "result_subjectNode_id": "CHEBI:9907",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 282,
    "edge_id": "medik:creative_edge#120",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:9907",
    "edge_subjectNode_name": "ursodiol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "ursodiol treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "ursodiol",
    "result_subjectNode_id": "CHEBI:9907",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 282,
    "edge_id": "medik:edge#157",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:9907",
    "edge_subjectNode_name": "ursodiol",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "ursodiol affects NR3C1",
    "primary_source": "infores:ctd",
    "publications": "PMID:18188457",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#120",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "ursodiol",
    "result_subjectNode_id": "CHEBI:9907",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 282,
    "edge_id": "medik:edge#158",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#120",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ibuprofen",
    "result_subjectNode_id": "CHEBI:5855",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 283,
    "edge_id": "medik:creative_edge#93",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5855",
    "edge_subjectNode_name": "Ibuprofen",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ibuprofen treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ibuprofen",
    "result_subjectNode_id": "CHEBI:5855",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 283,
    "edge_id": "medik:edge#103",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "CHEBI:5855",
    "edge_subjectNode_name": "Ibuprofen",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "Ibuprofen affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:17630191",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#93",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ibuprofen",
    "result_subjectNode_id": "CHEBI:5855",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 283,
    "edge_id": "medik:edge#104",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#93",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10004421",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 284,
    "edge_id": "medik:creative_edge#142",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10004421",
    "edge_subjectNode_name": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10004421",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 284,
    "edge_id": "medik:edge#201",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10004421",
    "edge_subjectNode_name": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:16821781",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#142",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "3,3,3-trifluoro-2-hydroxy-N-(4-methyl-1-oxo-2,3-benzoxazin-6-yl)-2-[(5-methyl-1,2,3,4-tetrahydronaphthalen-1-yl)methyl]propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10004421",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 284,
    "edge_id": "medik:edge#202",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#142",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151186",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 285,
    "edge_id": "medik:creative_edge#178",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10151186",
    "edge_subjectNode_name": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151186",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 285,
    "edge_id": "medik:edge#273",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "PUBCHEM.COMPOUND:10151186",
    "edge_subjectNode_name": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:21963986",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#178",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "7-[5,5,5-trifluoro-4-hydroxy-4-(1H-indol-2-ylmethyl)-2-methylpentan-2-yl]-2,3-dihydro-1-benzofuran-5-carbonitrile",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10151186",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 285,
    "edge_id": "medik:edge#274",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#178",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lead acetate",
    "result_subjectNode_id": "UNII:RX077P88RY",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 286,
    "edge_id": "medik:creative_edge#95",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:RX077P88RY",
    "edge_subjectNode_name": "lead acetate",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "lead acetate treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lead acetate",
    "result_subjectNode_id": "UNII:RX077P88RY",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 286,
    "edge_id": "medik:edge#107",
    "edge_object": "NCBIGene:3458",
    "edge_subject": "UNII:RX077P88RY",
    "edge_subjectNode_name": "lead acetate",
    "edge_objectNode_name": "IFNG",
    "predicate": "biolink:affects",
    "phrase": "lead acetate affects IFNG",
    "primary_source": "infores:ctd",
    "publications": "PMID:23088908",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#95",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lead acetate",
    "result_subjectNode_id": "UNII:RX077P88RY",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 286,
    "edge_id": "medik:edge#108",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:3458",
    "edge_subjectNode_name": "IFNG",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "IFNG gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:21884175;PMID:26632377;PMID:24467530;PMID:35844617;PMID:22431997;PMID:34768884;PMID:35368451;PMID:34858835;PMID:26085216;PMID:25722716;PMID:33332019;PMID:33968147;PMID:34904571;PMID:33925158;PMID:37266084;PMID:34659674;PMID:25879280;PMID:30714094;PMID:37754125;PMID:24364806;PMID:37601967;PMID:16784312;PMID:34239993;PMID:28620373;PMID:32793226;PMID:38090401;PMID:29062305;PMID:33431938;PMID:33717184;PMID:38022632",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#95",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "creative_DTD_prediction_19",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28874",
    "edge_subjectNode_name": "phosphatidylinositol",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "phosphatidylinositol treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:NCBIGene:2737--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2737",
    "edge_subjectNode_name": "GLI3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "GLI3 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:NCBIGene:26191--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:26191",
    "edge_subjectNode_name": "PTPN22",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPN22 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "PMID:18301444",
    "publications_count": 1,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:NCBIGene:190--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:diseases",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:190",
    "edge_subjectNode_name": "NR0B1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR0B1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:32938577;PMID:36918776;PMID:33381483;PMID:33381670;PMID:32903448;PMID:18493131;PMID:28637490;PMID:37280667;PMID:34130666;PMID:16968793;PMID:32060528;PMID:21274298;PMID:22337906;PMID:34823514;PMID:36763264;PMID:37118935;PMID:35046659;PMID:29956047;PMID:35432221;PMID:32028936",
    "publications_count": 20,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:NCBIGene:26191--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:diseases",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:26191",
    "edge_subjectNode_name": "PTPN22",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PTPN22 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:24614117;PMID:20959028;PMID:29310926;PMID:29849176;PMID:35456512;PMID:32971447;PMID:29529281;PMID:21205883;PMID:26618927;PMID:26405069;PMID:38957156;PMID:33966174;PMID:20455416;PMID:21617108;PMID:34074094;PMID:36980146;PMID:25579746;PMID:16403820;PMID:36755664;PMID:20969580",
    "publications_count": 20,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:NCBIGene:190--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:190",
    "edge_subjectNode_name": "NR0B1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR0B1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "PMID:12519885",
    "publications_count": 1,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:CHEBI:28874--biolink:interacts_with--None--None--None--UMLS:C0022009--infores:semmeddb",
    "edge_object": "UMLS:C0022009",
    "edge_subject": "CHEBI:28874",
    "edge_subjectNode_name": "phosphatidylinositol",
    "edge_objectNode_name": "Ion Channel",
    "predicate": "biolink:interacts_with",
    "phrase": "phosphatidylinositol interacts with Ion Channel",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11604134;PMID:12525701;PMID:16461542;PMID:16721610;PMID:16929940;PMID:16951556;PMID:18725531;PMID:18940816;PMID:19395084;PMID:19675354;PMID:19769794;PMID:19770351;PMID:21224382;PMID:21538413;PMID:21695261;PMID:22374095;PMID:22792379;PMID:23878375;PMID:24599956;PMID:24880859",
    "publications_count": 20,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:CHEBI:28874--biolink:interacts_with--None--None--None--NCBIGene:760--infores:semmeddb",
    "edge_object": "NCBIGene:760",
    "edge_subject": "CHEBI:28874",
    "edge_subjectNode_name": "phosphatidylinositol",
    "edge_objectNode_name": "CA2",
    "predicate": "biolink:interacts_with",
    "phrase": "phosphatidylinositol interacts with CA2",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:10051153;PMID:11892809;PMID:1320935;PMID:1375539;PMID:15574748;PMID:17125457;PMID:2541951;PMID:29078297;PMID:29715474;PMID:3031357;PMID:3036120;PMID:30790244;PMID:31447841;PMID:3580368;PMID:3778503;PMID:6259001;PMID:6577435;PMID:7694408;PMID:8073393;PMID:9888505",
    "publications_count": 20,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:UMLS:C0022009--biolink:causes--None--None--None--MONDO:0005027--infores:semmeddb",
    "edge_object": "MONDO:0005027",
    "edge_subject": "UMLS:C0022009",
    "edge_subjectNode_name": "Ion Channel",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:causes",
    "phrase": "Ion Channel causes epilepsy",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:17054683;PMID:15961349;PMID:28090678;PMID:34717959;PMID:20826656;PMID:25012379;PMID:25270294;PMID:19222019;PMID:27980289;PMID:30189204;PMID:25194485;PMID:35217970;PMID:22245138;PMID:10025538;PMID:10755273;PMID:12644745;PMID:11690625",
    "publications_count": 17,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "phosphatidylinositol",
    "result_subjectNode_id": "CHEBI:28874",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 287,
    "edge_id": "infores:rtx-kg2:NCBIGene:760--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:diseases",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:760",
    "edge_subjectNode_name": "CA2",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "CA2 gene associated with condition epilepsy",
    "primary_source": "infores:diseases",
    "publications": "PMID:33648390;PMID:32810346;PMID:37049983;PMID:35768159;PMID:33585783;PMID:31710714;PMID:37047767;PMID:31627429;PMID:37902389;PMID:31842669;PMID:33895779;PMID:37312840;PMID:37111236;PMID:34605430;PMID:38004276;PMID:23908634;PMID:34068564;PMID:36950364;PMID:34385849;PMID:22658432",
    "publications_count": 20,
    "support_graph_id": "aux_graph_55_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ellipticine",
    "result_subjectNode_id": "CHEBI:4776",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 288,
    "edge_id": "medik:creative_edge#132",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4776",
    "edge_subjectNode_name": "Ellipticine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ellipticine treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ellipticine",
    "result_subjectNode_id": "CHEBI:4776",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 288,
    "edge_id": "medik:edge#181",
    "edge_object": "NCBIGene:2908",
    "edge_subject": "CHEBI:4776",
    "edge_subjectNode_name": "Ellipticine",
    "edge_objectNode_name": "NR3C1",
    "predicate": "biolink:affects",
    "phrase": "Ellipticine affects NR3C1",
    "primary_source": "infores:bindingdb",
    "publications": "PMID:18412397",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#132",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ellipticine",
    "result_subjectNode_id": "CHEBI:4776",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 288,
    "edge_id": "medik:edge#182",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:2908",
    "edge_subjectNode_name": "NR3C1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "NR3C1 gene associated with condition Addison Disease",
    "primary_source": "infores:diseases",
    "publications": "PMID:7811221;PMID:35937837;PMID:28210018;PMID:33435513;PMID:10516483;PMID:35421980;PMID:31750312;PMID:25256348;PMID:34990712;PMID:32060528;PMID:33661460;PMID:32255605;PMID:30356882;PMID:33918733;PMID:35082759;PMID:28680378;PMID:21429213;PMID:37253115;PMID:28274682;PMID:25632229;PMID:35371924;PMID:24205034;PMID:23239757;PMID:24814581;PMID:37035097;PMID:28495406;PMID:30380518;PMID:33925349;PMID:37601967;PMID:36227196",
    "publications_count": 30,
    "support_graph_id": "medik:auxiliary_graph#132",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lithium hydride",
    "result_subjectNode_id": "CHEBI:30146",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 289,
    "edge_id": "medik:creative_edge#209",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30146",
    "edge_subjectNode_name": "lithium hydride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "lithium hydride treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "lithium hydride",
    "result_subjectNode_id": "CHEBI:30146",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 289,
    "edge_id": "medik:edge#349",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:30146",
    "edge_subjectNode_name": "lithium hydride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "lithium hydride studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:17386249;PMID:2717662",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#209",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "angiotensin II",
    "result_subjectNode_id": "UMLS:C0003009",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 290,
    "edge_id": "medik:creative_edge#211",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0003009",
    "edge_subjectNode_name": "angiotensin II",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "angiotensin II treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "angiotensin II",
    "result_subjectNode_id": "UMLS:C0003009",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 290,
    "edge_id": "medik:edge#351",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0003009",
    "edge_subjectNode_name": "angiotensin II",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "angiotensin II studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:3039766;PMID:476972",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#211",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "corticotropin-releasing hormone",
    "result_subjectNode_id": "UMLS:C0010132",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 291,
    "edge_id": "medik:creative_edge#210",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0010132",
    "edge_subjectNode_name": "corticotropin-releasing hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "corticotropin-releasing hormone treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "corticotropin-releasing hormone",
    "result_subjectNode_id": "UMLS:C0010132",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 291,
    "edge_id": "medik:edge#350",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0010132",
    "edge_subjectNode_name": "corticotropin-releasing hormone",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "corticotropin-releasing hormone studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:2832297;PMID:2997301",
    "publications_count": 2,
    "support_graph_id": "medik:auxiliary_graph#210",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dornase alfa",
    "result_subjectNode_id": "UNII:953A26OA1Y",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 292,
    "edge_id": "creative_DTD_prediction_20",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:953A26OA1Y",
    "edge_subjectNode_name": "Dornase alfa",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Dornase alfa treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dornase alfa",
    "result_subjectNode_id": "UNII:953A26OA1Y",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 292,
    "edge_id": "infores:rtx-kg2:NCBIGene:1773--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:1773",
    "edge_subjectNode_name": "DNASE1",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "DNASE1 gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim;infores:rtx-kg2:NCBIGene:1773--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet;infores:rtx-kg2:UNII:953A26OA1Y--biolink:derives_from--None--None--None--NCBIGene:1773--infores:drugbank_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dornase alfa",
    "result_subjectNode_id": "UNII:953A26OA1Y",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 292,
    "edge_id": "infores:rtx-kg2:UNII:953A26OA1Y--biolink:derives_from--None--None--None--NCBIGene:1773--infores:drugbank",
    "edge_object": "NCBIGene:1773",
    "edge_subject": "UNII:953A26OA1Y",
    "edge_subjectNode_name": "Dornase alfa",
    "edge_objectNode_name": "DNASE1",
    "predicate": "biolink:derives_from",
    "phrase": "Dornase alfa derives from DNASE1",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim;infores:rtx-kg2:NCBIGene:1773--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet;infores:rtx-kg2:UNII:953A26OA1Y--biolink:derives_from--None--None--None--NCBIGene:1773--infores:drugbank_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Dornase alfa",
    "result_subjectNode_id": "UNII:953A26OA1Y",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 292,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim;infores:rtx-kg2:NCBIGene:1773--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet;infores:rtx-kg2:UNII:953A26OA1Y--biolink:derives_from--None--None--None--NCBIGene:1773--infores:drugbank_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "liothyronine sodium",
    "result_subjectNode_id": "CHEBI:6484",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 293,
    "edge_id": "medik:creative_edge#226",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6484",
    "edge_subjectNode_name": "liothyronine sodium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "liothyronine sodium treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "liothyronine sodium",
    "result_subjectNode_id": "CHEBI:6484",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 293,
    "edge_id": "medik:edge#366",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:6484",
    "edge_subjectNode_name": "liothyronine sodium",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "liothyronine sodium studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:13879064",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#226",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "intrinsic factor",
    "result_subjectNode_id": "UMLS:C0021918",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 294,
    "edge_id": "medik:creative_edge#227",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0021918",
    "edge_subjectNode_name": "intrinsic factor",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "intrinsic factor treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "intrinsic factor",
    "result_subjectNode_id": "UMLS:C0021918",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 294,
    "edge_id": "medik:edge#367",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0021918",
    "edge_subjectNode_name": "intrinsic factor",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "intrinsic factor studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:13843195",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#227",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Opiates",
    "result_subjectNode_id": "UMLS:C0376196",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 295,
    "edge_id": "medik:creative_edge#213",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0376196",
    "edge_subjectNode_name": "Opiates",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Opiates treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Opiates",
    "result_subjectNode_id": "UMLS:C0376196",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 295,
    "edge_id": "medik:edge#353",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0376196",
    "edge_subjectNode_name": "Opiates",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Opiates studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:3024866",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#213",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "creative_DTD_prediction_21",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:17549",
    "edge_subjectNode_name": "Aminolevulinic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Aminolevulinic acid treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:NCBIGene:210--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:210",
    "edge_subjectNode_name": "ALAD",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ALAD gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "PMID:19798568",
    "publications_count": 1,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:NCBIGene:5498--biolink:gene_associated_with_condition--None--None--None--MONDO:0005027--infores:disgenet",
    "edge_object": "MONDO:0005027",
    "edge_subject": "NCBIGene:5498",
    "edge_subjectNode_name": "PPOX",
    "edge_objectNode_name": "epilepsy",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PPOX gene associated with condition epilepsy",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:HP:0002013--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "HP:0002013",
    "edge_subjectNode_name": "Vomiting",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "Vomiting manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:NCBIGene:4512--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4512",
    "edge_subjectNode_name": "COX1",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "COX1 gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:MESH:D008928--biolink:has_part--None--None--None--NCBIGene:4512--infores:semmeddb",
    "edge_object": "NCBIGene:4512",
    "edge_subject": "MESH:D008928",
    "edge_subjectNode_name": "Mitochondria",
    "edge_objectNode_name": "COX1",
    "predicate": "biolink:has_part",
    "phrase": "Mitochondria has part COX1",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:35068955;PMID:35087224;PMID:35325688;PMID:32092481;PMID:31854326;PMID:34839816;PMID:36296267;PMID:36415859;PMID:37120154;PMID:33150701;PMID:37106722;PMID:33880985;PMID:35507926;PMID:33294362;PMID:33597465;PMID:33202804;PMID:35221748;PMID:33490438;PMID:33518349;PMID:34026031",
    "publications_count": 20,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:CHEBI:17549--biolink:affects--None--None--None--NCBIGene:5498--infores:dgidb",
    "edge_object": "NCBIGene:5498",
    "edge_subject": "CHEBI:17549",
    "edge_subjectNode_name": "Aminolevulinic acid",
    "edge_objectNode_name": "PPOX",
    "predicate": "biolink:affects",
    "phrase": "Aminolevulinic acid affects PPOX",
    "primary_source": "infores:dgidb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:CHEBI:17549--biolink:affects--None--None--None--NCBIGene:5498--infores:semmeddb",
    "edge_object": "NCBIGene:5498",
    "edge_subject": "CHEBI:17549",
    "edge_subjectNode_name": "Aminolevulinic acid",
    "edge_objectNode_name": "PPOX",
    "predicate": "biolink:affects",
    "phrase": "Aminolevulinic acid affects PPOX",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:NCBIGene:210--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:210",
    "edge_subjectNode_name": "ALAD",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "ALAD gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:CHEBI:17549--biolink:affects--None--None--None--NCBIGene:210--infores:drugbank",
    "edge_object": "NCBIGene:210",
    "edge_subject": "CHEBI:17549",
    "edge_subjectNode_name": "Aminolevulinic acid",
    "edge_objectNode_name": "ALAD",
    "predicate": "biolink:affects",
    "phrase": "Aminolevulinic acid affects ALAD",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:CHEBI:17549--biolink:located_in--None--None--None--MESH:D008928--infores:semmeddb",
    "edge_object": "MESH:D008928",
    "edge_subject": "CHEBI:17549",
    "edge_subjectNode_name": "Aminolevulinic acid",
    "edge_objectNode_name": "Mitochondria",
    "predicate": "biolink:located_in",
    "phrase": "Aminolevulinic acid located in Mitochondria",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:15942660;PMID:26269666;PMID:27329428;PMID:28035368;PMID:28132645;PMID:29970567;PMID:32213740;PMID:33360951;PMID:34545713;PMID:35327417;PMID:35365766;PMID:35385661;PMID:35842630;PMID:36997341",
    "publications_count": 14,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:MONDO:0005027--biolink:manifestation_of--None--None--None--MONDO:0015129--infores:omim",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0005027",
    "edge_subjectNode_name": "epilepsy",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:manifestation_of",
    "phrase": "epilepsy manifestation of Addison Disease",
    "primary_source": "infores:omim",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:NCBIGene:5498--biolink:gene_associated_with_condition--None--None--None--HP:0002013--infores:disgenet",
    "edge_object": "HP:0002013",
    "edge_subject": "NCBIGene:5498",
    "edge_subjectNode_name": "PPOX",
    "edge_objectNode_name": "Vomiting",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "PPOX gene associated with condition Vomiting",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Aminolevulinic acid",
    "result_subjectNode_id": "CHEBI:17549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 296,
    "edge_id": "infores:rtx-kg2:CHEBI:17549--biolink:affects--None--None--None--NCBIGene:210--infores:semmeddb",
    "edge_object": "NCBIGene:210",
    "edge_subject": "CHEBI:17549",
    "edge_subjectNode_name": "Aminolevulinic acid",
    "edge_objectNode_name": "ALAD",
    "predicate": "biolink:affects",
    "phrase": "Aminolevulinic acid affects ALAD",
    "primary_source": "infores:semmeddb",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_59_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Desmopressin",
    "result_subjectNode_id": "CHEBI:4450",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 297,
    "edge_id": "medik:creative_edge#220",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4450",
    "edge_subjectNode_name": "Desmopressin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Desmopressin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Desmopressin",
    "result_subjectNode_id": "CHEBI:4450",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 297,
    "edge_id": "medik:edge#360",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:4450",
    "edge_subjectNode_name": "Desmopressin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Desmopressin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:9274696",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#220",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "thyrotropin",
    "result_subjectNode_id": "UMLS:C0040160",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 298,
    "edge_id": "medik:creative_edge#216",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0040160",
    "edge_subjectNode_name": "thyrotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "thyrotropin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "thyrotropin",
    "result_subjectNode_id": "UMLS:C0040160",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 298,
    "edge_id": "medik:edge#356",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0040160",
    "edge_subjectNode_name": "thyrotropin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "thyrotropin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:8675567",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#216",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "adrenomedullin",
    "result_subjectNode_id": "UMLS:C0215825",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 299,
    "edge_id": "medik:creative_edge#217",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0215825",
    "edge_subjectNode_name": "adrenomedullin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "adrenomedullin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "adrenomedullin",
    "result_subjectNode_id": "UMLS:C0215825",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 299,
    "edge_id": "medik:edge#357",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0215825",
    "edge_subjectNode_name": "adrenomedullin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "adrenomedullin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:9579224",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#217",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ampicillin",
    "result_subjectNode_id": "CHEBI:28971",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 300,
    "edge_id": "medik:creative_edge#219",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28971",
    "edge_subjectNode_name": "Ampicillin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ampicillin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ampicillin",
    "result_subjectNode_id": "CHEBI:28971",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 300,
    "edge_id": "medik:edge#359",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:28971",
    "edge_subjectNode_name": "Ampicillin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Ampicillin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:5947093",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#219",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "creative_DTD_prediction_22",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:29687",
    "edge_subjectNode_name": "Teicoplanin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Teicoplanin treats Addison Disease",
    "primary_source": "infores:arax",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "infores:rtx-kg2:CHEBI:29687--biolink:interacts_with--None--None--None--CHEBI:10033--infores:drugbank",
    "edge_object": "CHEBI:10033",
    "edge_subject": "CHEBI:29687",
    "edge_subjectNode_name": "Teicoplanin",
    "edge_objectNode_name": "Warfarin",
    "predicate": "biolink:interacts_with",
    "phrase": "Teicoplanin interacts with Warfarin",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_61_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "infores:rtx-kg2:MONDO:0018076--biolink:causes--None--None--None--MONDO:0015129--infores:semmeddb",
    "edge_object": "MONDO:0015129",
    "edge_subject": "MONDO:0018076",
    "edge_subjectNode_name": "tuberculosis",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:causes",
    "phrase": "tuberculosis causes Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11242694;PMID:1144751;PMID:12593426;PMID:1294374;PMID:13295493;PMID:15176303;PMID:16245432;PMID:17182208;PMID:18180983;PMID:18591375;PMID:1954952;PMID:19688243;PMID:2008821;PMID:208057;PMID:2284701;PMID:23565432;PMID:23926396;PMID:24772716;PMID:26321207;PMID:26516430",
    "publications_count": 20,
    "support_graph_id": "aux_graph_61_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "infores:rtx-kg2:CHEBI:10033--biolink:affects--None--None--None--NCBIGene:4524--infores:dgidb",
    "edge_object": "NCBIGene:4524",
    "edge_subject": "CHEBI:10033",
    "edge_subjectNode_name": "Warfarin",
    "edge_objectNode_name": "MTHFR",
    "predicate": "biolink:affects",
    "phrase": "Warfarin affects MTHFR",
    "primary_source": "infores:dgidb",
    "publications": "PMID:14723717",
    "publications_count": 1,
    "support_graph_id": "aux_graph_61_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "infores:rtx-kg2:CHEBI:29687--biolink:interacts_with--None--None--None--DRUGBANK:DB12768--infores:drugbank",
    "edge_object": "DRUGBANK:DB12768",
    "edge_subject": "CHEBI:29687",
    "edge_subjectNode_name": "Teicoplanin",
    "edge_objectNode_name": "BCG vaccine",
    "predicate": "biolink:interacts_with",
    "phrase": "Teicoplanin interacts with BCG vaccine",
    "primary_source": "infores:drugbank",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_61_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "infores:rtx-kg2:DRUGBANK:DB12768--biolink:treats_or_applied_or_studied_to_treat--None--None--None--MONDO:0018076--infores:semmeddb",
    "edge_object": "MONDO:0018076",
    "edge_subject": "DRUGBANK:DB12768",
    "edge_subjectNode_name": "BCG vaccine",
    "edge_objectNode_name": "tuberculosis",
    "predicate": "biolink:treats",
    "phrase": "BCG vaccine treats tuberculosis",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:11435479;PMID:11624067;PMID:13289245;PMID:15143372;PMID:15528375;PMID:16153758;PMID:17291358;PMID:18859161;PMID:20353587;PMID:2094669;PMID:21515327;PMID:21935486;PMID:2198061;PMID:3141765;PMID:31793413;PMID:3184361;PMID:33692198;PMID:33769193;PMID:35124102;PMID:35429637",
    "publications_count": 20,
    "support_graph_id": "aux_graph_61_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Teicoplanin",
    "result_subjectNode_id": "CHEBI:29687",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 301,
    "edge_id": "infores:rtx-kg2:NCBIGene:4524--biolink:gene_associated_with_condition--None--None--None--MONDO:0015129--infores:disgenet",
    "edge_object": "MONDO:0015129",
    "edge_subject": "NCBIGene:4524",
    "edge_subjectNode_name": "MTHFR",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:gene_associated_with_condition",
    "phrase": "MTHFR gene associated with condition Addison Disease",
    "primary_source": "infores:disgenet",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "aux_graph_61_creative_DTD_option_group_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Anticoagulants",
    "result_subjectNode_id": "UMLS:C0003280",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 302,
    "edge_id": "medik:creative_edge#223",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0003280",
    "edge_subjectNode_name": "Anticoagulants",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Anticoagulants treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Anticoagulants",
    "result_subjectNode_id": "UMLS:C0003280",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 302,
    "edge_id": "medik:edge#363",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UMLS:C0003280",
    "edge_subjectNode_name": "Anticoagulants",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Anticoagulants studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:25987566",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#223",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "TOLBUTAMIDE SODIUM, STERILE",
    "result_subjectNode_id": "UNII:E830VC49W5",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 303,
    "edge_id": "inferred_28",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:E830VC49W5",
    "edge_subjectNode_name": "TOLBUTAMIDE SODIUM, STERILE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "TOLBUTAMIDE SODIUM, STERILE treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "TOLBUTAMIDE SODIUM, STERILE",
    "result_subjectNode_id": "UNII:E830VC49W5",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 303,
    "edge_id": "psev_edge_28",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:E830VC49W5",
    "edge_subjectNode_name": "TOLBUTAMIDE SODIUM, STERILE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "TOLBUTAMIDE SODIUM, STERILE associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_28",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "bromazine hydrochloride",
    "result_subjectNode_id": "CHEBI:59178",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 304,
    "edge_id": "inferred_75",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:59178",
    "edge_subjectNode_name": "bromazine hydrochloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "bromazine hydrochloride treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "bromazine hydrochloride",
    "result_subjectNode_id": "CHEBI:59178",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 304,
    "edge_id": "psev_edge_75",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:59178",
    "edge_subjectNode_name": "bromazine hydrochloride",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "bromazine hydrochloride associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_75",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "insulin human",
    "result_subjectNode_id": "CHEBI:5931",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 305,
    "edge_id": "medik:creative_edge#221",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5931",
    "edge_subjectNode_name": "insulin human",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "insulin human treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "insulin human",
    "result_subjectNode_id": "CHEBI:5931",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 305,
    "edge_id": "medik:edge#361",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:5931",
    "edge_subjectNode_name": "insulin human",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "insulin human studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:19273569",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#221",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379989",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 306,
    "edge_id": "inferred_2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379989",
    "edge_subjectNode_name": "c[His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379989",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 306,
    "edge_id": "psev_edge_2",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379989",
    "edge_subjectNode_name": "c[His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_2",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[Gly-Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 307,
    "edge_id": "inferred_3",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379584",
    "edge_subjectNode_name": "c[Gly-Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[Gly-Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[Gly-Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 307,
    "edge_id": "psev_edge_3",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379584",
    "edge_subjectNode_name": "c[Gly-Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[Gly-Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_3",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp-His-Phe-Arg-D-Trp(bR-Me)-Lys-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73350129",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 308,
    "edge_id": "inferred_5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73350129",
    "edge_subjectNode_name": "Ac-Nle-Asp-His-Phe-Arg-D-Trp(bR-Me)-Lys-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp-His-Phe-Arg-D-Trp(bR-Me)-Lys-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp-His-Phe-Arg-D-Trp(bR-Me)-Lys-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73350129",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 308,
    "edge_id": "psev_edge_5",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73350129",
    "edge_subjectNode_name": "Ac-Nle-Asp-His-Phe-Arg-D-Trp(bR-Me)-Lys-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp-His-Phe-Arg-D-Trp(bR-Me)-Lys-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_5",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,5S,8S,11R,14S,17S,20S)-11-((1H-imidazol-5-yl)methyl)-5-((1H-indol-3-yl)methyl)-8,17-dibenzyl-2-(3-guanidinopropyl)-14-methyl-3,6,9,12,15,18,23-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosane-20-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:54580990",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 309,
    "edge_id": "inferred_8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:54580990",
    "edge_subjectNode_name": "(2S,5S,8S,11R,14S,17S,20S)-11-((1H-imidazol-5-yl)methyl)-5-((1H-indol-3-yl)methyl)-8,17-dibenzyl-2-(3-guanidinopropyl)-14-methyl-3,6,9,12,15,18,23-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosane-20-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,5S,8S,11R,14S,17S,20S)-11-((1H-imidazol-5-yl)methyl)-5-((1H-indol-3-yl)methyl)-8,17-dibenzyl-2-(3-guanidinopropyl)-14-methyl-3,6,9,12,15,18,23-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosane-20-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,5S,8S,11R,14S,17S,20S)-11-((1H-imidazol-5-yl)methyl)-5-((1H-indol-3-yl)methyl)-8,17-dibenzyl-2-(3-guanidinopropyl)-14-methyl-3,6,9,12,15,18,23-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosane-20-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:54580990",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 309,
    "edge_id": "psev_edge_8",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:54580990",
    "edge_subjectNode_name": "(2S,5S,8S,11R,14S,17S,20S)-11-((1H-imidazol-5-yl)methyl)-5-((1H-indol-3-yl)methyl)-8,17-dibenzyl-2-(3-guanidinopropyl)-14-methyl-3,6,9,12,15,18,23-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosane-20-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,5S,8S,11R,14S,17S,20S)-11-((1H-imidazol-5-yl)methyl)-5-((1H-indol-3-yl)methyl)-8,17-dibenzyl-2-(3-guanidinopropyl)-14-methyl-3,6,9,12,15,18,23-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosane-20-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_8",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL372274",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL372274",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 310,
    "edge_id": "inferred_11",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL372274",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL372274",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL372274 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL372274",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL372274",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 310,
    "edge_id": "psev_edge_11",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL372274",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL372274",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL372274 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_11",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Phe(4-I)-Trp-Arg-D-aThr-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285313",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 311,
    "edge_id": "inferred_12",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285313",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Phe(4-I)-Trp-Arg-D-aThr-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-Phe(4-I)-Trp-Arg-D-aThr-D-Pen(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Phe(4-I)-Trp-Arg-D-aThr-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285313",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 311,
    "edge_id": "psev_edge_12",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285313",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Phe(4-I)-Trp-Arg-D-aThr-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-Phe(4-I)-Trp-Arg-D-aThr-D-Pen(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_12",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4R,7S,10S,13R,16S)-7,13-dibenzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44577522",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 312,
    "edge_id": "inferred_18",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44577522",
    "edge_subjectNode_name": "(4R,7S,10S,13R,16S)-7,13-dibenzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(4R,7S,10S,13R,16S)-7,13-dibenzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4R,7S,10S,13R,16S)-7,13-dibenzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44577522",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 312,
    "edge_id": "psev_edge_18",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44577522",
    "edge_subjectNode_name": "(4R,7S,10S,13R,16S)-7,13-dibenzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(4R,7S,10S,13R,16S)-7,13-dibenzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_18",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-6-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277422",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 313,
    "edge_id": "inferred_22",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277422",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-6-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-6-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-6-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277422",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 313,
    "edge_id": "psev_edge_22",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277422",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-6-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-6-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_22",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bS-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71449181",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 314,
    "edge_id": "inferred_23",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71449181",
    "edge_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bS-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bS-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bS-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71449181",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 314,
    "edge_id": "psev_edge_23",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71449181",
    "edge_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bS-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bS-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_23",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Cys(1)-His-Tic-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354761",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 315,
    "edge_id": "inferred_30",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354761",
    "edge_subjectNode_name": "H-Phe-Cys(1)-His-Tic-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-Phe-Cys(1)-His-Tic-Arg-D-Trp-D-Cys(1)-D-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Cys(1)-His-Tic-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354761",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 315,
    "edge_id": "psev_edge_30",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354761",
    "edge_subjectNode_name": "H-Phe-Cys(1)-His-Tic-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-Phe-Cys(1)-His-Tic-Arg-D-Trp-D-Cys(1)-D-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_30",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-8-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277558",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 316,
    "edge_id": "inferred_33",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277558",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-8-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-8-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-8-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277558",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 316,
    "edge_id": "psev_edge_33",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277558",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-8-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-8-bromo-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_33",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-N(PrNH2)Gly-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285388",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 317,
    "edge_id": "inferred_34",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285388",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-N(PrNH2)Gly-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-His-Phe-N(PrNH2)Gly-D-Trp-D-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-N(PrNH2)Gly-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285388",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 317,
    "edge_id": "psev_edge_34",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285388",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-N(PrNH2)Gly-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-His-Phe-N(PrNH2)Gly-D-Trp-D-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_34",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[beta-Ala-His-D-phe-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379728",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 318,
    "edge_id": "inferred_37",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379728",
    "edge_subjectNode_name": "c[beta-Ala-His-D-phe-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[beta-Ala-His-D-phe-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[beta-Ala-His-D-phe-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379728",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 318,
    "edge_id": "psev_edge_37",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379728",
    "edge_subjectNode_name": "c[beta-Ala-His-D-phe-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[beta-Ala-His-D-phe-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_37",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-D-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285237",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 319,
    "edge_id": "inferred_43",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285237",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-D-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-D-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-D-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285237",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 319,
    "edge_id": "psev_edge_43",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285237",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-D-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-D-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_43",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "RY764",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:6918851",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 320,
    "edge_id": "inferred_48",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:6918851",
    "edge_subjectNode_name": "RY764",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "RY764 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "RY764",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:6918851",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 320,
    "edge_id": "psev_edge_48",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:6918851",
    "edge_subjectNode_name": "RY764",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "RY764 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_48",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Ser-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285223",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 321,
    "edge_id": "inferred_55",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285223",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Ser-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Ser-D-Pen(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Ser-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285223",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 321,
    "edge_id": "psev_edge_55",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285223",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Ser-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Ser-D-Pen(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_55",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Lys(iPr)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317071",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 322,
    "edge_id": "inferred_57",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317071",
    "edge_subjectNode_name": "Bu-His-D-Phe-Lys(iPr)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-D-Phe-Lys(iPr)-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Lys(iPr)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317071",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 322,
    "edge_id": "psev_edge_57",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317071",
    "edge_subjectNode_name": "Bu-His-D-Phe-Lys(iPr)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-D-Phe-Lys(iPr)-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_57",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[Gly-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380209",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 323,
    "edge_id": "inferred_63",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380209",
    "edge_subjectNode_name": "c[Gly-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[Gly-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[Gly-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380209",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 323,
    "edge_id": "psev_edge_63",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380209",
    "edge_subjectNode_name": "c[Gly-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[Gly-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_63",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-1Nal-Arg-D-Trp-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285239",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 324,
    "edge_id": "inferred_70",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285239",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-1Nal-Arg-D-Trp-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-His-1Nal-Arg-D-Trp-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-1Nal-Arg-D-Trp-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285239",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 324,
    "edge_id": "psev_edge_70",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285239",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-1Nal-Arg-D-Trp-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-His-1Nal-Arg-D-Trp-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_70",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)Gly-D-His-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 325,
    "edge_id": "inferred_76",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379968",
    "edge_subjectNode_name": "N(1)Gly-D-His-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N(1)Gly-D-His-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)Gly-D-His-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 325,
    "edge_id": "psev_edge_76",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379968",
    "edge_subjectNode_name": "N(1)Gly-D-His-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N(1)Gly-D-His-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_76",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-16-[(2-methyl-1H-imidazol-5-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 326,
    "edge_id": "inferred_77",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285102",
    "edge_subjectNode_name": "(4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-16-[(2-methyl-1H-imidazol-5-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-16-[(2-methyl-1H-imidazol-5-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-16-[(2-methyl-1H-imidazol-5-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285102",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 326,
    "edge_id": "psev_edge_77",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285102",
    "edge_subjectNode_name": "(4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-16-[(2-methyl-1H-imidazol-5-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(4S,7R,10S,13R,16S,19R)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-16-[(2-methyl-1H-imidazol-5-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_77",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285236",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 327,
    "edge_id": "inferred_80",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285236",
    "edge_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285236",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 327,
    "edge_id": "psev_edge_80",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285236",
    "edge_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_80",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-D-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71454570",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 328,
    "edge_id": "inferred_81",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71454570",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-D-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-D-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-D-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71454570",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 328,
    "edge_id": "psev_edge_81",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71454570",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-D-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-D-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_81",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-F)-Arg-D-Trp-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285136",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 329,
    "edge_id": "inferred_84",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285136",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-F)-Arg-D-Trp-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-His-Phe(4-F)-Arg-D-Trp-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-F)-Arg-D-Trp-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285136",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 329,
    "edge_id": "psev_edge_84",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285136",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-F)-Arg-D-Trp-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-His-Phe(4-F)-Arg-D-Trp-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_84",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9S,12S,20R,23R)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44325899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 330,
    "edge_id": "inferred_85",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44325899",
    "edge_subjectNode_name": "(3S,6S,9S,12S,20R,23R)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6S,9S,12S,20R,23R)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9S,12S,20R,23R)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44325899",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 330,
    "edge_id": "psev_edge_85",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44325899",
    "edge_subjectNode_name": "(3S,6S,9S,12S,20R,23R)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6S,9S,12S,20R,23R)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_85",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(3-methyl-3H-imidazol-4-yl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44269246",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 331,
    "edge_id": "inferred_105",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44269246",
    "edge_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(3-methyl-3H-imidazol-4-yl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(3-methyl-3H-imidazol-4-yl)-propionamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(3-methyl-3H-imidazol-4-yl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44269246",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 331,
    "edge_id": "psev_edge_105",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44269246",
    "edge_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(3-methyl-3H-imidazol-4-yl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(3-methyl-3H-imidazol-4-yl)-propionamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_105",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9S,12S,20R,23S)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44325927",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 332,
    "edge_id": "inferred_107",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44325927",
    "edge_subjectNode_name": "(3S,6S,9S,12S,20R,23S)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6S,9S,12S,20R,23S)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9S,12S,20R,23S)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44325927",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 332,
    "edge_id": "psev_edge_107",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44325927",
    "edge_subjectNode_name": "(3S,6S,9S,12S,20R,23S)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6S,9S,12S,20R,23S)-12-[[(2S)-2-acetamidohexanoyl]amino]-6-benzyl-3-[3-(diaminomethylideneamino)propyl]-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,22-hexaoxo-25-thia-1,4,7,10,15,21-hexazabicyclo[21.4.0]heptacosane-20-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_107",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle4-c[Asp5,D-Phe(pI)7,Lys10]R-MSH(4-10)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44355350",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 333,
    "edge_id": "inferred_111",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44355350",
    "edge_subjectNode_name": "Ac-Nle4-c[Asp5,D-Phe(pI)7,Lys10]R-MSH(4-10)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle4-c[Asp5,D-Phe(pI)7,Lys10]R-MSH(4-10)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle4-c[Asp5,D-Phe(pI)7,Lys10]R-MSH(4-10)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44355350",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 333,
    "edge_id": "psev_edge_111",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44355350",
    "edge_subjectNode_name": "Ac-Nle4-c[Asp5,D-Phe(pI)7,Lys10]R-MSH(4-10)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle4-c[Asp5,D-Phe(pI)7,Lys10]R-MSH(4-10)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_111",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)Gly-D-Pro-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379585",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 334,
    "edge_id": "inferred_113",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379585",
    "edge_subjectNode_name": "N(1)Gly-D-Pro-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N(1)Gly-D-Pro-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)Gly-D-Pro-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379585",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 334,
    "edge_id": "psev_edge_113",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379585",
    "edge_subjectNode_name": "N(1)Gly-D-Pro-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N(1)Gly-D-Pro-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_113",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bR-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71456276",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 335,
    "edge_id": "inferred_116",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71456276",
    "edge_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bR-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bR-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bR-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71456276",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 335,
    "edge_id": "psev_edge_116",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71456276",
    "edge_subjectNode_name": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bR-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Ser-Tyr-Ser-Met-Glu-His-Phe(bR-Me)-Arg-Trp-Gly-Lys-Pro-Val-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_116",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Hcy(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285432",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 336,
    "edge_id": "inferred_120",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285432",
    "edge_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Hcy(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Hcy(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Hcy(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285432",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 336,
    "edge_id": "psev_edge_120",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285432",
    "edge_subjectNode_name": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Hcy(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-Phe-Cys(1)-His-D-Phe-Arg-D-Trp-D-Hcy(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_120",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-Trp-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285368",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 337,
    "edge_id": "inferred_124",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285368",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-Trp-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-Phe-Trp-Arg-Trp-D-Pen(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-Trp-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285368",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 337,
    "edge_id": "psev_edge_124",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285368",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-Trp-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-Phe-Trp-Arg-Trp-D-Pen(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_124",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(5R,8R,11R,14S,17S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-8-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,20-hexaoxo-5-[(3-phenylmethoxy-1H-imidazol-3-ium-5-yl)methyl]-1,4,7,10,13,16-hexazacycloicosane-17-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379982",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 338,
    "edge_id": "inferred_125",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379982",
    "edge_subjectNode_name": "(5R,8R,11R,14S,17S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-8-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,20-hexaoxo-5-[(3-phenylmethoxy-1H-imidazol-3-ium-5-yl)methyl]-1,4,7,10,13,16-hexazacycloicosane-17-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(5R,8R,11R,14S,17S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-8-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,20-hexaoxo-5-[(3-phenylmethoxy-1H-imidazol-3-ium-5-yl)methyl]-1,4,7,10,13,16-hexazacycloicosane-17-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(5R,8R,11R,14S,17S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-8-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,20-hexaoxo-5-[(3-phenylmethoxy-1H-imidazol-3-ium-5-yl)methyl]-1,4,7,10,13,16-hexazacycloicosane-17-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379982",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 338,
    "edge_id": "psev_edge_125",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379982",
    "edge_subjectNode_name": "(5R,8R,11R,14S,17S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-8-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,20-hexaoxo-5-[(3-phenylmethoxy-1H-imidazol-3-ium-5-yl)methyl]-1,4,7,10,13,16-hexazacycloicosane-17-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(5R,8R,11R,14S,17S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-8-benzyl-11-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,20-hexaoxo-5-[(3-phenylmethoxy-1H-imidazol-3-ium-5-yl)methyl]-1,4,7,10,13,16-hexazacycloicosane-17-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_125",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)Gly-D-His-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379988",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 339,
    "edge_id": "inferred_133",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379988",
    "edge_subjectNode_name": "N(1)Gly-D-His-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N(1)Gly-D-His-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)Gly-D-His-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379988",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 339,
    "edge_id": "psev_edge_133",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379988",
    "edge_subjectNode_name": "N(1)Gly-D-His-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N(1)Gly-D-His-D-Phe-D-Arg-Trp-Glu(1)-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_133",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bR-Me)-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10510273",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 340,
    "edge_id": "inferred_138",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10510273",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bR-Me)-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bR-Me)-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bR-Me)-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10510273",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 340,
    "edge_id": "psev_edge_138",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10510273",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bR-Me)-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bR-Me)-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_138",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)His-D-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380208",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 341,
    "edge_id": "inferred_140",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380208",
    "edge_subjectNode_name": "N(1)His-D-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N(1)His-D-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)His-D-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380208",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 341,
    "edge_id": "psev_edge_140",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380208",
    "edge_subjectNode_name": "N(1)His-D-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N(1)His-D-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_140",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Cys-His-D-Phe-N-alpha-guanidinylbutyl-D-Cys]-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417550",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 342,
    "edge_id": "inferred_149",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417550",
    "edge_subjectNode_name": "Ac-c[Cys-His-D-Phe-N-alpha-guanidinylbutyl-D-Cys]-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-c[Cys-His-D-Phe-N-alpha-guanidinylbutyl-D-Cys]-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Cys-His-D-Phe-N-alpha-guanidinylbutyl-D-Cys]-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417550",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 342,
    "edge_id": "psev_edge_149",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417550",
    "edge_subjectNode_name": "Ac-c[Cys-His-D-Phe-N-alpha-guanidinylbutyl-D-Cys]-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-c[Cys-His-D-Phe-N-alpha-guanidinylbutyl-D-Cys]-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_149",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-Phe(3,4-diCl)-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71461643",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 343,
    "edge_id": "inferred_156",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71461643",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-Phe(3,4-diCl)-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-Phe-Arg-Phe(3,4-diCl)-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-Phe(3,4-diCl)-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71461643",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 343,
    "edge_id": "psev_edge_156",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71461643",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-Phe(3,4-diCl)-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-Phe-Arg-Phe(3,4-diCl)-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_156",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[beta-Ala-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 344,
    "edge_id": "inferred_165",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380007",
    "edge_subjectNode_name": "c[beta-Ala-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[beta-Ala-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[beta-Ala-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380007",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 344,
    "edge_id": "psev_edge_165",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380007",
    "edge_subjectNode_name": "c[beta-Ala-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[beta-Ala-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_165",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10534100",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 345,
    "edge_id": "inferred_167",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10534100",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp(1)-His-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10534100",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 345,
    "edge_id": "psev_edge_167",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10534100",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp(1)-His-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_167",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285017",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 346,
    "edge_id": "inferred_171",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285017",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-Phe-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285017",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 346,
    "edge_id": "psev_edge_171",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285017",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Phe-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-Phe-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_171",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10606077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 347,
    "edge_id": "inferred_172",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10606077",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10606077",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 347,
    "edge_id": "psev_edge_172",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10606077",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp(bS-Me)-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_172",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-c[Hcy-His-D-Phe-Arg-Trp-Cys]-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285417",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 348,
    "edge_id": "inferred_173",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285417",
    "edge_subjectNode_name": "H-D-Phe-c[Hcy-His-D-Phe-Arg-Trp-Cys]-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-c[Hcy-His-D-Phe-Arg-Trp-Cys]-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-c[Hcy-His-D-Phe-Arg-Trp-Cys]-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285417",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 348,
    "edge_id": "psev_edge_173",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285417",
    "edge_subjectNode_name": "H-D-Phe-c[Hcy-His-D-Phe-Arg-Trp-Cys]-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-c[Hcy-His-D-Phe-Arg-Trp-Cys]-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_173",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-Cl)-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285234",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 349,
    "edge_id": "inferred_184",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285234",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-Cl)-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-His-Phe(4-Cl)-Arg-D-Trp-D-Cys(1)-D-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-Cl)-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285234",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 349,
    "edge_id": "psev_edge_184",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285234",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe(4-Cl)-Arg-D-Trp-D-Cys(1)-D-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-His-Phe(4-Cl)-Arg-D-Trp-D-Cys(1)-D-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_184",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Asp(1)-His-D-Phe-Arg-D-Trp-D-Lys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285133",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 350,
    "edge_id": "inferred_190",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285133",
    "edge_subjectNode_name": "H-Phe-Asp(1)-His-D-Phe-Arg-D-Trp-D-Lys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-Phe-Asp(1)-His-D-Phe-Arg-D-Trp-D-Lys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-Phe-Asp(1)-His-D-Phe-Arg-D-Trp-D-Lys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285133",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 350,
    "edge_id": "psev_edge_190",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285133",
    "edge_subjectNode_name": "H-Phe-Asp(1)-His-D-Phe-Arg-D-Trp-D-Lys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-Phe-Asp(1)-His-D-Phe-Arg-D-Trp-D-Lys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_190",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10534101",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 351,
    "edge_id": "inferred_191",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10534101",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10534101",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 351,
    "edge_id": "psev_edge_191",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10534101",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-His-D-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp(1)-His-D-Phe(bS-Me)-Arg-Trp-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_191",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-D-Phe(4-I)-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285147",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 352,
    "edge_id": "inferred_194",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285147",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-D-Phe(4-I)-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-D-Phe(4-I)-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-D-Phe(4-I)-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285147",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 352,
    "edge_id": "psev_edge_194",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285147",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-D-Phe(4-I)-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-D-Phe(4-I)-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_194",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285101",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 353,
    "edge_id": "inferred_201",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285101",
    "edge_subjectNode_name": "(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285101",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 353,
    "edge_id": "psev_edge_201",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285101",
    "edge_subjectNode_name": "(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,5S,8S,11R,14R,23S)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-23-[[(2R)-2-amino-3-phenylpropanoyl]amino]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-11-(1H-indol-3-ylmethyl)-2-[(2-methyl-1H-imidazol-5-yl)methyl]-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_201",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379746",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 354,
    "edge_id": "inferred_213",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379746",
    "edge_subjectNode_name": "c[Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379746",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 354,
    "edge_id": "psev_edge_213",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379746",
    "edge_subjectNode_name": "c[Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[Pro-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_213",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354758",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 355,
    "edge_id": "inferred_215",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354758",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354758",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 355,
    "edge_id": "psev_edge_215",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354758",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-Trp-D-Pen(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_215",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,3R)-2-{[(4S,7R,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-{3-[(diaminomethylidene)amino]propyl}-16-(1H-imidazol-2-ylmethyl)-7-(1H-indol-3-ylmethyl)-13-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]formamido}-3-hydroxybutanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285416",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 356,
    "edge_id": "inferred_228",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285416",
    "edge_subjectNode_name": "(2S,3R)-2-{[(4S,7R,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-{3-[(diaminomethylidene)amino]propyl}-16-(1H-imidazol-2-ylmethyl)-7-(1H-indol-3-ylmethyl)-13-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]formamido}-3-hydroxybutanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,3R)-2-{[(4S,7R,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-{3-[(diaminomethylidene)amino]propyl}-16-(1H-imidazol-2-ylmethyl)-7-(1H-indol-3-ylmethyl)-13-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]formamido}-3-hydroxybutanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,3R)-2-{[(4S,7R,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-{3-[(diaminomethylidene)amino]propyl}-16-(1H-imidazol-2-ylmethyl)-7-(1H-indol-3-ylmethyl)-13-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]formamido}-3-hydroxybutanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285416",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 356,
    "edge_id": "psev_edge_228",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285416",
    "edge_subjectNode_name": "(2S,3R)-2-{[(4S,7R,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-{3-[(diaminomethylidene)amino]propyl}-16-(1H-imidazol-2-ylmethyl)-7-(1H-indol-3-ylmethyl)-13-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]formamido}-3-hydroxybutanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,3R)-2-{[(4S,7R,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-{3-[(diaminomethylidene)amino]propyl}-16-(1H-imidazol-2-ylmethyl)-7-(1H-indol-3-ylmethyl)-13-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]formamido}-3-hydroxybutanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_228",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CTOP",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:5311058",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 357,
    "edge_id": "inferred_233",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:5311058",
    "edge_subjectNode_name": "CTOP",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CTOP treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CTOP",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:5311058",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 357,
    "edge_id": "psev_edge_233",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:5311058",
    "edge_subjectNode_name": "CTOP",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CTOP associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_233",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5S,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379730",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 358,
    "edge_id": "inferred_238",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379730",
    "edge_subjectNode_name": "(2R,5S,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,5S,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5S,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379730",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 358,
    "edge_id": "psev_edge_238",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379730",
    "edge_subjectNode_name": "(2R,5S,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,5S,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_238",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4R,7S,10S,13R,16S)-13-benzyl-16-(cyclopentylmethyl)-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:24858480",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 359,
    "edge_id": "inferred_245",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:24858480",
    "edge_subjectNode_name": "(4R,7S,10S,13R,16S)-13-benzyl-16-(cyclopentylmethyl)-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(4R,7S,10S,13R,16S)-13-benzyl-16-(cyclopentylmethyl)-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4R,7S,10S,13R,16S)-13-benzyl-16-(cyclopentylmethyl)-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:24858480",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 359,
    "edge_id": "psev_edge_245",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:24858480",
    "edge_subjectNode_name": "(4R,7S,10S,13R,16S)-13-benzyl-16-(cyclopentylmethyl)-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(4R,7S,10S,13R,16S)-13-benzyl-16-(cyclopentylmethyl)-10-[3-(diaminomethylideneamino)propyl]-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_245",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)His-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379745",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 360,
    "edge_id": "inferred_253",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379745",
    "edge_subjectNode_name": "N(1)His-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N(1)His-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N(1)His-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379745",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 360,
    "edge_id": "psev_edge_253",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379745",
    "edge_subjectNode_name": "N(1)His-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N(1)His-Phe-Arg-D-Trp-D-Glu(1)-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_253",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285261",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 361,
    "edge_id": "inferred_254",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285261",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-His-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285261",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 361,
    "edge_id": "psev_edge_254",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285261",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-His-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-His-Phe-Arg-D-Trp-D-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_254",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5R,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379727",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 362,
    "edge_id": "inferred_255",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379727",
    "edge_subjectNode_name": "(2R,5R,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,5R,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5R,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44379727",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 362,
    "edge_id": "psev_edge_255",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44379727",
    "edge_subjectNode_name": "(2R,5R,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,5R,8R,11S,14S)-N-[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-5-benzyl-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-3,6,9,12,17,22-hexaoxo-1,4,7,10,13,18-hexazacyclodocosane-14-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_255",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2R)-3-phenyl-2-[[(2S)-2-(4-phenylbutanoylamino)-3-(3H-pyrrol-4-yl)propanoyl]amino]propanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45487403",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 363,
    "edge_id": "inferred_259",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:45487403",
    "edge_subjectNode_name": "(2S)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2R)-3-phenyl-2-[[(2S)-2-(4-phenylbutanoylamino)-3-(3H-pyrrol-4-yl)propanoyl]amino]propanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2R)-3-phenyl-2-[[(2S)-2-(4-phenylbutanoylamino)-3-(3H-pyrrol-4-yl)propanoyl]amino]propanoyl]amino]pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2R)-3-phenyl-2-[[(2S)-2-(4-phenylbutanoylamino)-3-(3H-pyrrol-4-yl)propanoyl]amino]propanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45487403",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 363,
    "edge_id": "psev_edge_259",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:45487403",
    "edge_subjectNode_name": "(2S)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2R)-3-phenyl-2-[[(2S)-2-(4-phenylbutanoylamino)-3-(3H-pyrrol-4-yl)propanoyl]amino]propanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2R)-3-phenyl-2-[[(2S)-2-(4-phenylbutanoylamino)-3-(3H-pyrrol-4-yl)propanoyl]amino]propanoyl]amino]pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_259",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[gamma-Abu-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380006",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 364,
    "edge_id": "inferred_261",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380006",
    "edge_subjectNode_name": "c[gamma-Abu-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c[gamma-Abu-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c[gamma-Abu-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44380006",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 364,
    "edge_id": "psev_edge_261",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44380006",
    "edge_subjectNode_name": "c[gamma-Abu-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c[gamma-Abu-His-D-Nal(2'')-Arg-Trp-Glu]-Val-Val-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_261",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285262",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 365,
    "edge_id": "inferred_267",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285262",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285262",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 365,
    "edge_id": "psev_edge_267",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285262",
    "edge_subjectNode_name": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-Cys(1)-Tyr-Trp-Arg-D-aThr-D-Cys(1)-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_267",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-c[Cys-His-D-Phe-Arg-Trp-Pen]-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285238",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 366,
    "edge_id": "inferred_268",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285238",
    "edge_subjectNode_name": "H-D-Phe-c[Cys-His-D-Phe-Arg-Trp-Pen]-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe-c[Cys-His-D-Phe-Arg-Trp-Pen]-Thr-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe-c[Cys-His-D-Phe-Arg-Trp-Pen]-Thr-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44285238",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 366,
    "edge_id": "psev_edge_268",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44285238",
    "edge_subjectNode_name": "H-D-Phe-c[Cys-His-D-Phe-Arg-Trp-Pen]-Thr-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe-c[Cys-His-D-Phe-Arg-Trp-Pen]-Thr-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_268",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(1H-imidazol-4-yl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11763303",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 367,
    "edge_id": "inferred_269",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11763303",
    "edge_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(1H-imidazol-4-yl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(1H-imidazol-4-yl)-propionamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(1H-imidazol-4-yl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11763303",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 367,
    "edge_id": "psev_edge_269",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11763303",
    "edge_subjectNode_name": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(1H-imidazol-4-yl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-Amino-N-[2-(4-butyryl-4-phenyl-piperidin-1-yl)-1-(4-methoxy-benzyl)-2-oxo-ethyl]-3-(1H-imidazol-4-yl)-propionamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_269",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ph(CH2)3CO-His-D-Phe-Arg-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45487404",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 368,
    "edge_id": "inferred_279",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:45487404",
    "edge_subjectNode_name": "Ph(CH2)3CO-His-D-Phe-Arg-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ph(CH2)3CO-His-D-Phe-Arg-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ph(CH2)3CO-His-D-Phe-Arg-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:45487404",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 368,
    "edge_id": "psev_edge_279",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:45487404",
    "edge_subjectNode_name": "Ph(CH2)3CO-His-D-Phe-Arg-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ph(CH2)3CO-His-D-Phe-Arg-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_279",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Oxytocin",
    "result_subjectNode_id": "CHEBI:7872",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 369,
    "edge_id": "medik:creative_edge#225",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7872",
    "edge_subjectNode_name": "Oxytocin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Oxytocin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Oxytocin",
    "result_subjectNode_id": "CHEBI:7872",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 369,
    "edge_id": "medik:edge#365",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEBI:7872",
    "edge_subjectNode_name": "Oxytocin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Oxytocin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:17712724",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#225",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe(3,4-diCl)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354641",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 370,
    "edge_id": "inferred_0",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354641",
    "edge_subjectNode_name": "butanoyl-His-D-Phe(3,4-diCl)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-Phe(3,4-diCl)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe(3,4-diCl)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354641",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 370,
    "edge_id": "psev_edge_0",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354641",
    "edge_subjectNode_name": "butanoyl-His-D-Phe(3,4-diCl)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-Phe(3,4-diCl)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_0",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372933",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 371,
    "edge_id": "inferred_4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372933",
    "edge_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372933",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 371,
    "edge_id": "psev_edge_4",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372933",
    "edge_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_4",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277299",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 372,
    "edge_id": "inferred_6",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277299",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277299",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 372,
    "edge_id": "psev_edge_6",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277299",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_6",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[4-cyclohexyl-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228843",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 373,
    "edge_id": "inferred_7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228843",
    "edge_subjectNode_name": "2-[4-cyclohexyl-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-[4-cyclohexyl-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[4-cyclohexyl-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228843",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 373,
    "edge_id": "psev_edge_7",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228843",
    "edge_subjectNode_name": "2-[4-cyclohexyl-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-[4-cyclohexyl-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_7",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-D-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:70695694",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 374,
    "edge_id": "inferred_9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:70695694",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-D-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-Phe-Arg-D-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-D-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:70695694",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 374,
    "edge_id": "psev_edge_9",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:70695694",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-D-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-Phe-Arg-D-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_9",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-(dimethylamino)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275371",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 375,
    "edge_id": "inferred_10",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275371",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-(dimethylamino)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-(dimethylamino)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-(dimethylamino)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275371",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 375,
    "edge_id": "psev_edge_10",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275371",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-(dimethylamino)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-(dimethylamino)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_10",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-chloro-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277301",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 376,
    "edge_id": "inferred_16",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277301",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-chloro-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-chloro-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-chloro-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277301",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 376,
    "edge_id": "psev_edge_16",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277301",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-chloro-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-chloro-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_16",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278194",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 377,
    "edge_id": "inferred_19",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278194",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278194",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 377,
    "edge_id": "psev_edge_19",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278194",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-ethyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_19",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-L-phe-arg-trp-Aoc)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413592",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 378,
    "edge_id": "inferred_27",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413592",
    "edge_subjectNode_name": "c(his-L-phe-arg-trp-Aoc)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c(his-L-phe-arg-trp-Aoc) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-L-phe-arg-trp-Aoc)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413592",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 378,
    "edge_id": "psev_edge_27",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413592",
    "edge_subjectNode_name": "c(his-L-phe-arg-trp-Aoc)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c(his-L-phe-arg-trp-Aoc) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_27",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yloxy-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278223",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 379,
    "edge_id": "inferred_35",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278223",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yloxy-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yloxy-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yloxy-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278223",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 379,
    "edge_id": "psev_edge_35",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278223",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yloxy-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yloxy-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_35",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-DPhe-Arg(CN)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317276",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 380,
    "edge_id": "inferred_38",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317276",
    "edge_subjectNode_name": "Bu-His-DPhe-Arg(CN)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-DPhe-Arg(CN)-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-DPhe-Arg(CN)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317276",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 380,
    "edge_id": "psev_edge_38",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317276",
    "edge_subjectNode_name": "Bu-His-DPhe-Arg(CN)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-DPhe-Arg(CN)-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_38",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe-Arg-D-Ala(benzothiophen-3-yl)(benzothiophen-3-yl)-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373317",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 381,
    "edge_id": "inferred_40",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373317",
    "edge_subjectNode_name": "butanoyl-His-Phe-Arg-D-Ala(benzothiophen-3-yl)(benzothiophen-3-yl)-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe-Arg-D-Ala(benzothiophen-3-yl)(benzothiophen-3-yl)-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe-Arg-D-Ala(benzothiophen-3-yl)(benzothiophen-3-yl)-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373317",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 381,
    "edge_id": "psev_edge_40",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373317",
    "edge_subjectNode_name": "butanoyl-His-Phe-Arg-D-Ala(benzothiophen-3-yl)(benzothiophen-3-yl)-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe-Arg-D-Ala(benzothiophen-3-yl)(benzothiophen-3-yl)-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_40",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(4-Me)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372908",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 382,
    "edge_id": "inferred_41",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372908",
    "edge_subjectNode_name": "butanoyl-His-Phe(4-Me)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe(4-Me)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(4-Me)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372908",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 382,
    "edge_id": "psev_edge_41",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372908",
    "edge_subjectNode_name": "butanoyl-His-Phe(4-Me)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe(4-Me)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_41",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-yloxyspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275175",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 383,
    "edge_id": "inferred_44",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275175",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-yloxyspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-yloxyspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-yloxyspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275175",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 383,
    "edge_id": "psev_edge_44",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275175",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-yloxyspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-yloxyspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_44",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL197695",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL197695",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 384,
    "edge_id": "inferred_54",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL197695",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL197695",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL197695 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL197695",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL197695",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 384,
    "edge_id": "psev_edge_54",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL197695",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL197695",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL197695 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_54",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Tyr(Et)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71456236",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 385,
    "edge_id": "inferred_59",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71456236",
    "edge_subjectNode_name": "butanoyl-His-D-Tyr(Et)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-Tyr(Et)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Tyr(Et)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71456236",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 385,
    "edge_id": "psev_edge_59",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71456236",
    "edge_subjectNode_name": "butanoyl-His-D-Tyr(Et)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-Tyr(Et)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_59",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Tyr-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372942",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 386,
    "edge_id": "inferred_60",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372942",
    "edge_subjectNode_name": "butanoyl-His-Tyr-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Tyr-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Tyr-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372942",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 386,
    "edge_id": "psev_edge_60",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372942",
    "edge_subjectNode_name": "butanoyl-His-Tyr-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Tyr-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_60",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71459896",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 387,
    "edge_id": "inferred_62",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71459896",
    "edge_subjectNode_name": "(2R)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71459896",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 387,
    "edge_id": "psev_edge_62",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71459896",
    "edge_subjectNode_name": "(2R)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_62",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2R)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401421",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 388,
    "edge_id": "inferred_64",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401421",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2R)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2R)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2R)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401421",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 388,
    "edge_id": "psev_edge_64",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401421",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2R)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2R)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_64",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethoxy-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275119",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 389,
    "edge_id": "inferred_65",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275119",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethoxy-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethoxy-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethoxy-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275119",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 389,
    "edge_id": "psev_edge_65",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275119",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethoxy-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethoxy-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_65",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(3-CF3)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372964",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 390,
    "edge_id": "inferred_66",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372964",
    "edge_subjectNode_name": "butanoyl-His-Phe(3-CF3)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe(3-CF3)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(3-CF3)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44372964",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 390,
    "edge_id": "psev_edge_66",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44372964",
    "edge_subjectNode_name": "butanoyl-His-Phe(3-CF3)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe(3-CF3)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_66",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL262470",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL262470",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 391,
    "edge_id": "inferred_67",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL262470",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL262470",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL262470 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL262470",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL262470",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 391,
    "edge_id": "psev_edge_67",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL262470",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL262470",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL262470 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_67",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(carbamoylamino)propyl]-8'-chloro-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275312",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 392,
    "edge_id": "inferred_68",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275312",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(carbamoylamino)propyl]-8'-chloro-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(carbamoylamino)propyl]-8'-chloro-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(carbamoylamino)propyl]-8'-chloro-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275312",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 392,
    "edge_id": "psev_edge_68",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275312",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(carbamoylamino)propyl]-8'-chloro-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(carbamoylamino)propyl]-8'-chloro-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_68",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6'-bromo-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275265",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 393,
    "edge_id": "inferred_69",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275265",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6'-bromo-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6'-bromo-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6'-bromo-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275265",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 393,
    "edge_id": "psev_edge_69",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275265",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6'-bromo-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6'-bromo-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_69",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Abu)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413577",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 394,
    "edge_id": "inferred_71",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413577",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Abu)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c(his-D-phe-arg-trp-Abu) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Abu)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413577",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 394,
    "edge_id": "psev_edge_71",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413577",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Abu)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c(his-D-phe-arg-trp-Abu) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_71",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-2Nal-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73345549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 395,
    "edge_id": "inferred_72",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73345549",
    "edge_subjectNode_name": "butanoyl-His-D-2Nal-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-2Nal-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-2Nal-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73345549",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 395,
    "edge_id": "psev_edge_72",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73345549",
    "edge_subjectNode_name": "butanoyl-His-D-2Nal-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-2Nal-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_72",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-2Nal-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71452716",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 396,
    "edge_id": "inferred_78",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71452716",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-2Nal-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-Phe-Arg-2Nal-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-2Nal-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71452716",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 396,
    "edge_id": "psev_edge_78",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71452716",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-2Nal-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-Phe-Arg-2Nal-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_78",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[2-[(1S)-1'-[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11215553",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 397,
    "edge_id": "inferred_82",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11215553",
    "edge_subjectNode_name": "N-[2-[(1S)-1'-[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[2-[(1S)-1'-[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[2-[(1S)-1'-[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11215553",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 397,
    "edge_id": "psev_edge_82",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11215553",
    "edge_subjectNode_name": "N-[2-[(1S)-1'-[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[2-[(1S)-1'-[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_82",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-ylspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275372",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 398,
    "edge_id": "inferred_88",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275372",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-ylspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-ylspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-ylspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275372",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 398,
    "edge_id": "psev_edge_88",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275372",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-ylspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)-8'-propan-2-ylspiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_88",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Aoc)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413535",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 399,
    "edge_id": "inferred_91",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413535",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Aoc)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c(his-D-phe-arg-trp-Aoc) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Aoc)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413535",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 399,
    "edge_id": "psev_edge_91",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413535",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Aoc)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c(his-D-phe-arg-trp-Aoc) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_91",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Cit-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317242",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 400,
    "edge_id": "inferred_93",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317242",
    "edge_subjectNode_name": "Bu-His-D-Phe-Cit-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-D-Phe-Cit-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Cit-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317242",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 400,
    "edge_id": "psev_edge_93",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317242",
    "edge_subjectNode_name": "Bu-His-D-Phe-Cit-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-D-Phe-Cit-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_93",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[(6S)-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228725",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 401,
    "edge_id": "inferred_97",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228725",
    "edge_subjectNode_name": "2-[(6S)-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-[(6S)-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[(6S)-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228725",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 401,
    "edge_id": "psev_edge_97",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228725",
    "edge_subjectNode_name": "2-[(6S)-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-[(6S)-6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_97",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-8'-methoxy-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73350214",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 402,
    "edge_id": "inferred_106",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73350214",
    "edge_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-8'-methoxy-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-8'-methoxy-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-8'-methoxy-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73350214",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 402,
    "edge_id": "psev_edge_106",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73350214",
    "edge_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-8'-methoxy-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-8'-methoxy-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_106",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL436329",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL436329",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 403,
    "edge_id": "inferred_110",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL436329",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL436329",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL436329 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL436329",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL436329",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 403,
    "edge_id": "psev_edge_110",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL436329",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL436329",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL436329 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_110",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3'S,6'R,9'S,15'R,23'S)-9'-benzyl-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-2',5',8',11',14',17'-hexaoxo-15'-(pentanoylamino)spiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275654",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 404,
    "edge_id": "inferred_114",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275654",
    "edge_subjectNode_name": "(3'S,6'R,9'S,15'R,23'S)-9'-benzyl-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-2',5',8',11',14',17'-hexaoxo-15'-(pentanoylamino)spiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3'S,6'R,9'S,15'R,23'S)-9'-benzyl-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-2',5',8',11',14',17'-hexaoxo-15'-(pentanoylamino)spiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3'S,6'R,9'S,15'R,23'S)-9'-benzyl-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-2',5',8',11',14',17'-hexaoxo-15'-(pentanoylamino)spiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275654",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 404,
    "edge_id": "psev_edge_114",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275654",
    "edge_subjectNode_name": "(3'S,6'R,9'S,15'R,23'S)-9'-benzyl-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-2',5',8',11',14',17'-hexaoxo-15'-(pentanoylamino)spiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3'S,6'R,9'S,15'R,23'S)-9'-benzyl-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-2',5',8',11',14',17'-hexaoxo-15'-(pentanoylamino)spiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_114",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-1Nal-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73350149",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 405,
    "edge_id": "inferred_115",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73350149",
    "edge_subjectNode_name": "butanoyl-His-D-1Nal-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-1Nal-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-1Nal-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73350149",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 405,
    "edge_id": "psev_edge_115",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73350149",
    "edge_subjectNode_name": "butanoyl-His-D-1Nal-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-1Nal-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_115",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[6-[(1-ethylindazol-3-yl)methyl]-6-methoxy-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 406,
    "edge_id": "inferred_117",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228849",
    "edge_subjectNode_name": "2-[6-[(1-ethylindazol-3-yl)methyl]-6-methoxy-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-[6-[(1-ethylindazol-3-yl)methyl]-6-methoxy-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[6-[(1-ethylindazol-3-yl)methyl]-6-methoxy-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228849",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 406,
    "edge_id": "psev_edge_117",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228849",
    "edge_subjectNode_name": "2-[6-[(1-ethylindazol-3-yl)methyl]-6-methoxy-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-[6-[(1-ethylindazol-3-yl)methyl]-6-methoxy-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_117",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4R,7S,10S,13S,16S)-13-[(4-aminophenyl)methyl]-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44577516",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 407,
    "edge_id": "inferred_121",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44577516",
    "edge_subjectNode_name": "(4R,7S,10S,13S,16S)-13-[(4-aminophenyl)methyl]-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(4R,7S,10S,13S,16S)-13-[(4-aminophenyl)methyl]-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(4R,7S,10S,13S,16S)-13-[(4-aminophenyl)methyl]-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44577516",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 407,
    "edge_id": "psev_edge_121",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44577516",
    "edge_subjectNode_name": "(4R,7S,10S,13S,16S)-13-[(4-aminophenyl)methyl]-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(4R,7S,10S,13S,16S)-13-[(4-aminophenyl)methyl]-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-21-nitro-6,9,12,15,18-pentaoxo-2-thia-5,8,11,14,17-pentazabicyclo[17.4.0]tricosa-1(19),20,22-triene-4-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_121",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL198772",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL198772",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 408,
    "edge_id": "inferred_123",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL198772",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL198772",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL198772 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL198772",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL198772",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 408,
    "edge_id": "psev_edge_123",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL198772",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL198772",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL198772 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_123",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(4-Cl)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373177",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 409,
    "edge_id": "inferred_127",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373177",
    "edge_subjectNode_name": "butanoyl-His-Phe(4-Cl)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe(4-Cl)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(4-Cl)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373177",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 409,
    "edge_id": "psev_edge_127",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373177",
    "edge_subjectNode_name": "butanoyl-His-Phe(4-Cl)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe(4-Cl)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_127",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Lys(Me2)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317278",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 410,
    "edge_id": "inferred_130",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317278",
    "edge_subjectNode_name": "Bu-His-D-Phe-Lys(Me2)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-D-Phe-Lys(Me2)-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Lys(Me2)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317278",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 410,
    "edge_id": "psev_edge_130",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317278",
    "edge_subjectNode_name": "Bu-His-D-Phe-Lys(Me2)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-D-Phe-Lys(Me2)-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_130",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-2-Nal-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44405832",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 411,
    "edge_id": "inferred_131",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44405832",
    "edge_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-2-Nal-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Penta-5-BrAtc-DPhe-Arg-2-Nal-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-2-Nal-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44405832",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 411,
    "edge_id": "psev_edge_131",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44405832",
    "edge_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-2-Nal-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Penta-5-BrAtc-DPhe-Arg-2-Nal-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_131",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Pentanoylamino-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid ((R)-1-{(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethyl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354716",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 412,
    "edge_id": "inferred_135",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354716",
    "edge_subjectNode_name": "2-Pentanoylamino-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid ((R)-1-{(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethyl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-Pentanoylamino-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid ((R)-1-{(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethyl)-amide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-Pentanoylamino-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid ((R)-1-{(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethyl)-amide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354716",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 412,
    "edge_id": "psev_edge_135",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354716",
    "edge_subjectNode_name": "2-Pentanoylamino-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid ((R)-1-{(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethyl)-amide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-Pentanoylamino-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid ((R)-1-{(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethyl)-amide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_135",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Glu-His-D-Nal(2)''-N-alpha-guanidinylbutyl-Orn]-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417402",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 413,
    "edge_id": "inferred_136",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417402",
    "edge_subjectNode_name": "Ac-c[Glu-His-D-Nal(2)''-N-alpha-guanidinylbutyl-Orn]-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-c[Glu-His-D-Nal(2)''-N-alpha-guanidinylbutyl-Orn]-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Glu-His-D-Nal(2)''-N-alpha-guanidinylbutyl-Orn]-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417402",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 413,
    "edge_id": "psev_edge_136",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417402",
    "edge_subjectNode_name": "Ac-c[Glu-His-D-Nal(2)''-N-alpha-guanidinylbutyl-Orn]-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-c[Glu-His-D-Nal(2)''-N-alpha-guanidinylbutyl-Orn]-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_136",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401371",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 414,
    "edge_id": "inferred_137",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401371",
    "edge_subjectNode_name": "(2S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401371",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 414,
    "edge_id": "psev_edge_137",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401371",
    "edge_subjectNode_name": "(2S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_137",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-[2,4-Dioxo-3-(6-fluoro-1H-indazol-3-ylmethylene)-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-diazepin-1-yl]-N-isopropyl-N-phenylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228763",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 415,
    "edge_id": "inferred_139",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228763",
    "edge_subjectNode_name": "(S)-2-[2,4-Dioxo-3-(6-fluoro-1H-indazol-3-ylmethylene)-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-diazepin-1-yl]-N-isopropyl-N-phenylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-[2,4-Dioxo-3-(6-fluoro-1H-indazol-3-ylmethylene)-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-diazepin-1-yl]-N-isopropyl-N-phenylacetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-[2,4-Dioxo-3-(6-fluoro-1H-indazol-3-ylmethylene)-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-diazepin-1-yl]-N-isopropyl-N-phenylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228763",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 415,
    "edge_id": "psev_edge_139",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228763",
    "edge_subjectNode_name": "(S)-2-[2,4-Dioxo-3-(6-fluoro-1H-indazol-3-ylmethylene)-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-diazepin-1-yl]-N-isopropyl-N-phenylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-[2,4-Dioxo-3-(6-fluoro-1H-indazol-3-ylmethylene)-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-diazepin-1-yl]-N-isopropyl-N-phenylacetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_139",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10123761",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 416,
    "edge_id": "inferred_152",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10123761",
    "edge_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Penta-5-BrAtc-DPhe-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10123761",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 416,
    "edge_id": "psev_edge_152",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10123761",
    "edge_subjectNode_name": "Penta-5-BrAtc-DPhe-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Penta-5-BrAtc-DPhe-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_152",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-Ala-D-Phe-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278071",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 417,
    "edge_id": "inferred_153",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278071",
    "edge_subjectNode_name": "butanoyl-Ala-D-Phe-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-Ala-D-Phe-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-Ala-D-Phe-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278071",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 417,
    "edge_id": "psev_edge_153",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278071",
    "edge_subjectNode_name": "butanoyl-Ala-D-Phe-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-Ala-D-Phe-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_153",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[3-[6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-2-oxopropyl]-phenoxyphosphinic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228850",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 418,
    "edge_id": "inferred_157",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228850",
    "edge_subjectNode_name": "[3-[6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-2-oxopropyl]-phenoxyphosphinic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "[3-[6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-2-oxopropyl]-phenoxyphosphinic acid treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[3-[6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-2-oxopropyl]-phenoxyphosphinic acid",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228850",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 418,
    "edge_id": "psev_edge_157",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228850",
    "edge_subjectNode_name": "[3-[6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-2-oxopropyl]-phenoxyphosphinic acid",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "[3-[6-(2H-indazol-3-ylmethyl)-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-2-oxopropyl]-phenoxyphosphinic acid associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_157",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-[[(2S)-2-(butylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-N'-(diaminomethylidene)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317254",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 419,
    "edge_id": "inferred_161",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317254",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-[[(2S)-2-(butylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-N'-(diaminomethylidene)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-[[(2S)-2-(butylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-N'-(diaminomethylidene)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-[[(2S)-2-(butylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-N'-(diaminomethylidene)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317254",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 419,
    "edge_id": "psev_edge_161",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317254",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-[[(2S)-2-(butylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-N'-(diaminomethylidene)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-[[(2S)-2-(butylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-N'-(diaminomethylidene)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_161",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-(dimethylamino)-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10373417",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 420,
    "edge_id": "inferred_162",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10373417",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-(dimethylamino)-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-(dimethylamino)-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-(dimethylamino)-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:10373417",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 420,
    "edge_id": "psev_edge_162",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:10373417",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-(dimethylamino)-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-(dimethylamino)-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_162",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Ava)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413576",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 421,
    "edge_id": "inferred_164",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413576",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Ava)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c(his-D-phe-arg-trp-Ava) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Ava)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413576",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 421,
    "edge_id": "psev_edge_164",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413576",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Ava)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c(his-D-phe-arg-trp-Ava) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_164",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-Gln-D-Phe-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73348170",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 422,
    "edge_id": "inferred_168",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73348170",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-Gln-D-Phe-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Nle-Asp(1)-Gln-D-Phe-Arg-Trp-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Nle-Asp(1)-Gln-D-Phe-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73348170",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 422,
    "edge_id": "psev_edge_168",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73348170",
    "edge_subjectNode_name": "Ac-Nle-Asp(1)-Gln-D-Phe-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Nle-Asp(1)-Gln-D-Phe-Arg-Trp-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_168",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Tyr(Me)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373197",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 423,
    "edge_id": "inferred_174",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373197",
    "edge_subjectNode_name": "butanoyl-His-Tyr(Me)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Tyr(Me)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Tyr(Me)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373197",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 423,
    "edge_id": "psev_edge_174",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373197",
    "edge_subjectNode_name": "butanoyl-His-Tyr(Me)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Tyr(Me)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_174",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(4-Br)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373198",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 424,
    "edge_id": "inferred_177",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373198",
    "edge_subjectNode_name": "butanoyl-His-Phe(4-Br)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe(4-Br)-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe(4-Br)-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44373198",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 424,
    "edge_id": "psev_edge_177",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44373198",
    "edge_subjectNode_name": "butanoyl-His-Phe(4-Br)-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe(4-Br)-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_177",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pentanoyl-D-Asp(1)-D-Phe(4-CF3)-Phe-D-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275656",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 425,
    "edge_id": "inferred_178",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275656",
    "edge_subjectNode_name": "pentanoyl-D-Asp(1)-D-Phe(4-CF3)-Phe-D-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "pentanoyl-D-Asp(1)-D-Phe(4-CF3)-Phe-D-Arg-Trp-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pentanoyl-D-Asp(1)-D-Phe(4-CF3)-Phe-D-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275656",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 425,
    "edge_id": "psev_edge_178",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275656",
    "edge_subjectNode_name": "pentanoyl-D-Asp(1)-D-Phe(4-CF3)-Phe-D-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "pentanoyl-D-Asp(1)-D-Phe(4-CF3)-Phe-D-Arg-Trp-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_178",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Glu-His-D-Phe-N-alpha-guanidinylbutyl-Dab]-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417553",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 426,
    "edge_id": "inferred_185",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417553",
    "edge_subjectNode_name": "Ac-c[Glu-His-D-Phe-N-alpha-guanidinylbutyl-Dab]-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-c[Glu-His-D-Phe-N-alpha-guanidinylbutyl-Dab]-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Glu-His-D-Phe-N-alpha-guanidinylbutyl-Dab]-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417553",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 426,
    "edge_id": "psev_edge_185",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417553",
    "edge_subjectNode_name": "Ac-c[Glu-His-D-Phe-N-alpha-guanidinylbutyl-Dab]-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-c[Glu-His-D-Phe-N-alpha-guanidinylbutyl-Dab]-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_185",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-2Thi-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71458041",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 427,
    "edge_id": "inferred_187",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71458041",
    "edge_subjectNode_name": "butanoyl-His-D-2Thi-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-2Thi-Arg-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-2Thi-Arg-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:71458041",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 427,
    "edge_id": "psev_edge_187",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:71458041",
    "edge_subjectNode_name": "butanoyl-His-D-2Thi-Arg-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-2Thi-Arg-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_187",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[2-[(1S)-1'-[(3R,4S)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46884748",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 428,
    "edge_id": "inferred_195",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46884748",
    "edge_subjectNode_name": "N-[2-[(1S)-1'-[(3R,4S)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[2-[(1S)-1'-[(3R,4S)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[2-[(1S)-1'-[(3R,4S)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46884748",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 428,
    "edge_id": "psev_edge_195",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46884748",
    "edge_subjectNode_name": "N-[2-[(1S)-1'-[(3R,4S)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[2-[(1S)-1'-[(3R,4S)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carbonyl]-5-chloro-6-methylspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]propan-2-yl]acetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_195",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Orn(diMe)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317070",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 429,
    "edge_id": "inferred_197",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317070",
    "edge_subjectNode_name": "Bu-His-D-Phe-Orn(diMe)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-D-Phe-Orn(diMe)-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Orn(diMe)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317070",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 429,
    "edge_id": "psev_edge_197",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317070",
    "edge_subjectNode_name": "Bu-His-D-Phe-Orn(diMe)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-D-Phe-Orn(diMe)-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_197",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3R)-N-[(2R)-3-(4-methoxyphenyl)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44269245",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 430,
    "edge_id": "inferred_198",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44269245",
    "edge_subjectNode_name": "(3R)-N-[(2R)-3-(4-methoxyphenyl)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3R)-N-[(2R)-3-(4-methoxyphenyl)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3R)-N-[(2R)-3-(4-methoxyphenyl)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44269245",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 430,
    "edge_id": "psev_edge_198",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44269245",
    "edge_subjectNode_name": "(3R)-N-[(2R)-3-(4-methoxyphenyl)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3R)-N-[(2R)-3-(4-methoxyphenyl)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxopropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_198",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(6-benzyl-4-cyclohexyl-5,7-dioxo-1,4-diazepin-1-yl)-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228841",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 431,
    "edge_id": "inferred_208",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228841",
    "edge_subjectNode_name": "2-(6-benzyl-4-cyclohexyl-5,7-dioxo-1,4-diazepin-1-yl)-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-(6-benzyl-4-cyclohexyl-5,7-dioxo-1,4-diazepin-1-yl)-N-(4-methoxyphenyl)-N-propan-2-ylacetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-(6-benzyl-4-cyclohexyl-5,7-dioxo-1,4-diazepin-1-yl)-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228841",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 431,
    "edge_id": "psev_edge_208",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228841",
    "edge_subjectNode_name": "2-(6-benzyl-4-cyclohexyl-5,7-dioxo-1,4-diazepin-1-yl)-N-(4-methoxyphenyl)-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-(6-benzyl-4-cyclohexyl-5,7-dioxo-1,4-diazepin-1-yl)-N-(4-methoxyphenyl)-N-propan-2-ylacetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_208",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-4-benzoyl-N-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401275",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 432,
    "edge_id": "inferred_210",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401275",
    "edge_subjectNode_name": "(2S)-4-benzoyl-N-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-4-benzoyl-N-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-4-benzoyl-N-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401275",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 432,
    "edge_id": "psev_edge_210",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401275",
    "edge_subjectNode_name": "(2S)-4-benzoyl-N-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-4-benzoyl-N-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]piperazine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_210",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(3-diphenoxyphosphoryl-2-oxopropyl)-6-(2H-indazol-3-ylmethyl)-4-phenyl-1,4-diazepine-5,7-dione",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228847",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 433,
    "edge_id": "inferred_220",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228847",
    "edge_subjectNode_name": "1-(3-diphenoxyphosphoryl-2-oxopropyl)-6-(2H-indazol-3-ylmethyl)-4-phenyl-1,4-diazepine-5,7-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(3-diphenoxyphosphoryl-2-oxopropyl)-6-(2H-indazol-3-ylmethyl)-4-phenyl-1,4-diazepine-5,7-dione treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(3-diphenoxyphosphoryl-2-oxopropyl)-6-(2H-indazol-3-ylmethyl)-4-phenyl-1,4-diazepine-5,7-dione",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228847",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 433,
    "edge_id": "psev_edge_220",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228847",
    "edge_subjectNode_name": "1-(3-diphenoxyphosphoryl-2-oxopropyl)-6-(2H-indazol-3-ylmethyl)-4-phenyl-1,4-diazepine-5,7-dione",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "1-(3-diphenoxyphosphoryl-2-oxopropyl)-6-(2H-indazol-3-ylmethyl)-4-phenyl-1,4-diazepine-5,7-dione associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_220",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Orn-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317279",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 434,
    "edge_id": "inferred_222",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317279",
    "edge_subjectNode_name": "Bu-His-D-Phe-Orn-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-D-Phe-Orn-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Orn-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317279",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 434,
    "edge_id": "psev_edge_222",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317279",
    "edge_subjectNode_name": "Bu-His-D-Phe-Orn-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-D-Phe-Orn-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_222",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL199037",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL199037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 435,
    "edge_id": "inferred_223",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL199037",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL199037",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL199037 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL199037",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL199037",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 435,
    "edge_id": "psev_edge_223",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL199037",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL199037",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL199037 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_223",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-1Nal-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73351850",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 436,
    "edge_id": "inferred_231",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73351850",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-1Nal-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-D-Phe-Arg-1Nal-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-D-Phe-Arg-1Nal-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73351850",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 436,
    "edge_id": "psev_edge_231",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73351850",
    "edge_subjectNode_name": "butanoyl-His-D-Phe-Arg-1Nal-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-D-Phe-Arg-1Nal-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_231",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL382511",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL382511",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 437,
    "edge_id": "inferred_232",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL382511",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL382511",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL382511 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL382511",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL382511",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 437,
    "edge_id": "psev_edge_232",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL382511",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL382511",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL382511 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_232",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pentanoyl-Asp(1)-Tic-D-Phe-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73348634",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 438,
    "edge_id": "inferred_234",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73348634",
    "edge_subjectNode_name": "pentanoyl-Asp(1)-Tic-D-Phe-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "pentanoyl-Asp(1)-Tic-D-Phe-Arg-Trp-Lys(1)-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pentanoyl-Asp(1)-Tic-D-Phe-Arg-Trp-Lys(1)-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73348634",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 438,
    "edge_id": "psev_edge_234",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73348634",
    "edge_subjectNode_name": "pentanoyl-Asp(1)-Tic-D-Phe-Arg-Trp-Lys(1)-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "pentanoyl-Asp(1)-Tic-D-Phe-Arg-Trp-Lys(1)-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_234",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277300",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 439,
    "edge_id": "inferred_237",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277300",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44277300",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 439,
    "edge_id": "psev_edge_237",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44277300",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methoxy-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_237",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethyl-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73347130",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 440,
    "edge_id": "inferred_241",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73347130",
    "edge_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethyl-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethyl-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethyl-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73347130",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 440,
    "edge_id": "psev_edge_241",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73347130",
    "edge_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethyl-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-8'-ethyl-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_241",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Ahp)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413536",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 441,
    "edge_id": "inferred_243",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413536",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Ahp)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c(his-D-phe-arg-trp-Ahp) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Ahp)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413536",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 441,
    "edge_id": "psev_edge_243",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413536",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Ahp)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c(his-D-phe-arg-trp-Ahp) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_243",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 442,
    "edge_id": "inferred_244",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317241",
    "edge_subjectNode_name": "Bu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317241",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 442,
    "edge_id": "psev_edge_244",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317241",
    "edge_subjectNode_name": "Bu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His(6)-Phe(7)-Arg(8)-Trp(9)-Gly(10)-NH(2) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_244",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 443,
    "edge_id": "inferred_246",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401462",
    "edge_subjectNode_name": "(2S,4S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401462",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 443,
    "edge_id": "psev_edge_246",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401462",
    "edge_subjectNode_name": "(2S,4S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4S)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_246",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yl-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278193",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 444,
    "edge_id": "inferred_248",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278193",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yl-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yl-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yl-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278193",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 444,
    "edge_id": "psev_edge_248",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278193",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yl-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(pentanoylamino)-5-propan-2-yl-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_248",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-8'-chloro-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275263",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 445,
    "edge_id": "inferred_250",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275263",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-8'-chloro-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-8'-chloro-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-8'-chloro-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44275263",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 445,
    "edge_id": "psev_edge_250",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44275263",
    "edge_subjectNode_name": "(3S,6R,9S,15R,23S)-9-benzyl-8'-chloro-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6R,9S,15R,23S)-9-benzyl-8'-chloro-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_250",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,11S,14S,17S,20R,23S)-20-benzyl-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-2,5,13,16,19,22-hexaoxo-3-(pentanoylamino)-1,6,12,15,18,21-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-11-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73347133",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 446,
    "edge_id": "inferred_252",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73347133",
    "edge_subjectNode_name": "(3S,11S,14S,17S,20R,23S)-20-benzyl-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-2,5,13,16,19,22-hexaoxo-3-(pentanoylamino)-1,6,12,15,18,21-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-11-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,11S,14S,17S,20R,23S)-20-benzyl-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-2,5,13,16,19,22-hexaoxo-3-(pentanoylamino)-1,6,12,15,18,21-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-11-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,11S,14S,17S,20R,23S)-20-benzyl-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-2,5,13,16,19,22-hexaoxo-3-(pentanoylamino)-1,6,12,15,18,21-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-11-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73347133",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 446,
    "edge_id": "psev_edge_252",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73347133",
    "edge_subjectNode_name": "(3S,11S,14S,17S,20R,23S)-20-benzyl-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-2,5,13,16,19,22-hexaoxo-3-(pentanoylamino)-1,6,12,15,18,21-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-11-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,11S,14S,17S,20R,23S)-20-benzyl-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-2,5,13,16,19,22-hexaoxo-3-(pentanoylamino)-1,6,12,15,18,21-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-11-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_252",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354704",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 447,
    "edge_id": "inferred_263",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354704",
    "edge_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73354704",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 447,
    "edge_id": "psev_edge_263",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73354704",
    "edge_subjectNode_name": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3S,6S,9R,12S,15S,23S)-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-(pentanoylamino)spiro[1,4,7,10,13,18-hexazacyclotricosane-12,3'-2,4-dihydro-1H-naphthalene]-23-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_263",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Lys(Bn)(Bn)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317277",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 448,
    "edge_id": "inferred_266",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317277",
    "edge_subjectNode_name": "Bu-His-D-Phe-Lys(Bn)(Bn)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Bu-His-D-Phe-Lys(Bn)(Bn)-Trp-Gly-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Bu-His-D-Phe-Lys(Bn)(Bn)-Trp-Gly-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317277",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 448,
    "edge_id": "psev_edge_266",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317277",
    "edge_subjectNode_name": "Bu-His-D-Phe-Lys(Bn)(Bn)-Trp-Gly-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Bu-His-D-Phe-Lys(Bn)(Bn)-Trp-Gly-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_266",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(4-methoxyphenyl)-2-[6-[(1-methylindazol-3-yl)methyl]-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228848",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 449,
    "edge_id": "inferred_273",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228848",
    "edge_subjectNode_name": "N-(4-methoxyphenyl)-2-[6-[(1-methylindazol-3-yl)methyl]-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-(4-methoxyphenyl)-2-[6-[(1-methylindazol-3-yl)methyl]-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-propan-2-ylacetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-(4-methoxyphenyl)-2-[6-[(1-methylindazol-3-yl)methyl]-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-propan-2-ylacetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:46228848",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 449,
    "edge_id": "psev_edge_273",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:46228848",
    "edge_subjectNode_name": "N-(4-methoxyphenyl)-2-[6-[(1-methylindazol-3-yl)methyl]-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-propan-2-ylacetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-(4-methoxyphenyl)-2-[6-[(1-methylindazol-3-yl)methyl]-5,7-dioxo-4-phenyl-1,4-diazepin-1-yl]-N-propan-2-ylacetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_273",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278195",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 450,
    "edge_id": "inferred_275",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278195",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44278195",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 450,
    "edge_id": "psev_edge_275",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44278195",
    "edge_subjectNode_name": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-5-methyl-2-(pentanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_275",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Ahx)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413537",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 451,
    "edge_id": "inferred_276",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413537",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Ahx)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "c(his-D-phe-arg-trp-Ahx) treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "c(his-D-phe-arg-trp-Ahx)",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413537",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 451,
    "edge_id": "psev_edge_276",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413537",
    "edge_subjectNode_name": "c(his-D-phe-arg-trp-Ahx)",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "c(his-D-phe-arg-trp-Ahx) associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_276",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(butanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73353216",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 452,
    "edge_id": "inferred_277",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73353216",
    "edge_subjectNode_name": "(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(butanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(butanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(butanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:73353216",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 452,
    "edge_id": "psev_edge_277",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:73353216",
    "edge_subjectNode_name": "(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(butanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2R)-1-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-(butanoylamino)-3,4-dihydro-1H-naphthalene-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_277",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-Butylamino-N-{(R)-1-[(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-3-(3H-imidazol-4-yl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317053",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 453,
    "edge_id": "inferred_280",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317053",
    "edge_subjectNode_name": "(S)-2-Butylamino-N-{(R)-1-[(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-3-(3H-imidazol-4-yl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-Butylamino-N-{(R)-1-[(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-3-(3H-imidazol-4-yl)-propionamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-Butylamino-N-{(R)-1-[(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-3-(3H-imidazol-4-yl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44317053",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 453,
    "edge_id": "psev_edge_280",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44317053",
    "edge_subjectNode_name": "(S)-2-Butylamino-N-{(R)-1-[(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-3-(3H-imidazol-4-yl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-Butylamino-N-{(R)-1-[(S)-1-[(S)-1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-2-(3H-imidazol-4-yl)-ethylcarbamoyl]-2-phenyl-ethyl}-3-(3H-imidazol-4-yl)-propionamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_280",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413831",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 454,
    "edge_id": "inferred_1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413831",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413831",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 454,
    "edge_id": "psev_edge_1",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413831",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_1",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "PhNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394788",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 455,
    "edge_id": "inferred_13",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394788",
    "edge_subjectNode_name": "PhNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "PhNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "PhNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394788",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 455,
    "edge_id": "psev_edge_13",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394788",
    "edge_subjectNode_name": "PhNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "PhNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_13",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(4-fluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394785",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 456,
    "edge_id": "inferred_14",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394785",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(4-fluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(4-fluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(4-fluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394785",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 456,
    "edge_id": "psev_edge_14",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394785",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(4-fluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(4-fluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_14",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(CN)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394659",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 457,
    "edge_id": "inferred_15",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394659",
    "edge_subjectNode_name": "deamino-Gly(CN)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "deamino-Gly(CN)-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(CN)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394659",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 457,
    "edge_id": "psev_edge_15",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394659",
    "edge_subjectNode_name": "deamino-Gly(CN)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "deamino-Gly(CN)-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_15",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394654",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 458,
    "edge_id": "inferred_17",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394654",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394654",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 458,
    "edge_id": "psev_edge_17",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394654",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_17",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-oxalamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322977",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 459,
    "edge_id": "inferred_20",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322977",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-oxalamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-oxalamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-oxalamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322977",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 459,
    "edge_id": "psev_edge_20",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322977",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-oxalamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-oxalamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_20",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "propionyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394626",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 460,
    "edge_id": "inferred_21",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394626",
    "edge_subjectNode_name": "propionyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "propionyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "propionyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394626",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 460,
    "edge_id": "psev_edge_21",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394626",
    "edge_subjectNode_name": "propionyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "propionyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_21",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-His-D-Phe-Arg-2-Nal-NHCH3",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413876",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 461,
    "edge_id": "inferred_24",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413876",
    "edge_subjectNode_name": "Ac-His-D-Phe-Arg-2-Nal-NHCH3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-His-D-Phe-Arg-2-Nal-NHCH3 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-His-D-Phe-Arg-2-Nal-NHCH3",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413876",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 461,
    "edge_id": "psev_edge_24",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413876",
    "edge_subjectNode_name": "Ac-His-D-Phe-Arg-2-Nal-NHCH3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-His-D-Phe-Arg-2-Nal-NHCH3 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_24",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413832",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 462,
    "edge_id": "inferred_25",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413832",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413832",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 462,
    "edge_id": "psev_edge_25",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413832",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_25",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-isonicotinamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394692",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 463,
    "edge_id": "inferred_26",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394692",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-isonicotinamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-isonicotinamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-isonicotinamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394692",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 463,
    "edge_id": "psev_edge_26",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394692",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-isonicotinamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-isonicotinamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_26",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-2-[[2-(2-chlorophenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401581",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 464,
    "edge_id": "inferred_29",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401581",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-2-[[2-(2-chlorophenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-2-[[2-(2-chlorophenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-2-[[2-(2-chlorophenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401581",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 464,
    "edge_id": "psev_edge_29",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401581",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-2-[[2-(2-chlorophenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-2-[[2-(2-chlorophenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_29",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413913",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 465,
    "edge_id": "inferred_31",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413913",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413913",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 465,
    "edge_id": "psev_edge_31",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413913",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_31",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1090161",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1090161",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 466,
    "edge_id": "inferred_32",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1090161",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1090161",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL1090161 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1090161",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1090161",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 466,
    "edge_id": "psev_edge_32",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1090161",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1090161",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL1090161 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_32",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid propionyl ester",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394656",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 467,
    "edge_id": "inferred_36",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394656",
    "edge_subjectNode_name": "[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid propionyl ester",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid propionyl ester treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid propionyl ester",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394656",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 467,
    "edge_id": "psev_edge_36",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394656",
    "edge_subjectNode_name": "[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid propionyl ester",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid propionyl ester associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_36",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylbenzoyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401341",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 468,
    "edge_id": "inferred_39",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401341",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylbenzoyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylbenzoyl)amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylbenzoyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401341",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 468,
    "edge_id": "psev_edge_39",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401341",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylbenzoyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylbenzoyl)amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_39",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "benzylcarbonyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394693",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 469,
    "edge_id": "inferred_42",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394693",
    "edge_subjectNode_name": "benzylcarbonyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "benzylcarbonyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "benzylcarbonyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394693",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 469,
    "edge_id": "psev_edge_42",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394693",
    "edge_subjectNode_name": "benzylcarbonyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "benzylcarbonyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_42",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11846669",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 470,
    "edge_id": "inferred_45",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11846669",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11846669",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 470,
    "edge_id": "psev_edge_45",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11846669",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_45",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(3,5-difluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394786",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 471,
    "edge_id": "inferred_46",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394786",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(3,5-difluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(3,5-difluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(3,5-difluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394786",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 471,
    "edge_id": "psev_edge_46",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394786",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(3,5-difluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[[4-(3,5-difluorophenyl)-4-oxobutanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_46",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "MeOAc-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322994",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 472,
    "edge_id": "inferred_47",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322994",
    "edge_subjectNode_name": "MeOAc-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "MeOAc-His-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "MeOAc-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322994",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 472,
    "edge_id": "psev_edge_47",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322994",
    "edge_subjectNode_name": "MeOAc-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "MeOAc-His-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_47",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe(4-F)-Arg-piperidide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44453850",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 473,
    "edge_id": "inferred_49",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44453850",
    "edge_subjectNode_name": "H-D-Phe(4-F)-Arg-piperidide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "H-D-Phe(4-F)-Arg-piperidide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "H-D-Phe(4-F)-Arg-piperidide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44453850",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 473,
    "edge_id": "psev_edge_49",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44453850",
    "edge_subjectNode_name": "H-D-Phe(4-F)-Arg-piperidide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "H-D-Phe(4-F)-Arg-piperidide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_49",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(OH)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394657",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 474,
    "edge_id": "inferred_50",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394657",
    "edge_subjectNode_name": "deamino-Gly(OH)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "deamino-Gly(OH)-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(OH)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394657",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 474,
    "edge_id": "psev_edge_50",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394657",
    "edge_subjectNode_name": "deamino-Gly(OH)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "deamino-Gly(OH)-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_50",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415913",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 475,
    "edge_id": "inferred_51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415913",
    "edge_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415913",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 475,
    "edge_id": "psev_edge_51",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415913",
    "edge_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(3H-imidazol-4-yl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_51",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Cys-His-D-Phe-Cys]-N-alpha-guanidinylbutyl-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417551",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 476,
    "edge_id": "inferred_52",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417551",
    "edge_subjectNode_name": "Ac-c[Cys-His-D-Phe-Cys]-N-alpha-guanidinylbutyl-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-c[Cys-His-D-Phe-Cys]-N-alpha-guanidinylbutyl-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-c[Cys-His-D-Phe-Cys]-N-alpha-guanidinylbutyl-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44417551",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 476,
    "edge_id": "psev_edge_52",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44417551",
    "edge_subjectNode_name": "Ac-c[Cys-His-D-Phe-Cys]-N-alpha-guanidinylbutyl-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-c[Cys-His-D-Phe-Cys]-N-alpha-guanidinylbutyl-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_52",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Me2NCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394732",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 477,
    "edge_id": "inferred_53",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394732",
    "edge_subjectNode_name": "Me2NCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Me2NCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Me2NCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394732",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 477,
    "edge_id": "psev_edge_53",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394732",
    "edge_subjectNode_name": "Me2NCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Me2NCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_53",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44323015",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 478,
    "edge_id": "inferred_56",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44323015",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44323015",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 478,
    "edge_id": "psev_edge_56",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44323015",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylsulfanylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_56",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413914",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 479,
    "edge_id": "inferred_58",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413914",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413914",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 479,
    "edge_id": "psev_edge_58",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413914",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_58",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-NATEGLINIDE",
    "result_subjectNode_id": "UNII:E9V3S85RHY",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 480,
    "edge_id": "inferred_61",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:E9V3S85RHY",
    "edge_subjectNode_name": "(S)-NATEGLINIDE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-NATEGLINIDE treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-NATEGLINIDE",
    "result_subjectNode_id": "UNII:E9V3S85RHY",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 480,
    "edge_id": "psev_edge_61",
    "edge_object": "MONDO:0015129",
    "edge_subject": "UNII:E9V3S85RHY",
    "edge_subjectNode_name": "(S)-NATEGLINIDE",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-NATEGLINIDE associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_61",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pivaloyl-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322958",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 481,
    "edge_id": "inferred_73",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322958",
    "edge_subjectNode_name": "pivaloyl-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "pivaloyl-His-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pivaloyl-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322958",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 481,
    "edge_id": "psev_edge_73",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322958",
    "edge_subjectNode_name": "pivaloyl-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "pivaloyl-His-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_73",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(3-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)propyl)urea",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416122",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 482,
    "edge_id": "inferred_74",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416122",
    "edge_subjectNode_name": "1-(3-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)propyl)urea",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(3-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)propyl)urea treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(3-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)propyl)urea",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416122",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 482,
    "edge_id": "psev_edge_74",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416122",
    "edge_subjectNode_name": "1-(3-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)propyl)urea",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "1-(3-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)propyl)urea associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_74",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413830",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 483,
    "edge_id": "inferred_79",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413830",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413830",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 483,
    "edge_id": "psev_edge_79",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413830",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_79",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401418",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 484,
    "edge_id": "inferred_83",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401418",
    "edge_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401418",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 484,
    "edge_id": "psev_edge_83",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401418",
    "edge_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(2-phenylethyl)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_83",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-His-Phe-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394622",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 485,
    "edge_id": "inferred_86",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394622",
    "edge_subjectNode_name": "Ac-His-Phe-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-His-Phe-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-His-Phe-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394622",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 485,
    "edge_id": "psev_edge_86",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394622",
    "edge_subjectNode_name": "Ac-His-Phe-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-His-Phe-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_86",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mes-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394789",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 486,
    "edge_id": "inferred_87",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394789",
    "edge_subjectNode_name": "Mes-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Mes-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Mes-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394789",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 486,
    "edge_id": "psev_edge_87",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394789",
    "edge_subjectNode_name": "Mes-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Mes-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_87",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394627",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 487,
    "edge_id": "inferred_89",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394627",
    "edge_subjectNode_name": "butanoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394627",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 487,
    "edge_id": "psev_edge_89",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394627",
    "edge_subjectNode_name": "butanoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_89",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394624",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 488,
    "edge_id": "inferred_90",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394624",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394624",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 488,
    "edge_id": "psev_edge_90",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394624",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_90",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409240",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 489,
    "edge_id": "inferred_92",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409240",
    "edge_subjectNode_name": "Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409240",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 489,
    "edge_id": "psev_edge_92",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409240",
    "edge_subjectNode_name": "Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_92",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3R)-N-[(2R)-1-[(2S,4R)-2-[3-(diaminomethylideneamino)propyl]-4-phenylmethoxypyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409104",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 490,
    "edge_id": "inferred_94",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409104",
    "edge_subjectNode_name": "(3R)-N-[(2R)-1-[(2S,4R)-2-[3-(diaminomethylideneamino)propyl]-4-phenylmethoxypyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(3R)-N-[(2R)-1-[(2S,4R)-2-[3-(diaminomethylideneamino)propyl]-4-phenylmethoxypyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(3R)-N-[(2R)-1-[(2S,4R)-2-[3-(diaminomethylideneamino)propyl]-4-phenylmethoxypyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409104",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 490,
    "edge_id": "psev_edge_94",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409104",
    "edge_subjectNode_name": "(3R)-N-[(2R)-1-[(2S,4R)-2-[3-(diaminomethylideneamino)propyl]-4-phenylmethoxypyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(3R)-N-[(2R)-1-[(2S,4R)-2-[3-(diaminomethylideneamino)propyl]-4-phenylmethoxypyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_94",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413932",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 491,
    "edge_id": "inferred_95",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413932",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413932",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 491,
    "edge_id": "psev_edge_95",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413932",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_95",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[3-[(2S,4R)-1-[(2R)-2-benzyl-4-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]-4-phenylmethoxypyrrolidin-2-yl]propyl]guanidine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409206",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 492,
    "edge_id": "inferred_96",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409206",
    "edge_subjectNode_name": "2-[3-[(2S,4R)-1-[(2R)-2-benzyl-4-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]-4-phenylmethoxypyrrolidin-2-yl]propyl]guanidine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "2-[3-[(2S,4R)-1-[(2R)-2-benzyl-4-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]-4-phenylmethoxypyrrolidin-2-yl]propyl]guanidine treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "2-[3-[(2S,4R)-1-[(2R)-2-benzyl-4-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]-4-phenylmethoxypyrrolidin-2-yl]propyl]guanidine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409206",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 492,
    "edge_id": "psev_edge_96",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409206",
    "edge_subjectNode_name": "2-[3-[(2S,4R)-1-[(2R)-2-benzyl-4-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]-4-phenylmethoxypyrrolidin-2-yl]propyl]guanidine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "2-[3-[(2S,4R)-1-[(2R)-2-benzyl-4-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]-4-phenylmethoxypyrrolidin-2-yl]propyl]guanidine associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_96",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "isobutyryl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394580",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 493,
    "edge_id": "inferred_98",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394580",
    "edge_subjectNode_name": "isobutyryl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "isobutyryl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "isobutyryl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394580",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 493,
    "edge_id": "psev_edge_98",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394580",
    "edge_subjectNode_name": "isobutyryl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "isobutyryl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_98",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-5-(diaminomethylideneamino)-N-[3-(diaminomethylideneamino)propyl]-2-(naphthalen-2-ylmethylamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44265751",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 494,
    "edge_id": "inferred_99",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44265751",
    "edge_subjectNode_name": "(2S)-5-(diaminomethylideneamino)-N-[3-(diaminomethylideneamino)propyl]-2-(naphthalen-2-ylmethylamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-5-(diaminomethylideneamino)-N-[3-(diaminomethylideneamino)propyl]-2-(naphthalen-2-ylmethylamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-5-(diaminomethylideneamino)-N-[3-(diaminomethylideneamino)propyl]-2-(naphthalen-2-ylmethylamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44265751",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 494,
    "edge_id": "psev_edge_99",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44265751",
    "edge_subjectNode_name": "(2S)-5-(diaminomethylideneamino)-N-[3-(diaminomethylideneamino)propyl]-2-(naphthalen-2-ylmethylamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-5-(diaminomethylideneamino)-N-[3-(diaminomethylideneamino)propyl]-2-(naphthalen-2-ylmethylamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_99",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "MeNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394731",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 495,
    "edge_id": "inferred_100",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394731",
    "edge_subjectNode_name": "MeNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "MeNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "MeNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394731",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 495,
    "edge_id": "psev_edge_100",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394731",
    "edge_subjectNode_name": "MeNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "MeNHCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_100",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-1-[(2S)-2-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N,4-dibenzylpyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401513",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 496,
    "edge_id": "inferred_101",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401513",
    "edge_subjectNode_name": "(2S,4R)-1-[(2S)-2-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N,4-dibenzylpyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-1-[(2S)-2-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N,4-dibenzylpyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-1-[(2S)-2-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N,4-dibenzylpyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401513",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 496,
    "edge_id": "psev_edge_101",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401513",
    "edge_subjectNode_name": "(2S,4R)-1-[(2S)-2-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N,4-dibenzylpyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-1-[(2S)-2-[[2-(1,3-benzodioxol-5-yl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N,4-dibenzylpyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_101",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413842",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 497,
    "edge_id": "inferred_102",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413842",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413842",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 497,
    "edge_id": "psev_edge_102",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413842",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_102",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(vinyl)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394585",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 498,
    "edge_id": "inferred_103",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394585",
    "edge_subjectNode_name": "deamino-Gly(vinyl)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "deamino-Gly(vinyl)-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(vinyl)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394585",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 498,
    "edge_id": "psev_edge_103",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394585",
    "edge_subjectNode_name": "deamino-Gly(vinyl)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "deamino-Gly(vinyl)-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_103",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid ethyl ester",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394655",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 499,
    "edge_id": "inferred_104",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394655",
    "edge_subjectNode_name": "[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid ethyl ester",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid ethyl ester treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid ethyl ester",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394655",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 499,
    "edge_id": "psev_edge_104",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394655",
    "edge_subjectNode_name": "[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid ethyl ester",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-carbamic acid ethyl ester associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_104",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11846844",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 500,
    "edge_id": "inferred_108",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11846844",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11846844",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 500,
    "edge_id": "psev_edge_108",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11846844",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_108",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413829",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 501,
    "edge_id": "inferred_109",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413829",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413829",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 501,
    "edge_id": "psev_edge_109",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413829",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_109",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-2,3,4,5,6-pentafluoro-benzamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394093",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 502,
    "edge_id": "inferred_112",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394093",
    "edge_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-2,3,4,5,6-pentafluoro-benzamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-2,3,4,5,6-pentafluoro-benzamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-2,3,4,5,6-pentafluoro-benzamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394093",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 502,
    "edge_id": "psev_edge_112",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394093",
    "edge_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-2,3,4,5,6-pentafluoro-benzamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-2,3,4,5,6-pentafluoro-benzamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_112",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-phenylpropanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:16007263",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 503,
    "edge_id": "inferred_118",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:16007263",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-phenylpropanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-phenylpropanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-phenylpropanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:16007263",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 503,
    "edge_id": "psev_edge_118",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:16007263",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-phenylpropanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-phenylpropanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_118",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "For-Gly-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394730",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 504,
    "edge_id": "inferred_119",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394730",
    "edge_subjectNode_name": "For-Gly-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "For-Gly-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "For-Gly-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394730",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 504,
    "edge_id": "psev_edge_119",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394730",
    "edge_subjectNode_name": "For-Gly-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "For-Gly-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_119",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(2-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)ethyl)urea",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416014",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 505,
    "edge_id": "inferred_122",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416014",
    "edge_subjectNode_name": "1-(2-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)ethyl)urea",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(2-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)ethyl)urea treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(2-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)ethyl)urea",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416014",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 505,
    "edge_id": "psev_edge_122",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416014",
    "edge_subjectNode_name": "1-(2-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)ethyl)urea",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "1-(2-((S)-1-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-2-yl)ethyl)urea associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_122",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(OH)-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322924",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 506,
    "edge_id": "inferred_126",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322924",
    "edge_subjectNode_name": "deamino-Gly(OH)-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "deamino-Gly(OH)-His-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Gly(OH)-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322924",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 506,
    "edge_id": "psev_edge_126",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322924",
    "edge_subjectNode_name": "deamino-Gly(OH)-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "deamino-Gly(OH)-His-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_126",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(3-phenylpropyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401607",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 507,
    "edge_id": "inferred_128",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401607",
    "edge_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(3-phenylpropyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(3-phenylpropyl)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(3-phenylpropyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401607",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 507,
    "edge_id": "psev_edge_128",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401607",
    "edge_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(3-phenylpropyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-(3-phenylpropyl)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_128",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-Acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845450",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 508,
    "edge_id": "inferred_129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845450",
    "edge_subjectNode_name": "(S)-2-Acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-Acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-Acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845450",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 508,
    "edge_id": "psev_edge_129",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845450",
    "edge_subjectNode_name": "(S)-2-Acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-Acetamido-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_129",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tf-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394748",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 509,
    "edge_id": "inferred_132",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394748",
    "edge_subjectNode_name": "Tf-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tf-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tf-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394748",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 509,
    "edge_id": "psev_edge_132",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394748",
    "edge_subjectNode_name": "Tf-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Tf-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_132",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416057",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 510,
    "edge_id": "inferred_134",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416057",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N1-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416057",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 510,
    "edge_id": "psev_edge_134",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416057",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N1-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_134",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845444",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 511,
    "edge_id": "inferred_141",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845444",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845444",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 511,
    "edge_id": "psev_edge_141",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845444",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_141",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-Benzyl-1-[(S)-5-guanidino-2-(2-naphthalen-1-yl-acetylamino)-pentanoyl]-pyrrolidine-2-carboxylic acid 4-methoxy-benzylamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401553",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 512,
    "edge_id": "inferred_142",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401553",
    "edge_subjectNode_name": "(2S,4R)-4-Benzyl-1-[(S)-5-guanidino-2-(2-naphthalen-1-yl-acetylamino)-pentanoyl]-pyrrolidine-2-carboxylic acid 4-methoxy-benzylamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-4-Benzyl-1-[(S)-5-guanidino-2-(2-naphthalen-1-yl-acetylamino)-pentanoyl]-pyrrolidine-2-carboxylic acid 4-methoxy-benzylamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-Benzyl-1-[(S)-5-guanidino-2-(2-naphthalen-1-yl-acetylamino)-pentanoyl]-pyrrolidine-2-carboxylic acid 4-methoxy-benzylamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401553",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 512,
    "edge_id": "psev_edge_142",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401553",
    "edge_subjectNode_name": "(2S,4R)-4-Benzyl-1-[(S)-5-guanidino-2-(2-naphthalen-1-yl-acetylamino)-pentanoyl]-pyrrolidine-2-carboxylic acid 4-methoxy-benzylamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-4-Benzyl-1-[(S)-5-guanidino-2-(2-naphthalen-1-yl-acetylamino)-pentanoyl]-pyrrolidine-2-carboxylic acid 4-methoxy-benzylamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_142",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 513,
    "edge_id": "inferred_143",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413968",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413968",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 513,
    "edge_id": "psev_edge_143",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413968",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_143",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413880",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 514,
    "edge_id": "inferred_144",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413880",
    "edge_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,4R)-1-((R)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413880",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 514,
    "edge_id": "psev_edge_144",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413880",
    "edge_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,4R)-1-((R)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_144",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pivaloyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394583",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 515,
    "edge_id": "inferred_145",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394583",
    "edge_subjectNode_name": "pivaloyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "pivaloyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "pivaloyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394583",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 515,
    "edge_id": "psev_edge_145",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394583",
    "edge_subjectNode_name": "pivaloyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "pivaloyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_145",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413970",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 516,
    "edge_id": "inferred_146",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413970",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413970",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 516,
    "edge_id": "psev_edge_146",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413970",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_146",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(3,4-dichlorophenyl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401285",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 517,
    "edge_id": "inferred_147",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401285",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(3,4-dichlorophenyl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(3,4-dichlorophenyl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(3,4-dichlorophenyl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401285",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 517,
    "edge_id": "psev_edge_147",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401285",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(3,4-dichlorophenyl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(3,4-dichlorophenyl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_147",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-3-(4-fluorophenyl)-2-(piperazin-1-yl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415920",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 518,
    "edge_id": "inferred_150",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415920",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-3-(4-fluorophenyl)-2-(piperazin-1-yl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((S)-4-((R)-3-(4-fluorophenyl)-2-(piperazin-1-yl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-3-(4-fluorophenyl)-2-(piperazin-1-yl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415920",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 518,
    "edge_id": "psev_edge_150",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415920",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-3-(4-fluorophenyl)-2-(piperazin-1-yl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((S)-4-((R)-3-(4-fluorophenyl)-2-(piperazin-1-yl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_150",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "picolinoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394690",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 519,
    "edge_id": "inferred_151",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394690",
    "edge_subjectNode_name": "picolinoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "picolinoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "picolinoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394690",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 519,
    "edge_id": "psev_edge_151",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394690",
    "edge_subjectNode_name": "picolinoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "picolinoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_151",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "hydrocinnamoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394694",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 520,
    "edge_id": "inferred_154",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394694",
    "edge_subjectNode_name": "hydrocinnamoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "hydrocinnamoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "hydrocinnamoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394694",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 520,
    "edge_id": "psev_edge_154",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394694",
    "edge_subjectNode_name": "hydrocinnamoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "hydrocinnamoyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_154",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:70684954",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 521,
    "edge_id": "inferred_155",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:70684954",
    "edge_subjectNode_name": "(2S)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:70684954",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 521,
    "edge_id": "psev_edge_155",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:70684954",
    "edge_subjectNode_name": "(2S)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_155",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401440",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 522,
    "edge_id": "inferred_158",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401440",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401440",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 522,
    "edge_id": "psev_edge_158",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401440",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-2-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_158",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-(3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416152",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 523,
    "edge_id": "inferred_159",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416152",
    "edge_subjectNode_name": "(S)-2-((S)-4-(3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((S)-4-(3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-(3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416152",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 523,
    "edge_id": "psev_edge_159",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416152",
    "edge_subjectNode_name": "(S)-2-((S)-4-(3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((S)-4-(3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_159",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(5-phenylpentanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394783",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 524,
    "edge_id": "inferred_160",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394783",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(5-phenylpentanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(5-phenylpentanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(5-phenylpentanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394783",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 524,
    "edge_id": "psev_edge_160",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394783",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(5-phenylpentanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(5-phenylpentanoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_160",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)acetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11846673",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 525,
    "edge_id": "inferred_163",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11846673",
    "edge_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)acetamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)acetamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11846673",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 525,
    "edge_id": "psev_edge_163",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11846673",
    "edge_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)acetamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)acetamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_163",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-nicotinamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394691",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 526,
    "edge_id": "inferred_166",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394691",
    "edge_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-nicotinamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-nicotinamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-nicotinamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394691",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 526,
    "edge_id": "psev_edge_166",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394691",
    "edge_subjectNode_name": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-nicotinamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[1-((S)-(S)-1-{1-[(S)-(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-nicotinamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_166",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413828",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 527,
    "edge_id": "inferred_169",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413828",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413828",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 527,
    "edge_id": "psev_edge_169",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413828",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2S,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_169",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenylpropanoylamino)pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401392",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 528,
    "edge_id": "inferred_170",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401392",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenylpropanoylamino)pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenylpropanoylamino)pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenylpropanoylamino)pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401392",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 528,
    "edge_id": "psev_edge_170",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401392",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenylpropanoylamino)pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-(3-phenylpropanoylamino)pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_170",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322987",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 529,
    "edge_id": "inferred_175",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322987",
    "edge_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "butanoyl-His-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322987",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 529,
    "edge_id": "psev_edge_175",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322987",
    "edge_subjectNode_name": "butanoyl-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "butanoyl-His-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_175",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845438",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 530,
    "edge_id": "inferred_176",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845438",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845438",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 530,
    "edge_id": "psev_edge_176",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845438",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_176",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413969",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 531,
    "edge_id": "inferred_179",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413969",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413969",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 531,
    "edge_id": "psev_edge_179",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413969",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_179",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-benzamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394734",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 532,
    "edge_id": "inferred_180",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394734",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-benzamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-benzamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-benzamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394734",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 532,
    "edge_id": "psev_edge_180",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394734",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-benzamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-benzamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_180",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413881",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 533,
    "edge_id": "inferred_181",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413881",
    "edge_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413881",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 533,
    "edge_id": "psev_edge_181",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413881",
    "edge_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_181",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Ala(F3)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 534,
    "edge_id": "inferred_182",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394584",
    "edge_subjectNode_name": "deamino-Ala(F3)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "deamino-Ala(F3)-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-Ala(F3)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394584",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 534,
    "edge_id": "psev_edge_182",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394584",
    "edge_subjectNode_name": "deamino-Ala(F3)-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "deamino-Ala(F3)-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_182",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415914",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 535,
    "edge_id": "inferred_183",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415914",
    "edge_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415914",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 535,
    "edge_id": "psev_edge_183",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415914",
    "edge_subjectNode_name": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-[(S)-4-{(R)-2-[(S)-2-acetylamino-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionyl}-3-(3-guanidino-propyl)-2-oxo-piperazin-1-yl]-N-methyl-3-naphthalen-2-yl-propionamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_183",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 536,
    "edge_id": "inferred_186",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413930",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413930",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 536,
    "edge_id": "psev_edge_186",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413930",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_186",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(prop-2-enylcarbamoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394733",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 537,
    "edge_id": "inferred_188",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394733",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(prop-2-enylcarbamoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(prop-2-enylcarbamoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(prop-2-enylcarbamoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394733",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 537,
    "edge_id": "psev_edge_188",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394733",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(prop-2-enylcarbamoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(prop-2-enylcarbamoylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_188",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845630",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 538,
    "edge_id": "inferred_189",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845630",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845630",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 538,
    "edge_id": "psev_edge_189",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845630",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2R,4S)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(4-hydroxyphenyl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_189",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "MeOAc-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 539,
    "edge_id": "inferred_192",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394586",
    "edge_subjectNode_name": "MeOAc-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "MeOAc-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "MeOAc-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394586",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 539,
    "edge_id": "psev_edge_192",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394586",
    "edge_subjectNode_name": "MeOAc-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "MeOAc-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_192",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(dimethoxyphosphinothioylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394750",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 540,
    "edge_id": "inferred_193",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394750",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(dimethoxyphosphinothioylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(dimethoxyphosphinothioylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(dimethoxyphosphinothioylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394750",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 540,
    "edge_id": "psev_edge_193",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394750",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(dimethoxyphosphinothioylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-(dimethoxyphosphinothioylamino)propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_193",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11847312",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 541,
    "edge_id": "inferred_196",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11847312",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11847312",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 541,
    "edge_id": "psev_edge_196",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11847312",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_196",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-guanidinoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416135",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 542,
    "edge_id": "inferred_199",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416135",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-guanidinoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-guanidinoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-guanidinoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416135",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 542,
    "edge_id": "psev_edge_199",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416135",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-guanidinoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-guanidinoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_199",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((R)-2-amino-3-(4-fluorophenyl)propanamido)-5-guanidino-N-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415972",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 543,
    "edge_id": "inferred_200",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415972",
    "edge_subjectNode_name": "(S)-2-((R)-2-amino-3-(4-fluorophenyl)propanamido)-5-guanidino-N-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((R)-2-amino-3-(4-fluorophenyl)propanamido)-5-guanidino-N-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((R)-2-amino-3-(4-fluorophenyl)propanamido)-5-guanidino-N-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415972",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 543,
    "edge_id": "psev_edge_200",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415972",
    "edge_subjectNode_name": "(S)-2-((R)-2-amino-3-(4-fluorophenyl)propanamido)-5-guanidino-N-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((R)-2-amino-3-(4-fluorophenyl)propanamido)-5-guanidino-N-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_200",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-hPhe-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394695",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 544,
    "edge_id": "inferred_202",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394695",
    "edge_subjectNode_name": "deamino-hPhe-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "deamino-hPhe-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "deamino-hPhe-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394695",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 544,
    "edge_id": "psev_edge_202",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394695",
    "edge_subjectNode_name": "deamino-hPhe-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "deamino-hPhe-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_202",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5R)-5-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]-6-phenylhexanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409339",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 545,
    "edge_id": "inferred_203",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409339",
    "edge_subjectNode_name": "(2R,5R)-5-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]-6-phenylhexanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,5R)-5-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]-6-phenylhexanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5R)-5-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]-6-phenylhexanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409339",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 545,
    "edge_id": "psev_edge_203",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409339",
    "edge_subjectNode_name": "(2R,5R)-5-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]-6-phenylhexanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,5R)-5-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]-6-phenylhexanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_203",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-phenylpyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401386",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 546,
    "edge_id": "inferred_204",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401386",
    "edge_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-phenylpyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-phenylpyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-phenylpyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401386",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 546,
    "edge_id": "psev_edge_204",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401386",
    "edge_subjectNode_name": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-phenylpyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-4-benzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]-N-phenylpyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_204",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-aminoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415991",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 547,
    "edge_id": "inferred_205",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415991",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-aminoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-aminoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-aminoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415991",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 547,
    "edge_id": "psev_edge_205",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415991",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-aminoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(2-aminoethyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_205",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413931",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 548,
    "edge_id": "inferred_206",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413931",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413931",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 548,
    "edge_id": "psev_edge_206",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413931",
    "edge_subjectNode_name": "(S)-2-acetamido-N1-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N1-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)pentanediamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_206",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-2-acetamido-N-[(2R)-1-[(2R,4S)-2-[3-(diaminomethylideneamino)propyl]-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-3-(1H-imidazol-5-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11847001",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 549,
    "edge_id": "inferred_207",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11847001",
    "edge_subjectNode_name": "(2S)-2-acetamido-N-[(2R)-1-[(2R,4S)-2-[3-(diaminomethylideneamino)propyl]-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-3-(1H-imidazol-5-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-2-acetamido-N-[(2R)-1-[(2R,4S)-2-[3-(diaminomethylideneamino)propyl]-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-3-(1H-imidazol-5-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-2-acetamido-N-[(2R)-1-[(2R,4S)-2-[3-(diaminomethylideneamino)propyl]-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-3-(1H-imidazol-5-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11847001",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 549,
    "edge_id": "psev_edge_207",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11847001",
    "edge_subjectNode_name": "(2S)-2-acetamido-N-[(2R)-1-[(2R,4S)-2-[3-(diaminomethylideneamino)propyl]-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-3-(1H-imidazol-5-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-2-acetamido-N-[(2R)-1-[(2R,4S)-2-[3-(diaminomethylideneamino)propyl]-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-3-(1H-imidazol-5-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_207",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845272",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 550,
    "edge_id": "inferred_209",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845272",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845272",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 550,
    "edge_id": "psev_edge_209",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845272",
    "edge_subjectNode_name": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_209",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413879",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 551,
    "edge_id": "inferred_211",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413879",
    "edge_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413879",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 551,
    "edge_id": "psev_edge_211",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413879",
    "edge_subjectNode_name": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,4R)-1-((R)-2-((S)-2-acetamido-3-(1H-imidazol-4-yl)propanamido)-3-phenylpropanoyl)-N-(2-guanidinoethyl)-4-(naphthalen-2-ylmethoxy)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_211",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-2-amino-N-[(2R)-1-cyclohexyl-5-(diaminomethylideneamino)pentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44453902",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 552,
    "edge_id": "inferred_212",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44453902",
    "edge_subjectNode_name": "(2R)-2-amino-N-[(2R)-1-cyclohexyl-5-(diaminomethylideneamino)pentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R)-2-amino-N-[(2R)-1-cyclohexyl-5-(diaminomethylideneamino)pentan-2-yl]-3-(4-fluorophenyl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-2-amino-N-[(2R)-1-cyclohexyl-5-(diaminomethylideneamino)pentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44453902",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 552,
    "edge_id": "psev_edge_212",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44453902",
    "edge_subjectNode_name": "(2R)-2-amino-N-[(2R)-1-cyclohexyl-5-(diaminomethylideneamino)pentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R)-2-amino-N-[(2R)-1-cyclohexyl-5-(diaminomethylideneamino)pentan-2-yl]-3-(4-fluorophenyl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_212",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401592",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 553,
    "edge_id": "inferred_214",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401592",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401592",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 553,
    "edge_id": "psev_edge_214",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401592",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(1H-indol-3-yl)acetyl]amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_214",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-2-amino-N-[(2R)-5-(diaminomethylideneamino)-1-phenylpentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:24882666",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 554,
    "edge_id": "inferred_216",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:24882666",
    "edge_subjectNode_name": "(2R)-2-amino-N-[(2R)-5-(diaminomethylideneamino)-1-phenylpentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R)-2-amino-N-[(2R)-5-(diaminomethylideneamino)-1-phenylpentan-2-yl]-3-(4-fluorophenyl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-2-amino-N-[(2R)-5-(diaminomethylideneamino)-1-phenylpentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:24882666",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 554,
    "edge_id": "psev_edge_216",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:24882666",
    "edge_subjectNode_name": "(2R)-2-amino-N-[(2R)-5-(diaminomethylideneamino)-1-phenylpentan-2-yl]-3-(4-fluorophenyl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R)-2-amino-N-[(2R)-5-(diaminomethylideneamino)-1-phenylpentan-2-yl]-3-(4-fluorophenyl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_216",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:70682904",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 555,
    "edge_id": "inferred_217",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:70682904",
    "edge_subjectNode_name": "(2R)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:70682904",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 555,
    "edge_id": "psev_edge_217",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:70682904",
    "edge_subjectNode_name": "(2R)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R)-N-(1H-indol-3-ylmethyl)-1-(naphthalen-1-ylmethyl)pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_217",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "then-3-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394736",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 556,
    "edge_id": "inferred_218",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394736",
    "edge_subjectNode_name": "then-3-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "then-3-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "then-3-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394736",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 556,
    "edge_id": "psev_edge_218",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394736",
    "edge_subjectNode_name": "then-3-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "then-3-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_218",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845440",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 557,
    "edge_id": "inferred_219",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845440",
    "edge_subjectNode_name": "N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-4-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-4-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845440",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 557,
    "edge_id": "psev_edge_219",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845440",
    "edge_subjectNode_name": "N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-4-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-((R)-1-((2R,4R)-2-(2-guanidinoethylcarbamoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)piperidine-4-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_219",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416060",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 558,
    "edge_id": "inferred_221",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416060",
    "edge_subjectNode_name": "N-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44416060",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 558,
    "edge_id": "psev_edge_221",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44416060",
    "edge_subjectNode_name": "N-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-((R)-3-(4-fluorophenyl)-1-((S)-2-(3-guanidinopropyl)-4-((S)-1-(methylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)-3-oxopiperazin-1-yl)-1-oxopropan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_221",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(R)-2-acetylamino-N-{(R)-1-benzyl-2-[(2S,4R)-4-benzyloxy-2-(3-guanidino-propyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-3-(4-hydroxy-phenyl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409103",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 559,
    "edge_id": "inferred_224",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409103",
    "edge_subjectNode_name": "(R)-2-acetylamino-N-{(R)-1-benzyl-2-[(2S,4R)-4-benzyloxy-2-(3-guanidino-propyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-3-(4-hydroxy-phenyl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(R)-2-acetylamino-N-{(R)-1-benzyl-2-[(2S,4R)-4-benzyloxy-2-(3-guanidino-propyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-3-(4-hydroxy-phenyl)-propionamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(R)-2-acetylamino-N-{(R)-1-benzyl-2-[(2S,4R)-4-benzyloxy-2-(3-guanidino-propyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-3-(4-hydroxy-phenyl)-propionamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409103",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 559,
    "edge_id": "psev_edge_224",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409103",
    "edge_subjectNode_name": "(R)-2-acetylamino-N-{(R)-1-benzyl-2-[(2S,4R)-4-benzyloxy-2-(3-guanidino-propyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-3-(4-hydroxy-phenyl)-propionamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(R)-2-acetylamino-N-{(R)-1-benzyl-2-[(2S,4R)-4-benzyloxy-2-(3-guanidino-propyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-3-(4-hydroxy-phenyl)-propionamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_224",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-malonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394660",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 560,
    "edge_id": "inferred_225",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394660",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-malonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-malonamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-malonamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394660",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 560,
    "edge_id": "psev_edge_225",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394660",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-malonamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(4-chloro-phenyl)-ethyl]-malonamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_225",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413938",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 561,
    "edge_id": "inferred_226",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413938",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44413938",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 561,
    "edge_id": "psev_edge_226",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44413938",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_226",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415912",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 562,
    "edge_id": "inferred_227",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415912",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44415912",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 562,
    "edge_id": "psev_edge_227",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44415912",
    "edge_subjectNode_name": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-((S)-4-((R)-2-amino-3-(4-fluorophenyl)propanoyl)-3-(3-guanidinopropyl)-2-oxopiperazin-1-yl)-N-methyl-3-(naphthalen-2-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_227",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cPrCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394581",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 563,
    "edge_id": "inferred_229",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394581",
    "edge_subjectNode_name": "cPrCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cPrCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cPrCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394581",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 563,
    "edge_id": "psev_edge_229",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394581",
    "edge_subjectNode_name": "cPrCO-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "cPrCO-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_229",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-piperidin-1-yl]-1-oxopropan-2-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:9867330",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 564,
    "edge_id": "inferred_230",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:9867330",
    "edge_subjectNode_name": "(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-piperidin-1-yl]-1-oxopropan-2-amine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-piperidin-1-yl]-1-oxopropan-2-amine treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-piperidin-1-yl]-1-oxopropan-2-amine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:9867330",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 564,
    "edge_id": "psev_edge_230",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:9867330",
    "edge_subjectNode_name": "(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-piperidin-1-yl]-1-oxopropan-2-amine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-piperidin-1-yl]-1-oxopropan-2-amine associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_230",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-yl-methoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845276",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 565,
    "edge_id": "inferred_235",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845276",
    "edge_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-yl-methoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-yl-methoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-yl-methoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845276",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 565,
    "edge_id": "psev_edge_235",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845276",
    "edge_subjectNode_name": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-yl-methoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-((R)-1-((2S,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-yl-methoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-phenylpropanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_235",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1089461",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1089461",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 566,
    "edge_id": "inferred_236",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1089461",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1089461",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "CHEMBL.COMPOUND:CHEMBL1089461 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1089461",
    "result_subjectNode_id": "CHEMBL.COMPOUND:CHEMBL1089461",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 566,
    "edge_id": "psev_edge_236",
    "edge_object": "MONDO:0015129",
    "edge_subject": "CHEMBL.COMPOUND:CHEMBL1089461",
    "edge_subjectNode_name": "CHEMBL.COMPOUND:CHEMBL1089461",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "CHEMBL.COMPOUND:CHEMBL1089461 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_236",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401573",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 567,
    "edge_id": "inferred_239",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401573",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44401573",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 567,
    "edge_id": "psev_edge_239",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44401573",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-phenylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_239",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "isobutyryl-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322986",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 568,
    "edge_id": "inferred_240",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322986",
    "edge_subjectNode_name": "isobutyryl-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "isobutyryl-His-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "isobutyryl-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322986",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 568,
    "edge_id": "psev_edge_240",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322986",
    "edge_subjectNode_name": "isobutyryl-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "isobutyryl-His-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_240",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845804",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 569,
    "edge_id": "inferred_242",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845804",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845804",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 569,
    "edge_id": "psev_edge_242",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845804",
    "edge_subjectNode_name": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(S)-2-acetamido-N-((R)-1-((2R,4R)-2-(3-guanidinopropyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-1-yl)-1-oxo-3-phenylpropan-2-yl)-3-(1H-imidazol-4-yl)propanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_242",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tic-D-Phe-Arg-2-Nal-NHCH3",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409257",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 570,
    "edge_id": "inferred_247",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409257",
    "edge_subjectNode_name": "Tic-D-Phe-Arg-2-Nal-NHCH3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Tic-D-Phe-Arg-2-Nal-NHCH3 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Tic-D-Phe-Arg-2-Nal-NHCH3",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409257",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 570,
    "edge_id": "psev_edge_247",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409257",
    "edge_subjectNode_name": "Tic-D-Phe-Arg-2-Nal-NHCH3",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Tic-D-Phe-Arg-2-Nal-NHCH3 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_247",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394784",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 571,
    "edge_id": "inferred_251",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394784",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394784",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 571,
    "edge_id": "psev_edge_251",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394784",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S)-3-(4-chlorophenyl)-2-[(5-oxo-5-phenylpentanoyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_251",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5R)-5-acetamido-6-(4-chlorophenyl)-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]hexanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409379",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 572,
    "edge_id": "inferred_256",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409379",
    "edge_subjectNode_name": "(2R,5R)-5-acetamido-6-(4-chlorophenyl)-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]hexanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2R,5R)-5-acetamido-6-(4-chlorophenyl)-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]hexanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2R,5R)-5-acetamido-6-(4-chlorophenyl)-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]hexanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409379",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 572,
    "edge_id": "psev_edge_256",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409379",
    "edge_subjectNode_name": "(2R,5R)-5-acetamido-6-(4-chlorophenyl)-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]hexanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2R,5R)-5-acetamido-6-(4-chlorophenyl)-N-[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-2-[(4-fluorophenyl)methyl]hexanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_256",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[(2-hydroxy-3-phenylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322787",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 573,
    "edge_id": "inferred_258",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322787",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[(2-hydroxy-3-phenylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[(2-hydroxy-3-phenylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[(2-hydroxy-3-phenylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322787",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 573,
    "edge_id": "psev_edge_258",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322787",
    "edge_subjectNode_name": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[(2-hydroxy-3-phenylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[(2-hydroxy-3-phenylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_258",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-1-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11308054",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 574,
    "edge_id": "inferred_260",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11308054",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-1-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-1-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-1-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11308054",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 574,
    "edge_id": "psev_edge_260",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11308054",
    "edge_subjectNode_name": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-1-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S,4R)-N,4-dibenzyl-1-[(2S)-5-(diaminomethylideneamino)-2-[(2-naphthalen-1-ylacetyl)amino]pentanoyl]pyrrolidine-2-carboxamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_260",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cPrCO-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322812",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 575,
    "edge_id": "inferred_262",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322812",
    "edge_subjectNode_name": "cPrCO-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "cPrCO-His-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "cPrCO-His-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44322812",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 575,
    "edge_id": "psev_edge_262",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44322812",
    "edge_subjectNode_name": "cPrCO-His-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "cPrCO-His-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_262",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "then-2-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394735",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 576,
    "edge_id": "inferred_264",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394735",
    "edge_subjectNode_name": "then-2-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "then-2-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "then-2-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394735",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 576,
    "edge_id": "psev_edge_264",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394735",
    "edge_subjectNode_name": "then-2-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "then-2-oyl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_264",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-2-[[(2R)-2-benzyl-4-[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]amino]-5-(diaminomethylideneamino)-N-[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409140",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 577,
    "edge_id": "inferred_270",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409140",
    "edge_subjectNode_name": "(2S)-2-[[(2R)-2-benzyl-4-[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]amino]-5-(diaminomethylideneamino)-N-[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "(2S)-2-[[(2R)-2-benzyl-4-[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]amino]-5-(diaminomethylideneamino)-N-[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]pentanamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "(2S)-2-[[(2R)-2-benzyl-4-[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]amino]-5-(diaminomethylideneamino)-N-[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]pentanamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44409140",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 577,
    "edge_id": "psev_edge_270",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44409140",
    "edge_subjectNode_name": "(2S)-2-[[(2R)-2-benzyl-4-[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]amino]-5-(diaminomethylideneamino)-N-[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]pentanamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "(2S)-2-[[(2R)-2-benzyl-4-[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]butanoyl]amino]-5-(diaminomethylideneamino)-N-[(2S)-1-(methylamino)-3-naphthalen-2-yl-1-oxopropan-2-yl]pentanamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_270",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(3-((2S,4R)-1-((R)-2-amino-3-phenylpropanoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-2-yl)propyl)guanidine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845813",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 578,
    "edge_id": "inferred_271",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845813",
    "edge_subjectNode_name": "1-(3-((2S,4R)-1-((R)-2-amino-3-phenylpropanoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-2-yl)propyl)guanidine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "1-(3-((2S,4R)-1-((R)-2-amino-3-phenylpropanoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-2-yl)propyl)guanidine treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "1-(3-((2S,4R)-1-((R)-2-amino-3-phenylpropanoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-2-yl)propyl)guanidine",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:11845813",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 578,
    "edge_id": "psev_edge_271",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:11845813",
    "edge_subjectNode_name": "1-(3-((2S,4R)-1-((R)-2-amino-3-phenylpropanoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-2-yl)propyl)guanidine",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "1-(3-((2S,4R)-1-((R)-2-amino-3-phenylpropanoyl)-4-(naphthalen-2-ylmethoxy)pyrrolidin-2-yl)propyl)guanidine associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_271",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fur-2-yl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 579,
    "edge_id": "inferred_272",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394689",
    "edge_subjectNode_name": "fur-2-yl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "fur-2-yl-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "fur-2-yl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394689",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 579,
    "edge_id": "psev_edge_272",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394689",
    "edge_subjectNode_name": "fur-2-yl-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "fur-2-yl-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_272",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-benzamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44323033",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 580,
    "edge_id": "inferred_274",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44323033",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-benzamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-benzamide treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-benzamide",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44323033",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 580,
    "edge_id": "psev_edge_274",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44323033",
    "edge_subjectNode_name": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-benzamide",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "N-[(S)-1-((S)-1-{(S)-1-[(S)-1-Carbamoyl-2-(1H-indol-3-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-(3H-imidazol-4-yl)-ethyl]-benzamide associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_274",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394625",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 581,
    "edge_id": "inferred_278",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394625",
    "edge_subjectNode_name": "Ac-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Ac-Phe(4-Cl)-Phe-Arg-Trp-NH2 treats Addison Disease",
    "primary_source": "infores:improving-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Ac-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:44394625",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 581,
    "edge_id": "psev_edge_278",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:44394625",
    "edge_subjectNode_name": "Ac-Phe(4-Cl)-Phe-Arg-Trp-NH2",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:associated_with",
    "phrase": "Ac-Phe(4-Cl)-Phe-Arg-Trp-NH2 associated with Addison Disease",
    "primary_source": "infores:spoke",
    "publications": "N/A",
    "publications_count": 0,
    "support_graph_id": "ag_278",
    "edge_type": "support"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prolactin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:168266256",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 582,
    "edge_id": "medik:creative_edge#222",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:168266256",
    "edge_subjectNode_name": "Prolactin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats",
    "phrase": "Prolactin treats Addison Disease",
    "primary_source": "infores:unsecret-agent",
    "publications": "N/A",
    "publications_count": 0,
    "edge_type": "primary"
  },
  {
    "pk": "pk-placeholder",
    "result_subjectNode_name": "Prolactin",
    "result_subjectNode_id": "PUBCHEM.COMPOUND:168266256",
    "result_objectNode_name": "Addison Disease",
    "result_objectNode_id": "MONDO:0015129",
    "result_counter": 582,
    "edge_id": "medik:edge#362",
    "edge_object": "MONDO:0015129",
    "edge_subject": "PUBCHEM.COMPOUND:168266256",
    "edge_subjectNode_name": "Prolactin",
    "edge_objectNode_name": "Addison Disease",
    "predicate": "biolink:treats_or_applied_or_studied_to_treat",
    "phrase": "Prolactin studied to treat Addison Disease",
    "primary_source": "infores:semmeddb",
    "publications": "PMID:10323386",
    "publications_count": 1,
    "support_graph_id": "medik:auxiliary_graph#222",
    "edge_type": "support"
  }
]
